Mass,MolecularFormula,KEGG_id,KEGG_name,KEGG_formula,KEGG_pathway,KEGG_module,KEGG_brite,KEGG_enzyme,KEGG_reaction
149.0243854,C8H6O3,cpd:C02137,alpha-Oxo-benzeneacetic acid;Benzoylformate;Benzoylformic acid;Phenylglyoxylic acid;Phenylglyoxylate;2-Oxo-2-phenylacetate,C8H6O3,Phenylalanine metabolism;Aminobenzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.379;1.1.1.-;1.1.99.31;1.2.1.58;3.1.2.25;4.1.1.7,R01764 R02450 R03790 R03792 R03793 R07294 R07664
149.0243854,C8H6O3,cpd:C03057,2-Carboxybenzaldehyde;Phthalaldehydic acid;o-Formylbenzoic acid;2-Formylbenzoic acid;2-Formylbenzoate,C8H6O3,Polycyclic aromatic hydrocarbon degradation;Microbial metabolism in diverse environments,NA,NA,1.2.1.78;4.1.2.34,R03465 R05643 R07713
149.0243854,C8H6O3,cpd:C10812,Piperonal,C8H6O3,NA,NA,NA,NA,NA
151.040039,C8H8O3,cpd:C00642,4-Hydroxyphenylacetate;4-Hydroxyphenylacetic acid,C8H8O3,Tyrosine metabolism;Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.2.1.5;1.2.1.29;1.2.1.39;1.2.1.53;1.2.3.13;1.14.13.18;1.14.14.9;4.1.1.83;6.2.1.-,R00042 R02514 R02516 R02695 R02697 R02698 R02699 R06790;R07312
151.040039,C8H8O3,cpd:C00755,4-Hydroxy-3-methoxy-benzaldehyde;Vanillin;Vanillaldehyde;4-Hydroxy-3-methoxybenzaldehyde,C8H8O3,Aminobenzoate degradation;Biosynthesis of various secondary metabolites - part 2;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments,NA,NA,1.1.3.38;1.2.1.67;1.2.3.9;1.11.1.16;1.13.11.43;1.13.11.88;2.6.1.119;4.1.2.61,R00043 R02877 R05273 R05699 R05773 R11503 R12302 R12566;R12622
151.040039,C8H8O3,cpd:C01983,(R)-Mandelate;(R)-2-Hydroxy-2-phenylacetic acid;(R)-2-Hydroxy-2-phenylacetate;(R)-Mandelic acid,C8H8O3,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; B BLOOD AND BLOOD FORMING ORGANS;  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;   B05C IRRIGATING SOLUTIONS;    B05CA Antiinfectives;     B05CA06 Mandelic acid;      C01983  (R)-Mandelate; J ANTIINFECTIVES FOR SYSTEMIC USE;  J01 ANTIBACTERIALS FOR SYSTEMIC USE;   J01X OTHER ANTIBACTERIALS;    J01XX Other antibacterials;     J01XX06 Mandelic acid;      C01983  (R)-Mandelate,1.1.1.379;3.5.1.86;5.1.2.2,R03790 R03791 R05783
151.040039,C8H8O3,cpd:C01984,(S)-Mandelate;(S)-2-Hydroxy-2-phenylacetic acid;(S)-2-Hydroxy-2-phenylacetate;(S)-Mandelic acid,C8H8O3,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; B BLOOD AND BLOOD FORMING ORGANS;  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;   B05C IRRIGATING SOLUTIONS;    B05CA Antiinfectives;     B05CA06 Mandelic acid;      C01984  (S)-Mandelate; J ANTIINFECTIVES FOR SYSTEMIC USE;  J01 ANTIBACTERIALS FOR SYSTEMIC USE;   J01X OTHER ANTIBACTERIALS;    J01XX Other antibacterials;     J01XX06 Mandelic acid;      C01984  (S)-Mandelate,1.1.1.-;1.1.99.31;1.14.16.6;5.1.2.2,R03791 R03792 R03793 R03794 R07664
151.040039,C8H8O3,cpd:C02181,Phenoxyacetate;Phenoxyacetic acid,C8H8O3,NA,NA,NA,NA,NA
151.040039,C8H8O3,cpd:C02519,4-Methoxybenzoate;4-Methoxybenzoic acid;4-Anisic acid,C8H8O3,Benzoate degradation;Degradation of aromatic compounds,NA,NA,1.14.99.15,R01306
151.040039,C8H8O3,cpd:C02639,3-Methoxytropolone,C8H8O3,NA,NA,NA,NA,NA
151.040039,C8H8O3,cpd:C02657,6-Methylsalicylate;6-Methylsalicylic acid;2-Hydroxy-6-methylbenzoic acid;6-Methyl-2-hydroxybenzenecarboxylate,C8H8O3,Biosynthesis of enediyne antibiotics;Metabolic pathways;Biosynthesis of secondary metabolites,"3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA",Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1301 Monocyclic aromatic polyketides;    C02657  6-Methylsalicylic acid,2.3.1.165;4.1.1.52;6.2.1.-,R03567 R07253 R11370
151.040039,C8H8O3,cpd:C03663,"2',4'-Dihydroxyacetophenone;2,4-Dihydroxyacetophenone;Resacetophenone",C8H8O3,NA,NA,NA,NA,NA
151.040039,C8H8O3,cpd:C04043,"3,4-Dihydroxyphenylacetaldehyde;Protocatechuatealdehyde",C8H8O3,Tyrosine metabolism;Isoquinoline alkaloid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Parkinson disease,NA,NA,1.2.1.5;1.2.1.29;1.2.1.39;1.4.3.4;1.4.3.21;1.4.3.-;1.4.9.2;4.1.1.107;4.2.1.78,R03300 R03302 R04084 R04300 R11916
151.040039,C8H8O3,cpd:C05593,3-Hydroxyphenylacetate;3-Hydroxyphenylacetic acid,C8H8O3,Tyrosine metabolism;Phenylalanine metabolism;Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.14.13.63;1.14.14.9,R02515 R02517 R03299 R06791
151.040039,C8H8O3,cpd:C05852,2-Hydroxyphenylacetate;2-Hydroxyphenylacetic acid,C8H8O3,Phenylalanine metabolism;Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.13.11.27;1.14.13.-;1.14.14.54,R01372 R05001 R05450 R05487
151.040039,C8H8O3,cpd:C10675,"3',4'-Dihydroxyacetophenone",C8H8O3,NA,NA,NA,NA,NA
151.040039,C8H8O3,cpd:C10804,2-(Hydroxymethyl)benzoic acid;2-Hydroxymethylbenzoic acid,C8H8O3,NA,NA,NA,NA,NA
151.040039,C8H8O3,cpd:C12064,Resorcinol monoacetate,C8H8O3,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; D DERMATOLOGICALS;  D10 ANTI-ACNE PREPARATIONS;   D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;    D10AX Other anti-acne preparations for topical use;     D10AX02 Resorcinol;      D02393  Resorcinol monoacetate (USP); S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01A ANTIINFECTIVES;    S01AX Other antiinfectives;     S01AX06 Resorcinol;      D02393  Resorcinol monoacetate (USP),NA,NA
151.040039,C8H8O3,cpd:C12305,Methyl salicylate;Methyl 2-hydroxybenzoate,C8H8O3,Biosynthesis of phenylpropanoids,NA,"Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  26  Epidermides;   264  Analgesics, anti-itchings, astringents, anti-inflammatory agents;    2641  Methyl salicylic acids;     D01087  Methyl salicylate (JP18/NF);Classification of Japanese OTC drugs [BR:br08313]; Agents for respiratory organs;  27 Gargles;   D01087  Methyl salicylate (JP18/NF); Agents for integumentary system;  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);   D01087  Methyl salicylate (JP18/NF);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Methyl salicylate;    D01087  Methyl salicylate (JP18/NF);Animal drugs in Japan [BR:br08331]; 95  Agents for external use;  953  Analgesics, anti-itchings, astringents and antiinflammatory agents;   9531  Methyl salicylate and preparations;    C12305  Methyl salicylate;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D01087  Methyl salicylate",2.1.1.274,R10448
151.040039,C8H8O3,cpd:C13635,"4-Hydroxyphenacyl alcohol;2,4'-Dihydroxyacetophenone",C8H8O3,Bisphenol degradation;Microbial metabolism in diverse environments,NA,NA,1.13.11.41;1.13.-.-,R01305 R06889
151.040039,C8H8O3,cpd:C13636,4-Hydroxyphenyl acetate,C8H8O3,Bisphenol degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.14.13.84;3.1.1.2,R06892 R06893
151.040039,C8H8O3,cpd:C14088,3-Methylsalicylate,C8H8O3,Naphthalene degradation;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.2.1.-;1.14.13.1,R06914 R06915
151.040039,C8H8O3,cpd:C14103,4-Methylsalicylate;m-Cresotic acid;2-Hydroxy-4-methylbenzoic acid,C8H8O3,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.14.13.1,R06938 R06939
151.040039,C8H8O3,cpd:C14108,4-Hydroxymethylsalicylaldehyde;2-Hydroxy-4-hydroxymethyl-benzaldehyde,C8H8O3,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.2.1.-;4.2.1.-,R06934 R06935
151.040039,C8H8O3,cpd:C17900,Menisdaurilide,C8H8O3,NA,NA,NA,NA,NA
151.040039,C8H8O3,cpd:C21167,4-Hydroxy-3-methylbenzoate;4-Hydroxy-m-toluate,C8H8O3,Toluene degradation;Microbial metabolism in diverse environments,NA,NA,1.2.1.96,R11195 R11196
157.05059,C7H10O4,cpd:C02631,2-Isopropylmaleate;beta-Isopropylmaleate,C7H10O4,"Valine, leucine and isoleucine biosynthesis;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism",NA,NA,4.2.1.33,R03968 R04001
157.05059,C7H10O4,cpd:C04670,"(1S,4S)-4-Hydroxy-3-oxocyclohexane-1-carboxylate",C7H10O4,NA,NA,NA,1.1.1.166,R05315
157.05059,C7H10O4,cpd:C04815,"5-D-(5/6)-5-C-(Hydroxymethyl)-2,6-dihydroxycyclohex-2-en-1-one;5D-(5/6)-5-C-(Hydroxymethyl)-2,6-dihydroxy-2-cyclohexen-1-one",C7H10O4,NA,NA,NA,4.3.3.1,R04367
157.05059,C7H10O4,cpd:C05126,"Dimethyl citraconate;Citraconic acid dimethyl ester;2-Butenedioic acid, 2-methyl-, dimethyl ester, (Z)-;Citraconate de dimethyle;Citraconic acid, dimethyl ester;Dimethyl methylmaleate;Methylmaleic acid, dimethyl ester",C7H10O4,NA,NA,NA,NA,NA
159.0298895,C6H8O5,cpd:C00322,2-Oxoadipate;2-Oxoadipic acid,C6H8O5,Lysine biosynthesis;Lysine degradation;Tryptophan metabolism;Methane metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine;Lysine degradation, lysine => saccharopine => acetoacetyl-CoA;Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate;2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   2-Oxocarboxylic acids;    C00322  2-Oxoadipate,1.1.1.87;1.1.1.172;1.1.1.286;1.2.4.2;1.5.1.-;1.8.1.4;2.3.1.61;2.3.3.-;2.6.1.39,R01932 R01933 R01934 R01936 R01937 R01938 R01939 R01940;R08331
159.0298895,C6H8O5,cpd:C00846,3-Oxoadipate;3-Oxoadipic acid;3-Keto-adipate,C6H8O5,Benzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Catechol ortho-cleavage, catechol => 3-oxoadipate",NA,1.3.1.32;2.8.3.6;3.1.1.24,R02988 R02989 R02990 R02991
159.0298895,C6H8O5,cpd:C04287,"3D-3,5/4-Trihydroxycyclohexane-1,2-dione;D-2,3-Diketo-4-deoxy-epi-inositol;(3R,4S,5R)-3,4,5-Trihydroxy-1,2-cyclohexanedione;3,5/4-Trihydroxycyclohexa-1,2-dione",C6H8O5,Inositol phosphate metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,3.7.1.22;4.2.1.44,R02782 R08603
159.0298895,C6H8O5,cpd:C06891,"D-2,3-Diketo 4-deoxy-epi-inositol;DKDI",C6H8O5,NA,NA,NA,NA,R05659
159.0298895,C6H8O5,cpd:C16159,2-Formylglutarate,C6H8O5,Nicotinate and nicotinamide metabolism;Microbial metabolism in diverse environments,NA,NA,1.1.1.291;3.5.2.18,R07984 R07985
159.0298895,C6H8O5,cpd:C20781,"2,4-Diketo-3-deoxy-L-fuconate;2,4-Diketo-3-deoxy-L-rhamnonate;2,4-Didehydro-3-deoxy-L-rhamnonate",C6H8O5,Fructose and mannose metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.401;1.1.1.-;3.7.1.26,R10690 R10691 R11339
159.0298895,C6H8O5,cpd:C22351,3-Dehydrolevoglucosan,C6H8O5,NA,NA,NA,1.1.1.425,R12713
159.0662487,C7H12O4,cpd:C02656,Pimelate;Pimelic acid;Heptanedioic acid;6-Carboxyhexanoate,C7H12O4,Biotin metabolism;Metabolic pathways;Biosynthesis of cofactors,"Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Dicarboxylic acids;    C02656  Pimelate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C02656  Heptanedioic acid,6.2.1.14,R03209
159.0662487,C7H12O4,cpd:C04687,"(1S,3R,4S)-3,4-Dihydroxycyclohexane-1-carboxylate",C7H12O4,NA,NA,NA,1.1.1.166,R05315
159.0662487,C7H12O4,cpd:C16657,2-Propylsuccinic acid;2-PSA,C7H12O4,Drug metabolism - cytochrome P450,NA,NA,NA,R08333
161.0455118,C6H10O5,cpd:C00478,Lichenin;Lichenan,C6H10O5,NA,NA,NA,NA,NA
161.0455118,C6H10O5,cpd:C01088,"(R)-3,3-Dimethylmalate",C6H10O5,Pantothenate and CoA biosynthesis,NA,NA,1.1.1.84;1.2.1.33,R01211 R03198
161.0455118,C6H10O5,cpd:C01989,3-Ethylmalate,C6H10O5,Glyoxylate and dicarboxylate metabolism,NA,NA,2.3.3.7,R01180
161.0455118,C6H10O5,cpd:C02360,2-Hydroxyadipate;2-Hydroxyadipic acid,C6H10O5,NA,NA,NA,1.1.1.172,R01932
161.0455118,C6H10O5,cpd:C02488,(R)-2-Ethylmalate,C6H10O5,Pyruvate metabolism,NA,NA,2.3.3.6,R00998
161.0455118,C6H10O5,cpd:C02991,"L-Rhamnono-1,4-lactone;L-Rhamno-1,4-lactone",C6H10O5,Fructose and mannose metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.173;1.1.1.377;1.1.1.378;3.1.1.65,R03772 R03942 R10788 R10995
161.0455118,C6H10O5,cpd:C03652,"(2R,3S)-2,3-Dimethylmalate",C6H10O5,Nicotinate and nicotinamide metabolism;Microbial metabolism in diverse environments,NA,NA,4.1.3.32;4.2.1.85,R01355 R03069
161.0455118,C6H10O5,cpd:C03761,3-Hydroxy-3-methylglutarate;3-Hydorxy-3-methylglutaric acid;beta-Hydroxy-beta-methylglutaric acid;Dicrotalic acid;3-Hydroxy-3-methylpentanedioic acid;Meglutol,C6H10O5,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C10 LIPID MODIFYING AGENTS;   C10A LIPID MODIFYING AGENTS, PLAIN;    C10AX Other lipid modifying agents;     C10AX05 Meglutol;      D04897  Meglutol (USAN/INN)",2.8.3.13;3.1.2.5,R02083 R02084
161.0455118,C6H10O5,cpd:C03827,2-Dehydro-3-deoxy-L-fuconate,C6H10O5,Fructose and mannose metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.-;4.2.1.68,R03688 R10690
161.0455118,C6H10O5,cpd:C03979,2-Dehydro-3-deoxy-L-rhamnonate,C6H10O5,Fructose and mannose metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.401;4.1.2.53;4.2.1.90,R02261 R03774 R11339
161.0455118,C6H10O5,cpd:C06158,"D-Fucono-1,4-lactone",C6H10O5,NA,NA,NA,NA,NA
161.0455118,C6H10O5,cpd:C06159,2-Dehydro-3-deoxy-D-fuconate,C6H10O5,NA,NA,NA,4.1.2.18;4.2.1.67,R03081 R03671
161.0455118,C6H10O5,cpd:C06474,"3,6-Anhydrogalactose;3,6-Anhydro-D-galactose",C6H10O5,NA,NA,"Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Aldoses;    C06474  3,6-Anhydrogalactose",NA,NA
161.0455118,C6H10O5,cpd:C06478,"3,6-Anhydroglucose;3,6-Anhydro-D-glucose",C6H10O5,NA,NA,"Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Aldoses;    C06478  3,6-Anhydroglucose",NA,NA
161.0455118,C6H10O5,cpd:C06485,"1,5-Anhydro-D-fructose",C6H10O5,NA,NA,NA,1.1.1.263;1.1.1.292;4.2.1.110;4.2.1.111,R05682 R08194 R09694 R09696
161.0455118,C6H10O5,cpd:C11592,Diethyl pyrocarbonate,C6H10O5,NA,NA,NA,NA,NA
161.0455118,C6H10O5,cpd:C16390,(S)-2-(Hydroxymethyl)glutarate,C6H10O5,Nicotinate and nicotinamide metabolism;Microbial metabolism in diverse environments,NA,NA,1.1.1.291,R07985 R07986
161.0455118,C6H10O5,cpd:C17209,2-Deoxy-scyllo-inosose;2-Deoxyinosose;2-Deoxy-L-scyllo-inosose,C6H10O5,"Neomycin, kanamycin and gentamicin biosynthesis;Biosynthesis of secondary metabolites",NA,NA,2.6.1.100;4.2.3.124,R08617 R08890
161.0455118,C6H10O5,cpd:C18028,"L-Fucono-1,5-lactone",C6H10O5,Fructose and mannose metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.122;3.1.1.-,R08926 R10689
161.0455118,C6H10O5,cpd:C20902,"3,6-Anhydro-alpha-L-galactopyranose",C6H10O5,NA,NA,NA,1.2.1.92,R10861 R10862
161.0455118,C6H10O5,cpd:C22311,3-Deoxyglucosone,C6H10O5,Diabetic cardiomyopathy,NA,NA,NA,NA
161.0455118,C6H10O5,cpd:C22350,"Levoglucosan;1,6-Anhydro-beta-D-glucopyranose",C6H10O5,NA,NA,NA,1.1.1.425;2.7.1.232,R12713 R12746
161.0818863,C7H14O4,cpd:C08234,"beta-Cymaropyranose;D-Cymarose;Cymarose;2,6-Dideoxy-3-O-methyl-D-ribo-hexose",C7H14O4,NA,NA,NA,NA,NA
161.0818863,C7H14O4,cpd:C08237,Oleandrose;beta-L-Oleandropyranose,C7H14O4,NA,NA,NA,NA,NA
165.0192912,C8H6O4,cpd:C01606,"Phthalate;o-Phthalic acid;1,2-Benzenedicarboxylic acid",C8H6O4,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;ABC transporters,"Phthalate degradation, phthalate => protocatechuate;Phthalate degradation, phthalate => protocatechuate",NA,1.2.1.78;1.3.1.19;1.11.1.19;1.14.12.7;1.14.12.-;3.5.1.79;3.7.1.-,R03630 R05167 R05643 R07703 R07802 R09227 R10915
165.0192912,C8H6O4,cpd:C03590,4-Hydroxyphenylglyoxylate;4-Hydroxybenzoylformate;4-Hydroxyphenylglyoxylic acid;2-(4-Hydroxyphenyl)-2-oxoacetate,C8H6O4,Monobactam biosynthesis;Aminobenzoate degradation;Biosynthesis of vancomycin group antibiotics;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments,NA,NA,1.1.3.46;1.1.99.31;2.6.1.72;2.6.1.103;4.1.1.7,R02672 R04160 R04234 R06626 R06633
165.0192912,C8H6O4,cpd:C06337,"Terephthalate;Terephthalic acid;1,4-Benzenedicarboxylic acid",C8H6O4,Polycyclic aromatic hydrocarbon degradation;Aminobenzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate",NA,1.14.12.15;3.1.1.102,R05148 R07835 R11541
165.0192912,C8H6O4,cpd:C14096,3-Formylsalicylic acid;2-Hydroxyisophthalaldehydic acid,C8H6O4,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.2.3.-;4.2.1.-,R06923 R06924
165.0192912,C8H6O4,cpd:C14100,4-Formylsalicylic acid;4-Formyl-2-hydroxybenzoic acid,C8H6O4,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,NA,R06929
165.0192912,C8H6O4,cpd:C22203,Isophthalate;Isophthalic acid,C8H6O4,NA,NA,NA,6.2.1.58,R12485
165.0556712,C9H10O3,cpd:C01198,3-(2-Hydroxyphenyl)propanoate;2-Hydroxyphenylpropanoate;3-(2-Hydroxyphenyl)propionic acid;Melilotate;3-(2-Hydroxyphenyl)propionate,C9H10O3,Phenylalanine metabolism;Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.3.1.11;1.14.13.4;3.1.1.35,R03369 R03692 R03709 R04899 R05537
165.0556712,C9H10O3,cpd:C01456,Tropate;Tropic acid;alpha-(Hydroxymethyl)phenylacetic acid,C9H10O3,"Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of secondary metabolites",NA,NA,3.1.1.10,R03563 R03564 R06744
165.0556712,C9H10O3,cpd:C01744,Phloretate;Phloretic acid;3-(4-Hydroxyphenyl)propanoate;3-(4-Hydroxyphenyl)propionic acid,C9H10O3,NA,NA,NA,1.3.8.15;3.7.1.4,R02901 R12534
165.0556712,C9H10O3,cpd:C02201,"Veratraldehyde;Veratric aldehyde;3,4-Dimethoxybenzaldehyde",C9H10O3,NA,NA,NA,1.11.1.14,R04461 R11501
165.0556712,C9H10O3,cpd:C02363,3-Ethoxybenzoate;3-Ethoxybenzoic acid,C9H10O3,NA,NA,NA,NA,NA
165.0556712,C9H10O3,cpd:C03080,4-Hydroxyhydratropate,C9H10O3,NA,NA,NA,NA,NA
165.0556712,C9H10O3,cpd:C05581,3-Methoxy-4-hydroxyphenylacetaldehyde;(4-Hydroxy-3-methoxyphenyl)acetaldehyde;Homovanillin,C9H10O3,Tyrosine metabolism;Metabolic pathways,NA,NA,1.2.1.5;1.4.3.4,R04888 R04889 R04890
165.0556712,C9H10O3,cpd:C05607,Phenyllactate;(R)-Phenyllactate;(R)-3-(phenyl)lactate,C9H10O3,"Phenylalanine metabolism;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Metabolic pathways",NA,NA,1.1.1.110;1.1.1.237;2.8.3.17,R01370 R01371 R07796
165.0556712,C9H10O3,cpd:C10712,Paeonol,C9H10O3,NA,NA,NA,NA,NA
165.0556712,C9H10O3,cpd:C11380,Apocynin;Acetovanillone,C9H10O3,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C11380  Apocynin",NA,NA
165.0556712,C9H10O3,cpd:C11457,3-(3-Hydroxyphenyl)propanoic acid;Dihydro-3-coumaric acid;3-Hydroxyphenylpropanoate;3-(3-Hydroxyphenyl)propanoate,C9H10O3,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.14.13.127,R06780 R06786
165.0556712,C9H10O3,cpd:C12206,Caffeyl alcohol,C9H10O3,Phenylpropanoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Caffeate derivatives;    C12206  Caffeyl alcohol,1.1.1.195;2.1.1.68,R06571 R06575 R06580
167.0349522,C8H8O4,cpd:C00544,"Homogentisate;Homogentisic acid;2,5-Dihydroxyphenylacetic acid;2,5-Dihydroxyphenylacetate",C8H8O4,Ubiquinone and other terpenoid-quinone biosynthesis;Tyrosine metabolism;Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors,"Tyrosine degradation, tyrosine => homogentisate;Tocopherol/tocotorienol biosynthesis, homogentisate + phytyl/geranylgeranyl-PP => tocopherol/tocotorienol;Plastoquinone biosynthesis, homogentisate + solanesyl-PP => plastoquinol",NA,1.13.11.5;1.13.11.27;1.13.12.-;1.14.13.18;1.14.13.63;1.14.13.-;2.5.1.115;2.5.1.116;2.5.1.117;4.1.1.-,R02514 R02515 R02516 R02517 R02518 R02519 R02520 R02521;R05450 R07500 R08782 R10708
167.0349522,C8H8O4,cpd:C01161,"3,4-Dihydroxyphenylacetate;3,4-Dihydroxyphenylacetic acid;Homoprotocatechuate",C8H8O4,Tyrosine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Dopaminergic synapse;Cocaine addiction;Amphetamine addiction;Alcoholism,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,1.2.1.5;1.2.1.29;1.2.1.39;1.13.11.15;1.14.12.9;1.14.14.9;2.1.1.6,R02698 R03299 R03300 R03302 R03303 R03304 R03306
167.0349522,C8H8O4,cpd:C01839,"Orsellinate;o-Orsellinic acid;2,4-Dihydroxy-6-methylbenzoic acid;2,4-Dihydroxy-6-methylbenzoate;4,6-Dihydroxy-o-toluic acid",C8H8O4,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1301 Monocyclic aromatic polyketides;    C01839  Orsellinic acid,3.1.1.40;4.1.1.58,R00054 R02831
167.0349522,C8H8O4,cpd:C03198,(S)-4-Hydroxymandelate;(S)-2-Hydroxy-2-(4-hydroxyphenyl)acetate;L-4-Hydroxymandelate;L-p-Hydroxymandelate,C8H8O4,Monobactam biosynthesis;Aminobenzoate degradation;Biosynthesis of vancomycin group antibiotics;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments,NA,NA,1.1.3.19;1.1.3.46;1.1.99.31;1.13.11.46;1.14.16.6;5.1.2.2,R02673 R03794 R04160 R04161 R06632 R06633
167.0349522,C8H8O4,cpd:C03235,4-Hydroxypheoxyacetate,C8H8O4,NA,NA,NA,NA,NA
167.0349522,C8H8O4,cpd:C05343,(R)-4-Hydroxymandelate,C8H8O4,Microbial metabolism in diverse environments,NA,NA,5.1.2.2,R04161
167.0349522,C8H8O4,cpd:C05577,"3,4-Dihydroxymandelaldehyde;3,4-Dihydroxyphenylglycolaldehyde",C8H8O4,Tyrosine metabolism;Metabolic pathways,NA,NA,1.1.1.1;1.2.1.5;1.4.3.4,R02532 R02919 R04880 R04882 R04883
167.0349522,C8H8O4,cpd:C06207,"2,6-Dihydroxyphenylacetate",C8H8O4,Phenylalanine metabolism,NA,NA,NA,R05001
167.0349522,C8H8O4,cpd:C06672,Vanillate;Vanillic acid;4-Hydroxy-3-methoxybenzoate;4-Hydroxy-3-methoxybenzoic acid,C8H8O4,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,NA,1.2.1.67;1.2.3.9;1.14.13.82;2.1.1.341;2.1.1.-;2.4.1.300,R05273 R05274 R05699 R07668 R09278 R10136 R10259 R10296;R10297
167.0349522,C8H8O4,cpd:C07087,"2-Hydroxy-6-oxoocta-2,4,7-trienoate",C8H8O4,Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.13.11.2;3.7.1.9,R05362 R05404
167.0349522,C8H8O4,cpd:C10331,"2,6-Dimethoxybenzoquinone;2,6-Dimetoxy-p-benzoquinone",C8H8O4,NA,NA,NA,NA,NA
167.0349522,C8H8O4,cpd:C11527,4-Hydroxymandelate;4-Hydroxymandelic acid,C8H8O4,NA,NA,NA,1.13.11.46,R05778
167.0349522,C8H8O4,cpd:C14109,4-Hydroxymethylsalicylate;2-Hydroxy-4-hydroxymethylbenzoic acid,C8H8O4,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.2.1.-;1.14.13.1,R06935 R06936
167.0349522,C8H8O4,cpd:C16215,"1,2-Dihydrophthalic acid;Cyclohexa-3,5-diene-1,2-dicarboxylate",C8H8O4,Polycyclic aromatic hydrocarbon degradation;Microbial metabolism in diverse environments,NA,NA,1.3.1.19,R07690 R07703
167.0349522,C8H8O4,cpd:C21895,2-Acetylphloroglucinol;Monoacetylphloroglucinol,C8H8O4,NA,NA,NA,2.3.1.272;3.7.1.24,R12087 R12392
169.014231,C7H6O5,cpd:C01424,"Gallate;Gallic acid;3,4,5-Trihydroxybenzoic acid;3,4,5-Trihydroxybenzoate;Pyrogallol-5-carboxylic acid",C7H6O5,Aminobenzoate degradation;Biosynthesis of phenylpropanoids;Microbial metabolism in diverse environments,NA,Phytochemical compounds [BR:br08003]; Others;  Tannins and galloyl derivatives;   Galloyl derivatives;    C01424  Gallate,1.13.11.3;1.13.11.8;1.13.11.57;2.1.1.341;2.4.1.136;3.1.1.20;4.1.1.59,R00053 R01637 R03247 R03297 R03549 R03550 R03551 R09271;R09565
169.014231,C7H6O5,cpd:C02236,4-Sulfobenzoate;4-Sulfobenzoic acid,C7H6O5S,Toluene degradation;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.2.1.62;1.14.12.8,R01636 R05272
171.012107,C7H8O3S,cpd:C06677,Toluene-4-sulfonate;Tosylate,C7H8O3S,Toluene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.14.12.14;1.14.13.-,R05281 R05294 R07663
171.102661,C9H16O3,cpd:C16322,9-Oxononanoic acid,C9H16O3,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C16322  9-Oxononanoic acid,NA,R07868
173.0455061,C7H10O5,cpd:C00493,"Shikimate;Shikimic acid;3,4,5-Trihydroxy-1-cyclohexenecarboxylic acid",C7H10O5,"Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors","Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",NA,1.1.1.25;1.1.1.282;1.1.5.8;2.3.1.133;2.7.1.71;3.1.1.-,R02412 R02413 R02415 R02416 R06847 R07433 R10701
173.0455061,C7H10O5,cpd:C04236,(2S)-2-Isopropyl-3-oxosuccinate;3-Carboxy-4-methyl-2-oxopentanoate;2-Oxo-4-methyl-3-carboxypentanoate,C7H10O5,"Valine, leucine and isoleucine biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism",NA,NA,1.1.1.85,R01652 R04426
173.0455061,C7H10O5,cpd:C16588,2-Oxopimelate;alpha-Ketopimelate;2-Oxoheptanedionic acid,C7H10O5,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   2-Oxocarboxylic acids;    C16588  2-Oxopimelate,1.1.1.-;2.3.3.-,R08214 R08332
173.0455061,C7H10O5,cpd:C17696,Valienone,C7H10O5,Acarbose and validamycin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,2.7.1.214;4.2.1.-,R11233 R11234
173.0455061,C7H10O5,cpd:C18307,2-Methyl-3-oxoadipate,C7H10O5,Toluene degradation;Microbial metabolism in diverse environments,NA,NA,1.3.1.32,R09224
173.0455061,C7H10O5,cpd:C18312,4-Methyl-3-oxoadipate,C7H10O5,Toluene degradation;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,3.1.1.-,R09226
173.0455061,C7H10O5,cpd:C21281,"Demethyl-4-deoxygadusol;2,3,5-Trihydroxy-5-(hydroxymethyl)cyclohex-2-en-1-one",C7H10O5,NA,NA,NA,4.2.3.154,R11326
173.0818846,C8H14O4,cpd:C08278,"Suberic acid;Cork acid;1,8-Octanedioic acid;Octanedioic acid;1,6-Hexanedicarboxylic acid",C8H14O4,NA,NA,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Dicarboxylic acids;    C08278  Suberate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C08278  Octanedioic acid,NA,NA
173.0818846,C8H14O4,cpd:C14570,Dimethyl adipate;Dimethyl hexanedioate,C8H14O4,NA,NA,NA,NA,NA
173.0818846,C8H14O4,cpd:C16658,2-Propylglutaric acid;2-PGA,C8H14O4,Drug metabolism - cytochrome P450,NA,NA,NA,R08334
173.0818846,C8H14O4,cpd:C19402,Dimethoxane,C8H14O4,NA,NA,NA,NA,NA
175.0611634,C7H12O5,cpd:C02123,3-Propylmalate,C7H12O5,Glyoxylate and dicarboxylate metabolism,NA,NA,2.3.3.12,R03040
175.0611634,C7H12O5,cpd:C02504,alpha-Isopropylmalate;(2S)-2-Isopropylmalate;(2S)-2-Hydroxy-2-isopropylsuccinic acid;2-Isopropylmalic acid;3-Carboxy-3-hydroxy-4-methylpentanoate;3-Carboxy-3-hydroxyisocaproate,C7H12O5,"Valine, leucine and isoleucine biosynthesis;Pyruvate metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids","Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",NA,2.3.3.13;4.2.1.33,R01213 R03968 R10170
175.0611634,C7H12O5,cpd:C03328,(R)-2-(n-Propyl)-malate,C7H12O5,NA,NA,NA,NA,NA
175.0611634,C7H12O5,cpd:C04411,"(2R,3S)-3-Isopropylmalate;3-Isopropylmalate;3-Carboxy-2-hydroxy-4-methylpentanoate;2-D-threo-Hydroxy-3-carboxy-isocaproate",C7H12O5,"Valine, leucine and isoleucine biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids","Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",NA,1.1.1.85;4.2.1.33,R04001 R04426 R10052 R10170
175.0611634,C7H12O5,cpd:C05994,"2-Propylmalate;2-Propylmalic acid;Malic acid, 2-propyl-",C7H12O5,Pyruvate metabolism,NA,NA,4.1.3.-,R05063
175.0611634,C7H12O5,cpd:C17210,2-(2'-Methylthio)ethylmalic acid;2-(2'-Methylthio)ethylmalate,C7H12O5S,Glucosinolate biosynthesis;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism,NA,NA,2.3.3.17;4.2.1.170,R08619 R08620
175.0611634,C7H12O5,cpd:C17212,3-(2'-Methylthio)ethylmalic acid;3-(2'-Methylthio)ethylmalate,C7H12O5S,Glucosinolate biosynthesis;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.-;4.2.1.170,R08620 R08621
175.0611634,C7H12O5,cpd:C21371,Validone,C7H12O5,NA,NA,NA,2.7.1.214,R11406
175.0975555,C8H16O4,cpd:C11917,L-Cladinose,C8H16O4,NA,NA,NA,NA,NA
175.0975555,C8H16O4,cpd:C18744,Metaldehyde,C8H16O4,NA,NA,Pesticides [BR:br08007]; Pesticides;  Others;   Molluscacide;    C18744  Metaldehyde,NA,NA
177.0556894,C10H10O3,cpd:C01624,"Vermelone;3,4-Dihydro-3,8-dihydroxy-1(2H)-naphthalenone",C10H10O3,NA,NA,NA,1.1.1.252,R03322
177.0556894,C10H10O3,cpd:C02666,Coniferyl aldehyde;Coniferaldehyde;4-Hydroxy-3-methoxycinnamaldehyde;Ferulaldehyde,C10H10O3,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Monolignol biosynthesis, phenylalanine/tyrosine => monolignol",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Coniferyl alcohol derivatives;    C02666  Coniferyl aldehyde,1.1.1.194;1.1.1.195;1.2.1.44;1.2.1.68;1.14.13.-;2.1.1.68,R02193 R02593 R05700 R05701 R06572 R06574
177.0556894,C10H10O3,cpd:C10667,3-Acetyl-6-methoxybenzaldehyde,C10H10O3,NA,NA,NA,NA,NA
177.0556894,C10H10O3,cpd:C14784,"1,2-Dihydroxy-3,4-epoxy-1,2,3,4-tetrahydronaphthalene",C10H10O3,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,R07016
177.0556894,C10H10O3,cpd:C20327,2-Oxo-4-phenylbutyric acid;2-Oxo-4-phenylbutanoic acid;2-Oxo-4-phenylbutanoate,C10H10O3,"Phenylalanine, tyrosine and tryptophan biosynthesis;Metabolic pathways;2-Oxocarboxylic acid metabolism",NA,NA,1.1.1.-;2.6.1.-,R10502 R10503
177.0556894,C10H10O3,cpd:C20646,(3S)-2-Oxo-3-phenylbutanoate;(3S)-beta-Methylphenylpyruvate,C10H10O3,NA,NA,NA,2.1.1.281;2.6.1.57;2.6.1.107,R10431 R10845
179.0349595,C9H8O4,cpd:C01179,3-(4-Hydroxyphenyl)pyruvate;4-Hydroxyphenylpyruvate;p-Hydroxyphenylpyruvic acid,C9H8O4,"Ubiquinone and other terpenoid-quinone biosynthesis;Monobactam biosynthesis;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Novobiocin biosynthesis;Isoquinoline alkaloid biosynthesis;Biosynthesis of various secondary metabolites - part 2;Biosynthesis of vancomycin group antibiotics;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors","Tyrosine biosynthesis, chorismate => HPP => tyrosine;Tyrosine degradation, tyrosine => homogentisate",NA,1.1.1.110;1.1.1.237;1.2.3.13;1.3.1.12;1.3.1.13;1.4.1.20;1.4.3.2;1.13.11.27;1.13.11.46;2.5.1.111;2.6.1.1;2.6.1.5;2.6.1.9;2.6.1.57;2.6.1.58;2.6.1.103;4.1.1.80;5.3.2.1,R00042 R00729 R00734 R01728 R01730 R02521 R03337 R03339;R03341 R03342 R05778 R06626 R06632 R06757 R09254 R09830
179.0349595,C9H8O4,cpd:C01197,"Caffeate;Caffeic acid;3,4-Dihydroxy-trans-cinnamate;trans-Caffeate;(2E)-3-(3,4-Dihydroxyphenyl)prop-2-enoate",C9H8O4,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites;Degradation of aromatic compounds,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Caffeate derivatives;    C01197  Caffeate,1.13.11.22;1.14.13.-;1.14.18.1;2.1.1.68;2.8.3.23;3.1.1.42;3.1.1.-;4.1.1.102;6.2.1.12,R01943 R02950 R02997 R03365 R03366 R03367 R07826 R10701;R11206
179.0349595,C9H8O4,cpd:C01405,Aspirin;Acetylsalicylic acid;2-Acetoxybenzenecarboxylic acid;Acetylsalicylate,C9H8O4,Bile secretion,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A01 STOMATOLOGICAL PREPARATIONS;   A01A STOMATOLOGICAL PREPARATIONS;    A01AD Other agents for local oral treatment;     A01AD05 Acetylsalicylic acid;      D00109  Aspirin (JP18/USP) &lt;JP&gt;; B BLOOD AND BLOOD FORMING ORGANS;  B01 ANTITHROMBOTIC AGENTS;   B01A ANTITHROMBOTIC AGENTS;    B01AC Platelet aggregation inhibitors excl. heparin;     B01AC06 Acetylsalicylic acid;      D00109  Aspirin (JP18/USP) &lt;JP&gt;; N NERVOUS SYSTEM;  N02 ANALGESICS;   N02B OTHER ANALGESICS AND ANTIPYRETICS;    N02BA Salicylic acid and derivatives;     N02BA01 Acetylsalicylic acid;      D00109  Aspirin (JP18/USP) &lt;JP&gt;;USP drug classification [BR:br08302]; Blood Products and Modifiers;  Platelet Modifying Agents;   Platelet Modifying Agents, Other;    Aspirin;     D00109  Aspirin (JP18/USP);Therapeutic category of drugs in Japan [BR:br08301]; 1  Agents affecting nervous system and sensory organs;  11  Agents affecting central nervous system;   114  Antipyretics and analgesics, anti-inflammatory agents;    1143  Salicylates;     D00109  Aspirin (JP18/USP); Aspalon (JAN); 3  Agents affecting metabolism;  33  Blood and body fluid agents;   339  Miscellaneous;    3399  Others;     D00109  Aspirin (JP18/USP); Aspalon (JAN);Classification of Japanese OTC drugs [BR:br08313]; Agents for nervous and sensory systems;  01 Cold remedy (oral use);   D00109  Aspirin (JP18/USP);  03 Antipyretic analgesic agents;   D00109  Aspirin (JP18/USP);Risk category of Japanese OTC drugs [BR:br08312]; Designated second-class OTC drugs;  Inorganic and organic chemicals;   Aspirin;    D00109  Aspirin (JP18/USP); Second-class OTC drugs;  Inorganic and organic chemicals;   Aspirin;    D00109  Aspirin (JP18/USP);Target-based classification of drugs [BR:br08310]; Enzymes;  Oxidoreductases (EC1);   Prostaglandin synthase;    PTGS1 (COX1);     D00109  Aspirin (JP18/USP) &lt;JP&gt;;    PTGS2 (COX2);     D00109  Aspirin (JP18/USP) &lt;JP&gt;;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00109  Aspirin;  D00109  Aspirin tablets;Rx-to-OTC switch list in the USA [br08315.html]; D00109",3.1.1.55,R02942
179.0349595,C9H8O4,cpd:C01481,"Caffeate;Caffeic acid;3,4-Dihydroxycinnamic acid",C9H8O4,NA,NA,NA,NA,NA
179.0349595,C9H8O4,cpd:C05350,2-Hydroxy-3-(4-hydroxyphenyl)propenoate;4-Hydroxy-enol-phenylpyruvate,C9H8O4,Tyrosine metabolism;Metabolic pathways,NA,NA,5.3.2.1,R03342
179.0349595,C9H8O4,cpd:C12623,"trans-2,3-Dihydroxycinnamate;(2E)-3-(2,3-Dihydroxyphenyl)prop-2-enoate",C9H8O4,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",NA,1.3.1.87;1.13.11.16;1.14.13.127,R06785 R06787 R06788
179.038358,C6H12O4S,cpd:C03089,5-Methylthio-D-ribose;S-Methyl-5-thio-D-ribose;5-(Methylsulfanyl)-D-ribose,C6H12O4S,Cysteine and methionine metabolism;Biosynthesis of plant secondary metabolites;Metabolic pathways,Methionine salvage pathway,NA,2.7.1.100;3.2.2.9;3.2.2.16,R01401 R04143
181.0142217,C8H6O5,cpd:C01853,"Stipitatate;Stipitatic acid;3,6-Dihydroxy-5-oxo-1,3,6-cycloheptatriene-1-carboxylic acid",C8H6O5,NA,NA,NA,4.1.1.60,R03739
181.0142217,C8H6O5,cpd:C06680,4-Hydroxyphthalate,C8H6O5,Polycyclic aromatic hydrocarbon degradation;Microbial metabolism in diverse environments,NA,NA,4.1.1.55,R05375
181.0142217,C8H6O5,cpd:C12325,"3,5-Dihydroxyphenylglyoxylate;2-(3,5-Dihydroxyphenyl)-2-oxoacetate",C8H6O5,Biosynthesis of vancomycin group antibiotics;Biosynthesis of secondary metabolites,NA,NA,1.13.11.80;2.6.1.103,R06624 R06634
181.0142217,C8H6O5,cpd:C14097,"2-Hydroxyisophthalic acid;2-Hydroxy-1,3-benzenedicarboxylic acid",C8H6O5,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.2.3.-;4.1.1.-,R06924 R06925
181.0142217,C8H6O5,cpd:C21168,"4-Hydroxyisophthalate;4-Hydroxy-1,3-benzenedicarboxylate",C8H6O5,Toluene degradation;Microbial metabolism in diverse environments,NA,NA,1.14.13.-,R11196 R11197 R11198
181.0506095,C9H10O4,cpd:C03672,3-(4-Hydroxyphenyl)lactate;4-Hydroxyphenyllactate;p-Hydroxyphenyllactate;2-Hydroxy-3-(4-hydroxyphenyl)propanoate,C9H10O4,NA,NA,NA,NA,NA
181.0506095,C9H10O4,cpd:C03964,(R)-3-(4-Hydroxyphenyl)lactate,C9H10O4,Ubiquinone and other terpenoid-quinone biosynthesis;Tyrosine metabolism;Metabolic pathways;Biosynthesis of secondary metabolites,NA,NA,1.1.1.110;1.1.1.237;2.8.3.17;4.2.1.-,R03337 R03339 R08766 R12492
181.0506095,C9H10O4,cpd:C04044,"3-(2,3-Dihydroxyphenyl)propanoate;2,3-Dihydroxyphenylpropanoate",C9H10O4,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.3.1.87;1.13.11.16;1.14.13.4;1.14.13.127,R03369 R04376 R06784 R06786
181.0506095,C9H10O4,cpd:C05582,Homovanillate;Homovanillic acid;3-Methoxy-4-hydroxyphenylacetate,C9H10O4,Tyrosine metabolism;Metabolic pathways;Dopaminergic synapse,NA,NA,1.2.1.5;2.1.1.6,R03304 R04888 R04889
181.0506095,C9H10O4,cpd:C05583,3-Methoxy-4-hydroxyphenylglycolaldehyde,C9H10O4,Tyrosine metabolism;Metabolic pathways,NA,NA,1.2.1.5;1.4.3.4,R04891 R04892 R04893 R04894
181.0506095,C9H10O4,cpd:C10447,"3,4-Dihydroxyphenylpropanoate;Dihydrocaffeic acid;3,4-Dihydroxyphenylpropionic acid;3-(3,4-Dihydroxyphenyl)propanoate",C9H10O4,Tyrosine metabolism,NA,NA,2.8.3.23;4.3.1.22,R08846 R08847 R11206
181.0506095,C9H10O4,cpd:C10680,"2',6'-Dihydroxy-4'-methoxyacetophenone;4-O-Methylphloracetophenone",C9H10O4,NA,NA,NA,NA,NA
181.0506095,C9H10O4,cpd:C12622,"cis-3-(3-Carboxyethenyl)-3,5-cyclohexadiene-1,2-diol;(2E)-3-(cis-5,6-Dihydroxycyclohexa-1,3-dien-1-yl)prop-2-enoate",C9H10O4,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",NA,1.3.1.87;1.14.12.19,R06783 R06785
181.0506095,C9H10O4,cpd:C20953,"3-[(4R)-4-Hydroxycyclohexa-1,5-dien-1-yl]-2-oxopropanoate",C9H10O4,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,"Bacilysin biosynthesis, prephenate => bacilysin",NA,4.1.1.100;5.3.3.19,R10934 R11065
181.0506095,C9H10O4,cpd:C21085,"3-[(1E,4R)-4-Hydroxycyclohex-2-en-1-ylidene]-2-oxopropanoate",C9H10O4,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,"Bacilysin biosynthesis, prephenate => bacilysin",NA,5.3.3.19,R11065 R11066
182.99346,C7H4O6,cpd:C03671,"2-Pyrone-4,6-dicarboxylate",C7H4O6,Benzoate degradation;Aminobenzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.312;1.13.11.3;1.13.11.8;1.13.11.-;3.1.1.57,R03549 R04277 R04278 R04279 R04280 R09274
182.99346,C7H4O6,cpd:C08476,"Chelidonic acid;4-Oxo-4H-pyran-2,6-dicarboxylic acid",C7H4O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Monocyclic gamma-pyrones;    C08476  Chelidonic acid,NA,NA
183.0298728,C8H8O5,cpd:C05580,"3,4-Dihydroxymandelate;3,4-Dihydroxymandelic acid;Dihydroxymandelic acid",C8H8O5,Tyrosine metabolism;Metabolic pathways,NA,NA,1.2.1.5;2.1.1.6,R04882 R04883 R04887
183.0298728,C8H8O5,cpd:C05616,3-O-Methylgallate;3-O-Methylgallic acid,C8H8O5,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,NA,1.13.11.8;1.13.11.-;2.1.1.341;2.1.1.-,R03551 R04280 R09270 R09271 R09272
183.0662671,C9H12O4,cpd:C04535,"7-Methyl-2-hydroxy-6-oxoocta-2,4-dienoate",C9H12O4,NA,NA,NA,NA,NA
183.0662671,C9H12O4,cpd:C05594,3-Methoxy-4-hydroxyphenylethyleneglycol,C9H12O4,Tyrosine metabolism;Metabolic pathways,NA,NA,2.1.1.6,R04881
183.0662671,C9H12O4,cpd:C06582,"2-Hydroxy-6-oxo-7-methylocta-2,4-dienoate",C9H12O4,Xylene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,3.7.1.-;4.1.1.-,R05364 R05377
183.0662671,C9H12O4,cpd:C10765,"Antiarol;3,4,5-Trimethoxyphenol",C9H12O4,NA,NA,NA,NA,NA
183.0662671,C9H12O4,cpd:C11456,"cis-3-(1-Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol",C9H12O4,NA,NA,NA,NA,NA
183.0662671,C9H12O4,cpd:C11588,"cis-3-(Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol;cis-3-(2-Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol;3-(cis-5,6-Dihydroxycyclohexa-1,3-dien-1-yl)propanoate",C9H12O4,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.3.1.87;1.14.12.19,R06782 R06784
185.009162,C7H6O6,cpd:C01163,"3-Carboxy-cis,cis-muconate;beta-Carboxy-cis,cis-muconate;cis,cis-Butadiene-1,2,4-tricarboxylate",C7H6O6,Benzoate degradation;Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.13.11.3;5.5.1.2;5.5.1.5,R01631 R03307 R03308
185.009162,C7H6O6,cpd:C01278,"2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate;5-Carboxy-2,5-dihydro-2-oxofuran-5-acetate;4-Carboxymuconolactone;gamma-Carboxymuconolactone",C7H6O6,Benzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,4.1.1.44;5.5.1.2,R03307 R03470
185.009162,C7H6O6,cpd:C02167,Maleylpyruvate;Maleylpyruvic acid;3-Maleylpyruvate,C7H6O6,Tyrosine metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.13.11.4;3.1.1.91;3.7.1.23;5.2.1.2;5.2.1.4,R02656 R03868 R10135 R11257
185.009162,C7H6O6,cpd:C02514,3-Fumarylpyruvate,C7H6O6,Tyrosine metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,3.7.1.5;3.7.1.20;5.2.1.2;5.2.1.4,R01085 R03868
185.009162,C7H6O6,cpd:C03666,"2-Carboxy-cis,cis-muconate",C7H6O6,NA,NA,NA,1.13.11.28,R01506
185.009162,C7H6O6,cpd:C04480,3-Carboxy-2-hydroxymuconate semialdehyde,C7H6O6,Benzoate degradation;Microbial metabolism in diverse environments,NA,NA,1.13.11.14;4.1.1.-,R01507 R02763
185.009162,C7H6O6,cpd:C04484,"4-Carboxy-2-hydroxymuconate semialdehyde;4-Carboxy-2-hydroxy-cis,cis-muconate 6-semialdehyde",C7H6O6,Benzoate degradation;Polycyclic aromatic hydrocarbon degradation;Aminobenzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.13.11.8;3.7.1.-,R01632 R04453 R04488 R04489
185.009162,C7H6O6,cpd:C04553,"3-Carboxy-2,5-dihydro-5-oxofuran-2-acetate;4-Carboxy-2,5-dihydro-2-oxofuran-5-acetate",C7H6O6,Benzoate degradation,NA,NA,5.5.1.5,R03308
185.009162,C7H6O6,cpd:C05375,"2-Hydroxy-2-hydropyrone-4,6-dicarboxylate",C7H6O6,Benzoate degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.1.1.312,R04278 R04279 R04489
185.0819076,C9H14O4,cpd:C14112,cis-2-Carboxycyclohexyl-acetic acid,C9H14O4,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,NA,R06900
185.1183343,C10H18O3,cpd:C02217,10-Oxodecanoate,C10H18O3,NA,NA,NA,1.1.1.66,R03886
185.1183343,C10H18O3,cpd:C11404,(3R)-6-Hydroxy-3-isopropenyl-heptanoate,C10H18O3,Limonene and pinene degradation;Degradation of aromatic compounds,NA,NA,3.1.1.83,R06390 R06394
185.1183343,C10H18O3,cpd:C11406,(5R)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,C10H18O3,Limonene and pinene degradation,NA,NA,3.1.1.83,R06391
185.1183343,C10H18O3,cpd:C11417,(3S)-6-Hydroxy-3-isopropenyl-heptanoate;6-Hydroxy-3-isopropenylheptanoate,C10H18O3,Limonene and pinene degradation,NA,NA,3.1.1.83,R06392 R06395
185.1183343,C10H18O3,cpd:C11420,(5S)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,C10H18O3,Limonene and pinene degradation,NA,NA,3.1.1.83,R06393
185.1183343,C10H18O3,cpd:C13945,2-Oxodecanoic acid;2-Oxodecanoate,C10H18O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C13945  2-Oxodecanoic acid,NA,NA
185.1183343,C10H18O3,cpd:C17620,"Epomediol;2,6-Dihydroxycineol",C10H18O3,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A05 BILE AND LIVER THERAPY;   A05B LIVER THERAPY, LIPOTROPICS;    A05BA Liver therapy;     A05BA05 Epomediol;      C17620  Epomediol",NA,NA
185.1183343,C10H18O3,cpd:C20714,3-Oxodecanoate,C10H18O3,NA,NA,NA,2.3.1.230,R10589
187.0070304,C7H8O4S,cpd:C06678,4-Sulfobenzyl alcohol;4-(Hydroxymethyl)benzenesulfonate,C7H8O4S,Toluene degradation;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.1.1.257;1.14.13.-,R05271 R05281
187.0247948,C7H8O6,cpd:C04002,"(Z)-But-1-ene-1,2,4-tricarboxylate;Homo-cis-aconitate;cis-Homoaconitate;(Z)-1,2,4-But-1-enetricarboxylic acid",C7H8O6,Lysine biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine;Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate;2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,4.2.1.36;4.2.1.114;4.2.1.-,R03444 R04371
187.0247948,C7H8O6,cpd:C04225,"(Z)-But-2-ene-1,2,3-tricarboxylate;cis-2-Methylaconitate",C7H8O6,Propanoate metabolism;Metabolic pathways,NA,NA,4.2.1.79;4.2.1.99;5.3.3.-,R04424 R04425 R11264
187.0247948,C7H8O6,cpd:C11514,(E)-3-(Methoxycarbonyl)pent-2-enedioate,C7H8O6,NA,NA,NA,2.1.1.144,R05763
187.0247948,C7H8O6,cpd:C11515,(E)-2-(Methoxycarbonylmethyl)butenedioate,C7H8O6,NA,NA,NA,2.1.1.145,R05764
187.0247948,C7H8O6,cpd:C16579,"trans-Homoaconitate;(E)-1,2,4-But-1-enetricarboxylic acid",C7H8O6,NA,NA,NA,NA,R08213
187.0247948,C7H8O6,cpd:C21250,2-Methyl-trans-aconitate,C7H8O6,Propanoate metabolism;Metabolic pathways,NA,NA,4.2.1.117;5.3.3.-,R11263 R11264
187.0611668,C8H12O5,cpd:C16589,2-Oxosuberate;2-Oxooctanedionic acid;alpha-Ketosuberate,C8H12O5,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   2-Oxocarboxylic acids;    C16589  2-Oxosuberate,1.1.1.-,R08215 R08328
187.0975585,C9H16O4,cpd:C08261,"Azelaic acid;Nonanedioic acid;1,7-Heptanedicarboxylic acid",C9H16O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C08261  Nonanedioic acid;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; D DERMATOLOGICALS;  D10 ANTI-ACNE PREPARATIONS;   D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;    D10AX Other anti-acne preparations for topical use;     D10AX03 Azelaic acid;      D03034  Azelaic acid (USAN/INN) &lt;US&gt;;USP drug classification [BR:br08302]; Dermatological Agents;  Acne and Rosacea Agents;   Acne and Rosea, Other;    Azelaic Acid;     D03034  Azelaic acid (USAN/INN)",NA,NA
187.0975585,C9H16O4,cpd:C17878,Eucommiol,C9H16O4,NA,NA,NA,NA,NA
187.1339488,C10H20O3,cpd:C02774,10-Hydroxydecanoic acid;10-Hydroxydecanoate,C10H20O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C02774  4-Hydroxybutanoic acid;    C02774  10-Hydroxydecanoic acid,1.1.1.66,R03886
187.1339488,C10H20O3,cpd:C18067,"6-Hydroxy-3,7-dimethyloctanoate",C10H20O3,NA,NA,NA,3.1.1.83,R08979
189.0404294,C7H10O6,cpd:C00944,3-Dehydroquinate;3-Dehydroquinic acid;5-Dehydroquinate;5-Dehydroquinic acid,C7H10O6,"Phenylalanine, tyrosine and tryptophan biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids","Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",NA,1.1.1.24;1.1.1.282;1.1.5.8;1.4.1.24;4.2.1.10;4.2.3.4,R01872 R01873 R03083 R03084 R06846 R08569 R09322
189.0404294,C7H10O6,cpd:C04049,4-Hydroxy-4-methyl-2-oxoadipate,C7H10O6,NA,NA,NA,NA,NA
189.0404294,C7H10O6,cpd:C05601,4-Hydroxy-2-oxo-heptanedioate;4-Hydroxy-2-ketopimelate;4-Hydroxy-2-oxoheptanedioic acid;4-Hydroxy-2-oxoheptanedioate,C7H10O6,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C05601  4-Hydroxy-2-oxo-heptandioic acid;   FA0117 Dicarboxylic acids;    C05601  4-Hydroxy-2-oxoheptanedioic acid,4.1.2.52;4.2.1.-,R01645 R04131 R04895
189.0404294,C7H10O6,cpd:C06201,"2,4-Dihydroxyhept-2-enedioate;2,4-Dihydroxyhept-2-1,7-dioate;2,4-Dihydroxyhept-2-enedioic acid",C7H10O6,Tyrosine metabolism;Metabolic pathways;Microbial metabolism in diverse environments,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C06201  2,4-Dihydroxyhept-2-enedioc acid",4.1.2.52;4.2.1.-,R01647 R04132 R06897
189.0404294,C7H10O6,cpd:C17695,2-Keto-5-epi-valiolone,C7H10O6,Acarbose and validamycin biosynthesis;Biosynthesis of secondary metabolites,NA,NA,NA,R11253 R11254
189.055705,C11H10O3,cpd:C11052,7-Ethoxycoumarin,C11H10O3,NA,NA,NA,NA,NA
189.055705,C11H10O3,cpd:C14105,"1,2-Dihydroxy-7-hydroxymethylnaphthalene",C11H10O3,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.3.1.29;1.13.-.-,R06931 R06932
189.055705,C11H10O3,cpd:C15102,"1,2,3,4-Tetrahydro-4-oxo-1-naphthoic acid",C11H10O3,NA,NA,NA,NA,NA
189.055705,C11H10O3,cpd:C17916,Coixinden A,C11H10O3,NA,NA,NA,NA,NA
189.0768259,C8H14O5,cpd:C04546,(R)-3-((R)-3-Hydroxybutanoyloxy)butanoate,C8H14O5,Butanoate metabolism;Metabolic pathways,NA,NA,3.1.1.22;3.1.1.75,R00048 R05118
189.0768259,C8H14O5,cpd:C17214,2-(3'-Methylthio)propylmalic acid;2-(3'-Methylthio)propylmalate,C8H14O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,2.3.3.17;4.2.1.170,R08623 R08624
189.0768259,C8H14O5,cpd:C17215,3-(3'-Methylthio)propylmalic acid;3-(3'-Methylthio)propylmalate,C8H14O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.-;4.2.1.170,R08624 R08625
191.0197048,C6H8O7,cpd:C00158,"Citrate;Citric acid;2-Hydroxy-1,2,3-propanetricarboxylic acid;2-Hydroxytricarballylic acid",C6H8O7,"Citrate cycle (TCA cycle);Alanine, aspartate and glutamate metabolism;Glyoxylate and dicarboxylate metabolism;Carbon fixation pathways in prokaryotes;Biosynthesis of various secondary metabolites - part 3;Biosynthesis of siderophore group nonribosomal peptides;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of terpenoids and steroids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of alkaloids derived from histidine and purine;Biosynthesis of alkaloids derived from terpenoid and polyketide;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors;Two-component system;Taste transduction;Glucagon signaling pathway;Central carbon metabolism in cancer","Citrate cycle (TCA cycle, Krebs cycle);Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate;Glyoxylate cycle;Reductive citrate cycle (Arnon-Buchanan cycle);Methylaspartate cycle","Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Tricarboxylic acids;    C00158  Citrate;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A09 DIGESTIVES, INCL. ENZYMES;   A09A DIGESTIVES, INCL. ENZYMES;    A09AB Acid preparations;     A09AB04 Citric acid;      D00037  Citric acid, anhydrous (USP);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Anhydrous citric acid;    D00037  Citric acid, anhydrous (USP);Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00037  Anhydrous citric acid",2.3.3.1;2.3.3.3;2.3.3.8;2.3.3.16;2.8.3.10;4.1.3.6;4.2.1.3;6.2.1.18;6.3.1.17;6.3.2.38;6.3.2.54;6.3.2.57;6.3.2.58;6.3.2.-,R00351 R00352 R00362 R01322 R01323 R01324 R01325 R10090;R10677 R12308 R12353 R12354 R12596
191.0197048,C6H8O7,cpd:C00311,"Isocitrate;Isocitric acid;1-Hydroxytricarballylic acid;1-Hydroxypropane-1,2,3-tricarboxylic acid",C6H8O7,"Citrate cycle (TCA cycle);Glyoxylate and dicarboxylate metabolism;Carbon fixation pathways in prokaryotes;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of terpenoids and steroids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of alkaloids derived from histidine and purine;Biosynthesis of alkaloids derived from terpenoid and polyketide;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors;Glucagon signaling pathway;Central carbon metabolism in cancer","Citrate cycle (TCA cycle, Krebs cycle);Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate;Glyoxylate cycle;Reductive citrate cycle (Arnon-Buchanan cycle);Methylaspartate cycle",Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Tricarboxylic acids;    C00311  Isocitrate,1.1.1.41;1.1.1.42;1.1.1.286;2.3.1.126;4.1.3.1;4.2.1.3,R00267 R00479 R00709 R01324 R01899 R01900 R01946
191.0197048,C6H8O7,cpd:C00451,"(1R,2S)-1-Hydroxypropane-1,2,3-tricarboxylate;D-threo-Isocitric acid",C6H8O7,NA,NA,NA,5.1.2.6,R02318
191.0197048,C6H8O7,cpd:C00679,"5-Dehydro-4-deoxy-D-glucarate;(2R,3S)-2,3-Dihydroxy-5-oxohexanedioate",C6H8O7,Ascorbate and aldarate metabolism;Metabolic pathways,NA,NA,4.1.2.20;4.2.1.40;4.2.1.41;4.2.1.42;4.2.1.156;5.5.1.27,R02279 R02752 R02754 R05608 R10847 R11075 R11083
191.0197048,C6H8O7,cpd:C02780,"2,5-Didehydro-D-gluconate;2,5-Diketogluconic acid",C6H8O7,NA,NA,NA,1.1.1.215;1.1.1.274;1.1.1.346;1.1.99.4,R05823 R07153 R08878 R08879
191.0197048,C6H8O7,cpd:C03600,Carboxymethyloxysuccinate;(Carboxymethoxy) succinic acid,C6H8O7,NA,NA,NA,4.2.99.12,R01336
191.0197048,C6H8O7,cpd:C03921,2-Dehydro-3-deoxy-D-glucarate,C6H8O7,Ascorbate and aldarate metabolism;Metabolic pathways,NA,NA,4.1.2.20;4.2.1.40,R03277 R08056
191.0197048,C6H8O7,cpd:C04575,"(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate;2,3-Diketo-L-gulonate",C6H8O7,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Metabolic pathways,NA,NA,1.1.1.130;3.1.1.17;4.1.1.-,R02637 R02639 R04515 R04784 R04785
191.0197048,C6H8O7,cpd:C04617,"(1S,2S)-1-Hydroxypropane-1,2,3-tricarboxylate;D-erythro-Isocitric acid",C6H8O7,NA,NA,NA,5.1.2.6,R02318
191.0197048,C6H8O7,cpd:C20889,"D-Galactaro-1,5-lactone",C6H8O7,Ascorbate and aldarate metabolism;Metabolic pathways,NA,NA,1.1.1.203;5.4.1.4,R10841 R10846
191.0197048,C6H8O7,cpd:C20890,"D-Glucaro-1,5-lactone",C6H8O7,NA,NA,NA,1.1.1.203,R10842
191.0197048,C6H8O7,cpd:C20896,"D-Galactaro-1,4-lactone",C6H8O7,Ascorbate and aldarate metabolism;Metabolic pathways,NA,NA,5.4.1.4;5.5.1.27,R10846 R10847
191.0197048,C6H8O7,cpd:C21091,"(2S,3R)-2,3-Dihydroxy-5-oxohexanedioate;3-Deoxy-D-threo-hex-2-ulosarate",C6H8O7,NA,NA,NA,4.2.1.158,R11077
191.0197048,C6H8O7,cpd:C21095,"D-Glucaro-1,4-lactone",C6H8O7,NA,NA,NA,5.5.1.27,R11083
191.0349544,C10H8O4,cpd:C01752,Scopoletin;7-Hydroxy-6-methoxy-2H-chromen-2-one,C10H8O4,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C01752  Scopoletin,1.14.11.60;2.4.1.128,R03594 R11550 R12222
191.0349544,C10H8O4,cpd:C03830,"3,4-Dehydro-6-hydroxymellein",C10H8O4,NA,NA,NA,NA,NA
191.0349544,C10H8O4,cpd:C04033,"1,3,6,8-Naphthalenetetrol;1,3,6,8-Tetrahydroxynaphthalene",C10H8O4,NA,NA,NA,1.1.1.252;2.3.1.233,R02906 R10965
191.0349544,C10H8O4,cpd:C06203,trans-o-Hydroxybenzylidenepyruvate;(3E)-4-(2-Hydroxyphenyl)-2-oxobut-3-enoate,C10H8O4,Naphthalene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Naphthalene degradation, naphthalene => salicylate",NA,4.1.2.45;5.99.1.4,R05136 R05137
191.0349544,C10H8O4,cpd:C06204,2-Hydroxychromene-2-carboxylate;2-Hydroxy-2H-chromene-2-carboxylate,C10H8O4,Naphthalene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Naphthalene degradation, naphthalene => salicylate",NA,1.13.11.56;5.99.1.4,R04117 R05137
191.0349544,C10H8O4,cpd:C10290,Acamelin,C10H8O4,NA,NA,NA,NA,NA
191.0349544,C10H8O4,cpd:C16913,Anemonin;Pulsatilla camphor,C10H8O4,NA,NA,Phytochemical compounds [BR:br08003]; Others;  Others;   Others;    C16913  Anemonin,NA,NA
191.0349544,C10H8O4,cpd:C18077,Methylenedioxycinnamic acid;MDCA,C10H8O4,NA,NA,NA,NA,NA
191.0349544,C10H8O4,cpd:C18079,Isoscopoletin,C10H8O4,NA,NA,NA,NA,NA
191.0349544,C10H8O4,cpd:C20462,"5,7-Dihydroxy-2-methyl-4H-chromen-4-one",C10H8O4,NA,NA,NA,2.3.1.216,R10238
191.0349544,C10H8O4,cpd:C21414,"Naphthalene-1,2,4,8-tetrol",C10H8O4,NA,NA,NA,1.17.3.4,R11495 R11496
191.0560833,C7H12O6,cpd:C00296,Quinate;Quinic acid;Kinic acid;Chinic acid;L-Quinic acid;L-Quinate;(-)-Quinic acid,C7H12O6,"Phenylalanine, tyrosine and tryptophan biosynthesis;Metabolic pathways",NA,NA,1.1.1.24;1.1.1.282;1.1.5.8;2.3.1.98;2.3.1.99;2.3.1.133;3.1.1.42,R01872 R01873 R01945 R02195 R02997 R02998 R06846 R07432;R09322
191.0560833,C7H12O6,cpd:C01295,"2D-5-O-Methyl-2,3,5/4,6-pentahydroxycyclohexanone;5D-5-O-Methyl-2,3,5/4,6-pentahydroxycyclohexanone;D-5-O-Methyl-2,3,5/4,6-pentahydroxycyclohexanone",C7H12O6,NA,NA,NA,1.1.1.142;1.1.1.143,R03497 R03498
191.0560833,C7H12O6,cpd:C12113,Valiolone,C7H12O6,NA,NA,NA,NA,NA
191.0560833,C7H12O6,cpd:C17691,"2-epi-5-epi-Valiolone;(2S,3S,4S,5R)-2,3,4,5-Tetrahydroxy-5-(hydroxymethyl)cyclohexan-1-one",C7H12O6,Acarbose and validamycin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose;Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,2.7.1.188;4.2.3.152;5.1.3.33,R10937 R11079 R11185
191.0560833,C7H12O6,cpd:C17694,5-epi-Valiolone,C7H12O6,Acarbose and validamycin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,4.2.1.-;5.1.3.33,R11079 R11233 R11253
191.0560833,C7H12O6,cpd:C21282,"2-epi-Valiolone;(2S,3S,4S,5S)-2,3,4,5-Tetrahydroxy-5-(hydroxymethyl)cyclohexan-1-one",C7H12O6,NA,NA,NA,4.2.3.155,R11327
191.071324,C11H12O3,cpd:C10435,Carpacin,C11H12O3,NA,NA,NA,NA,NA
191.071324,C11H12O3,cpd:C10480,Myristicin,C11H12O3,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Others;    C10480  Myristicin,NA,NA
191.071324,C11H12O3,cpd:C10493,Sarisan,C11H12O3,NA,NA,NA,NA,NA
191.071324,C11H12O3,cpd:C12343,Isoshinanolone,C11H12O3,NA,NA,NA,NA,NA
191.071324,C11H12O3,cpd:C14104,"cis-1,2-Dihydroxy-1,2-dihydro-7-hydroxymethylnaphthalene",C11H12O3,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.3.1.29;1.14.12.12,R06930 R06931
191.071324,C11H12O3,cpd:C16896,Nakitriol,C11H12O3,NA,NA,NA,NA,NA
191.071324,C11H12O3,cpd:C17840,Dehydrozingerone,C11H12O3,NA,NA,NA,NA,NA
191.071324,C11H12O3,cpd:C20465,Coumaryl acetate,C11H12O3,Phenylpropanoid biosynthesis,NA,NA,1.1.1.318;1.1.1.319;2.3.1.-,R10249 R10254 R10289
193.035344,C6H10O7,cpd:C00191,D-Glucuronate;Glucuronic acid;Glucuronate,C6H10O7,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Amino sugar and nucleotide sugar metabolism;Inositol phosphate metabolism;Metabolic pathways;Biosynthesis of cofactors,"Glucuronate pathway (uronate pathway);D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P;Ascorbate biosynthesis, animals, glucose-1P => ascorbate",Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C00191  D-Glucuronic acid;Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Sodium glucuronate hydrate;    C00191  D-Glucuronate,1.1.1.2;1.1.1.19;1.1.1.203;1.13.99.1;1.-.-.-;2.4.1.17;2.7.1.43;3.1.1.19;3.1.1.93;3.2.1.31;3.2.1.56;3.2.1.139;3.2.1.167;5.3.1.12,R01184 R01476 R01478 R01480 R01481 R01482 R01483 R01484;R04512 R04979 R06143 R07818 R08127 R08260 R08615 R09447;R09533 R10134 R10830 R10842
193.035344,C6H10O7,cpd:C00333,D-Galacturonate;D-Galacturonic acid,C6H10O7,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Amino sugar and nucleotide sugar metabolism;Metabolic pathways;Biosynthesis of cofactors;ABC transporters,"Pectin degradation;D-Galacturonate degradation (fungi), D-galacturonate => glycerol;D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P",Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C00333  D-Galacturonic acid,1.1.1.203;1.1.1.365;1.1.1.-;2.7.1.44;3.1.3.-;3.2.1.15;3.2.1.67;5.3.1.12,R01980 R01981 R01982 R01983 R01984 R04320 R06201 R07413;R07676 R10565 R10841 R12661
193.035344,C6H10O7,cpd:C00558,D-Tagaturonate;D-Tagaturonic acid,C6H10O7,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Inositol phosphate metabolism;Metabolic pathways,"D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P",Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C00558  D-Tagaturonic acid,1.1.1.58;1.1.1.414;5.1.2.7;5.1.-.-;5.3.1.12,R01983 R02555 R11624 R11772 R12146
193.035344,C6H10O7,cpd:C00618,3-Dehydro-L-gulonate,C6H10O7,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Metabolic pathways,Glucuronate pathway (uronate pathway),NA,1.1.1.45;1.1.1.130;2.7.1.53;4.1.1.34,R01905 R02637 R02639 R02640 R07127
193.035344,C6H10O7,cpd:C00905,D-Fructuronate;D-Fructuronic acid,C6H10O7,Pentose and glucuronate interconversions;Metabolic pathways,"D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P",Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C00905  D-Fructuronic acid,1.1.1.57;1.1.1.380;5.1.2.7;5.3.1.12,R01482 R02454 R10848 R11624
193.035344,C6H10O7,cpd:C01062,5-Dehydro-D-gluconate;5-Dehydrogluconate,C6H10O7,NA,NA,NA,1.1.1.69;1.1.1.215;1.1.1.264;1.1.1.366,R01738 R01740 R05683 R05684 R08879
193.035344,C6H10O7,cpd:C02024,D-Mannuronate;D-Mannuronic acid,C6H10O7,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C02024  D-Mannuronic acid,1.1.1.131,R02455 R02456
193.035344,C6H10O7,cpd:C03342,2-Dehydro-D-galactonate,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C06472,L-Iduronic acid,C6H10O7,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C06472  L-Iduronic acid,3.2.1.76,R07813 R07822
193.035344,C6H10O7,cpd:C06473,2-Keto-D-gluconic acid;2-Dehydro-D-gluconate;2-Dehydro-D-gluconic acid;alpha-D-arabino-2-Hexulosonic acid,C6H10O7,Pentose phosphate pathway;Metabolic pathways;Microbial metabolism in diverse environments,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C06473  2-Keto-D-gluconic acid,1.1.1.215;1.1.1.274;1.1.99.3;1.1.99.4;2.7.1.13,R01739 R01741 R01742 R02658 R02659 R05823 R07153
193.035344,C6H10O7,cpd:C06477,L-Guluronic acid,C6H10O7,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C06477  L-Guluronic acid,NA,NA
193.035344,C6H10O7,cpd:C08348,Galacturonic acid,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C08350,beta-D-Glucopyranuronic acid;beta-D-Glucuronic acid,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C15673,2-Dehydro-L-idonate;2-Dehydro-L-idonic acid;L-Sorbosonate;L-Sorbosonic acid;2-Keto-L-gulonate;2-Keto-L-gulonic acid;L-xylo-Hex-2-ulosonic acid;L-Ketoidonate;L-Ketoidonic acid,C6H10O7,NA,NA,NA,1.1.1.215;1.1.1.274;1.1.1.346,R08878 R08880
193.035344,C6H10O7,cpd:C16245,D-Glucuronic acid,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C21034,L-Altruronic acid;L-Altropyranuronic acid,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C21037,D-Alluronic acid;D-Allopyranuronic acid,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C21047,D-Guluronic acid;D-Gulopyranuronic acid,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C21059,D-Taluronic acid;D-Talopyranuronic acid,C6H10O7,NA,NA,NA,NA,NA
193.035344,C6H10O7,cpd:C21644,5-Dehydro-L-gluconate;5-Keto-L-gluconate,C6H10O7,Inositol phosphate metabolism;Metabolic pathways,NA,NA,3.7.1.-;5.1.-.-,R11771 R11772
193.0506185,C10H10O4,cpd:C00779,"Scytalone;3,4-Dihydro-3,6,8-trihydoroxy-1(2H)-napthalenone",C10H10O4,NA,NA,NA,1.1.1.252;4.2.1.94,R02906 R02907
193.0506185,C10H10O4,cpd:C01494,Ferulate;Ferulic acid;4-Hydroxy-3-methoxycinnamic acid;3-Methoxy-4-hydroxy-trans-cinnamate;4-Hydroxy-3-methoxycinnamate,C10H10O4,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Coniferyl alcohol derivatives;    C01494  Ferulate,1.2.1.68;1.14.13.-;2.1.1.68;2.4.1.120;2.4.1.126;3.1.1.73;3.5.1.71;4.1.1.102;6.2.1.12;6.2.1.34,R02194 R03366 R03579 R05700 R05701 R05744 R07292 R07440;R08839 R11071
193.0506185,C10H10O4,cpd:C02379,6-Hydroxymellein,C10H10O4,NA,NA,NA,2.1.1.108,R03934
193.0506185,C10H10O4,cpd:C09974,"2,4,8-Trihydroxy-1-tetralone",C10H10O4,NA,NA,NA,NA,NA
193.0506185,C10H10O4,cpd:C10470,Isoferulic acid,C10H10O4,NA,NA,NA,NA,NA
193.0506185,C10H10O4,cpd:C10477,Methyl caffeate,C10H10O4,NA,NA,NA,NA,NA
193.0506185,C10H10O4,cpd:C11233,Dimethyl phthalate,C10H10O4,NA,NA,"Pesticides [BR:br08007]; Pesticides;  Others;   Insect repellents;    C11233  Dimethyl phthalate;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;  P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS;   P03B INSECTICIDES AND REPELLENTS;    P03BX Other insecticides and repellents;     P03BX02 Dimethylphthalate;      C11233  Dimethyl phthalate",NA,NA
193.0506185,C10H10O4,cpd:C12204,5-Hydroxyconiferaldehyde,C10H10O4,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Monolignol biosynthesis, phenylalanine/tyrosine => monolignol",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C12204  5-Hydroxyconiferaldehyde,1.1.1.195;1.2.1.44;1.14.13.-;2.1.1.68,R06569 R06570 R06572 R06576
193.0506185,C10H10O4,cpd:C16982,Kakuol;Kakoul,C10H10O4,NA,NA,NA,NA,NA
193.0869794,C11H14O3,cpd:C17497,Zingerone;Zingiberone;Vanillylacetone;[0]-Paradol,C11H14O3,NA,NA,Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Others;   Zingiber derived compounds;    C17497  Zingerone,NA,NA
193.0869794,C11H14O3,cpd:C20342,Isobutylparaben;Isobutyl parahydroxybenzoate,C11H14O3,NA,NA,NA,NA,NA
195.0298806,C9H8O5,cpd:C04045,"3-(3,4-Dihydroxyphenyl)pyruvate;3,4-Dihydroxyphenylpyruvate",C9H8O5,Tyrosine metabolism;Metabolic pathways,NA,NA,1.1.1.237;1.13.12.15;2.6.1.49,R02077 R03373 R08920 R12252
195.051013,C6H12O7,cpd:C00257,D-Gluconic acid;D-Gluconate;D-gluco-Hexonic acid,C6H12O7,Pentose phosphate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism,"Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P;Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate;Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C00257  D-Gluconic acid;Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Calcium gluconate;    C00257  D-Gluconic acid,1.1.1.69;1.1.1.215;1.1.99.3;2.4.1.321;2.7.1.12;3.1.1.17;4.2.1.39;4.2.1.140,R01519 R01538 R01737 R01738 R01739 R01740 R01741 R01742;R10832
195.051013,C6H12O7,cpd:C00514,D-Mannonate,C6H12O7,Pentose and glucuronate interconversions;Metabolic pathways,"D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P",NA,1.1.1.57;1.1.1.131;4.2.1.8,R02454 R02455 R02456 R05606
195.051013,C6H12O7,cpd:C00770,L-Idonate,C6H12O7,NA,NA,NA,1.1.1.215;1.1.1.264;1.1.1.366,R05683 R05684 R08880
195.051013,C6H12O7,cpd:C00800,L-Gulonate;L-Gulonic acid;Gulonate;Gulonic acid,C6H12O7,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Metabolic pathways;Biosynthesis of cofactors,"Glucuronate pathway (uronate pathway);Ascorbate biosynthesis, animals, glucose-1P => ascorbate",NA,1.1.1.2;1.1.1.19;1.1.1.45;1.1.1.380;3.1.1.17;3.1.1.25,R01481 R02640 R02933 R10848
195.051013,C6H12O7,cpd:C00817,D-Altronate,C6H12O7,Pentose and glucuronate interconversions;Metabolic pathways,"D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P",NA,1.1.1.58;4.2.1.7,R01540 R02555
195.051013,C6H12O7,cpd:C00880,D-Galactonate;D-Galactonic acid,C6H12O7,Galactose metabolism;Metabolic pathways;Microbial metabolism in diverse environments,"Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate;D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P;Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,1.1.3.9;3.1.1.25;4.2.1.6;4.2.1.140,R01098 R03033 R03034 R10604
195.051013,C6H12O7,cpd:C03215,2-Carboxy-D-arabinitol,C6H12O7,NA,NA,NA,3.1.3.63,R04167
195.051013,C6H12O7,cpd:C15930,L-Galactonate;L-Galactonic acid,C6H12O7,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Metabolic pathways;Biosynthesis of cofactors,"D-Galacturonate degradation (fungi), D-galacturonate => glycerol",NA,1.1.1.365;1.1.1.414;1.1.1.-;3.1.1.-;4.2.1.146,R07676 R07680 R10532 R10565 R12146 R12155
195.0662555,C10H12O4,cpd:C06580,"2,3-Dihydroxy-p-cumate",C10H12O4,Xylene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,1.3.1.58;1.13.11.-,R05240 R05248
195.0662555,C10H12O4,cpd:C07351,"Phlorisobutyrophenone;2-Methyl-1-(2,4,6-trihydroxyphenyl)-1-propanone",C10H12O4,NA,NA,NA,2.3.1.156,R11584
195.0662555,C10H12O4,cpd:C10664,Acetosyringone,C10H12O4,NA,NA,NA,NA,NA
195.0662555,C10H12O4,cpd:C10684,"2',6'-Dimethoxy-4'-hydroxyacetophenone",C10H12O4,NA,NA,NA,NA,NA
195.0662555,C10H12O4,cpd:C10726,Xanthoxylin,C10H12O4,NA,NA,NA,NA,NA
195.0662555,C10H12O4,cpd:C12205,5-Hydroxyconiferyl alcohol,C10H12O4,Phenylpropanoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C12205  5-Hydroxyconiferyl alcohol,1.1.1.195;1.11.1.7;1.11.1.21;1.14.13.-;2.1.1.68,R06570 R06573 R06577 R07443
195.0662555,C10H12O4,cpd:C16778,Cantharidin,C10H12O4,NA,NA,NA,NA,NA
195.0662555,C10H12O4,cpd:C17455,Paeonilactone B,C10H12O4,NA,NA,NA,NA,NA
195.1390285,C12H20O2,cpd:C08486,"Ethyl(E,Z)-decadienoate;(2E,4Z)-2,4-Decadienoic acid, ethyl ester;Ethyl trans-2,cis-4-decadienoate",C12H20O2,NA,NA,NA,NA,NA
195.1390285,C12H20O2,cpd:C09837,"(1S,2R,4S)-(-)-Bornyl acetate",C12H20O2,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010212 Bicyclic monoterpenoids;     C09837  (1S,2R,4S)-(-)-Bornyl acetate;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Cyclic monoterpenes;    C09837  (1S,2R,4S)-(-)-Bornyl acetate",NA,NA
195.1390285,C12H20O2,cpd:C09861,Geranyl acetate,C12H20O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Linear monoterpenes;    C09861  Geranyl acetate,NA,NA
195.1390285,C12H20O2,cpd:C09863,Linalyl acetate,C12H20O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010201 Acyclic monoterpenoids;     C09863  Linalyl acetate;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Linear monoterpenes;    C09863  Linalyl acetate,NA,NA
195.1390285,C12H20O2,cpd:C11338,"Bornyl acetate;(1R,2S,4R)-(+)-Bornyl acetate",C12H20O2,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010212 Bicyclic monoterpenoids;     C11338  Bornyl acetate;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Cyclic monoterpenes;    C11338  (1R,2S,4R)-(+)-Bornyl acetate",2.3.1.69,R08532
195.1390285,C12H20O2,cpd:C12300,alpha-Terpinyl acetate;p-Menth-1-en-8-yl acetate,C12H20O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010209 Menthane monoterpenoids;     C12300  alpha-Terpinyl acetate;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Cyclic monoterpenes;    C12300  alpha-Terpinyl acetate,NA,NA
195.1390285,C12H20O2,cpd:C12301,"beta-Terpinyl acetate;Cyclohexanol, 1-methyl-4-(1-methylethenyl)-, 1-acetate",C12H20O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010209 Menthane monoterpenoids;     C12301  beta-Terpinyl acetate;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Cyclic monoterpenes;    C12301  beta-Terpinyl acetate,NA,NA
195.1390285,C12H20O2,cpd:C12302,"gamma-Terpinyl acetate;Cyclohexanol, 1-methyl-4-(1-methylethylidene)-, 1-acetate;p-Menth-4-en-1-yl acetate",C12H20O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010209 Menthane monoterpenoids;     C12302  gamma-Terpinyl acetate;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Cyclic monoterpenes;    C12302  gamma-Terpinyl acetate,NA,NA
195.1390285,C12H20O2,cpd:C12306,Allyl cyclohexylpropionate;2-Propenyl 3-cyclohexylpropanoate,C12H20O2,NA,NA,NA,NA,NA
197.0091324,C8H6O6,cpd:C03223,"3,4-Dihydroxyphthalate;3,4-Dihydroxyphthalic acid",C8H6O6,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Phthalate degradation, phthalate => protocatechuate",NA,1.3.1.-;4.1.1.69,R01634 R09228
197.0091324,C8H6O6,cpd:C03233,"4,5-Dihydroxyphthalate;4,5-Dihydroxyphthalic acid",C8H6O6,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Phthalate degradation, phthalate => protocatechuate",NA,1.3.1.64;4.1.1.55,R01635 R05275
197.0455262,C9H10O5,cpd:C01207,"3-(3,4-Dihydroxyphenyl)lactate;3,4-Dihydroxyphenyllactic acid",C9H10O5,NA,NA,NA,NA,NA
197.0455262,C9H10O5,cpd:C05584,3-Methoxy-4-hydroxymandelate;Vanillylmandelic acid,C9H10O5,Tyrosine metabolism;Metabolic pathways,NA,NA,1.2.1.5;2.1.1.6,R04887 R04891 R04892
197.0455262,C9H10O5,cpd:C10833,"Syringic acid;Syringate;4-Hydroxy-3,5-dimethoxybenzoate;Gallic acid 3,5-dimethyl ether",C9H10O5,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,NA,2.1.1.-,R09270
197.0455262,C9H10O5,cpd:C21086,"(3E)-3-[(1R,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]-2-oxopropanoate;Epoxy-3E-H2HPP",C9H10O5,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,"Bacilysin biosynthesis, prephenate => bacilysin",NA,NA,R11066 R11067
197.0455262,C9H10O5,cpd:C22038,"(R)-3-(3,4-Dihydroxyphenyl)lactate",C9H10O5,Tyrosine metabolism;Metabolic pathways,NA,NA,1.1.1.237;2.3.1.140,R03373 R03374 R08847 R12252
197.081905,C10H14O4,cpd:C06579,"cis-2,3-Dihydroxy-2,3-dihydro-p-cumate;cis-5,6-Dihydroxy-4-isopropylcyclohexa-1,3-dienecarboxylate;(2R,3S)-2,3-Dihydroxy-2,3-dihydro-p-cumate",C10H14O4,Xylene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,1.3.1.58;1.14.12.25,R05240 R05247
197.081905,C10H14O4,cpd:C09853,"1,2-Dihydroxymint lactone",C10H14O4,NA,NA,NA,NA,NA
197.081905,C10H14O4,cpd:C16644,"1-(3,4-Dimethoxyphenyl)ethane-1,2-diol",C10H14O4,NA,NA,NA,1.11.1.14,R04461
197.081905,C10H14O4,cpd:C17454,Paeonilactone A,C10H14O4,NA,NA,NA,NA,NA
197.081905,C10H14O4,cpd:C20789,"7-Deoxyloganetate;(1S,4aS,7S,7aR)-1-Hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate",C10H14O4,Monoterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,NA,1.14.14.161;2.4.1.323,R10834 R12182 R12230
198.9884145,C7H4O7,cpd:C20209,Meconic acid;Poppy acid,C7H4O7,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Monocyclic gamma-pyrones;    C20209  Meconic acid,NA,NA
199.0247649,C8H8O6,cpd:C01036,4-Maleylacetoacetate;4-Maleylacetoacetic acid,C8H8O6,Tyrosine metabolism;Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments,"Tyrosine degradation, tyrosine => homogentisate",NA,1.13.11.5;5.2.1.2,R02519 R03181
199.0247649,C8H8O6,cpd:C01061,4-Fumarylacetoacetate;4-Fumarylacetoacetic acid;Fumarylacetoacetate,C8H8O6,Tyrosine metabolism;Styrene degradation;Metabolic pathways;Microbial metabolism in diverse environments,"Tyrosine degradation, tyrosine => homogentisate",NA,3.7.1.2;5.2.1.2,R01364 R03181
199.0247649,C8H8O6,cpd:C04642,2-Hydroxy-5-carboxymethylmuconate semialdehyde;5-Carboxymethyl-2-hydroxymuconate semialdehyde;5-Carboxymethyl-2-hydroxymuconic semialdehyde,C8H8O6,Tyrosine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,1.1.1.312;1.2.1.60;1.13.11.15,R03303 R04418 R04419
199.0247649,C8H8O6,cpd:C04783,"cis-4,5-Dihydroxycyclohexa-1(6),2-diene-1,2-dicarboxylate;Phthalate-4,5-cis-dihydrodiol",C8H8O6,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Phthalate degradation, phthalate => protocatechuate",NA,1.3.1.64;1.14.12.7,R03630 R05275
199.0247649,C8H8O6,cpd:C05592,3-Carboxymethylmuconate,C8H8O6,NA,NA,NA,NA,NA
199.0247649,C8H8O6,cpd:C06318,"(3S,4R)-3,4-Dihydroxycyclohexa-1,5-diene-1,4-dicarboxylate;(1R,6S)-Dihydroxycyclohexa-2,4-diene-1,4-dicarboxylate;Terephthalate-1,2-cis-dihydrodiol;cis-4,5-Dihydroxycyclohexa-1(6),2-diene-1,4-dicarboxylate",C8H8O6,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate",NA,1.3.1.53;1.14.12.15,R01633 R05148
199.0247649,C8H8O6,cpd:C18314,"Phthalate 3,4-cis-dihydrodiol",C8H8O6,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Phthalate degradation, phthalate => protocatechuate",NA,1.3.1.-;1.14.12.-,R09227 R09228
199.0611766,C9H12O5,cpd:C21087,"3-[(1R,2S,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-2-oxopropanoate;Epoxy-4S-H4HPP",C9H12O5,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,"Bacilysin biosynthesis, prephenate => bacilysin",NA,NA,R11067 R11068
200.9863265,C7H6O5S,cpd:C02236,4-Sulfobenzoate;4-Sulfobenzoic acid,C7H6O5S,Toluene degradation;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.2.1.62;1.14.12.8,R01636 R05272
201.0404478,C8H10O6,cpd:C20581,cis-(Homo)2-aconitate,C8H10O6,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,4.2.1.114,R10392 R10393
201.076832,C9H14O5,cpd:C04067,"Diethyl 2-methyl-3-oxosuccinate;Diethyl oxalpropionate;Butanedioic acid, 2-methyl-3-oxo-, 1,4-diethyl ester",C9H14O5,NA,NA,NA,1.1.1.229,R04387
201.1132042,C10H18O4,cpd:C08277,Sebacic acid;Decanedioic acid,C10H18O4,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C08277  Decanedioic acid,NA,NA
201.1132042,C10H18O4,cpd:C14566,Diethyl adipate;Diethyl hexanedioate,C10H18O4,NA,NA,NA,NA,NA
201.1132042,C10H18O4,cpd:C17803,Dimethyl suberate;Octanedioic acid dimethyl,C10H18O4,NA,NA,NA,NA,NA
203.0196735,C7H8O7,cpd:C05533,Oxaloglutarate,C7H8O7,2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.87;1.1.1.286,R01936 R04862
203.034967,C11H8O4,cpd:C03657,"1,4-Dihydroxy-2-naphthoate;1,4-Dihydroxy-2-naphthoic acid",C11H8O4,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol;Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol",NA,2.5.1.74;2.5.1.-;3.1.2.28;4.1.3.36,R04150 R07262 R10757 R12254
203.034967,C11H8O4,cpd:C06986,Spirodilactone,C11H8O4,Ubiquinone and other terpenoid-quinone biosynthesis,NA,NA,NA,R05454 R05455
203.034967,C11H8O4,cpd:C10335,Droserone,C11H8O4,NA,NA,Phytochemical compounds [BR:br08003]; Others;  Naphthoquinones;   alpha-Naphthoquinones;    C10335  Droserone,NA,NA
203.034967,C11H8O4,cpd:C14093,"1,2-Dihydroxy-8-carboxynaphthalene;7,8-Dihydroxy-1-naphthalenecarboxylic acid",C11H8O4,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.1.-.-;1.13.-.-,R06920 R06921
203.034967,C11H8O4,cpd:C17018,"1,4-Dihydroxy-6-naphthoate",C11H8O4,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, futalosine pathway;Menaquinone biosynthesis, modified futalosine pathway",NA,1.14.-.-,R08589 R08596
203.0560949,C8H12O6,cpd:C18342,3-O-Ethyl-L-ascorbic acid;L-Ascorbic acid ethyl ester,C8H12O6,NA,NA,Target-based classification of compounds [BR:br08010]; Enzymes;  Oxidoreductases;   tyrosinase;    C18342  3-O-Ethyl-L-ascorbic acid,NA,NA
203.092492,C9H16O5,cpd:C04586,"Diethyl (2R,3R)-2-methyl-3-hydroxysuccinate",C9H16O5,NA,NA,NA,1.1.1.229,R04387
203.092492,C9H16O5,cpd:C04587,"Diethyl (2S,3R)-2-methyl-3-hydroxysuccinate",C9H16O5,NA,NA,NA,NA,NA
205.0142355,C10H6O5,cpd:C18012,"Flaviolin;2,5,7-Trihydroxy-1,4-naphthalenedione;4,5,7-Trihydroxynaphthalene-1,2-dione",C10H6O5,NA,NA,NA,1.14.19.69;2.5.1.123,R08912 R08913 R10969
205.0353493,C7H10O7,cpd:C01251,"(R)-2-Hydroxybutane-1,2,4-tricarboxylate;Homocitrate;Homocitric acid;3-Hydroxy-3-carboxyadipic acid;(R)-2-Hydroxy-1,2,4-butanetricarboxylic acid",C7H10O7,Lysine biosynthesis;Pyruvate metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine;Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate;2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,2.3.3.14;4.2.1.114;4.2.1.-,R00271 R03444 R09720
205.0353493,C7H10O7,cpd:C02225,"2-Methylcitrate;(2S,3S)-2-Methylcitrate;2-Hydroxybutane-1,2,3-tricarboxylate;(2S,3S)-2-Hydroxybutane-1,2,3-tricarboxylate",C7H10O7,Propanoate metabolism;Metabolic pathways,NA,NA,2.3.3.5;4.2.1.79;4.2.1.117,R00931 R04424 R11263
205.0353493,C7H10O7,cpd:C04593,"(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate;Methylisocitrate;Methylisocitric acid",C7H10O7,Propanoate metabolism;Metabolic pathways,NA,NA,4.1.3.30;4.2.1.99,R00409 R04425
205.0353493,C7H10O7,cpd:C05662,"Homoisocitrate;3-Carboxy-2-hydroxyadipate;(-)-1-Hydroxy-1,2,4-butanetricarboxylate;(1R,2S)-1-Hydroxybutane-1,2,4-tricarboxylate;(-)-threo-Homoisocitrate",C7H10O7,Lysine biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Biosynthesis of cofactors,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine;Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate;2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,1.1.1.87;1.1.1.286;4.2.1.36;4.2.1.114,R01934 R04371 R04862 R09720
205.0506195,C11H10O4,cpd:C09012,Lathodoratin,C11H10O4,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C09012  Lathodoratin,NA,NA
205.0506195,C11H10O4,cpd:C09311,"Scoparone;6,7-Dimethoxycoumarin",C11H10O4,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09311  Scoparone,NA,NA
205.0506195,C11H10O4,cpd:C14085,2-Hydroxy-8-methylchromene-2-carboxylate,C11H10O4,Naphthalene degradation;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.13.-.-;5.3.99.-,R06911 R06912
205.0506195,C11H10O4,cpd:C14086,2-Hydroxy-3-methylbenzalpyruvate,C11H10O4,Naphthalene degradation;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,4.2.1.-;5.3.99.-,R06912 R06913
205.0506195,C11H10O4,cpd:C14092,"cis-1,2-Dihydroxy-1,2-dihydro-8-carboxynaphthalene",C11H10O4,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.1.-.-;1.14.12.-,R06919 R06920
205.0506195,C11H10O4,cpd:C20210,Eugenin;2-Methyl-5-hydroxy-7-methoxychromone,C11H10O4,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C20210  Eugenin,NA,NA
205.1597744,C14H22O,cpd:C09690,alpha-Irone;(+)-cis-alpha-Irone,C14H22O,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09690  alpha-Irone,NA,NA
205.1597744,C14H22O,cpd:C11350,(+)-trans-alpha-Irone,C14H22O,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C11350  (+)-trans-alpha-Irone,NA,NA
205.1597744,C14H22O,cpd:C14132,4-Octylphenol;4-n-Octylphenol;p-Octylphenol,C14H22O,NA,NA,Endocrine disrupting compounds [BR:br08006]; Plasticizers and plastics;  Alkylphenols;   C14132  4-Octylphenol,NA,NA
205.1597744,C14H22O,cpd:C14205,"4-tert-Octylphenol;4-t-Octylphenol;4-(1,1,3,3-Tetramethylbutyl)phenol",C14H22O,NA,NA,NA,NA,NA
206.9934604,C9H4O6,cpd:C02080,Stipitatonate,C9H4O6,NA,NA,NA,4.1.1.60,R03739
207.0120956,C10H8O3S,cpd:C16201,1-Naphthalenesulfonic acid;Naphthalene-1-sulfonate,C10H8O3S,Naphthalene degradation,NA,NA,1.14.99.-,R07698
207.0120956,C10H8O3S,cpd:C16202,2-Naphthalenesulfonic acid;Naphthalene-2-sulfonate,C10H8O3S,Naphthalene degradation,NA,NA,1.14.99.-,R07699
207.0298786,C10H8O5,cpd:C09265,"Fraxetin;7,8-Dihydroxy-6-methoxy-2H-chromen-2-one",C10H8O5,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09265  Fraxetin,1.14.11.60;1.14.14.164,R12222 R12223
207.0298786,C10H8O5,cpd:C20772,3-[(1-Carboxyvinyl)oxy]benzoate;3-[(1-Carboxyethenyl)oxy]benzoic acid,C10H8O5,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, futalosine pathway;Menaquinone biosynthesis, modified futalosine pathway",NA,2.5.1.120;4.2.1.151,R10666 R10667
207.0332577,C7H12O5S,cpd:C17210,2-(2'-Methylthio)ethylmalic acid;2-(2'-Methylthio)ethylmalate,C7H12O5S,Glucosinolate biosynthesis;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism,NA,NA,2.3.3.17;4.2.1.170,R08619 R08620
207.0332577,C7H12O5S,cpd:C17212,3-(2'-Methylthio)ethylmalic acid;3-(2'-Methylthio)ethylmalate,C7H12O5S,Glucosinolate biosynthesis;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.-;4.2.1.170,R08620 R08621
207.0662676,C11H12O4,cpd:C02381,6-Methoxymellein,C11H12O4,NA,NA,NA,2.1.1.108,R03934
207.0662676,C11H12O4,cpd:C05610,Sinapoyl aldehyde;Sinapaldehyde,C11H12O4,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Monolignol biosynthesis, phenylalanine/tyrosine => monolignol",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C05610  Sinapoyl aldehyde,1.1.1.195;1.2.1.44;1.2.1.68;2.1.1.68,R02220 R03918 R06576 R07441 R07442
207.0662676,C11H12O4,cpd:C09816,Benzylsuccinate;(R)-2-Benzylsuccinate,C11H12O4,Toluene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Toluene degradation, anaerobic, toluene => benzoyl-CoA",NA,2.8.3.15;4.1.99.11,R05588 R05598
207.1390244,C13H20O2,cpd:C14236,4-Heptyloxyphenol;p-n-Heptyloxyphenol,C13H20O2,NA,NA,NA,NA,NA
209.0455336,C10H10O5,cpd:C05619,5-Hydroxyferulic acid methyl ester,C10H10O5,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Coniferyl alcohol derivatives;    C05619  5-Hydroxyferulate,1.14.13.-;2.1.1.68;6.2.1.12,R02379 R06583 R07440
209.0455336,C10H10O5,cpd:C21450,4-(2-Hydroxyethoxycarbonyl)benzoate;4-[(2-Hydroxyethoxy)carbonyl]benzoate;Mono(2-hydroxyethyl) terephthalate;Mono(ethylene terephthalate),C10H10O5,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,3.1.1.101;3.1.1.102,R11540 R11541
209.0455336,C10H10O5,cpd:C21896,"2,4-Diacetylphloroglucinol",C10H10O5,NA,NA,NA,2.3.1.272;3.7.1.24,R12087 R12392
209.0819189,C11H14O4,cpd:C02325,Sinapyl alcohol;Sinapoyl alcohol,C11H14O4,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Monolignol biosynthesis, phenylalanine/tyrosine => monolignol",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C02325  Sinapyl alcohol,1.1.1.195;1.11.1.7;1.11.1.21;2.1.1.68;2.4.1.111;3.2.1.126,R03604 R03605 R03918 R03919 R06577
209.0819189,C11H14O4,cpd:C07350,"Phlorisovalerophenone;3-Methyl-1-(2,4,6-trihydroxyphenyl)butan-1-one",C11H14O4,NA,NA,NA,2.3.1.156,R05331
209.0819189,C11H14O4,cpd:C10709,Multifidol,C11H14O4,NA,NA,NA,NA,NA
211.0247806,C9H8O6,cpd:C04366,"3-(2-Carboxyethenyl)-cis,cis-muconate",C9H8O6,Phenylpropanoid biosynthesis,NA,NA,1.13.11.22,R03365
211.0247806,C9H8O6,cpd:C12624,"2-Hydroxy-6-ketononatrienedioate;(2Z,4E,7E)-2-Hydroxy-6-oxonona-2,4,7-triene-1,9-dioate",C9H8O6,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",NA,1.13.11.16;3.7.1.14,R06788 R06789
211.0247806,C9H8O6,cpd:C18338,"5-Carboxyvanillic acid;5-Carboxyvanillate;4-Hydroxy-5-methoxy-1,3-benzenedicarboxylate;4-Hydroxy-5-methoxyisophthalate",C9H8O6,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,NA,NA,R09277 R09278
211.061167,C10H12O5,cpd:C10674,Danielone,C10H12O5,NA,NA,NA,NA,NA
211.061167,C10H12O5,cpd:C11155,n-Propyl gallate;Propyl gallate,C10H12O5,NA,NA,NA,NA,NA
211.0975757,C11H16O4,cpd:C20790,7-Deoxyloganetin,C11H16O4,Monoterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,NA,2.4.1.324,R05090 R10835
211.1339574,C12H20O3,cpd:C08482,Cucurbic acid,C12H20O3,NA,NA,NA,NA,NA
211.1339574,C12H20O3,cpd:C08509,Putaminoxin,C12H20O3,NA,NA,NA,NA,NA
211.1339574,C12H20O3,cpd:C16309,Traumatin;(10E)-12-Oxododecenoic acid,C12H20O3,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C16309  (10E)-12-Oxododecenoic acid,5.3.3.-,R07872
211.1339574,C12H20O3,cpd:C16311,12-Oxo-9(Z)-dodecenoic acid,C12H20O3,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C16311  12-Oxo-9(Z)-dodecenoic acid,5.3.3.-,R07870 R07872
213.0404504,C9H10O6,cpd:C04479,"2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate;(2Z,4E)-2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate",C9H10O6,Phenylalanine metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.13.11.16;3.7.1.14,R02603 R04376
213.14962,C12H22O3,cpd:C02367,3-Oxododecanoic acid;3-Oxododecanoate,C12H22O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C02367  3-Oxododecanoic acid,4.1.1.56,R03747
215.0560938,C9H12O6,cpd:C20582,cis-(Homo)3-aconitate,C9H12O6,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,4.2.1.114,R10395 R10396
215.1652537,C12H24O3,cpd:C08317,12-Hydroxydodecanoic acid;omega-Hydroxydodecanoic acid,C12H24O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C08317  12-Hydroxydodecanoic acid,NA,NA
215.1652537,C12H24O3,cpd:C21080,7-Hydroxydodecanoate,C12H24O3,NA,NA,NA,1.14.14.130,R11054
219.0298762,C11H8O5,cpd:C01275,(3E)-4-(2-Carboxyphenyl)-2-oxobut-3-enoate;trans-2'-Carboxybenzalpyruvate,C11H8O5,NA,NA,NA,1.13.11.38;4.1.2.34,R03465 R03466
219.0298762,C11H8O5,cpd:C09964,Purpurogallin,C11H8O5,NA,NA,NA,NA,NA
219.0298762,C11H8O5,cpd:C16149,(3Z)-4-(2-Carboxyphenyl)-2-oxobut-3-enoate;cis-2'-Carboxybenzalpyruvate,C11H8O5,Polycyclic aromatic hydrocarbon degradation;Microbial metabolism in diverse environments,NA,NA,1.13.11.38;4.1.2.34,R07657 R07713
219.0298762,C11H8O5,cpd:C16214,"3-[6-(Carboxymethylene)cyclohexa-2,4-dien-1-ylidene]-2-oxopropanate",C11H8O5,Polycyclic aromatic hydrocarbon degradation;Microbial metabolism in diverse environments,NA,NA,1.13.11.-,R07690 R07691
219.0298762,C11H8O5,cpd:C21320,"3,6,8-Trihydroxy-2-naphthoate;3,6,8-Trihydroxy-2-naphthoic acid",C11H8O5,Biosynthesis of enediyne antibiotics;Metabolic pathways;Biosynthesis of secondary metabolites,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,1.14.-.-,R11387
219.05101,C8H12O7,cpd:C16583,"(R)-(Homo)2-citrate;(R)-2-Hydroxy-1,2,5-pentanetricarboxylate;(R)-2-Hydroxy-1,2,5-pentanetricarboxylic acid",C8H12O7,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,2.3.3.-;4.2.1.114,R08331 R10391 R10392
219.05101,C8H12O7,cpd:C16597,"(-)-threo-Iso(homo)2-citrate;(-)-threo-1-Hydroxy-1,2,5-pentanetricarboxylic acid;1-Hydroxypentane-1,2,5-tricarboxylate;threo-(Homo)2-isocitrate",C8H12O7,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,1.1.1.-;4.2.1.114,R08214 R10391 R10393
221.0455371,C11H10O5,cpd:C02730,2-Succinylbenzoate;o-Succinylbenzoate;Succinylbenzoate,C11H10O5,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol;Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol",NA,4.2.1.113;6.2.1.26,R04030 R04031 R05454
221.0455371,C11H10O5,cpd:C09271,Leptodactylone,C11H10O5,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09271  Leptodactylone,NA,NA
221.0455371,C11H10O5,cpd:C10496,Sphagnum acid,C11H10O5,NA,NA,NA,NA,NA
221.0455371,C11H10O5,cpd:C12264,"6-(2-Methoxyvinyl)benzo[1,3]dioxole-5-carboxylic acid",C11H10O5,NA,NA,NA,NA,NA
221.0455371,C11H10O5,cpd:C14106,2-Hydroxy-7-hydroxymethylchromene-2-carboxylate,C11H10O5,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.13.-.-;5.3.99.-,R06932 R06933
221.0455371,C11H10O5,cpd:C14107,2-Hydroxy-4-hydroxymethylbenzalpyruvate,C11H10O5,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,4.2.1.-;5.3.99.-,R06933 R06934
221.0455371,C11H10O5,cpd:C17479,"Fraxidin;8-Hydroxy-6,7-dimethoxy-2H-1-benzopyran-2-one",C11H10O5,NA,NA,NA,NA,NA
221.0455371,C11H10O5,cpd:C17480,"Isofraxidin;7-Hydroxy-6,8-dimethoxy-2H-1-benzopyran-2-one",C11H10O5,NA,NA,NA,NA,NA
221.048884,C8H14O5S,cpd:C17214,2-(3'-Methylthio)propylmalic acid;2-(3'-Methylthio)propylmalate,C8H14O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,2.3.3.17;4.2.1.170,R08623 R08624
221.048884,C8H14O5S,cpd:C17215,3-(3'-Methylthio)propylmalic acid;3-(3'-Methylthio)propylmalate,C8H14O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.-;4.2.1.170,R08624 R08625
221.1546638,C14H22O2,cpd:C09715,Rishitin,C14H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09715  Rishitin,NA,NA
221.1546638,C14H22O2,cpd:C16977,Isokobusone,C14H22O2,NA,NA,NA,NA,NA
221.1546638,C14H22O2,cpd:C16983,Kobusone,C14H22O2,NA,NA,NA,NA,NA
223.024804,C10H8O6,cpd:C22007,"Sideretin;5,7,8-Trihydroxy-6-methoxy-2H-chromen-2-one",C10H8O6,NA,NA,NA,1.14.14.164,R12223
223.0611746,C11H12O5,cpd:C00482,"Sinapate;Sinapic acid;3,5-Dimethoxy-4-hydroxycinnamic acid",C11H12O5,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C00482  Sinapate,1.2.1.68;2.1.1.68;2.4.1.120;2.4.1.126;2.4.1.299;3.1.1.49;6.2.1.12,R02221 R02379 R02380 R02381 R07441 R07442 R08533 R10261;R10298 R10299
223.0611746,C11H12O5,cpd:C20653,2-Benzylmalic acid;2-Benzylmalate,C11H12O5,"Phenylalanine, tyrosine and tryptophan biosynthesis;Metabolic pathways;2-Oxocarboxylic acid metabolism",NA,NA,2.3.3.-;4.2.1.-,R10500 R10501
223.0611746,C11H12O5,cpd:C20654,3-Benzylmalic acid;3-Benzylmalate,C11H12O5,"Phenylalanine, tyrosine and tryptophan biosynthesis;Metabolic pathways;2-Oxocarboxylic acid metabolism",NA,NA,1.1.1.-;4.2.1.-,R10501 R10502
223.0975928,C12H16O4,cpd:C10673,Aspidinol,C12H16O4,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Others;   Phloroglucinols;    C10673  Aspidinol,NA,NA
223.0975928,C12H16O4,cpd:C20417,"2,4-Dihydroxy-6-pentylbenzoate;Olivetolic acid",C12H16O4,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Cannabidiol biosynthesis, malonyl-CoA => cannabidiol/dronabinol",NA,2.5.1.102;4.4.1.26,R10176 R10278
225.0404615,C10H10O6,cpd:C00251,"Chorismate;Chorismic acid;(3R,4R)-3-[(1-Carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylate",C10H10O6,"Ubiquinone and other terpenoid-quinone biosynthesis;Phenylalanine, tyrosine and tryptophan biosynthesis;Phenazine biosynthesis;Folate biosynthesis;Biosynthesis of various secondary metabolites - part 2;Biosynthesis of siderophore group nonribosomal peptides;Biosynthesis of enediyne antibiotics;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors","Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate;Tryptophan biosynthesis, chorismate => tryptophan;Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine;Tyrosine biosynthesis, chorismate => HPP => tyrosine;Tyrosine biosynthesis, chorismate => arogenate => tyrosine;Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol;Ubiquinone biosynthesis, prokaryotes, chorismate (+ polyprenyl-PP) => ubiquinol;C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA;Pyocyanine biosynthesis, chorismate => pyocyanine;Phenylalanine biosynthesis, chorismate => arogenate => phenylalanine;Menaquinone biosynthesis, futalosine pathway;Menaquinone biosynthesis, modified futalosine pathway;Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol",NA,2.6.1.85;2.6.1.86;3.3.2.13;4.1.3.27;4.1.3.40;4.1.3.45;4.2.1.151;4.2.3.5;5.4.4.2;5.4.99.5,R00985 R00986 R01302 R01714 R01715 R01716 R01717 R05552;R06603 R08956 R10583 R10597 R10666
225.0404615,C10H10O6,cpd:C00254,Prephenate;Prephenic acid,C10H10O6,"Phenylalanine, tyrosine and tryptophan biosynthesis;Novobiocin biosynthesis;Biosynthesis of various secondary metabolites - part 2;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors","Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine;Tyrosine biosynthesis, chorismate => HPP => tyrosine;Tyrosine biosynthesis, chorismate => arogenate => tyrosine;Bacilysin biosynthesis, prephenate => bacilysin;Phenylalanine biosynthesis, chorismate => arogenate => phenylalanine",NA,1.3.1.12;1.3.1.13;2.6.1.57;2.6.1.78;2.6.1.79;4.1.1.100;4.2.1.51;4.2.1.91;5.4.99.5,R01373 R01715 R01728 R01730 R01731 R07276 R10934
225.0404615,C10H10O6,cpd:C00885,Isochorismate;Isochorismic acid,C10H10O6,Ubiquinone and other terpenoid-quinone biosynthesis;Biosynthesis of siderophore group nonribosomal peptides;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol;Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol",NA,2.2.1.9;3.3.2.1;4.2.99.21;5.4.4.2,R01717 R03037 R06602 R08165
225.0768312,C11H14O5,cpd:C09780,Genipin,C11H14O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09780  Genipin,NA,NA
225.1132221,C12H18O4,cpd:C19142,Butopyronoxyl,C12H18O4,NA,NA,Pesticides [BR:br08007]; Obsolete pesticides;  Others;   Insect repellents;    C19142  Butopyronoxyl,NA,NA
225.1132221,C12H18O4,cpd:C21385,trans-12-Hydroxyjasmonic acid;trans-12-Hydroxyjasmonate,C12H18O4,NA,NA,NA,1.14.13.228,R11446
225.1132221,C12H18O4,cpd:C21669,12-Hydroxyjasmonate;12-Hydroxyjasmonic acid,C12H18O4,NA,NA,NA,2.8.2.39,R11796
227.0560867,C10H12O6,cpd:C06581,"2-Hydroxy-3-carboxy-6-oxo-7-methylocta-2,4-dienoate",C10H12O6,Xylene degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,1.13.11.-;4.1.1.-,R05248 R05377
227.1288895,C12H20O4,cpd:C16308,Traumatic acid;(2E)-Dodecenedioic acid;Dodec-2-enedioic acid,C12H20O4,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,NA,NA,NA,NA
229.1445434,C12H22O4,cpd:C02678,Dodecanedioic acid,C12H22O4,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C02678  Dodecanedioic acid,NA,NA
229.1445434,C12H22O4,cpd:C14523,Diisopropyl adipate,C12H22O4,NA,NA,NA,NA,NA
229.1445434,C12H22O4,cpd:C19143,Dibutyl succinate,C12H22O4,NA,NA,Pesticides [BR:br08007]; Obsolete pesticides;  Others;   Insect repellents;    C19143  Dibutyl succinate,NA,NA
233.0455425,C12H10O5,cpd:C07731,"2-Hydroxy-6-oxo-6-(2-hydroxyphenyl)-hexa-2,4-dienoate",C12H10O5,Dioxin degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.13.11.-;3.7.1.-,R05360 R05411
233.0455425,C12H10O5,cpd:C21001,"2-O,3-Dimethylflaviolin",C12H10O5,NA,NA,NA,2.5.1.124;2.5.1.125,R11086 R11087
233.0666905,C9H14O7,cpd:C16598,"(R)-(Homo)3-citrate;(R)-2-Hydroxy-1,2,6-hexanetricarboxylate;(R)-2-Hydroxy-1,2,6-hexanetricarboxylic acid",C9H14O7,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,2.3.3.-;4.2.1.114,R08332 R10394 R10395
233.0666905,C9H14O7,cpd:C16600,"(-)-threo-Iso(homo)3-citrate;(-)-threo-1-Hydroxy-1,2,6-hexanetricarboxylic acid;1-Hydroxyhexane-1,2,6-tricarboxylate;threo-(Homo)3-isocitrate",C9H14O7,Methane metabolism;Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,1.1.1.-;4.2.1.114,R08215 R10394 R10396
233.1547146,C15H22O2,cpd:C09350,Bakkenolide A,C15H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09350  Bakkenolide A,NA,NA
233.1547146,C15H22O2,cpd:C09376,Confertifolin,C15H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09376  Confertifolin,NA,NA
233.1547146,C15H22O2,cpd:C09399,Drimenin,C15H22O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010337 Drimane sesquiterpenoids;     C09399  Drimenin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09399  Drimenin,NA,NA
233.1547146,C15H22O2,cpd:C09409,Eremophilenolide,C15H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09409  Eremophilenolide,NA,NA
233.1547146,C15H22O2,cpd:C09677,Helminthosporal,C15H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09677  Helminthosporal,NA,NA
233.1547146,C15H22O2,cpd:C09686,Hydroxyisopatchoulenone,C15H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09686  Hydroxyisopatchoulenone,NA,NA
233.1547146,C15H22O2,cpd:C09712,Polygodial,C15H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Farnesenes;    C09712  Polygodial,NA,NA
233.1547146,C15H22O2,cpd:C09721,Sclerosporin,C15H22O2,NA,NA,NA,NA,NA
233.1547146,C15H22O2,cpd:C09739,Tetradymol,C15H22O2,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09739  Tetradymol,NA,NA
233.1547146,C15H22O2,cpd:C09743,Valerenic acid,C15H22O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010346 Valerenane sesquiterpenoids;     C09743  Valerenic acid;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09743  Valerenic acid,NA,NA
233.1547146,C15H22O2,cpd:C16942,Curcumenol,C15H22O2,NA,NA,NA,NA,NA
233.1547146,C15H22O2,cpd:C16949,Dehydrocurdione,C15H22O2,NA,NA,NA,NA,NA
233.1547146,C15H22O2,cpd:C17489,"(4S,5S)-(+)-Germacrone 4,5-epoxide",C15H22O2,NA,NA,NA,NA,NA
233.1547146,C15H22O2,cpd:C17491,13-Hydroxygermacrone,C15H22O2,NA,NA,NA,NA,NA
233.1547146,C15H22O2,cpd:C17492,Curcumenone,C15H22O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010340 Carabrane sesquiterpenoids;     C17492  Curcumenone,NA,NA
233.1547146,C15H22O2,cpd:C17504,Sugeonol,C15H22O2,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010345 Patchoulane sesquiterpenoids;     C17504  Sugeonol,NA,NA
233.1547146,C15H22O2,cpd:C17609,Chrysantherol,C15H22O2,NA,NA,NA,NA,NA
233.1547146,C15H22O2,cpd:C19678,"Germacrene A acid;Germacra-1(10),4,11(13)-trien-12-oate",C15H22O2,Sesquiterpenoid and triterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C19678  Germacrene A acid,1.14.14.95;1.14.14.150;1.14.14.168;1.14.14.170,R09548 R09575 R12128 R12130 R12131 R12266 R12273 R12275
233.1547146,C15H22O2,cpd:C20309,Artemisinate;Artemisinic acid,C15H22O2,NA,NA,NA,1.14.14.114,R10025 R10026
233.1547146,C15H22O2,cpd:C20404,1-Deoxypentalenate,C15H22O2,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,1.14.11.35;1.14.15.11,R10157 R10158 R11315
233.1547146,C15H22O2,cpd:C22011,"Zealexin A1;(4S)-4-(5,5-Dimethylcyclohex-1-en-1-yl)cyclohex-1-ene-1-carboxylate",C15H22O2,NA,NA,NA,1.14.14.160,R12226 R12229
235.0247976,C11H8O6,cpd:C14094,2-Carboxy-2-hydroxy-8-carboxychromene,C11H8O6,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,1.13.-.-;5.3.99.-,R06921 R06922
235.0247976,C11H8O6,cpd:C14095,2-Hydroxy-3-carboxybenzalpyruvate;3-(3-Carboxy-3-oxo-1-propenyl)-2-hydroxy-benzoic acid,C11H8O6,Naphthalene degradation;Microbial metabolism in diverse environments,NA,NA,4.2.1.-;5.3.99.-,R06922 R06923
235.0247976,C11H8O6,cpd:C21321,"3,6,7,8-Tetrahydroxy-2-naphthoate",C11H8O6,Biosynthesis of enediyne antibiotics;Metabolic pathways;Biosynthesis of secondary metabolites,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,1.14.-.-;2.1.1.-,R11387 R11388
235.0611823,C12H12O5,cpd:C09313,"5,6,7-Trimethoxycoumarin",C12H12O5,NA,NA,"Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09313  5,6,7-Trimethoxycoumarin",NA,NA
235.0611823,C12H12O5,cpd:C09958,Orthosporin,C12H12O5,NA,NA,NA,NA,NA
239.0561174,C11H12O6,cpd:C05817,"(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate;(1R,6R)-2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate;SHCHC",C11H12O6,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol;Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol",NA,4.2.1.113;4.2.99.20,R04031 R08166
243.1965724,C14H28O3,cpd:C13790,2S-Hydroxytetradecanoic acid;2S-Hydroxytetradecanoate,C14H28O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C13790  2S-Hydroxytetradecanoic acid,NA,NA
243.1965724,C14H28O3,cpd:C22001,(R)-3-Hydroxymyristic acid;(R)-3-Hydroxytetradecanoic acid,C14H28O3,NA,NA,NA,3.1.1.-,R12198 R12199
245.0455406,C13H10O5,cpd:C02162,"Isopimpinellin;5,8-Dimethoxypsoralen",C13H10O5,Biosynthesis of phenylpropanoids;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C02162  Isopimpinellin,2.1.1.69,R08538
245.0455406,C13H10O5,cpd:C06355,"2,3',4,6-Tetrahydroxybenzophenone",C13H10O5,NA,NA,NA,2.3.1.151,R04709
245.0455406,C13H10O5,cpd:C09285,Pimpinellin,C13H10O5,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09285  Pimpinellin,NA,NA
249.040461,C12H10O6,cpd:C07734,"2-Hydroxy-6-oxo-6-(2-hydroxyphenoxy)-hexa-2,4-dienoate",C12H10O6,Dioxin degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,NA,1.13.11.-;3.7.1.-,R05361 R05413
249.0768193,C13H14O5,cpd:C16765,Citrinin,C13H14O5,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C16765  Citrinin,NA,NA
249.0801818,C10H18O5S,cpd:C17222,2-(5'-Methylthio)pentylmalic acid;2-(5'-Methylthio)pentylmalate,C10H18O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,2.3.3.17;4.2.1.170,R08631 R08634
249.0801818,C10H18O5S,cpd:C17223,3-(5'-Methylthio)pentylmalic acid;3-(5'-Methylthio)pentylmalate,C10H18O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.-;4.2.1.170,R08634 R08636
249.11327,C14H18O4,cpd:C14468,Diisopropyl phthalate,C14H18O4,NA,NA,NA,NA,NA
249.11327,C14H18O4,cpd:C14469,Di-n-propylphthalate;Dipropyl phthalate,C14H18O4,NA,NA,Endocrine disrupting compounds [BR:br08006]; Plasticizers and plastics;  Phthalates;   C14469  Di-n-propylphthalate,NA,NA
249.1496305,C15H22O3,cpd:C07020,Gemfibrozil,C15H22O3,Chemical carcinogenesis - receptor activation,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C10 LIPID MODIFYING AGENTS;   C10A LIPID MODIFYING AGENTS, PLAIN;    C10AB Fibrates;     C10AB04 Gemfibrozil;      D00334  Gemfibrozil (JAN/USP/INN) &lt;US&gt;;USP drug classification [BR:br08302]; Cardiovascular Agents;  Dyslipidemics, Fibric Acid Derivatives;   Gemfibrozil;    D00334  Gemfibrozil (JAN/USP/INN);Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Thyroid hormone like receptors;   Peroxisome proliferator-activated receptor (PPAR);    NR1C1 (PPARA);     D00334  Gemfibrozil (JAN/USP/INN) &lt;US&gt;;Drug metabolizing enzymes and transporters [br08309.html]; Drug metabolizing enzymes;  D00334; Drug transporters;  D00334",NA,NA
249.1496305,C15H22O3,cpd:C09295,Arbusculin A,C15H22O3,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09295  Arbusculin A,NA,NA
249.1496305,C15H22O3,cpd:C09689,Ipomeamarone;(+)-Ngaione,C15H22O3,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010302 Furanoid farnesane sesquiterpenoids;     C09689  Ipomoeamarone;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Farnesenes;    C09689  Ipomeamarone,NA,NA
249.1496305,C15H22O3,cpd:C09711,Piperdial,C15H22O3,NA,NA,NA,NA,NA
249.1496305,C15H22O3,cpd:C09748,Warburganal,C15H22O3,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Farnesenes;    C09748  Warburganal,NA,NA
249.1496305,C15H22O3,cpd:C13453,"Xanthoxin;2-cis,4-trans-Xanthoxin",C15H22O3,Carotenoid biosynthesis;Biosynthesis of terpenoids and steroids;Metabolic pathways;Biosynthesis of secondary metabolites,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",NA,1.1.1.288;1.13.11.51,R06952 R06953 R06954 R06955 R09682
249.1496305,C15H22O3,cpd:C13456,Abscisic alcohol,C15H22O3,Carotenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010305 Cyclofarnesane sesquiterpenoids;     C13456  Abscisic alcohol,NA,R06958 R06959
249.1496305,C15H22O3,cpd:C14716,2-Ethylhexyl-4-hydroxybenzoate,C15H22O3,NA,NA,NA,NA,NA
249.1496305,C15H22O3,cpd:C20403,1-Deoxy-11beta-hydroxypentalenate,C15H22O3,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,1.1.1.340;1.14.11.35,R10156 R10157
249.1496305,C15H22O3,cpd:C20405,Pentalenate,C15H22O3,Biosynthesis of various secondary metabolites - part 1;Biosynthesis of secondary metabolites,NA,NA,1.14.15.11,R10158
249.1496305,C15H22O3,cpd:C21922,"6alpha-Hydroxygermacra-1(10),4,11(13)-trien-12-oate",C15H22O3,NA,NA,NA,1.14.14.150,R12131 R12132
249.1496305,C15H22O3,cpd:C22049,"8beta-Hydroxygermacra-1(10),4,11(13)-trien-12-oate;8beta-Hydroxygermacrene A acid",C15H22O3,NA,NA,NA,1.14.14.168;1.14.14.169,R12266 R12267 R12270
249.1496305,C15H22O3,cpd:C22051,"8alpha-Hydroxygermacra-1(10),4,11(13)-trien-12-oate",C15H22O3,NA,NA,NA,1.14.14.170,R12273 R12274
251.0925027,C13H16O5,cpd:C18541,Trinexapac-ethyl,C13H16O5,NA,NA,Pesticides [BR:br08007]; Pesticides;  Plant growth regulators;   Others;    C18541  Trinexapac-ethyl,NA,NA
251.0925027,C13H16O5,cpd:C20207,Grandinol,C13H16O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Others;   Phloroglucinols;    C20207  Grandinol,NA,NA
255.0874015,C12H16O6,cpd:C02578,Phenylgalactoside,C12H16O6,NA,NA,NA,NA,NA
255.0874015,C12H16O6,cpd:C03097,Aryl beta-D-glucoside,C12H16O6,NA,NA,NA,2.4.1.35,R01240
255.0874015,C12H16O6,cpd:C11611,Phenyl beta-D-glucopyranoside;Phenylglucoside,C12H16O6,NA,NA,NA,NA,NA
255.232943,C16H32O2,cpd:C00249,Hexadecanoic acid;Hexadecanoate;Hexadecylic acid;Palmitic acid;Palmitate;Cetylic acid,C16H32O2,"Fatty acid biosynthesis;Fatty acid elongation;Fatty acid degradation;Cutin, suberine and wax biosynthesis;Biosynthesis of unsaturated fatty acids;Biosynthesis of plant secondary metabolites;Metabolic pathways;Fatty acid metabolism","beta-Oxidation, acyl-CoA synthesis",Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Saturated fatty acids;    C00249  Palmitic acid (16:0);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C00249  Hexadecanoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Saturated fatty acids;    C00249  Palmitic acid,1.2.1.48;1.11.1.3;1.14.14.80;1.14.-.-;2.3.1.85;3.1.1.63;3.1.1.-;3.1.2.2;3.1.2.14;3.1.2.22;3.1.2.-;6.2.1.3;6.2.1.57,R01274 R01280 R01703 R01704 R01705 R01706 R02368 R03049;R08602 R09451 R12396 R12398
257.045585,C14H10O5,cpd:C10066,"Gentisin;1,7-Dihydroxy-3-methoxyxanthone",C14H10O5,NA,NA,NA,NA,NA
257.045585,C14H10O5,cpd:C10070,"Isogentisin;1,3-Dihydroxy--7-methoxyxanthone",C14H10O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10070  Isogentisin,NA,NA
257.045585,C14H10O5,cpd:C10081,"Mesuaxanthone A;1,5-Dihydroxy-3-methoxyxanthone",C14H10O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10081  Mesuaxanthone A,NA,NA
257.045585,C14H10O5,cpd:C10087,"Norlichexanthone;1,3,6-Trihydroxy-8-methyl-9H-xanthen-9-one",C14H10O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10087  Norlichexanthone,NA,NA
257.045585,C14H10O5,cpd:C10362,Kigelinone,C14H10O5,NA,NA,NA,NA,NA
257.045585,C14H10O5,cpd:C16838,Alternariol,C14H10O5,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C16838  Alternariol,NA,NA
257.045585,C14H10O5,cpd:C17671,Norrubrofusarin,C14H10O5,NA,NA,NA,NA,NA
257.045585,C14H10O5,cpd:C19357,3-Carbethoxypsoralen,C14H10O5,NA,NA,NA,NA,NA
257.1758209,C14H26O4,cpd:C14253,Dibutyl adipate;Di-n-butyl adipate,C14H26O4,NA,NA,NA,NA,NA
257.1758209,C14H26O4,cpd:C14260,Diisobutyl adipate,C14H26O4,NA,NA,NA,NA,NA
259.0248044,C13H8O6,cpd:C10056,"Demethylbellidifolin;1,3,5,8-Tetrahydroxyxanthone",C13H8O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10056  Demethylbellidifolin,NA,NA
259.0248044,C13H8O6,cpd:C10086,"Norathyriol;1,3,6,7-Tetrahydroxyxanthone",C13H8O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10086  Norathyriol,NA,NA
259.0248044,C13H8O6,cpd:C10088,"Norswertianin;1,2,6,8-Tetrahydroxyxanthone",C13H8O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10088  Norswertianin,NA,NA
259.0611595,C14H12O5,cpd:C09010,Khellin,C14H12O5,Biosynthesis of plant secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1311 Benzopyranoids;    C09010  Khellin;Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C09010  Khellin,NA,NA
261.0404605,C13H10O6,cpd:C09951,Maclurin,C13H10O6,NA,NA,NA,NA,NA
261.0404605,C13H10O6,cpd:C16264,"2-Hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate",C13H10O6,Polycyclic aromatic hydrocarbon degradation;Metabolic pathways;Microbial metabolism in diverse environments,NA,NA,1.13.-.-;3.7.1.-,R07801 R07802
261.1132313,C15H18O4,cpd:C09015,Methylripariochromene A,C15H18O4,NA,NA,NA,NA,NA
261.1132313,C15H18O4,cpd:C09344,Artemisin,C15H18O4,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010319 Eudesmane sesquiterpenoids;     C09344  Artemisin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Eudesmanes;    C09344  Artemisin,NA,NA
261.1132313,C15H18O4,cpd:C09396,Dihydrogriesenin,C15H18O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09396  Dihydrogriesenin,NA,NA
261.1132313,C15H18O4,cpd:C09450,Farinosin,C15H18O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Eudesmanes;    C09450  Farinosin,NA,NA
261.1132313,C15H18O4,cpd:C09472,Grosshemin,C15H18O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09472  Grosshemin,NA,NA
261.1132313,C15H18O4,cpd:C09473,Helenalin,C15H18O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09473  Helenalin,NA,NA
261.1132313,C15H18O4,cpd:C09504,Mexicanin I,C15H18O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09504  Mexicanin I,NA,NA
261.1132313,C15H18O4,cpd:C09508,Microhelenin A,C15H18O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09508  Microhelenin A,NA,NA
261.1132313,C15H18O4,cpd:C09523,Parthenin,C15H18O4,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010342 Pseudoguaiane sesquiterpenoids;     C09523  Parthenin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09523  Parthenin,NA,NA
261.1132313,C15H18O4,cpd:C09552,Stramonin B,C15H18O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09552  Stramonin B,NA,NA
261.1132313,C15H18O4,cpd:C09701,Marasmic acid,C15H18O4,NA,NA,NA,NA,NA
261.1132313,C15H18O4,cpd:C20398,Pentalenolactone E,C15H18O4,NA,NA,NA,1.14.11.36,R10143 R10144
261.1343654,C12H22O6,cpd:C19537,Triethylene glycol diglycidyl ether;Etoglucid,C12H22O6,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;  L01 ANTINEOPLASTIC AGENTS;   L01A ALKYLATING AGENTS;    L01AG Epoxides;     L01AG01 Etoglucid;      D07256  Etoglucid (INN),NA,NA
263.0925336,C14H16O5,cpd:C10427,1'-Acetoxyeugenol acetate,C14H16O5,NA,NA,NA,NA,NA
263.0958008,C11H20O5S,cpd:C17226,2-(6'-Methylthio)hexylmalic acid;2-(6'-Methylthio)hexylmalate,C11H20O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,2.3.3.17;4.2.1.170,R08640 R08641
263.0958008,C11H20O5S,cpd:C17227,3-(6'-Methylthio)hexylmalic acid;3-(6'-Methylthio)hexylmalate,C11H20O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.-;4.2.1.170,R08641 R08642
263.1288505,C15H20O4,cpd:C06082,Abscisate;Abscisic acid;(+)-Abscisic acid;ABA,C15H20O4,Carotenoid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of terpenoids and steroids;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Plant hormone signal transduction,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010305 Cyclofarnesane sesquiterpenoids;     C06082  Abscisate;Phytochemical compounds [BR:br08003]; Terpenoids;  Carotenoids and apocarotenoids;   Apocarotenoids;    C06082  Abscisate,1.2.3.14;1.14.14.137;2.4.1.263;3.2.1.175,R06956 R06957 R06959 R07202 R07575 R09723
263.1288505,C15H20O4,cpd:C09291,Amaralin,C15H20O4,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010342 Pseudoguaiane sesquiterpenoids;     C09291  Amaralin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09291  Amaralin,NA,NA
263.1288505,C15H20O4,cpd:C09304,Artemisiifolin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09304  Artemisiifolin,NA,NA
263.1288505,C15H20O4,cpd:C09349,Baileyin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09349  Baileyin,NA,NA
263.1288505,C15H20O4,cpd:C09355,Chamissonin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09355  Chamissonin,NA,NA
263.1288505,C15H20O4,cpd:C09381,Coronopilin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09381  Coronopilin,NA,NA
263.1288505,C15H20O4,cpd:C09453,Florilenalin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09453  Florilenalin,NA,NA
263.1288505,C15H20O4,cpd:C09456,Geigerin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09456  Geigerin,NA,NA
263.1288505,C15H20O4,cpd:C09470,Granilin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Eudesmanes;    C09470  Granilin,NA,NA
263.1288505,C15H20O4,cpd:C09481,Hymenolin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09481  Hymenolin,NA,NA
263.1288505,C15H20O4,cpd:C09498,Ludovicin A,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Eudesmanes;    C09498  Ludovicin A,NA,NA
263.1288505,C15H20O4,cpd:C09506,Michelenolide,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09506  Michelenolide,NA,NA
263.1288505,C15H20O4,cpd:C09530,Pleniradin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09530  Pleniradin,NA,NA
263.1288505,C15H20O4,cpd:C09531,Plenolin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09531  Plenolin,NA,NA
263.1288505,C15H20O4,cpd:C09540,Ridentin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09540  Ridentin,NA,NA
263.1288505,C15H20O4,cpd:C09542,Salonitenolide,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09542  Salonitenolide,NA,NA
263.1288505,C15H20O4,cpd:C09574,Vermeerin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09574  Vermeerin,NA,NA
263.1288505,C15H20O4,cpd:C09600,Vulgarin,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Eudesmanes;    C09600  Vulgarin,NA,NA
263.1288505,C15H20O4,cpd:C09683,Hirsutic acid C,C15H20O4,NA,NA,NA,NA,NA
263.1288505,C15H20O4,cpd:C09688,Illudin S,C15H20O4,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010359 Illudane and protoilludane sesquiterpenoids;     C09688  Illudin S;Natural toxins [BR:br08009]; Fungal toxins;  Mushroom toxins;   Terpenoids;    C09688  Illudin S,NA,NA
263.1288505,C15H20O4,cpd:C09708,Phomenone,C15H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09708  Phomenone,NA,NA
263.1288505,C15H20O4,cpd:C10766,Ascosalitoxin,C15H20O4,NA,NA,NA,NA,NA
263.1288505,C15H20O4,cpd:C11060,(-)-Abscisic acid;(-)-ABA,C15H20O4,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010305 Cyclofarnesane sesquiterpenoids;     C11060  (-)-Abscisic acid,NA,NA
263.1288505,C15H20O4,cpd:C20399,Pentalenolactone D,C15H20O4,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,1.14.11.36;1.14.13.170,R10143 R10145 R10154
263.1288505,C15H20O4,cpd:C20402,Neopentalenolactone D,C15H20O4,Biosynthesis of various secondary metabolites - part 1;Biosynthesis of secondary metabolites,NA,NA,1.14.13.171,R10155
265.1445151,C15H22O4,cpd:C09702,Mukaadial,C15H22O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Farnesenes;    C09702  Mukaadial,NA,NA
265.1445151,C15H22O4,cpd:C09717,Rugosal A;Rugosal,C15H22O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09717  Rugosal A,NA,NA
265.1445151,C15H22O4,cpd:C10840,Zinniol,C15H22O4,NA,NA,NA,NA,NA
265.1445151,C15H22O4,cpd:C13454,Xanthoxic acid,C15H22O4,Carotenoid biosynthesis,NA,NA,NA,R06955 R06956
265.1445151,C15H22O4,cpd:C22050,"6alpha,8beta-Dihydroxygermacra-1(10),4,11(13)-trien-12-oate",C15H22O4,NA,NA,NA,1.14.14.169,R12267 R12268
265.1478831,C12H26O4S,cpd:C22403,2-Butyloctyl sulfate,C12H26O4S,NA,NA,NA,3.1.6.22,R12798
267.0662133,C16H12O4,cpd:C00858,Formononetin,C16H12O4,Isoflavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Pterocarpan biosynthesis, daidzein => medicarpin",Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C00858  Formononetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C00858  Formononetin,1.14.14.88;1.14.14.89;1.14.14.90;2.1.1.46;2.4.1.170;4.2.1.105,R03006 R06560 R06564 R07723 R07729 R07733
267.0662133,C16H12O4,cpd:C10414,Dalbergin,C16H12O4,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1210 Neoflavonoids;    C10414  Dalbergin;Phytochemical compounds [BR:br08003]; Others;  Others;   Neoflavonoids;    C10414  Dalbergin,NA,NA
267.0662133,C16H12O4,cpd:C11621,Tectochrysin;Techtochrysin,C16H12O4,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C11621  Tectochrysin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C11621  Tectochrysin,NA,NA
267.0662133,C16H12O4,cpd:C12125,Isoformononetin;4'-Hydroxy-7-methoxyisoflavone,C16H12O4,Isoflavonoid biosynthesis;Biosynthesis of phenylpropanoids,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C12125  Isoformononetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C12125  Isoformononetin,2.1.1.150,R07724
267.0662133,C16H12O4,cpd:C15110,1-[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-3-yl]ethanone;6-Hydroxy-2-(4-hydroxyphenyl)-3-benzofuranyl methyl ketone,C16H12O4,NA,NA,NA,NA,NA
267.0662133,C16H12O4,cpd:C15203,6-Hydroxy-2'-methoxyflavone;6-Hydroxy-2-(2-methoxyphenyl)-4H-1-benzopyran-4-one,C16H12O4,NA,NA,NA,NA,NA
267.072149,C9H16O9,cpd:C11544,2-O-(alpha-D-Mannosyl)-D-glycerate;alpha-Mannosylglycerate;2-O-(alpha-D-Mannopyranosyl)-D-glycerate,C9H16O9,Fructose and mannose metabolism;Metabolic pathways;Phosphotransferase system (PTS),NA,NA,2.4.1.269;2.7.1.195;3.1.3.70;3.2.1.170,R05790 R09666 R11169 R12095
267.072149,C9H16O9,cpd:C19792,2-O-(alpha-D-Glucopyranosyl)-D-glycerate;(R)-2-(alpha-D-Glucopyranosyloxy)-3-hydroxypropanoate,C9H16O9,NA,NA,NA,2.4.1.268;2.4.1.352;3.1.3.85;3.2.1.208,R09664 R09665 R11959 R12250
267.072149,C9H16O9,cpd:C20934,3-Deoxy-D-glycero-D-galacto-non-2-ulosonic acid;2-Keto-3-deoxy-D-glycero-D-galacto-nononic acid;KDN;Deaminated neuraminic acid;Ketodeoxynonulonic acid;3-Deoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid,C9H16O9,NA,NA,NA,2.7.7.92;3.1.3.103,R11440 R11441
269.1758127,C15H26O4,cpd:C16506,(10S)-Juvenile hormone III acid diol,C15H26O4,Insect hormone biosynthesis,NA,NA,3.1.1.59,R08150 R08152
269.2122253,C16H30O3,cpd:C19614,16-Oxopalmitate,C16H30O3,"Cutin, suberine and wax biosynthesis;Metabolic pathways",NA,NA,1.1.-.-;1.2.-.-,R09448 R09457
271.0612148,C15H12O5,cpd:C00509,"Naringenin;4',5,7-Trihydroxyflavanone;(2S)-Naringenin;(-)-(2S)-Naringenin",C15H12O5,Flavonoid biosynthesis;Isoflavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Flavanone biosynthesis, phenylalanine => naringenin;Flavonoid biosynthesis, naringenin => pelargonidin;Isoflavone biosynthesis, liquiritigenin => daidzein / naringenin => genistein",Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C00509  Naringenin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C00509  Naringenin,1.1.1.234;1.14.11.9;1.14.14.81;1.14.14.82;1.14.14.87;1.14.19.76;1.14.20.5;2.1.1.231;2.1.1.232;2.4.1.185;2.5.1.70;5.5.1.6,R02442 R02443 R02444 R02445 R02446 R02897 R06553 R06610;R07778 R08026 R08129 R08951 R09791 R12213 R12278
271.0612148,C15H12O5,cpd:C01263,"3,6,9-Trihydroxypterocarpan;(6aS,11aS)-3,6a,9-Trihydroxypterocarpan;(-)-Glycinol",C15H12O5,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C01263  (6aS,11aS)-3,6a,9-Trihydroxypterocarpan;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C01263  3,6,9-Trihydroxypterocarpan",1.14.14.93;2.5.1.36,R03452 R07271 R07272
271.0612148,C15H12O5,cpd:C01592,"Licodione;1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)propane-1,3-dione",C15H12O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C01592  Licodione,1.14.14.162;2.1.1.65,R03623 R07198
271.0612148,C15H12O5,cpd:C03567,"2'-Hydroxydihydrodaidzein;2'-Hydroxy-2,3-dihydrodaidzein",C15H12O5,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C03567  2'-Hydroxydihydrodaidzein;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C03567  2'-Hydroxydihydrodaidzein,1.3.1.51,R03962 R07728
271.0612148,C15H12O5,cpd:C06561,"Naringenin chalcone;2',4,4',6'-Tetrahydroxychalcone;Isosalipurpol;Chalconaringenin",C15H12O5,Flavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Flavanone biosynthesis, phenylalanine => naringenin",Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C06561  Naringenin chalcone;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C06561  Naringenin chalcone,1.21.3.6;2.3.1.74;2.4.1.286;2.4.1.-;5.5.1.6,R01613 R02446 R07224 R08003 R08006 R08013
271.0612148,C15H12O5,cpd:C08578,Butein,C15H12O5,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C08578  Butein;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C08578  Butein,5.5.1.6,R07994 R07995
271.0612148,C15H12O5,cpd:C09047,Rubrofusarin,C15H12O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Naphthopyrones;    C09047  Rubrofusarin,NA,NA
271.0612148,C15H12O5,cpd:C09614,"Butin;(-)-Butin;7,3',4'-Trihydroxyflavanone",C15H12O5,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09614  Butin,1.14.11.9;1.14.14.82;5.5.1.6,R07995 R07997 R08002
271.0612148,C15H12O5,cpd:C09751,"Garbanzol;3,7,4'-Trihydroxyflavanone",C15H12O5,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C09751  Garbanzol,1.1.1.219;1.14.11.9;1.14.14.82,R07996 R07998 R08000 R08032
271.0612148,C15H12O5,cpd:C09826,"Pinobanksin;3,5,7-Trihydroxyflavanone",C15H12O5,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C09826  Pinobanksin,1.14.11.9;1.14.20.6,R07993 R08028 R08082
271.0612148,C15H12O5,cpd:C12087,p-Coumaroyltriacetic acid lactone,C15H12O5,NA,NA,NA,NA,NA
271.0612148,C15H12O5,cpd:C14458,"Dihydrogenistein;4',5,7-Trihydroxyisoflavan-4-one",C15H12O5,NA,NA,NA,NA,NA
271.0612148,C15H12O5,cpd:C15567,"2,7,4'-Trihydroxyisoflavanone;2,4',7-Trihydroxyisoflavanone",C15H12O5,Isoflavonoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Isoflavone biosynthesis, liquiritigenin => daidzein / naringenin => genistein","Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C15567  2,7,4'-Trihydroxyisoflavanone",1.14.14.87;2.1.1.212;4.2.1.105,R07317 R07714 R07722 R07777
271.0612148,C15H12O5,cpd:C16232,"6,7,4'-Trihydroxyflavanone",C15H12O5,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,NA,1.14.13.-;1.14.14.87,R07711 R07715
271.0612148,C15H12O5,cpd:C17673,Toralactone,C15H12O5,NA,NA,NA,NA,NA
271.082321,C12H16O7,cpd:C06186,Arbutin;Ursin;Uvasol;Hydroquinone-O-beta-D-glucopyranoside,C12H16O7,Glycolysis / Gluconeogenesis;Phosphotransferase system (PTS),NA,Glycosides [BR:br08021]; O-glycosides;  Phenolic glycosides;   C06186  Arbutin;Target-based classification of compounds [BR:br08010]; Enzymes;  Oxidoreductases;   tyrosinase;    C06186  Arbutin,2.4.1.218;2.7.1.-,R05132 R05769
271.082321,C12H16O7,cpd:C12079,alpha-Arbutin;4-Hydroxyphenyl-alpha-D-glucopyranoside,C12H16O7,NA,NA,NA,NA,NA
271.2278666,C16H32O3,cpd:C18218,16-Hydroxypalmitate;16-Hydroxypalmitic acid,C16H32O3,"Cutin, suberine and wax biosynthesis;Metabolic pathways",NA,NA,1.1.-.-;1.14.14.80;1.14.-.-;2.3.1.188,R09106 R09448 R09451 R09460
273.0404663,C14H10O6,cpd:C10052,"Athyriol;3-Methoxy-1,6,7-trihydroxyxanthone",C14H10O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10052  Athyriol,NA,NA
273.0404663,C14H10O6,cpd:C10053,"Bellidifolin;3-Methoxy-1,5,8-trihydroxyxanthone",C14H10O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10053  Bellidifolin,NA,NA
273.0404663,C14H10O6,cpd:C10069,"Isoathyriol;6-Methoxy-1,3,7-trihydroxyxanthone",C14H10O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10069  Isoathyriol,NA,NA
273.0404663,C14H10O6,cpd:C10092,"Swertianin;1,2,8-Trihydroxy-6-methoxyxanthone",C14H10O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10092  Swertianin,NA,NA
273.0404663,C14H10O6,cpd:C15218,"2,2',4,4'-Tetrahydroxybenzil;Bis(2,4-dihydroxyphenyl)ethanedione",C14H10O6,NA,NA,NA,NA,NA
273.0767921,C15H14O5,cpd:C00774,Phloretin,C15H14O5,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C00774  Phloretin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihydrochalcones;    C00774  Phloretin,2.3.1.74;2.4.1.357;3.7.1.4,R02901 R12088 R12117
273.0767921,C15H14O5,cpd:C08929,"alpha-Pyrufuran;1,3,4-Trimethoxy-2-dibenzofuranol",C15H14O5,NA,NA,NA,NA,NA
273.0767921,C15H14O5,cpd:C08948,"beta-Pyrufuran;1,2,4-Trimethoxy-3-dibenzofuranol",C15H14O5,NA,NA,NA,NA,NA
273.0767921,C15H14O5,cpd:C09029,Ptaerochromenol,C15H14O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C09029  Ptaerochromenol,NA,NA
273.0767921,C15H14O5,cpd:C09320,"Afzelechin;3,5,7,4'-Tetrahydroxyflavan",C15H14O5,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09320  Afzelechin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C09320  Afzelechin",1.17.1.3,R06615
273.0767921,C15H14O5,cpd:C09735,"Fisetinidol;3,7,3',4'-Tetrahydroxyflavan",C15H14O5,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09735  Fisetinidol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C09735  Fisetinidol",NA,NA
273.0767921,C15H14O5,cpd:C09952,Methysticin,C15H14O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   alpha-Pyrones;    C09952  Methysticin,NA,NA
273.0767921,C15H14O5,cpd:C12122,Luteoliflavan,C15H14O5,NA,NA,NA,NA,NA
273.0767921,C15H14O5,cpd:C12124,Apiforol,C15H14O5,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 4-ols;    C12124  Apiforol,1.1.1.234,R06610
273.0767921,C15H14O5,cpd:C12128,(-)-Epiafzelechin;epi-Afzelechin,C15H14O5,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C12128  (-)-Epiafzelechin,1.3.1.77,R06541
273.0767921,C15H14O5,cpd:C13767,"H37;5,8-Diethoxypsoralen",C15H14O5,NA,NA,NA,NA,NA
273.0767921,C15H14O5,cpd:C16415,5-Deoxyleucopelargonidin,C15H14O5,Flavonoid biosynthesis,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3,4-diols;    C16415  5-Deoxyleucopelargonidin",1.1.1.219,R07998 R08000
273.0979827,C12H18O7,cpd:C18825,Dikegulac;Diprogulic acid,C12H18O7,NA,NA,Pesticides [BR:br08007]; Pesticides;  Plant growth regulators;   Growth inhibitors / retardants;    C18825  Dikegulac,NA,NA
273.0979827,C12H18O7,cpd:C21671,12-Sulfooxyjasmonate;12-Hydroxyjasmonate sulfate,C12H18O7S,NA,NA,NA,2.8.2.39,R11796
273.2071317,C15H30O4,cpd:C13854,1-Dodecanoyl-sn-glycerol,C15H30O4,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA10 Fatty ethers;   C13854  1-Dodecanoyl-sn-glycerol; GL  Glycerolipids;  GL01 Monoradylglycerols;   GL0101 Monoacylglycerols;    C13854  1-Dodecanoyl-sn-glycerol,NA,NA
275.0772402,C11H16O8,cpd:C08512,Ranunculin,C11H16O8,NA,NA,Phytochemical compounds [BR:br08003]; Amino acid related compounds;  Cyanogenic glucosides;   Others;    C08512  Ranunculin;Glycosides [BR:br08021]; O-glycosides;  Cyanogenic glycosides;   C08512  Ranunculin;Natural toxins [BR:br08009]; Phytotoxins;  Others;   Others;    C08512  Ranunculin,NA,NA
275.0924724,C15H16O5,cpd:C09489,Lactucin,C15H16O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09489  Lactucin,NA,NA
275.0924724,C15H16O5,cpd:C09582,Vernolepin,C15H16O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09582  Vernolepin,NA,NA
275.0924724,C15H16O5,cpd:C09584,Vernomenin,C15H16O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09584  Vernomenin,NA,NA
275.0924724,C15H16O5,cpd:C09926,Dihydromethysticin,C15H16O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   alpha-Pyrones;    C09926  Dihydromethysticin,NA,NA
275.0924724,C15H16O5,cpd:C17483,Hamaudol,C15H16O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C17483  Hamaudol,NA,NA
275.0924724,C15H16O5,cpd:C17838,Visamminol,C15H16O5,NA,NA,NA,NA,NA
275.0924724,C15H16O5,cpd:C20407,Pentalenolactone;Arenaemycin E,C15H16O5,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,1.14.19.8,R10162
275.128896,C16H20O4,cpd:C09548,Scorpioidin,C16H20O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09548  Scorpioidin,NA,NA
275.128896,C16H20O4,cpd:C17745,"1-(3,4-Dihydroxyphenyl)-1-decene-3,5-dione",C16H20O4,"Stilbenoid, diarylheptanoid and gingerol biosynthesis;Biosynthesis of secondary metabolites",NA,NA,2.1.1.-,R08799 R08801 R08803
277.0717129,C14H14O6,cpd:C21322,"3-Hydroxy-6,7,8-trimethoxy-2-naphthoate",C14H14O6,Biosynthesis of enediyne antibiotics;Metabolic pathways;Biosynthesis of secondary metabolites,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,2.1.1.-,R11388 R11389
277.0928719,C11H18O8,cpd:C08561,Tuliposide A,C11H18O8,NA,NA,NA,NA,NA
277.0928719,C11H18O8,cpd:C20577,6-Tuliposide A;6-O-(4-Hydroxy-2-methylenebutanoyl)-D-glucose,C11H18O8,NA,NA,NA,4.2.99.22,R10494
277.1081298,C15H18O5,cpd:C09302,Artecanin;Chrysartemin B,C15H18O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09302  Artecanin,NA,NA
277.1081298,C15H18O5,cpd:C09354,Canin,C15H18O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09354  Canin,NA,NA
277.1081298,C15H18O5,cpd:C09363,Conchosin A,C15H18O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09363  Conchosin A,NA,NA
277.1081298,C15H18O5,cpd:C09379,Coriamyrtin,C15H18O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Tutinolide;    C09379  Coriamyrtin;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Sesquiterpenoids;    C09379  Coriamyrtin,NA,NA
277.1081298,C15H18O5,cpd:C09485,Isohelenol,C15H18O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09485  Isohelenol,NA,NA
277.1081298,C15H18O5,cpd:C09983,Zinnolide,C15H18O5,NA,NA,NA,NA,NA
277.1081298,C15H18O5,cpd:C20397,Pentalenolactone F,C15H18O5,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,1.14.11.36;1.14.19.8,R10144 R10145 R10162
277.1115043,C12H22O5S,cpd:C17230,2-(7'-Methylthio)heptylmalic acid;2-(7'-Methylthio)heptylmalate,C12H22O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,2.3.3.17;4.2.1.170,R08644 R08645
277.1115043,C12H22O5S,cpd:C17231,3-(7'-Methylthio)heptylmalic acid;3-(7'-Methylthio)heptylmalate,C12H22O5S,Glucosinolate biosynthesis;2-Oxocarboxylic acid metabolism,NA,NA,1.1.1.-;4.2.1.170,R08645 R08646
277.1445494,C16H22O4,cpd:C03343,Mono-(2-ethylhexyl)phthalate;2-Ethylhexyl phthalate,C16H22O4,NA,NA,NA,3.1.1.60,R04202
277.1445494,C16H22O4,cpd:C14214,"Dibutyl phthalate;Di-n-butyl phthalate;Dibutyl 1,2-benzenedicarboxylate",C16H22O4,NA,NA,"Endocrine disrupting compounds [BR:br08006]; Plasticizers and plastics;  Phthalates;   C14214  Dibutyl phthalate;Pesticides [BR:br08007]; Obsolete pesticides;  Others;   Insect repellents;    C14214  Dibutyl phthalate;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;  P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS;   P03B INSECTICIDES AND REPELLENTS;    P03BX Other insecticides and repellents;     P03BX03 Dibutylphthalate;      C14214  Dibutyl phthalate",NA,NA
277.1445494,C16H22O4,cpd:C15205,Diisobutyl phthalate;DIBP,C16H22O4,NA,NA,NA,NA,NA
277.180914,C17H26O3,cpd:C10482,"6-Paradol;3-Decanone, 1-(4-hydroxy-3-methoxyphenyl)-",C17H26O3,NA,NA,Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Others;   Zingiber derived compounds;    C10482  6-Paradol,NA,NA
277.180914,C17H26O3,cpd:C16792,Panaxytriol,C17H26O3,NA,NA,Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Polyynes;    C16792  Panaxytriol,NA,NA
279.123752,C15H20O5,cpd:C09346,Autumnolide,C15H20O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09346  Autumnolide,NA,NA
279.123752,C15H20O5,cpd:C09480,Hymenoflorin,C15H20O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09480  Hymenoflorin,NA,NA
279.123752,C15H20O5,cpd:C09707,Phaseic acid,C15H20O5,Carotenoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09707  Phaseic acid,NA,R07576 R07577
279.123752,C15H20O5,cpd:C15514,8'-Hydroxyabscisate;8'-Hydroxyabscisic acid,C15H20O5,Carotenoid biosynthesis,NA,NA,1.14.14.137,R07202 R07576
279.1601589,C16H24O4,cpd:C17748,"1-(3,4-Dihydroxyphenyl)-5-hydroxy-3-decanone",C16H24O4,"Stilbenoid, diarylheptanoid and gingerol biosynthesis;Biosynthesis of secondary metabolites",NA,NA,2.1.1.-,R08799 R08802 R08804
279.1601589,C16H24O4,cpd:C19417,"3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate",C16H24O4,NA,NA,NA,NA,NA
281.0456145,C16H10O5,cpd:C08722,"4,5-Methylenedioxy-6-hydroxyaurone",C16H10O5,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Aurones;    C08722  4,5-Methylenedioxy-6-hydroxyaurone",NA,NA
281.0456145,C16H10O5,cpd:C10522,Pseudobaptigenin,C16H10O5,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10522  Pseudobaptigenin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10522  Pseudobaptigenin,1.14.14.90;1.14.19.63,R07745 R07746
281.139466,C15H22O5,cpd:C09482,Hymenoxon,C15H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09482  Hymenoxon,NA,NA
281.139466,C15H22O5,cpd:C09538,Qing Hau Sau;Artemisinin,C15H22O5,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010319 Eudesmane sesquiterpenoids;     C09538  Artemisinin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09538  Artemisinin;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;  P01 ANTIPROTOZOALS;   P01B ANTIMALARIALS;    P01BE Artemisinin and derivatives, plain;     P01BE01 Artemisinin;      D02481  Artemisinin (INN);Antimicrobials [BR:br08307]; Antiparasitics;  Antmalarials;   Artemisinin and derivatives;    D02481  Artemisinin (INN)",NA,NA
281.139466,C15H22O5,cpd:C15971,Dihydrophaseic acid;(-)-Dihydrophaseic acid,C15H22O5,Carotenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010305 Cyclofarnesane sesquiterpenoids;     C15971  Dihydrophaseic acid,NA,R07577
281.1758341,C16H26O4,cpd:C16508,12-trans-Hydroxy juvenile hormone III,C16H26O4,Insect hormone biosynthesis,NA,NA,NA,R08155
283.0612636,C16H12O5,cpd:C00814,Biochanin A,C16H12O5,Isoflavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C00814  Biochanin A;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C00814  Biochanin A,1.3.1.46;1.14.14.88;1.14.14.90;2.1.1.46;2.4.1.170,R02931 R02954 R06561 R06795 R07776
283.0612636,C16H12O5,cpd:C01448,Questin,C16H12O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C01448  Questin,1.14.13.43;2.1.1.283,R02417 R10472
283.0612636,C16H12O5,cpd:C01470,"Acacetin;5,7-Dihydroxy-4'-methoxyflavone;4'-Methoxy-5,7-dihydroxyflavone",C16H12O5,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C01470  Acacetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C01470  Acacetin,2.1.1.75,R03571
283.0612636,C16H12O5,cpd:C01562,Calycosin;3'-Hydroxyformononetin,C16H12O5,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C01562  Calycosin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C01562  Calycosin,1.14.14.88;1.14.19.63,R03006 R07744 R07745
283.0612636,C16H12O5,cpd:C02920,2'-Hydroxyformononetin;2'-Hydroformononetin,C16H12O5,Isoflavonoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Pterocarpan biosynthesis, daidzein => medicarpin",Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C02920  2'-Hydroxyformononetin,1.3.1.45;1.14.14.89;1.14.14.90,R06560 R06562 R07735
283.0612636,C16H12O5,cpd:C10046,Genkwanin;Apigenin 7-methyl ether,C16H12O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10046  Genkwanin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10046  Genkwanin,NA,NA
283.0612636,C16H12O5,cpd:C10047,Geraldone;5-Deoxychrysoeriol,C16H12O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10047  Geraldone;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10047  Geraldone,NA,NA
283.0612636,C16H12O5,cpd:C10197,Wogonin;Norwogonin 8-methyl ether,C16H12O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10197  Wogonin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10197  Wogonin,NA,NA
283.0612636,C16H12O5,cpd:C10323,Cypripedin,C16H12O5,NA,NA,NA,NA,NA
283.0612636,C16H12O5,cpd:C10370,"Lucidin omega-methyl ether;2-(Methoxymethyl)-1,3-dihydroxyanthraquinone",C16H12O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10370  Lucidin omega-methyl ether,NA,NA
283.0612636,C16H12O5,cpd:C10502,(-)-Maackiain;Inermin,C16H12O5,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10502  (-)-Maackiain;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10502  (-)-Maackiain,2.4.1.170,R07752 R07753 R07756
283.0612636,C16H12O5,cpd:C10504,Melannin,C16H12O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1210 Neoflavonoids;    C10504  Melannin;Phytochemical compounds [BR:br08003]; Others;  Others;   Neoflavonoids;    C10504  Melannin,NA,NA
283.0612636,C16H12O5,cpd:C10521,Prunetin,C16H12O5,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10521  Prunetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10521  Prunetin,2.1.1.150,R06794
283.0612636,C16H12O5,cpd:C10536,"Texasin;6,7-Dihydroxy-3-(4-methoxyphenyl)-4-benzopyrone",C16H12O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10536  Texasin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10536  Texasin,NA,NA
283.0612636,C16H12O5,cpd:C11577,"3-Methylgalangin;5,7-Dihydroxy-3-methoxy-2-phenyl-4H-1-benzopyran-4-one",C16H12O5,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C11577  3-Methylgalangin,NA,NA
283.0612636,C16H12O5,cpd:C14536,"Glycitein;7,4'-Dihydroxy-6-methoxyisoflavone",C16H12O5,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C14536  Glycitein;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C14536  Glycitein,2.4.1.170,R07717 R07718
283.0612636,C16H12O5,cpd:C16229,(+)-Maackiain,C16H12O5,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C16229  (+)-Maackiain,NA,R07748 R07749
283.0612636,C16H12O5,cpd:C17039,Obtusifolin,C16H12O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C17039  Obtusifolin,NA,NA
283.0612636,C16H12O5,cpd:C17045,Physcion;Emodin monomethyl ether;Rheochrysidin;Parienin,C16H12O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C17045  Physcion,NA,NA
283.1914817,C16H28O4,cpd:C16505,(10S)-Juvenile hormone III diol,C16H28O4,Insect hormone biosynthesis,NA,NA,3.1.1.59,R08150 R08153 R08154
283.2278492,C17H32O3,cpd:C13792,2-Methoxy-5Z-hexadecenoic acid;2-Methoxy-5Z-hexadecenoate;(5Z)-2-Methoxyhexadecenoic acid,C17H32O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0108 Methoxy fatty acids;    C13792  (5Z)-2-Methoxyhexadecenoic acid,NA,NA
283.2278492,C17H32O3,cpd:C13946,2-Methoxy-6Z-hexadecenoic acid;2-Methoxy-6Z-hexadecenoate;(6Z)-2-Methoxyhexadecenoic acid,C17H32O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0108 Methoxy fatty acids;    C13946  (6Z)-2-Methoxyhexadecenoic acid,NA,NA
283.2278492,C17H32O3,cpd:C14996,"12-(2,3-Dihydroxycyclopentyl)-2-dodecanone",C17H32O3,NA,NA,NA,NA,NA
283.2642213,C18H36O2,cpd:C01530,Octadecanoic acid;Stearate;Stearic acid,C18H36O2,Fatty acid biosynthesis;Biosynthesis of unsaturated fatty acids;Biosynthesis of plant secondary metabolites;Phototransduction - fly,NA,Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Saturated fatty acids;    C01530  Stearic acid (18:0);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C01530  Octadecanoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Saturated fatty acids;    C01530  Stearic acid;Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Stearic acid;    D00119  Stearic acid (JP18/NF);Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00119  Stearic acid,3.1.2.2;3.1.2.14;6.2.1.57,R08163 R08174 R12393 R12395
283.2642213,C18H36O2,cpd:C20356,Isooctadecanoic acid;Isostearic acid,C18H36O2,NA,NA,NA,NA,NA
285.0403986,C15H10O6,cpd:C01514,"Luteolin;3',4',5,7-Tetrahydroxyflavone;5,7,3',4'-Tetrahydroxyflavone",C15H10O6,Flavonoid biosynthesis;Flavone and flavonol biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C01514  Luteolin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C01514  Luteolin,1.14.14.81;1.14.14.82;1.14.19.76;1.14.20.5;2.1.1.42;2.4.1.81;2.4.1.189,R03587 R03588 R03589 R03590 R06537 R10260 R12279
285.0403986,C15H10O6,cpd:C05903,"Kaempferol;3,4',5,7-Tetrahydroxyflavone;3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;5,7,4'-Trihydroxyflavonol;C.I. 75640;Indigo yellow;Kaempherol;Kempferol;Nimbecetin;Pelargidenolon;Populnetin;Rhamnolutein;Rhamnolutin;Robigenin;Swartziol;Trifolitin",C15H10O6,Flavonoid biosynthesis;Flavone and flavonol biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C05903  Kaempferol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C05903  Kaempferol,1.14.14.81;1.14.14.82;1.14.20.6;2.1.1.76;2.1.1.155;2.4.1.91;2.4.1.234;2.4.1.-;2.4.2.56,R03126 R05035 R06538 R06611 R06807 R06808 R09802 R10609
285.0403986,C15H10O6,cpd:C08576,Aureusidin,C15H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1213 Aurone flavonoids;    C08576  Aureusidin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Aurones;    C08576  Aureusidin,1.21.3.6,R07224 R07225 R08011
285.0403986,C15H10O6,cpd:C08720,Maritimetin,C15H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1213 Aurone flavonoids;    C08720  Maritimetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Aurones;    C08720  Maritimetin,NA,NA
285.0403986,C15H10O6,cpd:C10036,"Datiscetin;3,5,7,2'-Tetrahydroxyflavone",C15H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10036  Datiscetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10036  Datiscetin,NA,NA
285.0403986,C15H10O6,cpd:C10041,"Fisetin;7,3',4'-Trihydroxyflavonol",C15H10O6,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10041  Fisetin,NA,NA
285.0403986,C15H10O6,cpd:C10097,Isoscutellarein;8-Hydroxyapigenin,C15H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10097  Isoscutellarein;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10097  Isoscutellarein,NA,NA
285.0403986,C15H10O6,cpd:C10184,Scutellarein;Isocarthamidin;6-Hydroxyapigenin,C15H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C10184  Scutellarein;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10184  Scutellarein,NA,NA
285.0403986,C15H10O6,cpd:C10510,Orobol,C15H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10510  Orobol;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10510  Orobol,NA,NA
285.0403986,C15H10O6,cpd:C12134,"2'-Hydroxygenistein;2',4',5,7-Tetrahydroxyisoflavone",C15H10O6,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C12134  2'-Hydroxygenistein;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C12134  2'-Hydroxygenistein,1.14.14.90,R06607
285.0403986,C15H10O6,cpd:C17786,6-Demethoxycapillarisin,C15H10O6,NA,NA,NA,NA,NA
285.0403986,C15H10O6,cpd:C17810,Citreorosein;omega-Hydroxyemodin,C15H10O6,NA,NA,NA,NA,NA
285.076782,C16H14O5,cpd:C00786,(-)-Vestitone;Vestitone,C16H14O5,Isoflavonoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Pterocarpan biosynthesis, daidzein => medicarpin",Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C00786  (-)-Vestitone;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C00786  (-)-Vestitone,1.1.1.348;1.3.1.45,R02915 R06562 R06565 R07737
285.076782,C16H14O5,cpd:C02675,"Dihydrobiochanin A;2,3-Dihydrobiochanin A",C16H14O5,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C02675  Dihydrobiochanin A;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C02675  Dihydrobiochanin A,1.3.1.46,R02954
285.076782,C16H14O5,cpd:C02922,2'-O-Methyllicodione,C16H14O5,NA,NA,NA,2.1.1.65,R03623
285.076782,C16H14O5,cpd:C05334,"Isosakuranetin;4'-Methoxy-5,7-dihydroxyflavonone;4'-Methylnaringenin",C16H14O5,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C05334  4'-Methoxy-5,7-dihydroxyflavonone;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C05334  Isosakuranetin",2.1.1.231,R12213
285.076782,C16H14O5,cpd:C08844,Moracin A,C16H14O5,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   2-Arylbenzofurans;    C08844  Moracin A,NA,NA
285.076782,C16H14O5,cpd:C08974,Sainfuran,C16H14O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1216 Other Flavonoids;    C08974  Sainfuran;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   2-Arylbenzofurans;    C08974  Sainfuran,NA,NA
285.076782,C16H14O5,cpd:C09044,Quinquangulin,C16H14O5,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Naphthopyrones;    C09044  Quinquangulin,NA,NA
285.076782,C16H14O5,cpd:C09282,Oxypeucedanin,C16H14O5,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09282  Oxypeucedanin,NA,NA
285.076782,C16H14O5,cpd:C09833,Sakuranetin;Naringenin 7-methyl ether;(2S)-Sakuranetin,C16H14O5,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09833  Sakuranetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09833  Sakuranetin,2.1.1.232,R09791
285.076782,C16H14O5,cpd:C09920,Brazilin,C16H14O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1210 Neoflavonoids;    C09920  Brazilin,NA,NA
285.076782,C16H14O5,cpd:C09975,"2',4',6'-Trihydroxy-3'-formyldihydrochalcone",C16H14O5,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihydrochalcones;    C09975  2',4',6'-Trihydroxy-3'-formyldihydrochalcone",NA,NA
285.076782,C16H14O5,cpd:C10274,Phyllodulcin,C16H14O5,NA,NA,Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Stilbenoids;   Miscellaneous stilbenoids;    C10274  Phyllodulcin,NA,NA
285.076782,C16H14O5,cpd:C10508,(-)-Nissolin,C16H14O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10508  (-)-Nissolin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10508  (-)-Nissolin,NA,NA
285.076782,C16H14O5,cpd:C12434,"(S)-DNPA;4-Dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naphtho[2,3-c]pyran-3-acetic acid",C16H14O5,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,4.2.1.-,R06695 R09308
285.076782,C16H14O5,cpd:C16190,"2,7-Dihydroxy-4'-methoxyisoflavanone",C16H14O5,Isoflavonoid biosynthesis,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C16190  2,7-Dihydroxy-4'-methoxyisoflavanone",2.1.1.212;4.2.1.105,R07722 R07723
285.076782,C16H14O5,cpd:C18835,(R)-DNPA,C16H14O5,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,NA,R09311
285.0801953,C13H18O5S,cpd:C18829,Ethofumesate,C13H18O5S,NA,NA,Pesticides [BR:br08007]; Pesticides;  Herbicides;   Others;    C18829  Ethofumesate,NA,NA
285.0979564,C13H18O7,cpd:C01451,Salicin;Salicoside,C13H18O7,Glycolysis / Gluconeogenesis;Biosynthesis of phenylpropanoids;Phosphotransferase system (PTS);Taste transduction,NA,Glycosides [BR:br08021]; O-glycosides;  Phenolic glycosides;   C01451  Salicin,2.4.1.172;2.7.1.-,R03558 R04394
285.0979564,C13H18O7,cpd:C16964,Gastrodin;4-(Hydroxymethyl)phenyl-beta-D-glucopyranoside,C13H18O7,NA,NA,NA,NA,NA
285.0979564,C13H18O7,cpd:C17599,Methylarbutin,C13H18O7,NA,NA,NA,NA,NA
285.2071233,C16H30O4,cpd:C14987,"2,3-Dihydroxycyclopentaneundecanoic acid",C16H30O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0114 Carbocyclic fatty acids;    C14987  2,3-Dihydroxycyclopentaneundecanoic acid",NA,NA
285.2071233,C16H30O4,cpd:C19615,Hexadecanedioate,C16H30O4,"Cutin, suberine and wax biosynthesis;Metabolic pathways",NA,NA,1.2.-.-,R09457
285.2435555,C17H34O3,cpd:C11849,3-Hydroxy-palmitic acid methyl ester,C17H34O3,Two-component system,NA,NA,NA,NA
285.2435555,C17H34O3,cpd:C13947,2-Methoxyhexadecanoic acid;2-Methoxyhexadecanoate,C17H34O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0108 Methoxy fatty acids;    C13947  2-Methoxyhexadecanoic acid,NA,NA
287.0561209,C15H12O6,cpd:C00974,Dihydrokaempferol;Aromadendrin;(+)-Dihydrokaempferol;(+)-Aromadendrin,C15H12O6,Flavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Flavonoid biosynthesis, naringenin => pelargonidin",Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C00974  Dihydrokaempferol,1.1.1.219;1.14.11.9;1.14.14.81;1.14.14.82;1.14.20.4;1.14.20.6,R02444 R03123 R03124 R03125 R03126 R06540
287.0561209,C15H12O6,cpd:C01378,"Fustin;2,3-Dihydrofisetin",C15H12O6,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C01378  Fustin,1.1.1.219;1.14.11.9;1.14.14.82,R07997 R07999 R08001 R08032
287.0561209,C15H12O6,cpd:C05631,Eriodictyol,C15H12O6,Flavonoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C05631  Eriodictyol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C05631  Eriodictyol,1.1.1.234;1.14.11.9;1.14.14.81;1.14.14.82;1.14.19.76;1.14.20.5,R02442 R03590 R03640 R04901 R04902 R07991 R08012 R12279
287.0561209,C15H12O6,cpd:C08724,Okanin,C15H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C08724  Okanin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C08724  Okanin,NA,NA
287.0561209,C15H12O6,cpd:C09277,Micromelin,C15H12O6,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09277  Micromelin,NA,NA
287.0561209,C15H12O6,cpd:C10060,"3,5-Dimethoxy-1,6-dihydroxyxanthone",C15H12O6,NA,NA,"Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10060  3,5-Dimethoxy-1,6-dihydroxyxanthone",NA,NA
287.0561209,C15H12O6,cpd:C10064,"Gentiacaulein;2,8-Dihydroxy-1,6-dimethoxyxanthone",C15H12O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10064  Gentiacaulein,NA,NA
287.0561209,C15H12O6,cpd:C10083,"2-O-Methylswertianin;1,8-Dihydroxy-2,6-dimethoxyxanthone",C15H12O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10083  2-O-Methylswertianin,NA,NA
287.0561209,C15H12O6,cpd:C10091,"Swerchirin;5-O-Methylbellidifolin;3,5-Dimethoxy-1,8-dihydroxyxanthone",C15H12O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10091  Swerchirin,NA,NA
287.0561209,C15H12O6,cpd:C10415,(+-)-Dalbergioidin,C15H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10415  (+-)-Dalbergioidin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C10415  (+-)-Dalbergioidin,NA,NA
287.0561209,C15H12O6,cpd:C12631,"2-Hydroxy-2,3-dihydrogenistein;2,4',5,7-Tetrahydroxyisoflavanone",C15H12O6,Isoflavonoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Isoflavone biosynthesis, liquiritigenin => daidzein / naringenin => genistein","Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C12631  2-Hydroxy-2,3-dihydrogenistein",1.14.14.87;4.2.1.105,R06792 R06793 R07778
287.0561209,C15H12O6,cpd:C15525,"Eriodictyol chalcone;2',3,4,4',6'-Pentahydroxychalcone",C15H12O6,Flavonoid biosynthesis;Metabolic pathways,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C15525  Eriodictyol chalcone,1.21.3.6;2.3.1.74;2.4.1.286,R07225 R07988 R07991 R08005 R08007 R08031
287.0561209,C15H12O6,cpd:C16233,"2,6,7,4'-Tetrahydroxyisoflavanone",C15H12O6,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C16233  2,6,7,4'-Tetrahydroxyisoflavanone",1.14.14.87,R07715 R07716
287.0561209,C15H12O6,cpd:C16940,Carthamidin,C15H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C16940  Carthamidin,NA,NA
287.0924625,C16H16O5,cpd:C09471,Asebogenin;Phloretin 4'-methyl ether,C16H16O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C09471  Asebogenin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihydrochalcones;    C09471  Asebogenin,NA,NA
287.0924625,C16H16O5,cpd:C10292,Alkannin,C16H16O5,NA,NA,NA,NA,NA
287.0924625,C16H16O5,cpd:C12435,6-Deoxydihydrokalafungin;DDHK,C16H16O5,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,1.14.14.-,R06695 R06696 R09314
287.0924625,C16H16O5,cpd:C16187,"7,2'-Dihydroxy-4'-methoxy-isoflavanol;DMI;(3R,4R)-4'-Methoxyisoflavan-2',4,7-triol",C16H16O5,Isoflavonoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Pterocarpan biosynthesis, daidzein => medicarpin","Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanes;    C16187  7,2'-Dihydroxy-4'-methoxy-isoflavanol",1.1.1.348;4.2.1.139,R07737 R07738
287.0924625,C16H16O5,cpd:C17412,Shikonin,C16H16O5,Ubiquinone and other terpenoid-quinone biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Others;  Naphthoquinones;   alpha-Naphthoquinones;    C17412  Shikonin,NA,R09044
287.222802,C16H32O4,cpd:C08285,"10,16-Dihydroxyhexadecanoic acid;Hexadecanoic acid, 10,16-dihydroxy-",C16H32O4,"Cutin, suberine and wax biosynthesis",NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C08285  10,16-Dihydroxyhexadecanoic acid",1.14.-.-,R09460
289.0717792,C15H14O6,cpd:C03648,"cis-3,4-Leucopelargonidin",C15H14O6,Flavonoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Flavonoid biosynthesis, naringenin => pelargonidin","Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3,4-diols;    C03648  cis-3,4-Leucopelargonidin",1.1.1.219;1.14.20.4;1.17.1.3,R03123 R04276 R06540 R06615
289.0717792,C15H14O6,cpd:C05907,Luteoforol;3-Deoxyleucocyanidin,C15H14O6,Flavonoid biosynthesis,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C05907  Luteoforol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 4-ols;    C05907  Luteoforol",1.1.1.234,R04901
289.0717792,C15H14O6,cpd:C06562,"(+)-Catechin;D-Catechin;Cyanidanol;(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol;(2R,3S)-Catechin;(2R,3S)-(+)-Catechin;Cianidanol",C15H14O6,Flavonoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C06562  (+)-Catechin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C06562  (+)-Catechin",1.17.1.3,R06532
289.0717792,C15H14O6,cpd:C08739,alpha-Cotonefuran,C15H14O6,NA,NA,NA,NA,NA
289.0717792,C15H14O6,cpd:C08742,"2,8-Dihydroxy-3,4,7-trimethoxydibenzofuran",C15H14O6,NA,NA,NA,NA,NA
289.0717792,C15H14O6,cpd:C09030,Ptaeroglycol,C15H14O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C09030  Ptaeroglycol,NA,NA
289.0717792,C15H14O6,cpd:C09511,Mikanolide,C15H14O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09511  Mikanolide,NA,NA
289.0717792,C15H14O6,cpd:C09727,(-)-Epicatechin,C15H14O6,Flavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09727  (-)-Epicatechin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C09727  (-)-Epicatechin",1.3.1.77,R06542
289.0717792,C15H14O6,cpd:C09728,(+)-Epicatechin;ent-Epicatechin,C15H14O6,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09728  (+)-Epicatechin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C09728  (+)-Epicatechin",NA,NA
289.0717792,C15H14O6,cpd:C09736,"Fisetinidol-4beta-ol;(-)-Mollisacacidin;Fisetinin-3,4-diol;5-Deoxyleucocyanidin",C15H14O6,Flavonoid biosynthesis,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09736  Fisetinidol-4beta-ol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3,4-diols;    C09736  5-Deoxyleucocyanidin",1.1.1.219,R07999 R08001
289.0717792,C15H14O6,cpd:C09787,Isoplumericin,C15H14O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09787  Isoplumericin,NA,NA
289.0717792,C15H14O6,cpd:C09796,Plumericin,C15H14O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09796  Plumericin,NA,NA
289.0717792,C15H14O6,cpd:C14079,(-)-Catechin,C15H14O6,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C14079  (-)-Catechin,NA,NA
289.0717792,C15H14O6,cpd:C17590,Catechin;(+/-)-Catechin,C15H14O6,NA,NA,NA,NA,NA
289.1081798,C16H18O5,cpd:C09016,5-O-Methylvisamminol,C16H18O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1311 Benzopyranoids;    C09016  5-O-Methylvisamminol;Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C09016  5-O-Methylvisamminol,NA,NA
291.0873985,C15H16O6,cpd:C09397,Dihydromikanolide,C15H16O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09397  Dihydromikanolide,NA,NA
291.0873985,C15H16O6,cpd:C09529,Picrotoxinin,C15H16O6,GABA-A receptor agonists/antagonists,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010354 Picrotoxane sesquiterpenoids;     C09529  Picrotoxinin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09529  Picrotoxinin;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Sesquiterpenoids;    C09529  Picrotoxinin;Target-based classification of compounds [BR:br08010]; Ion channels;  Cys-loop superfamily;   GABA-A;    GABAA-receptor;     C09529  Picrotoxinin,NA,NA
291.1601807,C17H24O4,cpd:C09741,Trichodermin,C17H24O4,NA,NA,NA,NA,NA
291.1601807,C17H24O4,cpd:C10459,Gingerdione;[6]-Gingerdione,C17H24O4,NA,NA,NA,NA,NA
293.0302891,C13H10O8,cpd:C10406,Tricrozarin A,C13H10O8,NA,NA,NA,NA,NA
293.0666627,C14H14O7,cpd:C17017,Cyclic dehypoxanthine futalosine,C14H14O7,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, futalosine pathway;Menaquinone biosynthesis, modified futalosine pathway",NA,1.14.-.-;1.21.98.1,R08588 R08589
293.087809,C11H18O9,cpd:C08570,Tuliposide B,C11H18O9,NA,NA,NA,NA,NA
293.087809,C11H18O9,cpd:C21186,"6-Tuliposide B;6-O-[(3S)-3,4-Dihydroxy-2-methylenebutanoyl]-D-glucose",C11H18O9,NA,NA,NA,4.2.99.23,R11215
293.1030428,C15H18O6,cpd:C09570,Tutin,C15H18O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Tutinolide;    C09570  Tutin;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Sesquiterpenoids;    C09570  Tutin,NA,NA
293.1757938,C17H26O4,cpd:C09709,Phytuberin,C17H26O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09709  Phytuberin,NA,NA
293.1757938,C17H26O4,cpd:C10342,Embelin,C17H26O4,NA,NA,NA,NA,NA
293.1757938,C17H26O4,cpd:C10462,[6]-Gingerol;(S)-(+)-[6]Gingerol;6-Gingerol,C17H26O4,"Stilbenoid, diarylheptanoid and gingerol biosynthesis;Biosynthesis of secondary metabolites",NA,Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Others;   Zingiber derived compounds;    C10462  [6]-Gingerol,2.1.1.-,R08800 R08804
293.2121856,C18H30O3,cpd:C04594,"(9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoic acid;(9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoate;13(S)-EOD",C18H30O3,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0107 Epoxy fatty acids;    C04594  (9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoic acid",NA,NA
293.2121856,C18H30O3,cpd:C04780,"8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate;OPC-8:0",C18H30O3,alpha-Linolenic acid metabolism;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites,Jasmonic acid biosynthesis,NA,1.3.1.42;6.2.1.-,R03401 R07887
293.2121856,C18H30O3,cpd:C13798,8-(5-Hexyl-furan-2-yl)-octanoic acid;8-(5-Hexyl-furan-2-yl)-octanoate,C18H30O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0115 Heterocyclic fatty acids;    C13798  8-(5-Hexyl-furan-2-yl)-octanoic acid,NA,NA
293.2121856,C18H30O3,cpd:C14765,"13-OxoODE;13-KODE;(9Z,11E)-13-Oxooctadeca-9,11-dienoic acid",C18H30O3,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14765  (9Z,11E)-13-Oxooctadeca-9,11-dienoic acid",1.1.1.-,R07058
293.2121856,C18H30O3,cpd:C14766,"9-OxoODE;9-KODE;(10E,12Z)-9-Oxooctadeca-10,12-dienoic acid",C18H30O3,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14766  (10E,12Z)-9-Oxooctadeca-10,12-dienoic acid",NA,NA
293.2121856,C18H30O3,cpd:C16316,"13(S)-HOT;(9Z,11E,15Z)-(13S)-Hydroxyoctadeca-9,11,15-trienoate;(9Z,11E,15Z)-(13S)-13-Hydroxyoctadeca-9,11,15-trienoic acid;(9Z,11E,13S,15Z)-13-Hydroxyoctadeca-9,11,15-trienoic acid;13(S)-HOTrE",C18H30O3,alpha-Linolenic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C16316  (9Z,11E,14Z)-(13S)-13-Hydroxyoctadeca-9,11,14-trienoic acid",NA,NA
293.2121856,C18H30O3,cpd:C16326,"9(S)-HOT;(9S)-(10E,12Z,15Z)-9-Hydroxyoctadecatri-10,12,15-enoic acid;9(S)-HOTrE",C18H30O3,alpha-Linolenic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C16326  (9S)-(10E,12Z,15Z)-9-Hydroxyoctadecatri-10,12,15-enoic acid",NA,NA
293.2121856,C18H30O3,cpd:C16342,"2(R)-HOT;(2R)-(9Z,12Z,15Z)-2-Hydroxyoctadecatri-9,12,15-enoic acid;2(R)-HOTrE",C18H30O3,alpha-Linolenic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C16342  (2R)-(9Z,12Z,15Z)-2-Hydroxyoctadecatri-9,12,15-enoic acid",NA,NA
293.2121856,C18H30O3,cpd:C16346,"17-Hydroxylinolenic acid;(9Z,12Z,15Z)-17-Hydroxyoctadecatri-9,12,15-enoic acid",C18H30O3,alpha-Linolenic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C16346  (9Z,12Z,15Z)-17-Hydroxyoctadecatri-9,12,15-enoic acid",NA,NA
293.2121856,C18H30O3,cpd:C19613,"Juvenile hormone I;Methyl (2E,6E,10R,11S)-10,11-epoxy-7-ethyl-3,11-dimethyl-2,6-tridecadienoate",C18H30O3,NA,NA,NA,3.1.1.59,R10983
293.2121856,C18H30O3,cpd:C19827,"Colneleate;(8E)-9-[(1E,3Z)-Nona-1,3-dien-1-yloxy]non-8-enoate",C18H30O3,NA,NA,NA,4.2.1.121,R09699
295.0459239,C13H12O8,cpd:C10483,Phaseolic acid,C13H12O8,NA,NA,NA,NA,NA
295.0823102,C14H16O7,cpd:C17010,Dehypoxanthine futalosine,C14H16O7,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, futalosine pathway;Menaquinone biosynthesis, modified futalosine pathway",NA,1.21.98.1;3.2.2.26;3.2.2.30,R08587 R08588 R10668
295.1186999,C15H20O6,cpd:C09747,Vomitoxin;Deoxynivalenol;DON,C15H20O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010318 Trichothecane sesquiterpenoids;     C09747  Vomitoxin;Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Trichothecenes;    C09747  Vomitoxin,NA,NA
295.1186999,C15H20O6,cpd:C14537,"Trimethylolpropane triacrylate;2-Ethyl-2-(hydroxymethyl)-1,3-propanediol triacrylate;TMPTA",C15H20O6,NA,NA,NA,NA,NA
295.1550934,C16H24O5,cpd:C09674,Graphinone;Ovalicin,C16H24O5,NA,NA,NA,NA,NA
295.1914978,C17H28O4,cpd:C02195,Steryl sulfate,C17H28O4S,NA,NA,NA,NA,NA
295.1914978,C17H28O4,cpd:C11993,10-Deoxymethynolide,C17H28O4,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin",Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C11993  10-Deoxymethynolide,2.3.1.239;2.4.1.277,R06458 R06460
295.2278932,C18H32O3,cpd:C08318,"(9Z,12Z)-(8R)-Hydroxyoctadeca-9,12-dienoic acid;Laetisaric acid;8-Hydroxylinoleic acid",C18H32O3,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C08318  (9Z,12Z)-(8R)-Hydroxyoctadeca-9,12-dienoic acid",NA,NA
295.2278932,C18H32O3,cpd:C08368,"Vernolic acid;(9Z)-(12S,13R)-12,13-Epoxyoctadecenoic acid;cis-12,13-Epoxy-cis-9-octadecenoic acid",C18H32O3,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0107 Epoxy fatty acids;    C08368  (9Z)-(12S,13R)-12,13-Epoxyoctadecenoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Others;    C08368  Vernolic acid",NA,NA
295.2278932,C18H32O3,cpd:C14762,"13(S)-HODE;(13S)-Hydroxyoctadecadienoic acid;(9Z,11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid",C18H32O3,Linoleic acid metabolism;PPAR signaling pathway,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14762  (9Z, 11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid",1.1.1.-,R07058
295.2278932,C18H32O3,cpd:C14767,"9(S)-HODE;(9S)-Hydroxyoctadecadienoic acid;(10E,12Z)-(9S)-9-Hydroxyoctadeca-10,12-dienoic acid",C18H32O3,Linoleic acid metabolism;PPAR signaling pathway,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14767  (10E,12Z)-(9S)-9-Hydroxyoctadeca-10,12-dienoic acid",NA,NA
295.2278932,C18H32O3,cpd:C14825,"9(10)-EpOME;(9R,10S)-(12Z)-9,10-Epoxyoctadecenoic acid",C18H32O3,Linoleic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14825  (9R,10S)-(12Z)-9,10-Epoxyoctadecenoic acid",1.14.14.1;1.14.14.-;3.3.2.-,R07055 R07122
295.2278932,C18H32O3,cpd:C14826,"12(13)-EpOME;(12R,13S)-(9Z)-12,13-Epoxyoctadecenoic acid",C18H32O3,Linoleic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14826  (12R,13S)-(9Z)-12,13-Epoxyoctadecenoic acid",1.14.14.1;1.14.14.-;3.3.2.-,R07056 R07121
295.2278932,C18H32O3,cpd:C19617,18-Oxooleate,C18H32O3,"Cutin, suberine and wax biosynthesis",NA,NA,1.1.-.-;1.2.-.-,R09455 R09458
297.0404451,C16H10O6,cpd:C10202,Bowdichione,C16H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1208 Isoflavans;    C10202  Bowdichione;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10202  Bowdichione,NA,NA
297.0404451,C16H10O6,cpd:C10467,Irilone,C16H10O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10467  Irilone;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10467  Irilone,NA,NA
297.0404451,C16H10O6,cpd:C16226,"2',7-Dihydroxy-4',5'-methylenedioxyisoflavone;DMI",C16H10O6,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C16226  2',7-Dihydroxy-4',5'-methylenedioxyisoflavone",1.3.1.45;1.14.14.90,R07746 R07747 R07751
297.0404451,C16H10O6,cpd:C19587,Aflatoxin P1;AFP1,C16H10O6,NA,NA,NA,NA,NA
297.0404451,C16H10O6,cpd:C19727,"5-Hydroxypseudobaptigenin;5,7-Dihydroxy-3',4'-methylenedioxyisoflavone",C16H10O6,Isoflavonoid biosynthesis,NA,NA,1.14.19.63,R09602
297.0616176,C13H14O8,cpd:C00994,D-Prephenyllactate,C13H14O8,NA,NA,NA,NA,NA
297.0768202,C17H14O5,cpd:C10019,"Apigenin 7,4'-dimethyl ether;Apigenin dimethylether",C17H14O5,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10019  Apigenin 7,4'-dimethyl ether",NA,NA
297.0768202,C17H14O5,cpd:C10199,Afrormosin,C17H14O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10199  Afrormosin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10199  Afrormosin,NA,NA
297.0768202,C17H14O5,cpd:C10527,Sayanedine,C17H14O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10527  Sayanedine;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10527  Sayanedine,NA,NA
297.0768202,C17H14O5,cpd:C18599,Coumafuryl;Fumarin,C17H14O5,NA,NA,"Pesticides [BR:br08007]; Obsolete pesticides;  Rodenticides;   Coumarin rodenticides;    C18599  Coumafuryl;Animal drugs in Japan [BR:br08331]; 99  Agents for not mainly purpose of therapeutic;  994  Rodentickides;   9943  Cumarin, derivatives and preparations;    C18599  Fumarin",NA,NA
297.0768202,C17H14O5,cpd:C18840,R1128A,C17H14O5,NA,NA,NA,NA,NA
297.0979904,C14H18O7,cpd:C10720,Picein,C14H18O7,NA,NA,NA,NA,NA
297.1343669,C15H22O6,cpd:C19146,Sesamex,C15H22O6,NA,NA,Pesticides [BR:br08007]; Obsolete pesticides;  Others;   Synergists;    C19146  Sesamex,NA,NA
297.1343669,C15H22O6,cpd:C19956,Neoilludin A,C15H22O6,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mushroom toxins;   Terpenoids;    C19956  Neoilludin A,NA,NA
297.2071434,C17H30O4,cpd:C17158,Plakortic acid,C17H30O4,NA,NA,NA,NA,NA
297.2435339,C18H34O3,cpd:C00869,2-Oxooctadecanoic acid;2-Oxostearate,C18H34O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C00869  2-Oxooctadecanoic acid,1.1.1.98;1.1.1.99,R03021 R03022
297.2435339,C18H34O3,cpd:C08365,Ricinoleic acid;(9Z)-(12R)-Hydroxyoctadecenoic acid;12-Hydroxy-9-octadecenoic acid;12-Hydroxy-cis-9-octadecenoic acid,C18H34O3,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C08365  (9Z)-(12R)-Hydroxyoctadecenoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Unsaturated fatty acids;    C08365  Ricinoleic acid,NA,NA
297.2435339,C18H34O3,cpd:C13791,"(6R,7S)-6,7-Epoxyoctadecanoic acid;6R,7S-Epoxy-octadecanoic acid;6R,7S-Epoxy-octadecanoate",C18H34O3,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C13791  (6R,7S)-6,7-Epoxyoctadecanoic acid",NA,NA
297.2435339,C18H34O3,cpd:C19418,"cis-9,10-Epoxystearic acid",C18H34O3,"Cutin, suberine and wax biosynthesis",NA,NA,1.11.2.3;1.14.-.-;3.3.2.-,R09453 R09462 R09465
297.2435339,C18H34O3,cpd:C19616,18-Hydroxyoleate,C18H34O3,"Cutin, suberine and wax biosynthesis",NA,NA,1.1.-.-;1.11.2.3;1.14.14.80,R09452 R09455 R09463
299.0196529,C15H8O7,cpd:C10394,Pseudopurpurin,C15H8O7,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10394  Pseudopurpurin,NA,NA
299.056113,C16H12O6,cpd:C04293,"Chrysoeriol;5,7,4'-Trihydroxy-3'-methoxyflavone;3'-O-Methylluteolin",C16H12O6,Flavone and flavonol biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C04293  Chrysoeriol,2.1.1.42,R03587
299.056113,C16H12O6,cpd:C05902,3-Methoxyapigenin;3-O-Methylkaempferol,C16H12O6,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C05902  3-Methoxyapigenin,2.1.1.76,R05035
299.056113,C16H12O6,cpd:C08651,Leptosidin,C16H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1213 Aurone flavonoids;    C08651  Leptosidin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Aurones;    C08651  Leptosidin,NA,NA
299.056113,C16H12O6,cpd:C10038,Diosmetin;Luteolin 4'-methyl ether,C16H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10038  Diosmetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10038  Diosmetin,NA,NA
299.056113,C16H12O6,cpd:C10058,Hispidulin;Dinatin;Scutellarein 6-methyl ether,C16H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10058  Hispidulin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10058  Hispidulin,NA,NA
299.056113,C16H12O6,cpd:C10098,Kaempferide;Kempferide;Kaempferol 4'-methyl ether,C16H12O6,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10098  Kaempferide;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10098  Kaempferide,2.1.1.155,R06807
299.056113,C16H12O6,cpd:C10203,Cajanin,C16H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10203  Cajanin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10203  Cajanin,NA,NA
299.056113,C16H12O6,cpd:C10520,Pratensein;3'-Hydroxybiochanin A,C16H12O6,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10520  Pratensein;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10520  Pratensein,1.14.14.88;1.14.19.63,R07776 R09602
299.056113,C16H12O6,cpd:C10534,Tectorigenin,C16H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10534  Tectorigenin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10534  Tectorigenin,NA,NA
299.056113,C16H12O6,cpd:C12135,2'-Hydroxybiochanin A;Dehydroferreirin,C16H12O6,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C12135  2'-Hydroxybiochanin A;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C12135  2'-Hydroxybiochanin A,1.3.1.45;1.14.14.90,R06561 R06563
299.056113,C16H12O6,cpd:C16227,(+)-Sophorol,C16H12O6,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C16227  (+)-Sophorol,1.3.1.45,R07747 R07748
299.056113,C16H12O6,cpd:C16228,(-)-Sophorol,C16H12O6,Isoflavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C16228  (-)-Sophorol,1.3.1.45,R07751 R07752
299.056113,C16H12O6,cpd:C16230,(+)-6a-Hydroxymaackiain,C16H12O6,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C16230  (+)-6a-Hydroxymaackiain;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C16230  (+)-6a-Hydroxymaackiain,2.1.1.270,R07749 R07750
299.056113,C16H12O6,cpd:C17059,"Rhamnocitrin;7-Methylkaempferol;3,4',5-Trihydroxy-7-methoxyflavone",C16H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C17059  Rhamnocitrin,NA,NA
299.056113,C16H12O6,cpd:C17811,"Questinol;1,6-Dihydroxy-3-(hydroxymethyl)-8-methoxy-9,10-anthracenedione",C16H12O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C17811  Questinol,NA,NA
299.077257,C13H16O8,cpd:C03993,4-(beta-D-Glucosyloxy)benzoate;4-Hydroxybenzoate-O-glucoside,C13H16O8,Ubiquinone and other terpenoid-quinone biosynthesis,NA,NA,2.4.1.194;3.2.1.-,R01304 R09039
299.092538,C17H16O5,cpd:C09734,Farrerol,C17H16O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09734  Farrerol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09734  Farrerol,NA,NA
299.092538,C17H16O5,cpd:C10251,Coelogin,C17H16O5,NA,NA,Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Stilbenoids;   Dihydrophenanthrenes;    C10251  Coelogin,NA,NA
299.092538,C17H16O5,cpd:C10461,4-Hydroxyhomopterocarpin,C17H16O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10461  4-Hydroxyhomopterocarpin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10461  4-Hydroxyhomopterocarpin,NA,NA
299.092538,C17H16O5,cpd:C10531,(-)-Sparticarpin,C17H16O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10531  (-)-Sparticarpin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10531  (-)-Sparticarpin,NA,NA
299.092538,C17H16O5,cpd:C10539,(-)-Variabilin,C17H16O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10539  (-)-Variabilin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10539  (-)-Variabilin,NA,NA
299.092538,C17H16O5,cpd:C17047,Phellopterin,C17H16O5,NA,NA,NA,NA,NA
299.092538,C17H16O5,cpd:C17416,"Astrapterocarpan;(6aR,11aR)-3-Hydroxy-9,10-dimethoxypterocarpan",C17H16O5,NA,NA,NA,NA,NA
299.092538,C17H16O5,cpd:C17503,Cnidilin;Isophellopterin,C17H16O5,NA,NA,NA,NA,NA
299.1136487,C14H20O7,cpd:C06046,Salidroside;p-Hydroxyphenethyl alcohol 1-O-beta-D-glucoside;Tyrosol glucoside,C14H20O7,Tyrosine metabolism;Metabolic pathways,NA,Glycosides [BR:br08021]; O-glycosides;  Phenolic glycosides;   C06046  Salidroside,2.4.1.-,R05083
300.9990067,C14H6O8,cpd:C10788,Ellagic acid,C14H6O8,NA,NA,Phytochemical compounds [BR:br08003]; Others;  Tannins and galloyl derivatives;   Galloyl derivatives;    C10788  Ellagic acid;Target-based classification of compounds [BR:br08010]; Enzymes;  Oxidoreductases;   tyrosinase;    C10788  Ellagic acid,NA,NA
301.0353371,C15H10O7,cpd:C00389,"Quercetin;3,3',4,5,7-Pentahydroxyflavone;3,5,7,3',4'-Pentahydroxyflavone",C15H10O7,Flavonoid biosynthesis;Flavone and flavonol biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;AMPK signaling pathway,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C00389  Quercetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C00389  Quercetin;Target-based classification of compounds [BR:br08010]; Transporters;  Solute carrier family;   SLC22;    SLC22A8;     C00389  Quercetin,1.13.11.24;1.14.14.81;1.14.14.82;1.14.20.6;2.1.1.76;2.4.1.91;2.4.1.237;2.4.1.-;2.8.2.25;3.2.1.66,R02156 R02157 R02158 R02159 R02160 R02436 R06538 R06810;R09803 R10258
301.0353371,C15H10O7,cpd:C02806,8-Hydroxykaempferol,C15H10O7,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C02806  8-Hydroxykaempferol,NA,NA
301.0353371,C15H10O7,cpd:C03662,2'-Hydroxypseudobaptigenin,C15H10O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C03662  2'-Hydroxypseudobaptigenin,NA,NA
301.0353371,C15H10O7,cpd:C08577,Bracteatin,C15H10O7,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Aurones;    C08577  Bracteatin,1.21.3.6,R08005 R08011
301.0353371,C15H10O7,cpd:C10068,6-Hydroxykaempferol,C15H10O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10068  6-Hydroxykaempferol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10068  6-Hydroxykaempferol,NA,NA
301.0353371,C15H10O7,cpd:C10072,"6-Hydroxyluteolin;5,6,7,3',4'-Pentahydroxyflavone",C15H10O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10072  6-Hydroxyluteolin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10072  6-Hydroxyluteolin,NA,NA
301.0353371,C15H10O7,cpd:C10078,Hypolaetin;8-Hydroxyluteolin,C15H10O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10078  Hypolaetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10078  Hypolaetin,NA,NA
301.0353371,C15H10O7,cpd:C10079,"Isoetin;5,7,2',4',5'-Pentahydroxyflavone",C15H10O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10079  Isoetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10079  Isoetin,NA,NA
301.0353371,C15H10O7,cpd:C10105,"Morin;3,5,7,2',4'-Pentahydroxyflavone;C.I.Natural Yellow 8",C15H10O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10105  Morin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10105  Morin,NA,NA
301.0353371,C15H10O7,cpd:C10177,Robinetin;5-Deoxymyricetin,C15H10O7,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10177  Robinetin,NA,NA
301.0353371,C15H10O7,cpd:C10192,"Tricetin;5,7,3',4',5'-Pentahydroxyflavone",C15H10O7,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10192  Tricetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10192  Tricetin,1.14.14.81;1.14.20.5;2.1.1.169;2.1.1.175,R06551 R09611 R09612 R09679 R10260
301.0353371,C15H10O7,cpd:C15031,"2-(4-Hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one;5,6,7,8,4'-Pentahydroxyflavone;Nortangeretin",C15H10O7,NA,NA,NA,NA,NA
301.071731,C16H14O6,cpd:C01709,"Hesperetin;3',5,7-Trihydroxy-4'-methoxyflavanone",C16H14O6,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C01709  Hesperetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C01709  Hesperetin,2.4.1.185;3.2.1.168,R08021 R08026 R09534
301.071731,C16H14O6,cpd:C09756,Homoeriodictyol;Eriodictyol 3'-methyl ether,C16H14O6,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09756  Homoeriodictyol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09756  Homoeriodictyol,NA,R07992 R08012
301.071731,C16H14O6,cpd:C09931,Haematoxylin;Natural Black 1;C.I. 75290,C16H14O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1210 Neoflavonoids;    C09931  Haematoxylin,NA,NA
301.071731,C16H14O6,cpd:C10377,"Nanafrocin;(1S,3R)-Nanaomycin A",C16H14O6,NA,NA,NA,NA,NA
301.071731,C16H14O6,cpd:C10419,"Ferreirin;2,3-Dihydro-5,7-dihydroxy-3-(2-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one",C16H14O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10419  Ferreirin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C10419  Ferreirin,1.3.1.45,R06563
301.071731,C16H14O6,cpd:C12436,Dihydrokalafungin;DHK,C16H14O6,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,1.14.14.-,R06696 R06698 R09312 R09314
301.071731,C16H14O6,cpd:C16405,Homoeriodictyol chalcone,C16H14O6,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C16405  Homoeriodictyol chalcone,2.3.1.74,R07989 R07992 R08031
301.108084,C17H18O5,cpd:C09807,Odoratol,C17H18O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C09807  Odoratol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihydrochalcones;    C09807  Odoratol,NA,NA
301.108084,C17H18O5,cpd:C10495,Lotisoflavan,C17H18O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1208 Isoflavans;    C10495  Lotisoflavan;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanes;    C10495  Lotisoflavan,NA,NA
301.108084,C17H18O5,cpd:C10507,Mucronulatol,C17H18O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1208 Isoflavans;    C10507  Mucronulatol;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanes;    C10507  Mucronulatol,NA,NA
301.1656868,C15H26O6,cpd:C13870,Tributyrin;Glyceryl tributyrate;Glycerol tributyrate,C15H26O6,NA,NA,Lipids [BR:br08002]; GL  Glycerolipids;  GL03 Triradylglycerols;   GL0301 Triacylglycerols;    C13870  Tributyrin,NA,NA
303.0509967,C15H12O7,cpd:C01617,Taxifolin;Dihydroquercetin;(+)-Dihydroquercetin;(+)-Taxifolin;trans-Dihydroquercetin,C15H12O7,Flavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C01617  Taxifolin,1.1.1.219;1.14.11.9;1.14.13.19;1.14.14.81;1.14.14.82;1.14.20.4;1.14.20.6,R02160 R03124 R03636 R03637 R03638 R03639 R03640 R05723
303.0509967,C15H12O7,cpd:C05911,Pentahydroxyflavanone;Dihydrotricetin,C15H12O7,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C05911  Pentahydroxyflavanone,1.14.11.9;1.14.14.81;1.14.20.5,R02443 R04902 R05039 R06551
303.0509967,C15H12O7,cpd:C12316,cis-Dihydroquercetin,C15H12O7,NA,NA,NA,1.14.20.4,R07366
303.0874072,C16H16O6,cpd:C08740,beta-Cotonefuran,C16H16O6,NA,NA,NA,NA,NA
303.0874072,C16H16O6,cpd:C08761,6-Methoxy-alpha-pyrufuran,C16H16O6,NA,NA,NA,NA,NA
303.0874072,C16H16O6,cpd:C18354,(S)-Chiral alcohol,C16H16O6,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,1.1.1.-,R09306 R09307
303.0874072,C16H16O6,cpd:C18356,(S)-Hemiketal,C16H16O6,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,4.2.1.-,R09307 R09308
303.0874072,C16H16O6,cpd:C18360,Dihydrokalafungin dihydroquinone form;DHKred,C16H16O6,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,1.14.14.-,R09312 R09313
303.0874072,C16H16O6,cpd:C18836,Griseophenone C,C16H16O6,NA,NA,NA,NA,NA
303.1237677,C17H20O5,cpd:C09293,Angustibalin;Helenalin 6-acetate,C17H20O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09293  Angustibalin,NA,NA
303.1237677,C17H20O5,cpd:C09303,Arteglasin A,C17H20O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09303  Arteglasin A,NA,NA
303.1237677,C17H20O5,cpd:C09496,Linifolin A,C17H20O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09496  Linifolin A,NA,NA
305.0302677,C14H10O8,cpd:C04524,"2-Protocatechoylphloroglucinolcarboxylate;2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate",C14H10O8,NA,NA,NA,1.13.11.24,R02156
305.0666446,C15H14O7,cpd:C05906,"Leucocyanidin;2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,4,5,7-tetrol;3,3',4,4',5,7-Flavanhexol;3,4-Cyanidiol;Leucoanthocyanidol;Leucocianidol;Leucocyanidol;Leukocyanidine;Procyanidol;Resivit;2,3-trans-3,4-cis-Leucocyanidin",C15H14O7,Flavonoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C05906  Leucocyanidin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3,4-diols;    C05906  Leucocyanidin",1.1.1.219;1.14.20.4;1.17.1.3,R03636 R05036 R05723 R06532 R07366
305.0666446,C15H14O7,cpd:C12127,(+)-Gallocatechin;Gallocatechol,C15H14O7,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C12127  (+)-Gallocatechin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C12127  (+)-Gallocatechin",1.17.1.3,R06533
305.0666446,C15H14O7,cpd:C12136,(-)-Epigallocatechin;Epigallocatechol,C15H14O7,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C12136  (-)-Epigallocatechin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C12136  (-)-Epigallocatechin",1.3.1.77,R06543
305.0699832,C12H18O7S,cpd:C21671,12-Sulfooxyjasmonate;12-Hydroxyjasmonate sulfate,C12H18O7S,NA,NA,NA,2.8.2.39,R11796
305.1030232,C16H18O6,cpd:C09000,Cimifugin,C16H18O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C09000  Cimifugin,NA,NA
305.1030232,C16H18O6,cpd:C21323,"3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoate;3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoic acid",C16H18O6,Biosynthesis of enediyne antibiotics;Metabolic pathways;Biosynthesis of secondary metabolites,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,NA,R11389 R11390
305.1394456,C17H22O5,cpd:C09299,Arnicolide A;Dihydrohelenalin acatate,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09299  Arnicolide A,NA,NA
305.1394456,C17H22O5,cpd:C09374,Confertiflorin;(+)-Confertiflorin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09374  Confertiflorin,NA,NA
305.1394456,C17H22O5,cpd:C09431,Eupaformonin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09431  Eupaformonin,NA,NA
305.1394456,C17H22O5,cpd:C09455,Gaillardin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09455  Gaillardin,NA,NA
305.1394456,C17H22O5,cpd:C09487,Isotenulin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09487  Isotenulin,NA,NA
305.1394456,C17H22O5,cpd:C09494,Ligulatin B;Incanin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09494  Ligulatin B,NA,NA
305.1394456,C17H22O5,cpd:C09497,Lipiferolide,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09497  Lipiferolide,NA,NA
305.1394456,C17H22O5,cpd:C09499,Matricin,C17H22O5,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010341 Guaiane sesquiterpenoids;     C09499  Matricin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09499  Matricin,NA,NA
305.1394456,C17H22O5,cpd:C09522,Ovatifolin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09522  Ovatifolin,NA,NA
305.1394456,C17H22O5,cpd:C09536,Pyrethrosin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09536  Pyrethrosin,NA,NA
305.1394456,C17H22O5,cpd:C09557,Tenulin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09557  Tenulin,NA,NA
305.1394456,C17H22O5,cpd:C09587,Viscidulin B,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09587  Viscidulin B,NA,NA
305.1394456,C17H22O5,cpd:C09602,Xanthinin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09602  Xanthinin,NA,NA
305.1394456,C17H22O5,cpd:C09603,Xanthumin,C17H22O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09603  Xanthumin,NA,NA
305.1757683,C18H26O4,cpd:C14183,Compactin diol lactone;ML-236A,C18H26O4,NA,NA,NA,NA,NA
305.1757683,C18H26O4,cpd:C14300,Di-n-pentyl phthalate;Diamyl phthalate,C18H26O4,NA,NA,Endocrine disrupting compounds [BR:br08006]; Plasticizers and plastics;  Phthalates;   C14300  Di-n-pentyl phthalate,NA,NA
305.1757683,C18H26O4,cpd:C20203,Capsiate,C18H26O4,NA,NA,Phytochemical compounds [BR:br08003]; Amino acid related compounds;  Others;   Capsaicinoids and derivatives;    C20203  Capsiate,NA,NA
307.0822895,C15H16O7,cpd:C09766,Allamandin,C15H16O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09766  Allamandin,NA,NA
307.1186985,C16H20O6,cpd:C08483,14-Dihydroxycornestin;Cornexistin,C16H20O6,NA,NA,NA,NA,NA
307.1186985,C16H20O6,cpd:C09953,Monocerin,C16H20O6,NA,NA,NA,NA,NA
307.1551064,C17H24O5,cpd:C09483,Inulicin,C17H24O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09483  Inulicin,NA,NA
307.1551064,C17H24O5,cpd:C09638,Cinnamodial,C17H24O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09638  Cinnamodial,NA,NA
307.191503,C18H28O4,cpd:C10373,5-O-Methylembelin,C18H28O4,NA,NA,NA,NA,NA
307.191503,C18H28O4,cpd:C15818,Soraphen O,C18H28O4,NA,NA,NA,NA,NA
309.0979719,C15H18O7,cpd:C04164,trans-Cinnamoyl beta-D-glucoside;1-O-trans-Cinnamoyl-beta-D-glucopyranose,C15H18O7,NA,NA,NA,2.3.1.152;2.4.1.177,R02256 R04409 R04410 R04411 R05061
309.0979719,C15H18O7,cpd:C09502,Mellitoxin;Hyenanchin,C15H18O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09502  Mellitoxin,NA,NA
309.0979719,C15H18O7,cpd:C09528,Picrotin,C15H18O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09528  Picrotin,NA,NA
309.1707918,C17H26O5,cpd:C09622,Botrydial,C17H26O5,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010364 Botrydial sesquiterpenoids;     C09622  Botrydial,NA,NA
309.2071721,C18H30O4,cpd:C04785,"13(S)-HPOT;(9Z,11E,15Z)-(13S)-Hydroperoxyoctadeca-9,11,15-trienoate;(9Z,11E,15Z)-(13S)-13-Hydroperoxyoctadeca-9,11,15-trienoic acid;13(S)-HpOTrE;13-HPOT",C18H30O4,alpha-Linolenic acid metabolism;Metabolic pathways;Biosynthesis of secondary metabolites,Jasmonic acid biosynthesis,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0104 Hydroperoxy fatty acids;    C04785  (9Z,11E,14Z)-(13S)-13-Hydroperoxyoctadeca-9,11,14-trienoic acid",1.13.11.12;4.2.1.92,R07863 R07869 R07870 R07871
309.2071721,C18H30O4,cpd:C07357,"(9Z,12Z,15Z)-(7S,8S)-Dihydroxyoctadeca-9,12,15-trienoic acid;(9Z,12Z,15Z)-(7S,8S)-Dihydroxyoctadeca-9,12,15-trienoate",C18H30O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C07357  (9Z,12Z,15Z)-(7S,8S)-Dihydroxyoctadeca-9,12,15-trienoic acid",NA,NA
309.2071721,C18H30O4,cpd:C15753,Dihydroalbocycline,C18H30O4,NA,NA,NA,NA,NA
309.2071721,C18H30O4,cpd:C16321,"9(S)-HPOT;(10E,12Z,15Z)-(9S)-9-Hydroperoxyoctadeca-10,12,15-trienoic acid;9(S)-HpOTrE;(9S,10E,12Z,15Z)-9-Hydroperoxy-10,12,15-octadecatrienoate",C18H30O4,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C16321  (10E,12Z,15Z)-(9S)-9-Hydroperoxyoctadeca-10,12,15-trienoic acid",1.13.11.12;4.2.1.92;4.2.1.121,R07864 R07865 R07867 R07868
309.2071721,C18H30O4,cpd:C16341,"2(R)-HPOT;(2R)-(9Z,12Z,15Z)-2-Hydroperoxyoctadecatri-9,12,15-enoic acid;2(R)-HpOTrE",C18H30O4,alpha-Linolenic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C16341  (2R)-(9Z,12Z,15Z)-2-Hydroperoxyoctadecatri-9,12,15-enoic acid",1.13.11.92,R12775
309.2071721,C18H30O4,cpd:C19936,"(9R,10E,12Z,15Z)-9-Hydroperoxyoctadeca-10,12,15-trienoate",C18H30O4,NA,NA,NA,1.13.11.61,R09810
309.2071721,C18H30O4,cpd:C20704,"(8E,10S,12Z,15Z)-10-Hydroperoxyoctadeca-8,12,15-trienoate",C18H30O4,NA,NA,NA,1.13.11.77,R10578
309.2071721,C18H30O4,cpd:C21923,"9-Hydroxy-12-oxo-10(E),15(Z)-octadecadienoic acid",C18H30O4,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,NA,NA,1.3.1.-,R12140 R12141
311.056066,C17H12O6,cpd:C02007,Aspulvinone G,C17H12O6,NA,NA,NA,NA,NA
311.056066,C17H12O6,cpd:C06800,Aflatoxin B1,C17H12O6,Aflatoxin biosynthesis;Metabolism of xenobiotics by cytochrome P450;Metabolic pathways;Biosynthesis of secondary metabolites;Chemical carcinogenesis - DNA adducts;Hepatocellular carcinoma,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",Lipids [BR:br08002]; PK  Polyketides;  PK10 Aflatoxins and related substances;   C06800  Aflatoxin B1;Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Aflatoxins;    C06800  Aflatoxin B1,1.14.14.1;1.14.14.117;1.14.14.-,R09404 R09405 R09407 R09408 R10319
311.056066,C17H12O6,cpd:C10201,Betavulgarin,C17H12O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10201  Betavulgarin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10201  Betavulgarin,NA,NA
311.056066,C17H12O6,cpd:C20444,Dihydrodemethylsterigmatocystin;DHDMST,C17H12O6,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,NA,2.1.1.109,R10403 R10480
311.1136407,C15H20O7,cpd:C05855,4-Hydroxycinnamyl alcohol 4-D-glucoside;p-Coumaryl alcohol 4-O-glucoside,C15H20O7,Phenylpropanoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Paracoumaryl alcohol derivatives;    C05855  4-Hydroxycinnamyl alcohol 4-D-glucoside,2.4.1.111;3.2.1.126,R04005 R04006
311.1136407,C15H20O7,cpd:C06080,Nivalenol,C15H20O7,Sesquiterpenoid and triterpenoid biosynthesis,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Trichothecenes;    C06080  Nivalenol,NA,R03740
311.1136407,C15H20O7,cpd:C12076,Deoxyanisatin,C15H20O7,NA,NA,NA,NA,NA
311.2227964,C18H32O4,cpd:C04717,"(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid;(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoate;13(S)-HPODE;13S-Hydroperoxy-9Z,11E-octadecadienoic acid",C18H32O4,Linoleic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0104 Hydroperoxy fatty acids;    C04717  (9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid",1.13.11.12;1.13.11.33,R03626
311.2227964,C18H32O4,cpd:C07338,"(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid;(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoate",C18H32O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0104 Hydroperoxy fatty acids;    C07338  (9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid",1.13.11.45,R05718
311.2227964,C18H32O4,cpd:C07354,"(7S,8S)-DiHODE;(9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoic acid;(7S,8S,9Z,12Z)-7,8-Dihydroxyoctadeca-9,12-dienoate",C18H32O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C07354  (9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoic acid",5.4.4.6,R07062
311.2227964,C18H32O4,cpd:C14827,"9(S)-HPODE;9(S)-HPOD;(10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid;(9S,10E,12Z)-9-Hydroperoxy-10,12-octadecadienoate",C18H32O4,Linoleic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14827  (10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid",1.13.11.58;4.2.1.121,R07057 R09699
311.2227964,C18H32O4,cpd:C14831,"8(R)-HPODE;(9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid;(8R,9Z,12Z)-8-Hydroperoxyoctadeca-9,12-dienoate",C18H32O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14831  (9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid",1.13.11.60;5.4.4.5;5.4.4.6,R07061 R07062 R09905
311.2227964,C18H32O4,cpd:C14832,"12,13-Epoxy-9-hydroxy-10-octadecenoate;12(R),13(S)-Epoxy-9(S)-hydroxy-10(E)-octadecenoic acid;(10E)-(9S,12R,13S)-12,13-Epoxy-9-hydroxyoctadec-10-enoic acid",C18H32O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14832  (10E)-(9S,12R,13S)-12,13-Epoxy-9-hydroxyoctadec-10-enoic acid",NA,NA
311.2227964,C18H32O4,cpd:C14834,"9,10-Epoxy-13-hydroxy-11-octadecenoate;(11E)-9,10-Epoxyoctadecenoic acid",C18H32O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14834  (11E)-9,10-Epoxyoctadecenoic acid",NA,NA
311.2227964,C18H32O4,cpd:C14836,"9,10-12,13-Diepoxyoctadecanoate;9,10-12,13-Diepoxyoctadecanoic acid",C18H32O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14836  9,10-12,13-Diepoxyoctadecanoic acid",NA,NA
311.2227964,C18H32O4,cpd:C19618,"Octadec-9-ene-1,18-dioic-acid",C18H32O4,"Cutin, suberine and wax biosynthesis",NA,NA,1.2.-.-,R09458
311.2227964,C18H32O4,cpd:C19937,"(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate",C18H32O4,Linoleic acid metabolism,NA,NA,1.13.11.62,R09811
311.2227964,C18H32O4,cpd:C20186,"5S,8R-DiHODE;(5S,8R)-DiHODE;(5S,8R,9Z,12Z)-5,8-Dihydroxyoctadeca-9,12-dienoate",C18H32O4,Linoleic acid metabolism,NA,NA,5.4.4.5,R09905
311.2227964,C18H32O4,cpd:C20703,"(8E,10S,12Z)-10-Hydroperoxyoctadeca-8,12-dienoate",C18H32O4,NA,NA,NA,1.13.11.77,R10577
311.2227964,C18H32O4,cpd:C21924,9-Hydroxy-12-oxo-15(Z)-octadecenoic acid,C18H32O4,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,NA,NA,1.3.1.-,R12141
313.0353991,C16H10O7,cpd:C10541,Wedelolactone,C16H10O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1209 Coumestan flavonoids;    C10541  Wedelolactone;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Coumestanes;    C10541  Wedelolactone,NA,NA
313.0718003,C17H14O6,cpd:C10407,"Ventinone A;1,4,5-Trihydroxy-7-methoxy-2,3-dimethylanthraquinone",C17H14O6,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10407  Ventinone A,NA,NA
313.0718003,C17H14O6,cpd:C10471,Irisolidone,C17H14O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10471  Irisolidone;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10471  Irisolidone,NA,NA
313.0718003,C17H14O6,cpd:C10516,Pisatin;(+)-Pisatin,C17H14O6,Isoflavonoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10516  Pisatin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10516  Pisatin,2.1.1.270,R07750
313.0718003,C17H14O6,cpd:C15100,"6-Hydroxy-2-(4-hydroxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one;4',6-Dihydroxy-5,7-dimethoxyflavone",C17H14O6,NA,NA,NA,NA,NA
313.0718003,C17H14O6,cpd:C16418,Pinobanksin 3-O-acetate,C17H14O6,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C16418  Pinobanksin 3-O-acetate,NA,R08028
313.0718003,C17H14O6,cpd:C16753,Aflatoxin B2,C17H14O6,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK10 Aflatoxins and related substances;   C16753  Aflatoxin B2;Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Aflatoxins;    C16753  Aflatoxin B2,1.14.14.117,R10320
313.0718003,C17H14O6,cpd:C17784,"4'-Methylcapillarisin;5,7-Dihydroxy-4',6-dimethoxyflavone",C17H14O6,NA,NA,NA,NA,NA
313.0718003,C17H14O6,cpd:C17785,7-Methylcapillarisin;Cirsimaritin;Scrophulein,C17H14O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C17785  7-Methylcapillarisin,NA,NA
313.0718003,C17H14O6,cpd:C19584,Aflatoxicol;AFL,C17H14O6,NA,NA,NA,NA,NA
313.092869,C14H18O8,cpd:C19808,Glucovanillin,C14H18O8,NA,NA,NA,NA,NA
313.180854,C20H26O3,cpd:C09119,Jatrophatrione,C20H26O3,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Mesotricyclic diterpenoids;    C09119  Jatrophatrione,NA,NA
313.180854,C20H26O3,cpd:C09194,Taxodione,C20H26O3,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Abietanes;    C09194  Taxodione,NA,NA
313.180854,C20H26O3,cpd:C14670,"17-Ethynyl-10-hydroxy-19-nortestosterone;17alpha-Ethinyl-10beta,17beta-dihydroxy-4-estren-3-one;10beta-Hydroxynorethindrone",C20H26O3,NA,NA,NA,NA,NA
313.180854,C20H26O3,cpd:C14930,"3-Methoxy-androsta-3,5-diene-7,17-dione",C20H26O3,NA,NA,NA,NA,NA
313.180854,C20H26O3,cpd:C14999,"10-Hydroxyestra-1,4-dien-3-one acetate",C20H26O3,NA,NA,NA,NA,NA
313.180854,C20H26O3,cpd:C15228,"beta-Estradiol 17-acetate;Estra-1,3,5(10)-triene-3,17beta-diol 17-acetate;17beta-Acetylestradiol",C20H26O3,NA,NA,NA,NA,NA
313.180854,C20H26O3,cpd:C16678,all-trans-4-Oxoretinoic acid,C20H26O3,Retinol metabolism;Metabolic pathways,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0109 Retinoids;    C16678  all-trans-4-Oxoretinoic acid,NA,NA
313.180854,C20H26O3,cpd:C18015,Momilactone A,C20H26O3,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010408 Pimarane diterpenoids;     C18015  Momilactone A,1.1.1.295,R08916 R08917
313.2384493,C18H34O4,cpd:C07355,"(9Z)-(7S,8S)-Dihydroxyoctadecenoic acid;(Z)-(7S,8S)-Dihydroxyoctadeca-9-enoic acid;(Z)-(7S,8S)-Dihydroxyoctadeca-9-enoate",C18H34O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C07355  (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid",NA,NA
313.2384493,C18H34O4,cpd:C14828,"9,10-DHOME;9,10-DHOA;(12Z)-9,10-Dihydroxyoctadec-12-enoic acid",C18H34O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C14828  (12Z)-9,10-Dihydroxyoctadec-12-enoic acid",3.3.2.-,R07122
313.2384493,C18H34O4,cpd:C14829,"12,13-DHOME;12,13-DHOA;(9Z)-12,13-Dihydroxyoctadec-9-enoic acid",C18H34O4,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C14829  (9Z)-12,13-Dihydroxyoctadec-9-enoic acid",3.3.2.-,R07121
313.2384493,C18H34O4,cpd:C19620,"9,10-Epoxy-18-hydroxystearate",C18H34O4,"Cutin, suberine and wax biosynthesis",NA,NA,1.11.2.3;1.14.-.-;3.3.2.-,R09453 R09463 R09464
313.2384493,C18H34O4,cpd:C20702,"(8E,10S)-10-Hydroperoxyoctadeca-8-enoate;(8E,10S)-10-Hydroperoxy-8-octadecenoate",C18H34O4,NA,NA,NA,1.13.11.77,R10576
315.0510446,C16H12O7,cpd:C04443,"3-O-Methylquercetin;3',4',5,7-Tetrahydroxy-3-methoxyflavone;3-Methoxy-5,7,3',4'-tetrahydroxyflavone",C16H12O7,Flavone and flavonol biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C04443  3-O-Methylquercetin,2.1.1.76;2.1.1.82,R02157 R05323
315.0510446,C16H12O7,cpd:C08999,Capillarisin,C16H12O7,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C08999  Capillarisin,NA,NA
315.0510446,C16H12O7,cpd:C10022,Azaleatin;Quercetin 5-methyl ether,C16H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10022  Azaleatin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10022  Azaleatin,NA,NA
315.0510446,C16H12O7,cpd:C10084,Isorhamnetin;3-Methylquercetin;Quercetin 3'-methyl ether,C16H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10084  Isorhamnetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10084  Isorhamnetin,NA,NA
315.0510446,C16H12O7,cpd:C10119,"Pedalitin;3',4',5,6-Tetrahydroxy-7-methoxyflavone",C16H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10119  Pedalitin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10119  Pedalitin,NA,NA
315.0510446,C16H12O7,cpd:C10120,Pinoquercetin;6-C-Methylquercetin,C16H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10120  Pinoquercetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10120  Pinoquercetin,NA,NA
315.0510446,C16H12O7,cpd:C10176,Rhamnetin;Quercetin 7-methyl ether,C16H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10176  Rhamnetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10176  Rhamnetin,NA,NA
315.0510446,C16H12O7,cpd:C10185,Sexangularetin;Herbacetin 8-methyl ether,C16H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10185  Sexangularetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10185  Sexangularetin,NA,NA
315.0510446,C16H12O7,cpd:C10188,Tamarixetin;Quercetin 4'-methyl ether,C16H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10188  Tamarixetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10188  Tamarixetin,NA,NA
315.0510446,C16H12O7,cpd:C19739,3'-O-Methyltricetin;Selagin;Tricetin 3'-methyl ether,C16H12O7,NA,NA,NA,2.1.1.169;2.1.1.175,R09612 R09613
315.0874417,C17H16O6,cpd:C10204,Cajanol,C17H16O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10204  Cajanol;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C10204  Cajanol,NA,NA
315.0874417,C17H16O6,cpd:C10457,Homoferreirin,C17H16O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10457  Homoferreirin,NA,NA
315.0874417,C17H16O6,cpd:C14969,"2,3-Dihydro-6-hydroxy-2-(4-hydroxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one;4',6-Dihydroxy-5,7-dimethoxyflavanone",C17H16O6,NA,NA,NA,NA,NA
315.0874417,C17H16O6,cpd:C16914,Isobyakangelicol;Anhydrobyakangelicin,C17H16O6,NA,NA,NA,NA,NA
315.0874417,C17H16O6,cpd:C16925,Byakangelicol,C17H16O6,NA,NA,NA,NA,NA
315.0874417,C17H16O6,cpd:C17126,Neobyakangelicol,C17H16O6,NA,NA,NA,NA,NA
315.2540989,C18H36O4,cpd:C08314,"(9R,10R)-Dihydroxyoctadecanoic acid;9,10-Dihydroxystearic acid",C18H36O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C08314  (9R,10R)-Dihydroxyoctadecanoic acid",NA,NA
315.2540989,C18H36O4,cpd:C15988,"(9S,10S)-9,10-Dihydroxyoctadecanoate",C18H36O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C15988  (9S,10S)-9,10-Dihydroxyoctadecanoic acid",3.1.3.76,R07582
315.2540989,C18H36O4,cpd:C19622,"9,10-Dihydroxystearate",C18H36O4,"Cutin, suberine and wax biosynthesis",NA,NA,1.14.-.-;3.3.2.-,R09461 R09465
317.0302614,C15H10O8,cpd:C04109,"Gossypetin;3,3',4',5,7,8-Hexahydroxyflavone",C15H10O8,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C04109  3,3',4',5,7,8-Hexahydroxyflavone;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C04109  Gossypetin",2.1.1.88,R04398
317.0302614,C15H10O8,cpd:C10107,"Myricetin;3,5,7,3',4',5'-Hexahydroxyflavone",C15H10O8,Flavonoid biosynthesis;Flavone and flavonol biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10107  Myricetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10107  Myricetin,1.14.14.81;1.14.20.6;2.1.1.267,R06539 R06815 R10258
317.0302614,C15H10O8,cpd:C10122,Quercetagetin;6-Hydroxyquercetin,C15H10O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10122  Quercetagetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10122  Quercetagetin,NA,NA
317.0666484,C16H14O7,cpd:C02868,Lecanoric acid;Orsellinate depside,C16H14O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1308 Depsides and depsidones;    C02868  Lecanoric acid,3.1.1.40,R00054
317.0666484,C16H14O7,cpd:C15504,Demethylsulochrin,C16H14O7,NA,NA,NA,1.14.13.43,R02417
317.1030767,C17H18O6,cpd:C17453,Paeoniflorigenone,C17H18O6,NA,NA,NA,NA,NA
317.1030767,C17H18O6,cpd:C17456,Paeonilactone C,C17H18O6,NA,NA,NA,NA,NA
317.1395121,C18H22O5,cpd:C09981,Zearalenone,C18H22O5,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C09981  Zearalenone;Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C09981  Zearalenone,NA,NA
317.1969474,C16H30O6,cpd:C03962,(-)-Menthyl O-beta-D-glucoside,C16H30O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010209 Menthane monoterpenoids;     C03962  (-)-Menthyl O-beta-D-glucoside,2.4.1.127,R02179
317.1969474,C16H30O6,cpd:C04165,(+)-Neomenthyl O-beta-D-glucoside,C16H30O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010209 Menthane monoterpenoids;     C04165  (+)-Neomenthyl O-beta-D-glucoside,NA,NA
319.045964,C15H12O8,cpd:C02906,Dihydromyricetin;Ampelopsin;(+)-Dihydromyricetin;(+)-Ampelopsin,C15H12O8,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C02906  Dihydromyricetin,1.1.1.219;1.14.11.9;1.14.14.81;1.14.20.6,R03125 R03639 R05038 R05039 R06539
319.045964,C15H12O8,cpd:C03052,"2,3-Dihydrogossypetin",C15H12O8,NA,NA,NA,1.14.13.19,R03637 R03638
319.045964,C15H12O8,cpd:C18348,"2,2',3-Trihydroxy-3'-methoxy-5,5'-dicarboxybiphenyl",C15H12O8,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,NA,NA,R09275 R09276
319.0823241,C16H16O7,cpd:C02947,4-Coumaroylshikimate;trans-5-O-(4-Coumaroyl)shikimate,C16H16O7,"Phenylpropanoid biosynthesis;Flavonoid biosynthesis;Stilbenoid, diarylheptanoid and gingerol biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites","Monolignol biosynthesis, phenylalanine/tyrosine => monolignol",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Paracoumaryl alcohol derivatives;    C02947  4-Coumaroylshikimate,1.14.14.96;2.3.1.133,R02416 R06582
319.0823241,C16H16O7,cpd:C11586,alpha-Naphthyl-beta-D-glucuronide;1-Naphthyl glucuronide,C16H16O7,NA,NA,NA,NA,NA
319.0823241,C16H16O7,cpd:C18358,DHKred-OH;Hydroxylated dihydrokalafungin dihydroquinone,C16H16O7,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,1.14.14.-,R06697 R09313
319.1186607,C17H20O6,cpd:C06079,PR-toxin;PR Toxin,C17H20O6,Sesquiterpenoid and triterpenoid biosynthesis,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C06079  PR-toxin,NA,R03798
319.1186607,C17H20O6,cpd:C09298,Arctolide,C17H20O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09298  Arctolide,NA,NA
319.1186607,C17H20O6,cpd:C09373,Conchosin B,C17H20O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09373  Conchosin B,NA,NA
319.1186607,C17H20O6,cpd:C20380,Mycophenolate,C17H20O6,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;  L04 IMMUNOSUPPRESSANTS;   L04A IMMUNOSUPPRESSANTS;    L04AA Selective immunosuppressants;     L04AA06 Mycophenolic acid;      D05096  Mycophenolic acid (USAN/INN);USP drug classification [BR:br08302]; Immunological Agents;  Immunosuppressants;   Antimetabolites, Antiproliferative;    Mycophenolic Acid;     D05096  Mycophenolic acid (USAN/INN);Target-based classification of drugs [BR:br08310]; Enzymes;  Oxidoreductases (EC1);   Dehydrogenases;    IMPDH;     D05096  Mycophenolic acid (USAN/INN);Pharmacogenomic biomarkers [br08341.html]; Polymorphisms and mutations affecting drug response;  D05096;Prodrugs [br08324.html]; D05096",3.1.1.93,R10134
319.1186607,C17H20O6,cpd:C21422,"1-(4-Hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol",C17H20O6,NA,NA,NA,1.11.1.16,R11503
319.1550666,C18H24O5,cpd:C14750,alpha-Zearalenol;trans-Zearalenol,C18H24O5,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C14750  alpha-Zearalenol,NA,NA
319.1550666,C18H24O5,cpd:C14751,beta-Zearalenol;beta-trans-Zearalenol,C18H24O5,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C14751  beta-Zearalenol,NA,NA
319.1550666,C18H24O5,cpd:C14754,Zearalanone;(S)-Zearalanone,C18H24O5,NA,NA,NA,NA,NA
321.0251959,C14H10O9,cpd:C01572,Digallate;Digallic acid,C14H10O9,NA,NA,NA,3.1.1.20,R00053
321.0615483,C15H14O8,cpd:C05909,Leucodelphinidin,C15H14O8,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3,4-diols;    C05909  Leucodelphinidin",1.1.1.219;1.14.20.4;1.17.1.3,R05037 R05038 R06533
321.134388,C17H22O6,cpd:C09559,Tetraneurin A,C17H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09559  Tetraneurin A,NA,NA
321.134388,C17H22O6,cpd:C09568,epi-Tulipinolide diepoxide,C17H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09568  epi-Tulipinolide diepoxide,NA,NA
321.1707387,C18H26O5,cpd:C14752,alpha-Zearalanol;Zeranol,C18H26O5,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C14752  alpha-Zearalanol,NA,NA
321.1707387,C18H26O5,cpd:C14753,beta-Zearalanol;Taleranol,C18H26O5,NA,NA,NA,NA,NA
323.0983677,C12H20O10,cpd:C04333,"Bis-D-fructose 2',1:2,1'-dianhydride;Difructose anhydride I",C12H20O10,NA,NA,NA,3.2.1.134,R03685 R06161
323.0983677,C12H20O10,cpd:C04420,"D-Fructofuranose 1,2':2,3'-dianhydride",C12H20O10,NA,NA,NA,NA,NA
323.150012,C17H24O6,cpd:C09560,Tetraneurin E;Ambrosanolide,C17H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09560  Tetraneurin E,NA,NA
323.168655,C18H28O3S,cpd:C19147,Piperonyl sulfoxide,C18H28O3S,NA,NA,Pesticides [BR:br08007]; Obsolete pesticides;  Others;   Synergists;    C19147  Piperonyl sulfoxide,NA,NA
323.2227785,C19H32O4,cpd:C15495,"Decylubiquinol;6-Decylubiquinol;2-Decyl-5,6-dimethoxy-3-methyl-1,4-benzenediol",C19H32O4,NA,NA,NA,1.8.5.2,R07177
323.2227785,C19H32O4,cpd:C20851,"Dihydromonacolin L acid;(3R,5R)-7-[(1S,2S,4aR,6R,8aS)-2,6-Dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen1yl]-3,5-dihydroxyheptanoate",C19H32O4,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,NA,NA,1.14.14.124;3.1.2.31,R10791 R10793 R11187
325.0564782,C14H14O9,cpd:C02750,Sinapoyltartronate,C14H14O9,NA,NA,NA,2.3.1.106,R03965
325.0929127,C15H18O8,cpd:C04415,4-O-beta-D-Glucosyl-4-hydroxycinnamate,C15H18O8,NA,NA,NA,2.4.1.126,R02951
325.0929127,C15H18O8,cpd:C05158,trans-beta-D-Glucosyl-2-hydroxycinnamate;beta-D-Glucosyl-2-coumarate,C15H18O8,Phenylpropanoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Others;    C05158  trans-beta-D-Glucosyl-2-hydroxycinnamate,2.4.1.114;5.2.1.-,R03710 R04686
325.0929127,C15H18O8,cpd:C05839,cis-beta-D-Glucosyl-2-hydroxycinnamate;beta-D-Glucosyl-2-coumarinate,C15H18O8,Phenylpropanoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Others;    C05839  cis-beta-D-Glucosyl-2-hydroxycinnamate,3.2.1.21;5.2.1.-,R04686 R04998
325.0929127,C15H18O8,cpd:C06739,4'-O-beta-D-Glucosyl-cis-p-coumarate,C15H18O8,NA,NA,NA,2.4.1.209,R05324
325.0929127,C15H18O8,cpd:C07605,Bilobalide,C15H18O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Ginkgolides;    C07605  Bilobalide,NA,NA
325.0929127,C15H18O8,cpd:C16827,p-Coumaroyl-D-glucose;1-O-(4-Coumaroyl)-beta-D-glucose;1-O-(4-Hydroxycinnamoyl)-beta-D-glucose,C15H18O8,NA,NA,NA,2.3.1.213;2.4.1.126,R08534 R10236
325.1139839,C12H22O10,cpd:C08244,2-O-alpha-L-Rhamnopyranosyl-D-glucopyranose;Neohesperidose,C12H22O10,NA,NA,NA,NA,NA
325.1139839,C12H22O10,cpd:C08246,Robinobiose,C12H22O10,NA,NA,NA,NA,NA
325.1139839,C12H22O10,cpd:C08247,Rutinose,C12H22O10,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C08247  Rutinose,3.2.1.168,R09534
325.1139839,C12H22O10,cpd:C19635,Scillabiose;6-Deoxy-4-O-beta-D-glucopyranosyl-L-mannose,C12H22O10,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C19635  Scillabiose,NA,NA
325.1139839,C12H22O10,cpd:C19758,beta-D-Galactosyl-(1->4)-L-rhamnose,C12H22O10,NA,NA,NA,2.4.1.247,R09632
325.1139839,C12H22O10,cpd:C20354,3-O-alpha-D-Glucopyranosyl-L-rhamnopyranose;3-O-alpha-D-Glucosyl-L-rhamnose,C12H22O10,NA,NA,NA,2.4.1.282,R10098
325.1293054,C16H22O7,cpd:C15451,Hinokitiol glucoside;beta-Thujaplicin 2-O-beta-D-glucoside,C16H22O7,NA,NA,NA,NA,NA
325.2020271,C18H30O5,cpd:C14794,"2,3-Dinor-8-iso prostaglandin F2alpha;2,3-Dinor-8-iso PGF2alpha",C18H30O5,Arachidonic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C14794  2,3-Dinor-8-iso prostaglandin F2alpha;   FA0311 Isoprostanes;    C14794  2,3-Dinor-8-iso prostaglandin F2alpha",NA,NA
327.0510759,C17H12O7,cpd:C10198,(-)-Acanthocarpan,C17H12O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10198  (-)-Acanthocarpan;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10198  (-)-Acanthocarpan,NA,NA
327.0510759,C17H12O7,cpd:C16755,Aflatoxin G1,C17H12O7,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK10 Aflatoxins and related substances;   C16755  Aflatoxin G1;Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Aflatoxins;    C16755  Aflatoxin G1,NA,R10483
327.0510759,C17H12O7,cpd:C16756,Aflatoxin M1,C17H12O7,Metabolism of xenobiotics by cytochrome P450,NA,Lipids [BR:br08002]; PK  Polyketides;  PK10 Aflatoxins and related substances;   C16756  Aflatoxin M1;Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Aflatoxins;    C16756  Aflatoxin M1,1.14.14.1,R09405 R09406
327.0510759,C17H12O7,cpd:C19585,Aflatoxin Q1,C17H12O7,Metabolism of xenobiotics by cytochrome P450,NA,NA,1.14.14.1;1.14.14.-,R09404
327.0510759,C17H12O7,cpd:C19586,"Aflatoxin B1-exo-8,9-epoxide;2,3-Epoxyaflatoxin B1",C17H12O7,Metabolism of xenobiotics by cytochrome P450;Chemical carcinogenesis - DNA adducts,NA,NA,1.14.14.1;1.14.14.-;2.5.1.18;3.3.2.9,R09408 R09409 R09410
327.0510759,C17H12O7,cpd:C19595,"Aflatoxin B1-endo-8,9-epoxide",C17H12O7,Metabolism of xenobiotics by cytochrome P450,NA,NA,1.14.14.1,R09407
327.0721385,C14H16O9,cpd:C09919,Bergenin,C14H16O9,NA,NA,NA,NA,NA
327.0721385,C14H16O9,cpd:C16519,2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate;5-Enolpyruvoyl-6-hydroxy-2-succinylcyclohex-3-ene-1-carboxylate;SEPHCHC,C14H16O9,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors,"Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol;Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol",NA,2.2.1.9;4.2.99.20,R08165 R08166
327.087433,C18H16O6,cpd:C09479,"Betagarin;5,2'-Dimethoxy-6,7-methylenedioxyflavanone",C18H16O6,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09479  Betagarin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09479  Betagarin,NA,NA
327.087433,C18H16O6,cpd:C14985,"6-Hydroxy-2-(4-methoxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one;6-Hydroxy-4',5,7-trimethoxyflavone",C18H16O6,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C14985  6-Hydroxy-2-(4-methoxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one",NA,NA
327.087433,C18H16O6,cpd:C14986,"2-(4-Hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one;4'-Hydroxy-5,6,7-trimethoxyflavone",C18H16O6,NA,NA,NA,NA,NA
327.087433,C18H16O6,cpd:C16188,"7-Hydroxy-2',4',5'-trimethoxyisoflavone",C18H16O6,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C16188  7-Hydroxy-2',4',5'-trimethoxyisoflavone;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C16188  7-Hydroxy-2',4',5'-trimethoxyisoflavone",NA,R07735 R07736
327.087433,C18H16O6,cpd:C16189,9-Demethylmunduserone,C18H16O6,Isoflavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,NA,NA,R07736
327.087433,C18H16O6,cpd:C17475,Ophiopogonanone A,C18H16O6,NA,NA,NA,NA,NA
327.1085585,C15H20O8,cpd:C09294,Anisatin,C15H20O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09294  Anisatin;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Sesquiterpenoids;    C09294  Anisatin,NA,NA
327.1085585,C15H20O8,cpd:C10717,Paeonoside,C15H20O8,NA,NA,NA,NA,NA
327.1449418,C16H24O7,cpd:C09965,Rhododendrin,C16H24O7,NA,NA,NA,NA,NA
327.1635488,C17H28O4S,cpd:C02195,Steryl sulfate,C17H28O4S,NA,NA,NA,NA,NA
327.2176656,C18H32O5,cpd:C14795,"2,3-Dinor-8-iso prostaglandin F1alpha;2,3-Dinor-8-iso PGF1alpha",C18H32O5,Arachidonic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C14795  2,3-Dinor-8-iso prostaglandin F1alpha",NA,NA
329.0666326,C17H14O7,cpd:C01265,"3,7-Di-O-methylquercetin;3',4',5-Trihydroxy-3,7-dimethoxyflavone",C17H14O7,Flavone and flavonol biosynthesis,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C01265  3,7-Di-O-methylquercetin",2.1.1.82;2.1.1.83,R03456 R05323
329.0666326,C17H14O7,cpd:C03036,(+)-Bisdechlorogeodin,C17H14O7,NA,NA,NA,1.21.3.4,R00060
329.0666326,C17H14O7,cpd:C03040,(-)-Bisdechlorogeodin,C17H14O7,NA,NA,NA,1.21.3.5,R00061
329.0666326,C17H14O7,cpd:C10033,Cirsiliol,C17H14O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10033  Cirsiliol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10033  Cirsiliol,NA,NA
329.0666326,C17H14O7,cpd:C10193,"Tricin;Tricetin 3',5'-di-methyl ether;3',5'-O-Dimethyltricetin",C17H14O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10193  Tricin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10193  Tricin,2.1.1.169;2.1.1.175,R09611 R09613 R09678
329.0666326,C17H14O7,cpd:C10424,Hildecarpin,C17H14O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10424  Hildecarpin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10424  Hildecarpin,NA,NA
329.0666326,C17H14O7,cpd:C16754,Aflatoxin G2,C17H14O7,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK10 Aflatoxins and related substances;   C16754  Aflatoxin G2;Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Aflatoxins;    C16754  Aflatoxin G2,NA,R10482
329.0666326,C17H14O7,cpd:C17670,Aurantio-obtusin,C17H14O7,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C17670  Aurantio-obtusin,NA,NA
329.0878133,C14H18O9,cpd:C20470,1-O-Vanilloyl-beta-D-glucose,C14H18O9,NA,NA,NA,2.4.1.300,R10259 R10296 R10297
329.1030819,C18H18O6,cpd:C08781,Samaderin A,C18H18O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Others;    C08781  Samaderin A,NA,NA
329.1030819,C18H18O6,cpd:C14894,"3',6'-Dihydroxy-2',4,4'-trimethoxy-chalcone;1-(3,6-Dihydroxy-2,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-2-propen-1-one",C18H18O6,NA,NA,NA,NA,NA
329.1030819,C18H18O6,cpd:C14997,"2,3-Dihydro-6-hydroxy-2-(4-methoxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one;6-Hydroxy-4',5,7-trimethoxyflavanone",C18H18O6,NA,NA,NA,NA,NA
329.1030819,C18H18O6,cpd:C15019,"2,3-Dihydro-2-(4-hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one;4'-Hydroxy-5,6,7-trimethoxyflavanone",C18H18O6,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C15019  2,3-Dihydro-2-(4-hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",NA,NA
329.1030819,C18H18O6,cpd:C17413,Acetylshikonin,C18H18O6,NA,NA,NA,NA,NA
329.1030819,C18H18O6,cpd:C21802,(+)-Didemethylpinoresinol;Sesamin dicatechol,C18H18O6,NA,NA,NA,2.1.5.1,R11956
329.1605793,C16H26O7,cpd:C11656,8-Epiiridodial glucoside,C16H26O7,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11656  8-Epiiridodial glucoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11656  8-Epiiridodial glucoside",NA,NA
329.1605793,C16H26O7,cpd:C11670,Iridodial glucoside,C16H26O7,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11670  Iridodial glucoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11670  Iridodial glucoside",NA,NA
329.1605793,C16H26O7,cpd:C17055,Picrocrocin,C16H26O7,Biosynthesis of various secondary metabolites - part 1,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Carotenoids and apocarotenoids;   Apocarotenoids;    C17055  Picrocrocin,NA,R12136 R12137
329.1605793,C16H26O7,cpd:C17634,Schizonepetoside A,C16H26O7,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17634  Schizonepetoside A,NA,NA
329.1605793,C16H26O7,cpd:C17635,Schizonepetoside B,C16H26O7,NA,NA,NA,NA,NA
329.1605793,C16H26O7,cpd:C17636,Schizonepetoside C,C16H26O7,NA,NA,NA,NA,NA
329.1605793,C16H26O7,cpd:C17637,Schizonepetoside D,C16H26O7,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17637  Schizonepetoside D,NA,NA
329.1757852,C20H26O4,cpd:C09069,Carnosol,C20H26O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Abietanes;    C09069  Carnosol,NA,NA
329.1757852,C20H26O4,cpd:C14162,Gibberellin A15,C20H26O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C14162  Gibberellin A15,NA,NA
329.1757852,C20H26O4,cpd:C14529,Dicyclohexyl phthalate,C20H26O4,NA,NA,Endocrine disrupting compounds [BR:br08006]; Plasticizers and plastics;  Phthalates;   C14529  Dicyclohexyl phthalate,NA,NA
329.1757852,C20H26O4,cpd:C20632,Methyl gibberellin A9,C20H26O4,NA,NA,NA,2.1.1.275,R10449
329.233352,C18H34O5,cpd:C14833,"9,12,13-TriHOME;9(S),12(S),13(S)-Trihydroxy-10(E)-octadecenoic acid;(10E)-(9S,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoic acid",C18H34O5,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14833  (10E)-(9S,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoic acid",NA,NA
329.233352,C18H34O5,cpd:C14835,"9,10,13-TriHOME;9,10,13-Trihydroxyoctadec-11-enoic acid;(11E)-9,10,13-Trihydroxyoctadec-11-enoic acid",C18H34O5,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14835  (11E)-9,10,13-Trihydroxyoctadec-11-enoic acid",NA,NA
329.233352,C18H34O5,cpd:C14837,"9,10-Dihydroxy-12,13-epoxyoctadecanoate;9,10-Dihydroxy-12,13-epoxyoctadecanoic acid",C18H34O5,Linoleic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0200 Other Octadecanoids;    C14837  9,10-Dihydroxy-12,13-epoxyoctadecanoic acid",NA,NA
331.0459492,C16H12O8,cpd:C04527,"Corniculatusin;3,3',4',5,7-Pentahydroxy-8-methoxyflavone",C16H12O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C04527  Corniculatusin,2.1.1.88,R04398
331.0459492,C16H12O8,cpd:C10118,Patuletin;Quercetagetin 6-methyl ether,C16H12O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10118  Patuletin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10118  Patuletin,NA,NA
331.0459492,C16H12O8,cpd:C12633,Laricitrin;3'-O-Methylmyricetin,C16H12O8,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12633  Laricitrin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C12633  Laricitrin,2.1.1.267,R06815 R06816
331.0670788,C13H16O10,cpd:C01158,1-O-Galloyl-beta-D-glucose;1-Galloyl-beta-glucose;beta-Glucogallin;1-Galloyl-beta-D-glucose,C13H16O10,Biosynthesis of phenylpropanoids,NA,NA,2.3.1.90;2.3.1.143;2.4.1.136,R00049 R03297 R04498
331.0823663,C17H16O7,cpd:C00495,Sulochrin,C17H16O7,NA,NA,NA,1.21.3.4;1.21.3.5,R00060 R00061
331.1550272,C19H24O5,cpd:C02035,Gibberellin A20;Gibberellin 20,C19H24O5,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C02035  Gibberellin A20;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C02035  Gibberellin A20,1.14.11.12;1.14.11.13;1.14.11.15;1.14.11.-,R03009 R03807 R03809 R06332 R06346
331.1550272,C19H24O5,cpd:C09742,Trichothecin,C19H24O5,NA,NA,NA,NA,NA
331.1550272,C19H24O5,cpd:C11864,Gibberellin A4,C19H24O5,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites;Plant hormone signal transduction,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1;Gibberellin A1 biosynthesis, GGPP => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11864  Gibberellin A4;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11864  Gibberellin A4,1.14.11.13;1.14.11.15;2.1.1.276,R06327 R06336 R06338 R06617 R06619 R10450
331.1550272,C19H24O5,cpd:C11865,Gibberellin A51,C19H24O5,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11865  Gibberellin A51;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11865  Gibberellin A51,1.14.11.13,R06337 R06343
331.1762465,C16H28O7,cpd:C04655,"(2S,3S)-2-Hydroxytridecane-1,2,3-tricarboxylate",C16H28O7,NA,NA,NA,2.3.3.2,R03735
331.1914667,C20H28O4,cpd:C09067,Callicarpone,C20H28O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09067  Callicarpone,NA,NA
331.1914667,C20H28O4,cpd:C09081,"7beta,12alpha-Dihydroxykaurenolide",C20H28O4,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010413 Kaurane and phyllocladane diterpenoids;     C09081  7beta,12alpha-Dihydroxykaurenolide;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Kaurenes;    C09081  7beta,12alpha-Dihydroxykaurenolide",NA,NA
331.1914667,C20H28O4,cpd:C09128,Marrubiin,C20H28O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09128  Marrubiin,NA,NA
331.1914667,C20H28O4,cpd:C09177,Premarrubiin,C20H28O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09177  Premarrubiin,NA,NA
331.1914667,C20H28O4,cpd:C11853,Gibberellin A14 aldehyde,C20H28O4,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A1 biosynthesis, GGPP => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11853  Gibberellin A14 aldehyde;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11853  Gibberellin A14 aldehyde,NA,R06339 R06341
331.1914667,C20H28O4,cpd:C11857,Gibberellin A12,C20H28O4,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A12 biosynthesis, GAPP => GA12;Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11857  Gibberellin A12;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11857  Gibberellin A12,1.14.11.12;1.14.14.107,R06297 R06322 R06329 R06333 R10067
331.1914667,C20H28O4,cpd:C11905,Gibberellin A53 aldehyde,C20H28O4,Diterpenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11905  Gibberellin A53 aldehyde;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11905  Gibberellin A53 aldehyde,NA,R06328 R06340
331.1914667,C20H28O4,cpd:C15068,17beta-Hydroxy-4-oxa-5alpha-androst-1-en-3-one acetate,C20H28O4,NA,NA,NA,NA,NA
331.1914667,C20H28O4,cpd:C15459,"13-Hydroxy-2-(hydroxymethylene)-3-oxo-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone",C20H28O4,NA,NA,NA,NA,NA
331.1914667,C20H28O4,cpd:C18175,"5,6-Epoxy-18R-HEPE;5,6-Epoxy,18R-hydroxy-7E,9E,11Z,14Z,16E-eicosapentaenoic acid",C20H28O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0307 Hydroxy/hydroperoxyeicosapentaenoic acids;    C18175  5,6-Epoxy-18R-HEPE",NA,NA
331.1914667,C20H28O4,cpd:C21818,"Carnosic acid;Salvin;11,12-Dihydroxyabieta-8,11,13-trien-20-oic acid",C20H28O4,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,NA,1.14.14.61,R11973
331.1914667,C20H28O4,cpd:C21824,"11,20-Dihydroxysugiol",C20H28O4,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,NA,1.14.14.67,R11979
331.1914667,C20H28O4,cpd:C21846,Sordaricin,C20H28O4,NA,NA,NA,2.4.1.353,R12012
331.2489588,C18H36O5,cpd:C19621,"9,10,18-Trihydroxystearate",C18H36O5,"Cutin, suberine and wax biosynthesis",NA,NA,1.14.-.-;3.3.2.-,R09461 R09464
333.0615907,C16H14O8,cpd:C09770,6-Methoxytaxifolin,C16H14O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C09770  6-Methoxytaxifolin,NA,NA
333.0615907,C16H14O8,cpd:C18347,"5,5'-Dehydrodivanillate",C16H14O8,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,NA,NA,R09275
333.0979832,C17H18O7,cpd:C09141,Byakangelicin,C17H18O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09141  Byakangelicin,NA,NA
333.13434,C18H22O6,cpd:C21419,"1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol",C18H22O6,NA,NA,NA,1.11.1.14,R11501
333.2071472,C20H30O4,cpd:C05949,"12-Keto-leukotriene B4;12-Keto-LTB4;5-Hydroxy-12-oxo-Delta5,8,11,14-eicosapolyenoic acid",C20H30O4,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0302 Leukotrienes;    C05949  12-Keto-leukotriene B4,NA,R03863 R03864
333.2071472,C20H30O4,cpd:C05953,Prostaglandin A2;PGA2;Medullin,C20H30O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C05953  Prostaglandin A2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05953  Prostaglandin A2,NA,R02583 R05056
333.2071472,C20H30O4,cpd:C05954,Prostaglandin B2;PGB2,C20H30O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C05954  Prostaglandin B2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05954  Prostaglandin B2,NA,R05057
333.2071472,C20H30O4,cpd:C05955,Prostaglandin C2;PGC2,C20H30O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C05955  Prostaglandin C2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05955  Prostaglandin C2,NA,R05056 R05057
333.2071472,C20H30O4,cpd:C05957,Prostaglandin J2;PGJ2,C20H30O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C05957  Prostaglandin J2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05957  Prostaglandin J2,NA,R02801 R05058
333.2071472,C20H30O4,cpd:C05958,Delta-12-Prostaglandin J2;Delta-12-PGJ2,C20H30O4,Arachidonic acid metabolism;Metabolic pathways,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05958  delta-12-Prostaglandin J2,NA,R05058 R07067
333.2071472,C20H30O4,cpd:C09125,Lathyrol,C20H30O4,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010431 Lathyrane diterpenoids;     C09125  Lathyrol;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09125  Lathyrol,NA,NA
333.2071472,C20H30O4,cpd:C09150,17-Oxogrindelic acid,C20H30O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Farnesenes;    C09150  17-Oxogrindelic acid,NA,NA
333.2071472,C20H30O4,cpd:C11876,"6beta,7beta-Dihydroxykaurenoic acid;ent-6alpha,7alpha-Dihydroxykaur-16-en-19-oic acid",C20H30O4,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010413 Kaurane and phyllocladane diterpenoids;     C11876  6beta,7beta-Dihydroxykaurenoic acid;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Kaurenes;    C11876  6beta,7beta-Dihydroxykaurenoic acid",1.14.14.107,R06296
333.2071472,C20H30O4,cpd:C14504,"Di-n-hexyl phthalate;Dihexyl 1,2-benzenedicarboxylate;Dihexyl phthalate",C20H30O4,NA,NA,Endocrine disrupting compounds [BR:br08006]; Plasticizers and plastics;  Phthalates;   C14504  Di-n-hexyl phthalate,NA,NA
333.2071472,C20H30O4,cpd:C14815,"5,6-Epoxytetraene;(7E,9E,11Z,13E)-(5S,6S,15S)-5,6-Epoxy-15-hydroxyeicosa-7,9,11,13-tetraenoic acid;(7E,9E,11Z,13E)-(5S,6S,15S)-5,6-Epoxy-15-hydroxyicosa-7,9,11,13-tetraenoic acid",C20H30O4,Arachidonic acid metabolism,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C14815  5,6-Epoxytetraene",3.3.2.-,R07031 R07032
333.2071472,C20H30O4,cpd:C14913,17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetate,C20H30O4,NA,NA,NA,NA,NA
333.2071472,C20H30O4,cpd:C15159,"3beta,13-Dihydroxy-16-(hydroxymethylene)-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone",C20H30O4,NA,NA,NA,NA,NA
333.2071472,C20H30O4,cpd:C18173,"Resolvin E2;5S,18R-Dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid",C20H30O4,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0307 Hydroxy/hydroperoxyeicosapentaenoic acids;    C18173  Resolvin E2,NA,NA
335.0772424,C16H16O8,cpd:C10296,Altersolanol A,C16H16O8,NA,NA,NA,NA,NA
335.0772424,C16H16O8,cpd:C10434,5-O-Caffeoylshikimic acid,C16H16O8,"Phenylpropanoid biosynthesis;Flavonoid biosynthesis;Stilbenoid, diarylheptanoid and gingerol biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites","Monolignol biosynthesis, phenylalanine/tyrosine => monolignol",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Caffeate derivatives;    C10434  5-O-Caffeoylshikimic acid,1.14.14.96;2.3.1.133;3.1.1.-,R06582 R07433 R10701
335.2227874,C20H32O4,cpd:C00959,Prostaglandin B1;PGB1,C20H32O4,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C00959  Prostaglandin B1;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C00959  Prostaglandin B1,NA,NA
335.2227874,C20H32O4,cpd:C02165,"Leukotriene B4;(6Z,8E,10E,14Z)-(5S,12R)-5,12-Dihydroxyeicosa-6,8,10,14-tetraenoate;(6Z,8E,10E,14Z)-(5S,12R)-5,12-Dihydroxyicosa-6,8,10,14-tetraenoate;LTB4",C20H32O4,Arachidonic acid metabolism;Metabolic pathways;PPAR signaling pathway;Neuroactive ligand-receptor interaction;Serotonergic synapse;Inflammatory mediator regulation of TRP channels;Bile secretion;Eicosanoids,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Leukotrienes;    C02165  Leukotriene B4;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0302 Leukotrienes;    C02165  Leukotriene B4,1.14.14.94;3.3.2.6,R03057 R03863 R03864 R03866
335.2227874,C20H32O4,cpd:C04685,"(13E)-(15S)-15-Hydroxy-9-oxoprosta-10,13-dienoate;Prostaglandin A1;PGA1",C20H32O4,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C04685  Prostaglandin A1;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C04685  Prostaglandin A1,5.3.3.9,R04565
335.2227874,C20H32O4,cpd:C04686,"(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate;Prostaglandin C1",C20H32O4,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C04686  Prostaglandin C1;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C04686  Prostaglandin C1,5.3.3.9,R04565
335.2227874,C20H32O4,cpd:C04822,"8(R)-HPETE;(5Z,9E,11Z,14Z)-(8R)-8-Hydroperoxyeicosa-5,9,11,14-tetraenoate;(5Z,9E,11Z,14Z)-(8R)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate",C20H32O4,Arachidonic acid metabolism;Serotonergic synapse,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C04822  8(R)-HPETE,1.13.11.40,R01594
335.2227874,C20H32O4,cpd:C04849,"(5Z,9E,14Z)-(8xi,11R,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid;(5Z,9E,14Z)-(8xi,11R,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoate;Hepoxilin A3",C20H32O4,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0107 Epoxy fatty acids;    C04849  (5Z,9E,14Z)-(8xi,11R,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid;  FA03 Eicosanoids;   FA0309 Hepoxilins;    C04849  Hepoxilin A3",3.3.2.7,R04609
335.2227874,C20H32O4,cpd:C05356,"5(S)-HPETE;5(S)-Hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid;(6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyeicosa-6,8,11,14-tetraenoate;(6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyeicosa-6,8,11,14-tetraenoic acid;(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate",C20H32O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse;Ovarian steroidogenesis;Eicosanoids,NA,"Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Leukotrienes;    C05356  5-HPETE;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0104 Hydroperoxy fatty acids;    C05356  (6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyicosa-6,8,11,14-tetraenoic acid;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C05356  5(S)-HPETE",1.11.1.9;1.13.11.34,R01595 R03058 R07034
335.2227874,C20H32O4,cpd:C05965,"12(S)-HPETE;(5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid;(5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate;12-Hydroperoxyeicosatetraenoate;12-Hydroperoxyicosatetraenoate;12-Hydroperoxyeicosatetraenoic acid;12-Hydroperoxyicosatetraenoic acid",C20H32O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse;Inflammatory mediator regulation of TRP channels,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0104 Hydroperoxy fatty acids;    C05965  (5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C05965  12(S)-HPETE",1.13.11.31;5.4.4.-,R01596 R07039 R07040
335.2227874,C20H32O4,cpd:C05966,"15(S)-HPETE;(5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoic acid;15-Hydroperoxyeicosatetraenoate;15-Hydroperoxyicosatetraenoate;15-Hydroperoxyeicosatetraenoic acid;15-Hydroperoxyicosatetraenoic acid;(5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoate",C20H32O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse;Inflammatory mediator regulation of TRP channels;Ovarian steroidogenesis,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0104 Hydroperoxy fatty acids;    C05966  (5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoic acid;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C05966  15(S)-HPETE",1.11.1.9;1.13.11.33;1.14.14.1,R01593 R07035 R07042 R07043
335.2227874,C20H32O4,cpd:C09087,Diterpenoid SP-II,C20H32O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Tiglianes;    C09087  Diterpenoid SP-II,NA,NA
335.2227874,C20H32O4,cpd:C09175,Portulal,C20H32O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09175  Portulal,NA,NA
335.2227874,C20H32O4,cpd:C14781,"15H-11,12-EETA;15-Hydroxy-11,12-epoxyeicosatrienoic acid;(5Z,8Z,13E)-(15S)-11,12-Epoxy-15-hydroxyeicosa-5,8,13-trienoic acid;(5Z,8Z,13E)-(15S)-11,12-Epoxy-15-hydroxyicosa-5,8,13-trienoic acid",C20H32O4,Arachidonic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0308 Epoxyeicosatrienoic acids;    C14781  15-Hydroxy-11,12-EETA",1.14.14.1,R07042 R07044
335.2227874,C20H32O4,cpd:C14808,"Hepoxilin A3;(5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyeicosa-5,9,14-trienoic acid;(5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid",C20H32O4,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0309 Hepoxilins;    C14808  Hepoxilin A3,3.3.2.7;5.4.4.-,R07036 R07039
335.2227874,C20H32O4,cpd:C14810,"Hepoxilin B3;(5Z,8Z,14Z)-(11S,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoic acid;(5Z,8Z,14Z)-(11S,12S)-11,12-Epoxy-10-hydroxyicosa-5,8,14-trienoic acid",C20H32O4,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0309 Hepoxilins;    C14810  Hepoxilin B3,3.3.2.-;5.4.4.-,R07037 R07040
335.2227874,C20H32O4,cpd:C14812,"12(R)-HPETE;(5Z,8Z,10E,14Z)-(12R)-12-Hydroperoxyeicosa-5,8,10,14-tetraenoic acid;(5Z,8Z,10E,14Z)-(12R)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid",C20H32O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C14812  12(R)-HPETE,1.13.11.-,R07038
335.2227874,C20H32O4,cpd:C14813,"11H-14,15-EETA;11-Hydroxy-14,15-EETA;11-Hydroxy-14,15-epoxyeicosatrienoic acid;(5Z,8Z,12E)-14,15-Epoxy-11-hydroxyeicosa-5,8,12-trienoic acid;(5Z,8Z,12E)-14,15-Epoxy-11-hydroxyicosa-5,8,12-trienoic acid",C20H32O4,Arachidonic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0308 Epoxyeicosatrienoic acids;    C14813  11-Hydroxy-14,15-EETA",1.14.14.1,R07043 R07045
335.2227874,C20H32O4,cpd:C14820,"11(R)-HPETE;(5Z,8Z,12E,14Z)-(11R)-Hydroperoxyeicosa-5,8,12,14-tetraenoic acid;(5Z,8Z,12E,14Z)-(11R)-Hydroperoxyicosa-5,8,12,14-tetraenoic acid",C20H32O4,Arachidonic acid metabolism;Serotonergic synapse,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C14820  11(R)-HPETE,1.13.11.-,R07047
335.2227874,C20H32O4,cpd:C14821,"9(S)-HPETE;(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyeicosa-5,7,11,14-tetraenoic acid;(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyicosa-5,7,11,14-tetraenoic acid",C20H32O4,Arachidonic acid metabolism;Serotonergic synapse,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C14821  9(S)-HPETE,1.13.11.-,R07049
335.2227874,C20H32O4,cpd:C14823,"8(S)-HPETE;(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyeicosa-5,9,11,14-tetraenoic acid;(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoic acid",C20H32O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;    C14823  8(S)-HPETE,1.13.11.-,R07053
337.0929018,C16H18O8,cpd:C10432,1-Caffeoyl-4-deoxyquinic acid,C16H18O8,NA,NA,NA,NA,NA
337.0929018,C16H18O8,cpd:C10441,4-p-Coumaroylquinic acid,C16H18O8,NA,NA,NA,NA,NA
337.0929018,C16H18O8,cpd:C12208,p-Coumaroyl quinic acid;trans-5-O-(4-Coumaroyl)-D-quinate,C16H18O8,"Phenylpropanoid biosynthesis;Flavonoid biosynthesis;Stilbenoid, diarylheptanoid and gingerol biosynthesis;Biosynthesis of secondary metabolites",NA,NA,1.14.14.96;2.3.1.133,R04342 R07432
337.1292932,C17H22O7,cpd:C09526,1-Peroxyferolide,C17H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09526  1-Peroxyferolide,NA,NA
337.1656796,C18H26O6,cpd:C08503,Pinolidoxin,C18H26O6,NA,NA,NA,NA,NA
337.1656796,C18H26O6,cpd:C14538,"Trimethylolpropane trimethacrylate;2-Ethyl-2(hydroxymethyl)-1,3-propanediol trimethacrylate;TMPT",C18H26O6,NA,NA,NA,NA,NA
337.2019977,C19H30O5,cpd:C09725,Shiromodiol diacetate,C19H30O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09725  Shiromodiol diacetate,NA,NA
337.2019977,C19H30O5,cpd:C18880,Piperonyl butoxide,C19H30O5,NA,NA,Pesticides [BR:br08007]; Pesticides;  Others;   Synergist;    C18880  Piperonyl butoxide;Animal drugs in Japan [BR:br08331]; 99  Agents for not mainly purpose of therapeutic;  993  Insecticides and insect-repellents;   9939  Other insecticides and insect repellents;    D08383  Piperonyl butoxide,NA,NA
337.2019977,C19H30O5,cpd:C20854,"Monacolin J acid;(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-Hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid",C19H30O5,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Lovastatin biosynthesis, malonyl-CoA => lovastatin acid",NA,1.14.14.125;2.3.1.238,R10794 R11126
337.238495,C20H34O4,cpd:C06088,Aphidicolin,C20H34O4,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Aphidicolane;    C06088  Aphidicolin,NA,R06316 R06317
337.238495,C20H34O4,cpd:C09205,Zoapatanol,C20H34O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09205  Zoapatanol,NA,NA
337.238495,C20H34O4,cpd:C14772,"5,6-DHET;(8Z,11Z,14Z)-5,6-Dihydroxyeicosa-8,11,14-trienoic acid;(8Z,11Z,14Z)-5,6-Dihydroxyicosa-8,11,14-trienoic acid",C20H34O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;    C14772  5,6-DHET",3.3.2.10,R07111
337.238495,C20H34O4,cpd:C14773,"8,9-DHET;(5Z,11Z,14Z)-8,9-Dihydroxyeicosa-5,11,14-trienoic acid;(5Z,11Z,14Z)-8,9-Dihydroxyicosa-5,11,14-trienoic acid",C20H34O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;    C14773  8,9-DHET",3.3.2.10,R07110
337.238495,C20H34O4,cpd:C14774,"11,12-DHET;(5Z,8Z,14Z)-11,12-Dihydroxyeicosa-5,8,14-trienoic acid;(5Z,8Z,14Z)-11,12-Dihydroxyicosa-5,8,14-trienoic acid",C20H34O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;    C14774  11,12-DHET",3.3.2.10,R07109
337.238495,C20H34O4,cpd:C14775,"14,15-DHET;(5Z,8Z,11Z)-14,15-Dihydroxyeicosa-5,8,11-trienoic acid;(5Z,8Z,11Z)-14,15-Dihydroxyicosa-5,8,11-trienoic acid",C20H34O4,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;    C14775  14,15-DHET",3.3.2.10,R07108
339.0511035,C18H12O7,cpd:C20575,Versicolorin B,C18H12O7,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,4.2.1.143,R10402 R10479 R10480
339.0721694,C15H16O9,cpd:C01421,Daphnin,C15H16O9,NA,NA,NA,2.4.1.104,R03548
339.0721694,C15H16O9,cpd:C02887,Sinapoyl malate;Sinapoyl-(S)-malate,C15H16O9,Phenylpropanoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C02887  Sinapoyl malate,2.3.1.92,R03323
339.0721694,C15H16O9,cpd:C09206,Cichoriin,C15H16O9,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09206  Cichoriin;Glycosides [BR:br08021]; O-glycosides;  Coumarin glycosides;   C09206  Cichoriin,NA,NA
339.0721694,C15H16O9,cpd:C09264,Esculin;Esculoside,C15H16O9,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09264  Esculin;Glycosides [BR:br08021]; O-glycosides;  Coumarin glycosides;   C09264  Esculin,NA,NA
339.2176974,C19H32O5,cpd:C20852,"3alpha-Hydroxy-3,5-dihydromonacolin L acid;(3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-Hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate",C19H32O5,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Lovastatin biosynthesis, malonyl-CoA => lovastatin acid",NA,1.14.14.124,R10791 R10792
341.0878132,C15H18O9,cpd:C10431,Caffeic acid 3-glucoside,C15H18O9,NA,NA,NA,NA,NA
341.0878132,C15H18O9,cpd:C10433,1-Caffeoyl-beta-D-glucose,C15H18O9,NA,NA,NA,NA,NA
341.103021,C19H18O6,cpd:C14472,"4',5,6,7-Tetramethoxyflavone;Tetra-O-methylscutellarein",C19H18O6,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C14472  4',5,6,7-Tetramethoxyflavone;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C14472  4',5,6,7-Tetramethoxyflavone",NA,NA
341.103021,C19H18O6,cpd:C15076,"3-(4-Methoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one;5,6,7,4'-Tetramethoxyisoflavone",C19H18O6,NA,NA,NA,NA,NA
341.103021,C19H18O6,cpd:C18678,UWM6,C19H18O6,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,2.4.1.-,R09340 R09341 R09342 R09345
341.103021,C19H18O6,cpd:C21801,(+)-Demethylpiperitol;Sesamin monocatechol,C19H18O6,NA,NA,NA,2.1.5.1,R11955 R11956
341.109,C12H22O11,cpd:C00089,Sucrose;Cane sugar;Saccharose;1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside,C12H22O11,Galactose metabolism;Starch and sucrose metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Phosphotransferase system (PTS);Taste transduction;Carbohydrate digestion and absorption,NA,"Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C00089  Sucrose; Cane sugar;Therapeutic category of drugs in Japan [BR:br08301]; 7  Agents not mainly for therapeutic purpose;  71  Dispensing medicines;   714  Flavorings, deodorants, coloring agents;    7149  Others;     D00025  Sucrose (JP18/NF); White soft sugar (JP18); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   White soft sugar;    D00025  Sucrose (JP18/NF);Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00025  White soft sugar;  D00025  Sucrose",1.1.99.13;2.4.1.4;2.4.1.5;2.4.1.7;2.4.1.9;2.4.1.10;2.4.1.13;2.4.1.82;2.4.1.99;2.4.1.125;2.4.1.166;2.4.1.167;2.4.1.362;2.4.1.372;2.4.1.373;2.7.1.211;3.1.3.24;3.2.1.10;3.2.1.20;3.2.1.22;3.2.1.26;3.2.1.48;5.4.99.11,R00015 R00039 R00801 R00802 R00803 R00805 R00806 R00807;R00808 R00809 R00810 R00811 R01103 R01823 R02120 R02411;R04194 R05140 R07256 R08616 R08676 R12349 R12527 R12528
341.109,C12H22O11,cpd:C00185,Cellobiose;1-beta-D-Glucopyranosyl-4-D-glucopyranose,C12H22O11,Starch and sucrose metabolism;Metabolic pathways;ABC transporters;Phosphotransferase system (PTS),NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C00185  Cellobiose,1.1.99.18;2.4.1.20;2.7.1.85;2.7.1.205;3.2.1.4;3.2.1.21;3.2.1.74;3.2.1.91;5.1.3.11,R00026 R00306 R00952 R01441 R01442 R01443 R01444 R01445;R02365 R02886 R02887 R11172 R11308
341.109,C12H22O11,cpd:C00208,Maltose;Malt sugar;alpha-D-Glucopyranosyl-(1->4)-D-glucopyranose,C12H22O11,Starch and sucrose metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Bacterial chemotaxis;Phosphotransferase system (PTS);Taste transduction;Carbohydrate digestion and absorption,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C00208  Maltose; Malt sugar,2.3.1.79;2.4.1.8;2.4.1.25;2.4.1.139;2.7.1.175;2.7.1.208;3.1.3.90;3.2.1.1;3.2.1.2;3.2.1.20;3.2.1.133;5.4.99.16,R00028 R00957 R01555 R01556 R01557 R02112 R04111 R05196;R09945 R10486 R11262
341.109,C12H22O11,cpd:C00243,Lactose;1-beta-D-Galactopyranosyl-4-D-glucopyranose;beta-D-Gal-(1->4)-D-Glc;Milk sugar,C12H22O11,Galactose metabolism;Metabolic pathways;ABC transporters;Phosphotransferase system (PTS);Carbohydrate digestion and absorption,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C00243  Lactose; Milk sugar;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00046  Anhydrous lactose,1.1.99.13;2.4.1.22;2.7.1.207;3.2.1.23;3.2.1.108;3.2.1.140,R00503 R01100 R01678 R01680 R04393 R05166
341.109,C12H22O11,cpd:C00252,Isomaltose;Brachiose,C12H22O11,Starch and sucrose metabolism,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C00252  Isomaltose,3.2.1.10;3.2.1.11;3.2.1.204;3.2.1.205,R01718 R11309 R11788 R11790 R11791
341.109,C12H22O11,cpd:C00897,alpha-Maltose;alpha-Malt sugar,C12H22O11,NA,NA,NA,5.1.3.21,R07319
341.109,C12H22O11,cpd:C01083,"alpha,alpha-Trehalose;alpha,alpha'-Trehalose;Trehalose",C12H22O11,Starch and sucrose metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Phosphotransferase system (PTS),"Trehalose biosynthesis, D-glucose 1P => trehalose",Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C01083  Trehalose,2.3.1.122;2.3.1.279;2.4.1.64;2.4.1.231;2.4.1.245;2.7.1.201;2.8.2.37;3.1.3.12;3.2.1.28;3.2.1.141;5.4.99.16,R00010 R01557 R02727 R02778 R02780 R07248 R07265 R08946;R09995 R10525 R10971 R11256 R11306 R12287
341.109,C12H22O11,cpd:C01235,alpha-D-Galactosyl-(1->3)-1D-myo-inositol;O-alpha-D-Galactosyl-(1->3)-1D-myo-inositol;3-O-alpha-D-Galactosyl-1D-myo-inositol;1-alpha-D-Galactosyl-myo-inositol;Galactinol,C12H22O11,Galactose metabolism;Metabolic pathways,NA,NA,2.4.1.67;2.4.1.82;2.4.1.123;3.2.1.22,R01192 R01194 R02411 R03418
341.109,C12H22O11,cpd:C01518,Nigerose;Sakebiose;3-O-alpha-D-Glucopyranosyl-D-glucose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C01518  Nigerose,2.4.1.279;2.4.1.334,R09941 R11140
341.109,C12H22O11,cpd:C01711,Inulobiose;1-O-beta-D-Fructo-furanosyl-D-fructose,C12H22O11,NA,NA,NA,3.2.1.134,R03685
341.109,C12H22O11,cpd:C01725,Levanbiose,C12H22O11,Starch and sucrose metabolism,NA,NA,3.2.1.64;3.2.1.65,R10784 R11311
341.109,C12H22O11,cpd:C01728,"Mannobiose;alpha-1,6-Mannobiose;alpha-D-Manp-(1->6)-D-Manp",C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C01728  Mannobiose,3.2.1.163,R10809
341.109,C12H22O11,cpd:C01742,Palatinose;Isomaltulose;6-O-alpha-D-Glucopyranosyl-D-fructofuranose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C01742  Palatinose,5.4.99.11,R00810
341.109,C12H22O11,cpd:C01970,beta-Lactose;beta-D-Lactose,C12H22O11,NA,NA,NA,NA,NA
341.109,C12H22O11,cpd:C01971,beta-Maltose,C12H22O11,NA,NA,NA,5.1.3.21,R07319
341.109,C12H22O11,cpd:C02048,Laminaribiose;Laminariaceae;3-beta-D-Glucosyl-D-glucose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C02048  Laminaribiose,2.4.1.31,R00953
341.109,C12H22O11,cpd:C02964,4-O-beta-D-Glucopyranosyl-D-mannose,C12H22O11,NA,NA,NA,5.1.3.11,R01445
341.109,C12H22O11,cpd:C04147,"alpha-D-Glucosyl-(1,3)-D-mannose",C12H22O11,NA,NA,NA,NA,NA
341.109,C12H22O11,cpd:C04219,alpha-D-Aldosyl beta-D-fructoside;alpha-D-Aldosyl1 beta-D-fructoside;alpha-D-Aldosyl2 beta-D-fructoside,C12H22O11,NA,NA,NA,2.4.1.162,R04422
341.109,C12H22O11,cpd:C05400,Epimelibiose;6-O-(alpha-D-Galactopyranosyl)-D-mannopyranose,C12H22O11,Galactose metabolism,NA,NA,3.2.1.22,R01329
341.109,C12H22O11,cpd:C05402,Melibiose;6-O-(alpha-D-Galactopyranosyl)-D-glucopyranose;D-Gal-alpha1->6D-Glucose,C12H22O11,Galactose metabolism;Metabolic pathways;ABC transporters,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C05402  Melibiose,3.2.1.22;3.2.1.26,R01101 R02410 R05549
341.109,C12H22O11,cpd:C06421,alpha-Cellobiose;1-beta-D-Glucopyranosyl-4-alpha-D-glucopyranose,C12H22O11,NA,NA,NA,NA,NA
341.109,C12H22O11,cpd:C06422,beta-Cellobiose;1-beta-D-Glucopyranosyl-4-beta-D-glucopyranose,C12H22O11,NA,NA,NA,NA,NA
341.109,C12H22O11,cpd:C07064,Lactulose,C12H22O11,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A06 DRUGS FOR CONSTIPATION;   A06A DRUGS FOR CONSTIPATION;    A06AD Osmotically acting laxatives;     A06AD11 Lactulose;      D00352  Lactulose (JP18/USP/INN) &lt;JP/US&gt;;USP drug classification [BR:br08302]; Gastrointestinal Agents;  Anti-Constipation Agents;   Lactulose;    D00352  Lactulose (JP18/USP/INN);Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  23  Digestive organ agents;   235  Purgatives, clysters;    2359  Others;     D00352  Lactulose (JP18/USP/INN); 3  Agents affecting metabolism;  39  Other agents affecting metabolism;   399  Miscellaneous;    3999  Others;     D00352  Lactulose (JP18/USP/INN);Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00352  Lactulose",NA,NA
341.109,C12H22O11,cpd:C08240,Gentiobiose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C08240  Gentiobiose,NA,NA
341.109,C12H22O11,cpd:C08250,Sophorose;alpha-Sophorose;2-O-beta-D-Glucopyranosyl-beta-D-glucopyranose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C08250  Sophorose,2.4.1.333;3.2.1.214,R11128 R12634
341.109,C12H22O11,cpd:C15548,2-alpha-D-Glucosyl-D-glucose,C12H22O11,NA,NA,NA,2.4.1.230,R07264
341.109,C12H22O11,cpd:C18068,beta-D-Fructofuranosyl-alpha-D-mannopyranoside;Mannosylfructose,C12H22O11,NA,NA,NA,3.1.3.79,R08982
341.109,C12H22O11,cpd:C19632,Kojibiose;2-O-alpha-D-Glucopyranosyl-D-glucose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C19632  Kojibiose,NA,NA
341.109,C12H22O11,cpd:C19633,Maltulose;4-O-alpha-D-Glucopyranosyl-D-fructose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C19633  Maltulose,NA,NA
341.109,C12H22O11,cpd:C19634,Melibiulose;6-O-alpha-D-Galactopyranosyl-D-fructose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C19634  Melibiulose,NA,NA
341.109,C12H22O11,cpd:C19636,Turanose;3-O-alpha-D-Glucopyranosyl-D-fructose;D-Turanose,C12H22O11,NA,NA,Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C19636  Turanose,NA,NA
341.109,C12H22O11,cpd:C19773,3-O-alpha-D-Mannopyranosyl-alpha-D-mannopyranose,C12H22O11,NA,NA,NA,2.7.8.32,R09642
341.109,C12H22O11,cpd:C20236,4-O-beta-D-Mannopyranosyl-D-glucopyranose,C12H22O11,NA,NA,NA,2.4.1.281;5.1.3.11,R09943 R10810
341.109,C12H22O11,cpd:C20861,"Mannobiose;beta-1,4-Mannobiose",C12H22O11,NA,NA,NA,2.4.1.319;5.1.3.11,R10810 R10811
341.109,C12H22O11,cpd:C21336,"beta-1,2-Mannobiose;beta-D-Mannopyranosyl-(1->2)-D-mannopyranose",C12H22O11,NA,NA,NA,2.4.1.339;3.2.1.197,R11398 R11544
341.1241934,C16H22O8,cpd:C00761,Coniferin,C16H22O8,Phenylpropanoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Coniferyl alcohol derivatives;    C00761  Coniferin,2.4.1.111;3.2.1.126,R02594 R02595
343.0459527,C17H12O8,cpd:C10836,"3,4,3'-Tri-O-methylellagic acid",C17H12O8,NA,NA,"Phytochemical compounds [BR:br08003]; Others;  Tannins and galloyl derivatives;   Ellagitannins;    C10836  3,4,3'-Tri-O-methylellagic acid",NA,NA
343.0459527,C17H12O8,cpd:C19594,"Aflatoxin-M1-8,9-epoxide",C17H12O8,Metabolism of xenobiotics by cytochrome P450,NA,NA,1.14.14.1,R09406
343.0670853,C14H16O10,cpd:C10834,Theogallin,C14H16O10,NA,NA,NA,NA,NA
343.0823347,C18H16O7,cpd:C04444,"3,7,4'-Tri-O-methylquercetin;3',5-Dihydroxy-3,4',7-trimethoxyflavone",C18H16O7,Flavone and flavonol biosynthesis,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C04444  3,7,4'-Tri-O-methylquercetin",2.1.1.83,R03456
343.0823347,C18H16O7,cpd:C10032,Cirsilineol,C18H16O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10032  Cirsilineol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10032  Cirsilineol,NA,NA
343.0823347,C18H16O7,cpd:C10040,Eupatilin,C18H16O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10040  Eupatilin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10040  Eupatilin,NA,NA
343.0823347,C18H16O7,cpd:C10101,(-)-Usnic acid;(S)-Usnic acid;(S)-Usnate,C18H16O7,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones;    C10101  (-)-Usnic acid",1.1.1.199,R07345
343.0823347,C18H16O7,cpd:C10111,Nevadensin,C18H16O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10111  Nevadensin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10111  Nevadensin,NA,NA
343.0823347,C18H16O7,cpd:C10117,"Pachypodol;Quercetin 3,7,3'-trimethyl ether",C18H16O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10117  Pachypodol;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10117  Pachypodol,NA,NA
343.0823347,C18H16O7,cpd:C10180,Santin,C18H16O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10180  Santin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10180  Santin,NA,NA
343.0823347,C18H16O7,cpd:C10189,"Tambulin;Herbacetin 7,8,4'-trimethyl ether",C18H16O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10189  Tambulin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10189  Tambulin,NA,NA
343.0823347,C18H16O7,cpd:C14476,"Xanthomicrol;4',5-Dihydroxy-6,7,8-trimethoxyflavone",C18H16O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C14476  Xanthomicrol,NA,NA
343.0823347,C18H16O7,cpd:C17040,Obtusin,C18H16O7,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C17040  Obtusin,NA,NA
343.0823347,C18H16O7,cpd:C19807,"3',4',5'-O-Trimethyltricetin;5,7-Dihydroxy-3',4',5'-trimethoxyflavone",C18H16O7,NA,NA,NA,2.1.1.169,R09678 R09679
343.1187313,C19H20O6,cpd:C09353,Calaxin,C19H20O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09353  Calaxin,NA,NA
343.1187313,C19H20O6,cpd:C09388,Deoxyelephantopin,C19H20O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010309 Germacrane sesquiterpenoids;     C09388  Deoxyelephantopin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09388  Deoxyelephantopin,NA,NA
343.1187313,C19H20O6,cpd:C10338,"Echinone;6-((1S)-1-(Acetyloxy)-4-methyl-3-pentenyl)-8-hydroxy-5-methoxy-1,4-naphthalenedione",C19H20O6,NA,NA,NA,NA,NA
343.1187313,C19H20O6,cpd:C15118,"2,3-Dihydro-2-(4-methoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one;4',5,6,7-Tetramethoxyflavanone",C19H20O6,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C15118  2,3-Dihydro-2-(4-methoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",NA,NA
343.1398405,C16H24O8,cpd:C11652,8-Epiiridotrial glucoside;Boschnaloside,C16H24O8,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11652  8-Epiiridotrial glucoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11652  8-Epiiridotrial glucoside",NA,NA
343.1398405,C16H24O8,cpd:C11653,Iridotrial glucoside,C16H24O8,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11653  Iridotrial glucoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11653  Iridotrial glucoside",NA,NA
345.0616049,C17H14O8,cpd:C04581,"Tomentin;3',4',5,6-Tetrahydroxy-3,7-dimethoxyflavone",C17H14O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C04581  Tomentin,2.1.1.84,R04505
345.0616049,C17H14O8,cpd:C09967,Taxifolin 3-O-acetate,C17H14O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C09967  Taxifolin 3-O-acetate,NA,NA
345.0616049,C17H14O8,cpd:C10021,"Axillarin;Quercetagetin 3,6-dimethyl ether",C17H14O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10021  Axillarin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10021  Axillarin,NA,NA
345.0616049,C17H14O8,cpd:C11620,"Syringetin;3',5'-O-Dimethylmyricetin;3,5,7,4'-Tetrahydroxy-3',5'-dimethoxyflavone",C17H14O8,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C11620  Syringetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C11620  Syringetin,2.1.1.267,R06816
345.0616049,C17H14O8,cpd:C17788,Eupatolitin,C17H14O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C17788  Eupatolitin,NA,NA
345.0616049,C17H14O8,cpd:C19588,"Aflatoxin B1 diol;Aflatoxin B1-2,3-dihydrodiol",C17H14O8,Metabolism of xenobiotics by cytochrome P450,NA,NA,3.3.2.9,R09410 R09411
345.0616049,C17H14O8,cpd:C19589,Aflatoxin B1 dialdehyde,C17H14O8,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,R09411 R09412 R09413
345.0979761,C18H18O7,cpd:C15591,"(6R)-2-Acetyl-6-(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)-3-hydroxy-6-methyl-2,4-cyclohexadien-1-one;Reduced-(S)-usnate",C18H18O7,NA,NA,NA,1.1.1.199,R07345
345.1191094,C15H22O9,cpd:C09771,Aucubin,C15H22O9,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09771  Aucubin;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09771  Aucubin;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09771  Aucubin",NA,NA
345.1191094,C15H22O9,cpd:C11671,Deutzioside,C15H22O9,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11671  Deutzioside;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C11671  Deutzioside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11671  Deutzioside",NA,NA
345.1343775,C19H22O6,cpd:C01699,Gibberellin A3;Gibberellic acid;Gibberellin,C19H22O6,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C01699  Gibberellin A3;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C01699  Gibberellin A3;Pesticides [BR:br08007]; Pesticides;  Plant growth regulators;   Others;    C01699  Gibberellin A3,1.14.11.-;2.4.1.176,R03680 R06347 R06618
345.1343775,C19H22O6,cpd:C09062,Antheridic acid;Antheridiogen-An,C19H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C09062  Antheridic acid,NA,NA
345.1343775,C19H22O6,cpd:C09104,Hallactone A,C19H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09104  Hallactone A,NA,NA
345.1343775,C19H22O6,cpd:C09174,Ponalactone A,C19H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09174  Ponalactone A,NA,NA
345.1343775,C19H22O6,cpd:C09190,Strigol,C19H22O6,Carotenoid biosynthesis;Biosynthesis of plant hormones;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Carotenoids and apocarotenoids;   Apocarotenoids;    C09190  Strigol,1.14.13.-,R08990
345.1343775,C19H22O6,cpd:C09385,Cynaropicrin,C19H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09385  Cynaropicrin,NA,NA
345.1343775,C19H22O6,cpd:C09512,Molephantin,C19H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09512  Molephantin,NA,NA
345.1343775,C19H22O6,cpd:C09547,Saupirin,C19H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09547  Saupirin,NA,NA
345.1343775,C19H22O6,cpd:C11855,Gibberellin A29-catabolite,C19H22O6,Diterpenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11855  Gibberellin A29-catabolite;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11855  Gibberellin A29-catabolite,1.14.11.13,R06344
345.1343775,C19H22O6,cpd:C11856,Gibberellin A6,C19H22O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11856  Gibberellin A6;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11856  Gibberellin A6,NA,R06348
345.1343775,C19H22O6,cpd:C11869,Gibberellin A34-catabolite,C19H22O6,Diterpenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11869  Gibberellin A34-catabolite;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11869  Gibberellin A34-catabolite,1.14.11.13,R06342
345.1707088,C20H26O5,cpd:C09509,Microhelenin C,C20H26O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09509  Microhelenin C,NA,NA
345.1707088,C20H26O5,cpd:C09518,Nobilin,C20H26O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09518  Nobilin,NA,NA
345.1707088,C20H26O5,cpd:C11861,Gibberellin A24,C20H26O5,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11861  Gibberellin A24;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11861  Gibberellin A24,1.14.11.12,R06323 R06326 R06331 R06335
345.1707088,C20H26O5,cpd:C12308,Gibberellin A44;Gibberellin 44,C20H26O5,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C12308  Gibberellin A44;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C12308  Gibberellin A44,1.14.11.12,R07184
345.1707088,C20H26O5,cpd:C14161,Gibberellin A37,C20H26O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C14161  Gibberellin A37,NA,NA
345.1707088,C20H26O5,cpd:C20633,Methyl gibberellin A4,C20H26O5,NA,NA,NA,2.1.1.276,R10450
345.1918792,C17H30O7,cpd:C04529,"(3S,4S)-3-Hydroxytetradecane-1,3,4-tricarboxylate",C17H30O7,NA,NA,NA,2.3.3.4,R03859
347.0772514,C17H16O8,cpd:C19591,"1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal",C17H16O8,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,R09412 R09414
347.0772514,C17H16O8,cpd:C19592,"alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde",C17H16O8,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,R09413 R09415
347.1347506,C15H24O9,cpd:C17011,Leonuridine,C15H24O9,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17011  Leonuridine,NA,NA
347.1500222,C19H24O6,cpd:C00859,Gibberellin A1;Gibberellin 1,C19H24O6,Diterpenoid biosynthesis;Biosynthesis of terpenoids and steroids;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Plant hormone signal transduction,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1;Gibberellin A1 biosynthesis, GGPP => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C00859  Gibberellin A1;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C00859  Gibberellin A1,1.14.11.13;1.14.11.15,R03008 R03009 R06619
347.1500222,C19H24O6,cpd:C04597,"1,2-Bis(3,4-dimethoxyphenyl)propane-1,3-diol;1,2-Bis(3,4-dimethoxyphenyl)-1,3-propanediol",C19H24O6,NA,NA,NA,1.11.1.14,R04461
347.1500222,C19H24O6,cpd:C04844,"3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate;(1E,2Z)-3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate;DSHA",C19H24O6,Steroid degradation;Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds,NA,"Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0202 C19 steroids (androgens) and derivatives;    C04844  3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate",1.13.11.25;3.7.1.17,R04597 R09883
347.1500222,C19H24O6,cpd:C06096,Gibberellin A29,C19H24O6,Diterpenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C06096  Gibberellin A29;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C06096  Gibberellin A29,1.14.11.13,R03809 R06344
347.1500222,C19H24O6,cpd:C08759,Eurycomalactone,C19H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Others;    C08759  Eurycomalactone,NA,NA
347.1500222,C19H24O6,cpd:C09356,Chamissonin diacetate,C19H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09356  Chamissonin diacetate,NA,NA
347.1500222,C19H24O6,cpd:C09407,Eremantholide A;Eremantholide,C19H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09407  Eremantholide A,NA,NA
347.1500222,C19H24O6,cpd:C09520,Onopordopicrin,C19H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09520  Onopordopicrin,NA,NA
347.1500222,C19H24O6,cpd:C09539,Radiatin,C19H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09539  Radiatin,NA,NA
347.1500222,C19H24O6,cpd:C09554,Tagitinin F,C19H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09554  Tagitinin F,NA,NA
347.1500222,C19H24O6,cpd:C11868,Gibberellin A34,C19H24O6,Diterpenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11868  Gibberellin A34;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11868  Gibberellin A34,1.14.11.13,R06338 R06342
347.1711449,C16H28O8,cpd:C17638,Schizonepetoside E,C16H28O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17638  Schizonepetoside E,NA,NA
347.1863967,C20H28O5,cpd:C06094,Gibberellin A53,C20H28O5,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C06094  Gibberellin A53;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C06094  Gibberellin A53,1.14.11.12,R05097 R06329 R06340
347.1863967,C20H28O5,cpd:C09112,Ingenol,C20H28O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09112  Ingenol,NA,NA
347.1863967,C20H28O5,cpd:C11858,Gibberellin A14,C20H28O5,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A1 biosynthesis, GGPP => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11858  Gibberellin A14;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11858  Gibberellin A14,NA,R06324 R06333 R06339
347.1863967,C20H28O5,cpd:C11860,Gibberellin A15 open lactone,C20H28O5,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11860  Gibberellin A15 open lactone;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11860  Gibberellin A15 open lactone,1.14.11.12,R06322 R06323 R06330 R06334
349.0929107,C17H18O8,cpd:C19590,"6-[2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,2-dihydro-7-hydroxy-9-methoxy-cyclopenta[c][1]benzopyran-3,4-dione",C17H18O8,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,R09414 R09415
349.1656651,C19H26O6,cpd:C09290,Alatolide,C19H26O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010309 Germacrane sesquiterpenoids;     C09290  Alatolide;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09290  Alatolide,NA,NA
349.1656651,C19H26O6,cpd:C09297,Arctiopicrin,C19H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09297  Arctiopicrin,NA,NA
349.202058,C20H30O5,cpd:C04707,"(5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate;(5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprosta-13-enoate",C20H30O5,NA,NA,NA,1.1.1.141;1.3.1.48,R02580 R04556 R04557
349.202058,C20H30O5,cpd:C04758,"(5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate;15-Dehydro-prostaglandin D2",C20H30O5,NA,NA,NA,1.1.1.196,R02800
349.202058,C20H30O5,cpd:C04835,"(5Z,13E)-6,9alpha-Epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate",C20H30O5,NA,NA,NA,1.1.1.231,R03520
349.202058,C20H30O5,cpd:C06439,Prostaglandin E3,C20H30O5,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C06439  Prostaglandin E3;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C06439  Prostaglandin E3,NA,NA
349.202058,C20H30O5,cpd:C13802,Prostaglandin D3,C20H30O5,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C13802  Prostaglandin D3,NA,NA
349.202058,C20H30O5,cpd:C18171,"Resolvin E1;5S,12R,18R-Trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",C20H30O5,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0307 Hydroxy/hydroperoxyeicosapentaenoic acids;    C18171  Resolvin E1;Target-based classification of compounds [BR:br08010]; G Protein-coupled receptors;  Rhodopsin family: other receptors;   Leukotriene B4 receptor;    leukotriene B4 receptor 1;     C18171  Resolvin E1;    leukotriene B4 receptor 2;     C18171  Resolvin E1,NA,NA
349.202058,C20H30O5,cpd:C18176,"5S-Hydroperoxy-18R-HEPE;5S-Hydroperoxy-18R-hydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid",C20H30O5,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0307 Hydroxy/hydroperoxyeicosapentaenoic acids;    C18176  5S-Hydroperoxy-18R-HEPE,NA,NA
349.202058,C20H30O5,cpd:C18848,Chalcolactone,C20H30O5,NA,NA,NA,NA,NA
349.202058,C20H30O5,cpd:C20214,Andrographolide,C20H30O5,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Labdanes;    C20214  Andrographolide,NA,NA
351.0357662,C15H12O10,cpd:C18349,4-[2-(5-Carboxy-2-hydroxy-3-methoxyphenyl)-2-oxoethylidene]-2-hydroxy-2-pentenedioate,C15H12O10,Aminobenzoate degradation;Microbial metabolism in diverse environments,NA,NA,NA,R09276 R09277
351.056964,C12H16O12,cpd:C04733,4-(4-Deoxy-beta-D-gluc-4-enuronosyl)-D-galacturonate,C12H16O12,NA,NA,NA,NA,NA
351.056964,C12H16O12,cpd:C06118,4-(4-Deoxy-alpha-D-gluc-4-enuronosyl)-D-galacturonate;4-(4-Deoxy-alpha-D-galact-4-enuronosyl)-D-galacturonate;Unsaturated digalacturonate,C12H16O12,Pentose and glucuronate interconversions;Metabolic pathways,NA,NA,4.2.2.2;4.2.2.6;4.2.2.9,R02361 R04382
351.072165,C16H16O9,cpd:C11584,4-Methylumbelliferone glucuronide;4-Methylumbelliferyl glucuronide,C16H16O9,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Coumarin glycosides;   C11584  4-Methylumbelliferone glucuronide,NA,NA
351.217722,C20H32O5,cpd:C00427,"Prostaglandin H2;(5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate;(5Z,13E,15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate;PGH2;(5Z,9alpha,11alpha,13E,15S)-9,11-Epidioxy-15-hydroxy-prosta-5,13-dienoate",C20H32O5,Arachidonic acid metabolism;Metabolic pathways;Platelet activation;Retrograde endocannabinoid signaling;Serotonergic synapse;Oxytocin signaling pathway;Eicosanoids;Prostaglandins,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C00427  Prostaglandin H2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C00427  Prostaglandin H2,1.1.1.-;1.11.1.20;1.14.99.1;5.3.99.2;5.3.99.3;5.3.99.4;5.3.99.5,R00073 R01599 R02264 R02265 R02266 R02267 R02268 R09506
351.217722,C20H32O5,cpd:C00584,"Prostaglandin E2;(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate;(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate;Dinoprostone;PGE2",C20H32O5,Arachidonic acid metabolism;Metabolic pathways;cAMP signaling pathway;Neuroactive ligand-receptor interaction;C-type lectin receptor signaling pathway;Serotonergic synapse;Inflammatory mediator regulation of TRP channels;Oxytocin signaling pathway;Regulation of lipolysis in adipocytes;Renin secretion;Bile secretion;Leishmaniasis;African trypanosomiasis;Amoebiasis;Human cytomegalovirus infection;Human papillomavirus infection;Pathways in cancer;Rheumatoid arthritis,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C00584  Prostaglandin E2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C00584  Prostaglandin E2;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; G GENITO URINARY SYSTEM AND SEX HORMONES;  G02 OTHER GYNECOLOGICALS;   G02A UTEROTONICS;    G02AD Prostaglandins;     G02AD02 Dinoprostone;      D00079  Dinoprostone (JAN/USP/INN) &lt;JP/US&gt;;Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  24  Hormones;   249  Miscellaneous;    2499  Others;     D00079  Dinoprostone (JAN/USP/INN);Target-based classification of drugs [BR:br08310]; G Protein-coupled receptors;  Rhodopsin family;   Prostaglandin;    PTGER2;     D00079  Dinoprostone (JAN/USP/INN) &lt;JP/US&gt;,1.1.1.141;1.1.1.184;1.1.1.189;5.3.99.3,R02265 R02580 R02581 R02583
351.217722,C20H32O5,cpd:C00696,"Prostaglandin D2;(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate;(5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate;PGD2",C20H32O5,Arachidonic acid metabolism;Metabolic pathways;Neuroactive ligand-receptor interaction;Fc epsilon RI signaling pathway;Serotonergic synapse;African trypanosomiasis;Asthma,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C00696  Prostaglandin D2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C00696  Prostaglandin D2,1.1.1.188;1.1.1.196;5.3.99.2,R02266 R02684 R02799 R02800 R02801
351.217722,C20H32O5,cpd:C01312,"Prostaglandin I2;(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate;Prostacyclin;PGI2;Epoprostenol",C20H32O5,Arachidonic acid metabolism;Metabolic pathways;cAMP signaling pathway;Neuroactive ligand-receptor interaction;Vascular smooth muscle contraction;VEGF signaling pathway;Platelet activation,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C01312  Prostaglandin I2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C01312  Prostaglandin I2;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; B BLOOD AND BLOOD FORMING ORGANS;  B01 ANTITHROMBOTIC AGENTS;   B01A ANTITHROMBOTIC AGENTS;    B01AC Platelet aggregation inhibitors excl. heparin;     B01AC09 Epoprostenol;      D00106  Epoprostenol (USAN/INN);USP drug classification [BR:br08302]; Respiratory Tract/Pulmonary Agents;  Pulmonary Antihypertensives;   Prostacyclin Vasodilators;    Epoprostenol;     D00106  Epoprostenol (USAN/INN);Target-based classification of drugs [BR:br08310]; G Protein-coupled receptors;  Rhodopsin family;   Prostacyclin;    PTGIR;     D00106  Epoprostenol (USAN/INN),1.1.1.231;5.3.99.4,R02267 R03520 R03521
351.217722,C20H32O5,cpd:C02198,"Thromboxane A2;(5Z,13E)-(15S)-9alpha,11alpha-Epoxy-15-hydroxythromboxa-5,13-dienoate;(5Z,9alpha,11alpha,13E,15S)-9,11-Epoxy-15-hydroxythromboxa-5,13-dien-1-oic acid;TXA2",C20H32O5,Arachidonic acid metabolism;Metabolic pathways;Neuroactive ligand-receptor interaction;Platelet activation;Serotonergic synapse;Eicosanoids,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Thromboxanes;    C02198  Thromboxane A2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0303 Thromboxanes;    C02198  Thromboxane A2,5.3.99.5,R02268 R03878
351.217722,C20H32O5,cpd:C04654,"(13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate",C20H32O5,NA,NA,NA,1.1.1.197,R04552
351.217722,C20H32O5,cpd:C04671,"(5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate",C20H32O5,NA,NA,NA,1.3.1.48,R04556 R04557
351.217722,C20H32O5,cpd:C04853,"20-OH-Leukotriene B4;20-OH-LTB4;20-Hydroxy-leukotriene B4;(6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyeicosa-6,8,10,14-tetraenoate;(6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate",C20H32O5,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0302 Leukotrienes;    C04853  20-Hydroxy-leukotriene B4,1.14.14.94,R03866 R04616
351.217722,C20H32O5,cpd:C05960,15-Keto-prostaglandin F2alpha;15-Keto-prostaglandin F2a;15-Keto-PGF2alpha;15-Keto-PGF2a,C20H32O5,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05960  15-Keto-prostaglandin F2alpha,1.1.1.141;1.1.1.196,R02683
351.217722,C20H32O5,cpd:C06314,"Lipoxin A4;LXA4;5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid;(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid",C20H32O5,Arachidonic acid metabolism;Neuroactive ligand-receptor interaction;Toxoplasmosis,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0304 Lipoxins;    C06314  Lipoxin A4;Target-based classification of compounds [BR:br08010]; G Protein-coupled receptors;  Rhodopsin family: other receptors;   Cysteinyl leukotriene;    cysteinyl leukotriene receptor 1;     C06314  Lipoxin A4,3.3.2.-,R07031
351.217722,C20H32O5,cpd:C06315,"Lipoxin B4;LXB4;5S,14R,15S-Trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid;(6E,8Z,10E,12E)-(5S,14R,15S)-Trihydroxyicosa-6,8,10,12-tetraenoic acid",C20H32O5,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0304 Lipoxins;    C06315  Lipoxin B4;Target-based classification of compounds [BR:br08010]; G Protein-coupled receptors;  Rhodopsin family: other receptors;   Cysteinyl leukotriene;    cysteinyl leukotriene receptor 1;     C06315  Lipoxin B4,3.3.2.-,R07032
351.217722,C20H32O5,cpd:C06476,Prostaglandin F3alpha,C20H32O5,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C06476  Prostaglandin F3alpha;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C06476  Prostaglandin F3alpha,NA,NA
351.217722,C20H32O5,cpd:C11997,Narbonolide,C20H32O5,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin",NA,2.3.1.240;2.4.1.277,R06459 R06461
351.217722,C20H32O5,cpd:C13807,"Levuglandin E2;LGE2;10,11-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid;10,11-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoate",C20H32O5,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0310 Levuglandins;    C13807  Levuglandin E2,NA,NA
351.217722,C20H32O5,cpd:C13808,"Levuglandin D2;LGD2;9,10-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid;9,10-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoate",C20H32O5,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0310 Levuglandins;    C13808  Levuglandin D2,NA,NA
351.217722,C20H32O5,cpd:C17652,Cinncassiol D1,C20H32O5,NA,NA,NA,NA,NA
351.217722,C20H32O5,cpd:C17656,Cinncassiol D4,C20H32O5,NA,NA,NA,NA,NA
351.254038,C21H36O4,cpd:C09137,Montanol,C21H36O4,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09137  Montanol,NA,NA
353.0514178,C15H14O10,cpd:C02927,2-Caffeoylisocitrate;(E)-Caffeoylisocitrate,C15H14O10,NA,NA,NA,2.3.1.126,R01946
353.0877913,C16H18O9,cpd:C00852,Chlorogenate;Chlorogenic acid;Caffeoyl quinic acid;trans-5-O-Caffeoyl-D-quinate,C16H18O9,"Phenylpropanoid biosynthesis;Flavonoid biosynthesis;Stilbenoid, diarylheptanoid and gingerol biosynthesis;Biosynthesis of secondary metabolites",NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Caffeate derivatives;    C00852  Chlorogenate,1.14.14.96;2.3.1.98;2.3.1.99;2.3.1.133;3.1.1.42,R01945 R02997 R02998 R04342
353.0877913,C16H18O9,cpd:C01527,Scopolin,C16H18O9,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C01527  Scopolin;Glycosides [BR:br08021]; O-glycosides;  Coumarin glycosides;   C01527  Scopolin,2.4.1.128,R03594
353.0877913,C16H18O9,cpd:C08996,Biflorin,C16H18O9,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C08996  Biflorin;Glycosides [BR:br08021]; C-glycosides;  C08996  Biflorin,NA,NA
353.0877913,C16H18O9,cpd:C17147,Neochlorogenic acid;trans-Neochlorogenic acid;Neochlorogenate,C16H18O9,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Caffeate derivatives;    C17147  Neochlorogenic acid,NA,NA
353.1241951,C17H22O8,cpd:C19583,Fusarenone X;Fusarenon-X,C17H22O8,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Trichothecenes;    C19583  Fusarenone X,NA,NA
353.2333587,C20H34O5,cpd:C00639,"Prostaglandin F2alpha;(5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate;(+)-Prostaglandin F2a;7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid;9a,11a-PGF2;Amoglandin;Cyclosin;Dinoprost;Enzaprost;Enzaprost F;Panacelan;PGF2a;9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid;Prostaglandin F2a;Prostin F 2 alpha;Protamodin;U 14583;(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoate",C20H34O5,Arachidonic acid metabolism;Metabolic pathways;Phospholipase D signaling pathway;Neuroactive ligand-receptor interaction;Serotonergic synapse;Ovarian steroidogenesis;Oxytocin signaling pathway;Bile secretion,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C00639  Prostaglandin F2alpha;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C00639  Prostaglandin F2alpha;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; G GENITO URINARY SYSTEM AND SEX HORMONES;  G02 OTHER GYNECOLOGICALS;   G02A UTEROTONICS;    G02AD Prostaglandins;     G02AD01 Dinoprost;      D00081  Dinoprost (JP18/USAN/INN) &lt;JP&gt;;Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  24  Hormones;   249  Miscellaneous;    2499  Others;     D00081  Dinoprost (JP18/USAN/INN);Animal drugs in Japan [BR:br08331]; 94  Agents for breeding;  941  Hormone preparations (except posterior-pituitary hormone and preparations);   9419  Other hormone preparations;    C00639  Dinoprost;Target-based classification of drugs [BR:br08310]; G Protein-coupled receptors;  Rhodopsin family;   Prostaglandin;    PTGFR;     D00081  Dinoprost (JP18/USAN/INN) &lt;JP&gt;;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00081  Dinoprost,1.1.1.141;1.1.1.184;1.1.1.188;1.1.1.189;1.1.1.196;1.1.1.-;1.11.1.20,R02264 R02581 R02683 R02684 R09506
353.2333587,C20H34O5,cpd:C02314,"Prostaglandin F2beta;Prostaglandin F2b;Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-,(5Z,9beta,11alpha,13E,15S)-;5-Heptenoic acid, 7-[3,5-dihydroxy-2(3-hydroxy-1-octenyl)cyclopentyl]-, stereoisomer;9beta,11alpha-PGF2a;9beta,11alpha-PGF2alpha;PGF2b;PGF2beta",C20H34O5,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C02314  Prostaglandin F2beta;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C02314  Prostaglandin F2beta,NA,NA
353.2333587,C20H34O5,cpd:C04741,"Alprostadil;Prostaglandin E1;(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate;PGE1",C20H34O5,NA,NA,"Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C04741  Prostaglandin E1;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C04741  Prostaglandin E1;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C01 CARDIAC THERAPY;   C01E OTHER CARDIAC PREPARATIONS;    C01EA Prostaglandins;     C01EA01 Alprostadil;      D00180  Alprostadil (JP18/USP/INN) &lt;JP/US&gt;; G GENITO URINARY SYSTEM AND SEX HORMONES;  G04 UROLOGICALS;   G04B UROLOGICALS;    G04BE Drugs used in erectile dysfunction;     G04BE01 Alprostadil;      D00180  Alprostadil (JP18/USP/INN) &lt;JP/US&gt;;USP drug classification [BR:br08302]; Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins);  Alprostadil;   D00180  Alprostadil (JP18/USP/INN); Sexual Disorder Agents;  Sexual Disorder Agents (Male);   Alprostadil;    D00180  Alprostadil (JP18/USP/INN);Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  21  Cardiovascular agents;   219  Miscellaneous;    2190  Miscellaneous;     D00180  Alprostadil (JP18/USP/INN);Target-based classification of drugs [BR:br08310]; G Protein-coupled receptors;  Rhodopsin family;   Prostaglandin;    PTGER1;     D00180  Alprostadil (JP18/USP/INN) &lt;JP/US&gt;;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00180  Alprostadil;  D00180  Alprostadil injection",1.1.1.197,R04552
353.2333587,C20H34O5,cpd:C04843,"(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoate;(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoic acid;Trioxilin A3",C20H34O5,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0309 Hepoxilins;    C04843  Trioxilin A3,3.3.2.7,R04609
353.2333587,C20H34O5,cpd:C05959,11-epi-Prostaglandin F2alpha;11-epi-Prostaglandin F2a;11-epi-PGF2alpha;11-epi-PGF2a,C20H34O5,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05959  11-epi-Prostaglandin F2alpha,1.1.1.188,R02799
353.2333587,C20H34O5,cpd:C06438,Prostaglandin D1,C20H34O5,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C06438  Prostaglandin D1;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C06438  Prostaglandin D1,NA,NA
353.2333587,C20H34O5,cpd:C13809,"9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid;8-Isoprostaglandin F2alpha;8-Isoprostane;8-epi-Prostaglandin F2alpha",C20H34O5,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0311 Isoprostanes;    C13809  8-Isoprostaglandin F2alpha,NA,NA
353.2333587,C20H34O5,cpd:C14782,"11,12,15-THETA;11,12,15-Trihydroxyicosatrienoic acid;(5Z,8Z,13E)-(15S)-11,12,15-Trihydroxyeicosa-5,8,12-trienoic acid;(5Z,8Z,13E)-(15S)-11,12,15-Trihydroxyicosa-5,8,12-trienoic acid",C20H34O5,Arachidonic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;    C14782  11,12,15-THETA",1.14.14.1,R07044
353.2333587,C20H34O5,cpd:C14809,"Trioxilin A3;(5Z,9E,14Z)-(11R,12S)-8,11,12-Trihydroxyeicosa-5,9,14-trienoic acid;(5Z,9E,14Z)-(11R,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoic acid",C20H34O5,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0309 Hepoxilins;    C14809  Trioxilin A3,3.3.2.7,R07036
353.2333587,C20H34O5,cpd:C14811,"Trioxilin B3;(5Z,8Z,14Z)-(11R,12R)-10,11,12-Trihydroxyeicosa-5,8,14-trienoic acid;(5Z,8Z,14Z)-(11R,12R)-10,11,12-Trihydroxyicosa-5,8,14-trienoic acid",C20H34O5,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0309 Hepoxilins;    C14811  Trioxilin B3,3.3.2.-,R07037
353.2333587,C20H34O5,cpd:C14814,"11,14,15-THETA;11,14,15-Trihydroxyicosatrienoic acid;(5Z,8Z,12E)-11,14,15-Trihydroxyeicosa-5,8,12-trienoic acid;(5Z,8Z,12E)-11,14,15-Trihydroxyicosa-5,8,12-trienoic acid",C20H34O5,Arachidonic acid metabolism;Metabolic pathways,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;    C14814  11,14,15-THETA",1.14.14.1,R07045
355.0823496,C19H16O7,cpd:C12372,Tetracenomycin M,C19H16O7,NA,NA,NA,NA,NA
355.0823496,C19H16O7,cpd:C12451,Fridamycin E,C19H16O7,Biosynthesis of type II polyketide products,NA,NA,NA,NA
355.1034529,C16H20O9,cpd:C09782,Gentiopicrin;Gentiopicroside,C16H20O9,Biosynthesis of alkaloids derived from terpenoid and polyketide;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09782  Gentiopicrin;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Secoiridoids;    C09782  Gentiopicrin",NA,R08500
355.1034529,C16H20O9,cpd:C17759,1-O-Feruloyl-beta-D-glucose;1-Feruloyl-D-glucose,C16H20O9,NA,NA,NA,2.3.1.-;2.4.1.120;2.4.1.126,R08819 R08823 R08839
355.2489816,C20H36O5,cpd:C06475,"Prostaglandin F1alpha;(13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-oic acid",C20H36O5,NA,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C06475  Prostaglandin F1alpha;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C06475  Prostaglandin F1alpha,NA,NA
357.0615824,C18H14O8,cpd:C20507,Versiconal,C18H14O8,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.353;3.1.1.94;4.2.1.143,R10400 R10401 R10402
357.0979627,C19H18O7,cpd:C15109,"Gardenin B;5-Hydroxy-2-(4-methoxyphenyl)-6,7,8-trimethoxy-4H-1-benzopyran-4-one;5-Hydroxy-4',6,7,8-tetramethoxyflavone;Demethyltangeretin",C19H18O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C15109  Gardenin B;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C15109  Gardenin B,NA,NA
357.0979627,C19H18O7,cpd:C17669,Chryso-obtusin,C19H18O7,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C17669  Chryso-obtusin,NA,NA
357.103844,C12H22O12,cpd:C20888,Cellobionate;Cellobionic acid;4-O-beta-D-Glucopyranosyl-D-gluconate,C12H22O12,NA,NA,NA,2.4.1.321,R10832
357.119116,C16H22O9,cpd:C11654,Tarennoside,C16H22O9,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11654  Tarennoside,NA,NA
357.119116,C16H22O9,cpd:C11672,10-Deoxygeniposidic acid,C16H22O9,Monoterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C11672  10-Deoxygeniposidic acid;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11672  10-Deoxygeniposidic acid,NA,R05898 R05899
357.119116,C16H22O9,cpd:C17071,Sweroside,C16H22O9,NA,NA,NA,NA,NA
357.1343653,C20H22O6,cpd:C05366,(+)-Pinoresinol,C20H22O6,Biosynthesis of various secondary metabolites - part 2;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C05366  (+)-Pinoresinol,1.14.19.74;1.17.9.2;1.23.1.1,R10225 R12126 R12153 R12653
357.1343653,C20H22O6,cpd:C08831,Miroestrol,C20H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Others;    C08831  Miroestrol,NA,NA
357.1343653,C20H22O6,cpd:C09077,Columbin,C20H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09077  Columbin,NA,NA
357.1343653,C20H22O6,cpd:C09515,Multiradiatin,C20H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09515  Multiradiatin,NA,NA
357.1343653,C20H22O6,cpd:C09516,Multistatin,C20H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09516  Multistatin,NA,NA
357.1343653,C20H22O6,cpd:C10317,Coleone A,C20H22O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010406 Cycloaibetiane and Abeoabietaine diterpenoids;     C10317  Coleone A,NA,NA
357.1343653,C20H22O6,cpd:C10558,Dihydrocubebin,C20H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10558  Dihydrocubebin,NA,NA
357.1343653,C20H22O6,cpd:C10682,"Matairesinol;(-)-Matairesinol;(3R,4R)-3,4-Bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one",C20H22O6,Biosynthesis of various secondary metabolites - part 2;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10682  Matairesinol,1.1.1.331;1.14.19.72,R10129 R11222
357.1343653,C20H22O6,cpd:C17414,Isobutylshikonin;Isobutyrylshikonin,C20H22O6,NA,NA,NA,NA,NA
357.1343653,C20H22O6,cpd:C17508,Isocolumbin,C20H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C17508  Isocolumbin,NA,NA
357.1343653,C20H22O6,cpd:C17808,Clemaphenol A,C20H22O6,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C17808  Clemaphenol A,NA,NA
357.1343653,C20H22O6,cpd:C20455,(-)-Pinoresinol,C20H22O6,Biosynthesis of various secondary metabolites - part 2;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C20455  (-)-Pinoresinol,1.23.1.3,R10227 R12145
359.0772292,C18H16O8,cpd:C01850,Rosmarinate;Rosmarinic acid,C18H16O8,Tyrosine metabolism;Metabolic pathways,NA,NA,2.3.1.140,R03374
359.0772292,C18H16O8,cpd:C04552,"Chrysosplenol D;3',4',5-Trihydroxy-3,6,7-trimethoxyflavone",C18H16O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C04552  Chrysosplenol D,2.1.1.84,R04505
359.0772292,C18H16O8,cpd:C09764,6-Methoxyaromadendrin 3-O-acetate,C18H16O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C09764  6-Methoxyaromadendrin 3-O-acetate,NA,NA
359.0772292,C18H16O8,cpd:C09982,Acerosin,C18H16O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C09982  Acerosin,NA,NA
359.0772292,C18H16O8,cpd:C10031,"Chrysosplenol C;Quercetagetin 3,7,3'-trimethyl ether",C18H16O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10031  Chrysosplenol C;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10031  Chrysosplenol C,NA,NA
359.0772292,C18H16O8,cpd:C10115,Oxyanin A;Oxyayanin A,C18H16O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10115  Oxyayanin A;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10115  Oxyanin A,NA,NA
359.0772292,C18H16O8,cpd:C10116,Oxyanin B;Oxyayanin B,C18H16O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10116  Oxyayanin B;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10116  Oxyanin B,NA,NA
359.0772292,C18H16O8,cpd:C10191,Thymonin,C18H16O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10191  Thymonin,NA,NA
359.0772292,C18H16O8,cpd:C17787,Arcapillin,C18H16O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C17787  Arcapillin,NA,NA
359.0772292,C18H16O8,cpd:C17957,Irigenin,C18H16O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C17957  Irigenin,NA,NA
359.0772292,C18H16O8,cpd:C20508,Versiconol,C18H16O8,Aflatoxin biosynthesis;Biosynthesis of secondary metabolites,NA,NA,1.1.1.353;3.1.1.94,R10398 R10400
359.1136269,C19H20O7,cpd:C09403,Elephantopin,C19H20O7,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010309 Germacrane sesquiterpenoids;     C09403  Elephantopin;Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09403  Elephantopin,NA,NA
359.1136269,C19H20O7,cpd:C09467,Goyazensolide,C19H20O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09467  Goyazensolide,NA,NA
359.1136269,C19H20O7,cpd:C09576,Vernodalin,C19H20O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09576  Vernodalin,NA,NA
359.1136269,C19H20O7,cpd:C14940,"2,3-Dihydro-2-(4-hydroxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",C19H20O7,NA,NA,NA,NA,NA
359.1347484,C16H24O9,cpd:C11636,7-Deoxyloganate,C16H24O9,Monoterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C11636  7-Deoxyloganate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11636  7-Deoxyloganate,1.14.14.85;2.4.1.323,R05832 R10834
359.1347484,C16H24O9,cpd:C11649,8-Epideoxyloganic acid,C16H24O9,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11649  8-Epideoxyloganic acid,NA,NA
359.1500072,C20H24O6,cpd:C09204,Triptolide,C20H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09204  Triptolide,NA,NA
359.1500072,C20H24O6,cpd:C09449,Euponin,C20H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09449  Euponin,NA,NA
359.1500072,C20H24O6,cpd:C09452,Fastigilin C,C20H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09452  Fastigilin C,NA,NA
359.1500072,C20H24O6,cpd:C09513,Molephantinin,C20H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09513  Molephantinin,NA,NA
359.1500072,C20H24O6,cpd:C09514,Multigilin,C20H24O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09514  Multigilin,NA,NA
359.1500072,C20H24O6,cpd:C10646,Lariciresinol;(+)-Lariciresinol,C20H24O6,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,"Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10646  (+)-Lariciresinol,1.23.1.1;1.23.1.2,R10225 R10226
359.1500072,C20H24O6,cpd:C14289,Dibenzo-18-crown-6,C20H24O6,NA,NA,NA,NA,NA
359.1500072,C20H24O6,cpd:C20454,(-)-Lariciresinol,C20H24O6,Biosynthesis of various secondary metabolites - part 2;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C20454  (-)-Lariciresinol,1.23.1.3;1.23.1.4,R10227 R10228
359.186428,C21H28O5,cpd:C00762,"Cortisone;17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione;Kendall's compound E;Reichstein's substance Fa",C21H28O5,Steroid hormone biosynthesis;Metabolic pathways;Aldosterone-regulated sodium reabsorption;Pathways in cancer;Prostate cancer;Glucocorticoid and mineralocorticoid receptor agonists/antagonists,"C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001]; Steroids;  21-Carbon atoms;   Pregnane derivatives;    C00762  Cortisone; Hormones and transmitters;  Steroid hormones;   Glucocorticoids;    C00762  Cortisone;Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;    C00762  Cortisone;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;  H02 CORTICOSTEROIDS FOR SYSTEMIC USE;   H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;    H02AB Glucocorticoids;     H02AB10 Cortisone;      D07749  Cortisone (INN); S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01B ANTIINFLAMMATORY AGENTS;    S01BA Corticosteroids, plain;     S01BA03 Cortisone;      D07749  Cortisone (INN);Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Estrogen like receptors;   3-Ketosteroid receptor;    NR3C1 (GR);     D07749  Cortisone (INN)",1.1.1.146;1.1.1.-;1.3.1.3;1.3.1.22,R02834 R02836 R02892 R02893
359.186428,C21H28O5,cpd:C01780,"Aldosterone;11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al",C21H28O5,Steroid hormone biosynthesis;Metabolic pathways;Aldosterone synthesis and secretion;Aldosterone-regulated sodium reabsorption;Glucocorticoid and mineralocorticoid receptor agonists/antagonists,"C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001]; Steroids;  21-Carbon atoms;   Pregnane derivatives;    C01780  Aldosterone; Hormones and transmitters;  Steroid hormones;   Mineralocorticoids;    C01780  Aldosterone;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;  H02 CORTICOSTEROIDS FOR SYSTEMIC USE;   H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;    H02AA Mineralocorticoids;     H02AA01 Aldosterone;      D10528  Aldosterone (INN);Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Estrogen like receptors;   3-Ketosteroid receptor;    NR3C2 (MR);     D10528  Aldosterone (INN)",1.3.1.3;1.14.15.4;1.14.15.5,R03263 R03713 R03714 R08949 R08953
359.186428,C21H28O5,cpd:C07369,Prednisolone,C21H28O5,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;   A07E INTESTINAL ANTIINFLAMMATORY AGENTS;    A07EA Corticosteroids acting locally;     A07EA01 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;; C CARDIOVASCULAR SYSTEM;  C05 VASOPROTECTIVES;   C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;    C05AA Corticosteroids;     C05AA04 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;; D DERMATOLOGICALS;  D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS;   D07A CORTICOSTEROIDS, PLAIN;    D07AA Corticosteroids, weak (group I);     D07AA03 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;;   D07X CORTICOSTEROIDS, OTHER COMBINATIONS;    D07XA Corticosteroids, weak, other combinations;     D07XA02 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;; H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;  H02 CORTICOSTEROIDS FOR SYSTEMIC USE;   H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;    H02AB Glucocorticoids;     H02AB06 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;; R RESPIRATORY SYSTEM;  R01 NASAL PREPARATIONS;   R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;    R01AD Corticosteroids;     R01AD02 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;; S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01B ANTIINFLAMMATORY AGENTS;    S01BA Corticosteroids, plain;     S01BA04 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;;   S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;    S01CB Corticosteroids/antiinfectives/mydriatics in combination;     S01CB02 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;;  S02 OTOLOGICALS;   S02B CORTICOSTEROIDS;    S02BA Corticosteroids;     S02BA03 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;;  S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;   S03B CORTICOSTEROIDS;    S03BA Corticosteroids;     S03BA02 Prednisolone;      D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;;USP drug classification [BR:br08302]; Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal);  Prednisolone;   D00472  Prednisolone (JP18/USP/INN); Inflammatory Bowel Disease Agents;  Glucocorticoids;   Prednisolone;    D00472  Prednisolone (JP18/USP/INN); Ophthalmic Agents;  Ophthalmic Anti-inflammatories;   Glucocorticoids, Ophthalmic;    Prednisolone;     D00472  Prednisolone (JP18/USP/INN);Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  24  Hormones;   245  Adrenal hormone preparations;    2456  Prednisolones;     D00472  Prednisolone (JP18/USP/INN);  26  Epidermides;   264  Analgesics, anti-itchings, astringents, anti-inflammatory agents;    2646  Adrenocorticotropic hormones;     D00472  Prednisolone (JP18/USP/INN);Classification of Japanese OTC drugs [BR:br08313]; Agents for integumentary system;  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);   D00472  Prednisolone (JP18/USP/INN); Agents for dental and stomatological use;  74 Stomatitis remedies;   D00472  Prednisolone (JP18/USP/INN);Risk category of Japanese OTC drugs [BR:br08312]; Designated second-class OTC drugs;  Inorganic and organic chemicals;   Prednisolone;    D00472  Prednisolone (JP18/USP/INN); Second-class OTC drugs;  Inorganic and organic chemicals;   Prednisolone;    D00472  Prednisolone (JP18/USP/INN);Animal drugs in Japan [BR:br08331]; 95  Agents for external use;  954  Anti-dermoinfectives;   9549  Other anti-dermoinfectives;    C07369  Prednisolone; 96  Agents affecting metabolism;  961  Hormone preparations (except agents for breeding and external use);   9612  Adrenal hormone preparations;    C07369  Prednisolone;Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Estrogen like receptors;   3-Ketosteroid receptor;    NR3C1 (GR);     D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00472  Prednisolone;  D00472  Prednisolone tablets;Drug metabolizing enzymes and transporters [br08309.html]; Drug metabolizing enzymes;  D00472;Topical steroids potency [br08317.html]; Classification in Japan;  D00472",NA,NA
359.186428,C21H28O5,cpd:C09846,Cinerin II,C21H28O5,NA,NA,"Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Others;    C09846  Cinerin II;Target-based classification of compounds [BR:br08010]; Ion channels;  Voltage-gated cation channels;   Na+ channel, SCN alpha, NaV1.x;    voltage-gated sodium channel;     C09846  Cinerin II",NA,NA
359.186428,C21H28O5,cpd:C10723,Tricyclodehydroisohumulone,C21H28O5,NA,NA,NA,NA,NA
359.186428,C21H28O5,cpd:C18039,"Aldosterone hemiacetal;11beta,18-Epoxy-18,21-dihydroxypregn-4-ene-3,20-dione",C21H28O5,Steroid hormone biosynthesis,NA,NA,NA,R08953
361.1140426,C15H22O10,cpd:C09768,Antirrhinoside,C15H22O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09768  Antirrhinoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09768  Antirrhinoside,NA,NA
361.1140426,C15H22O10,cpd:C09773,Catalpol,C15H22O10,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09773  Catalpol;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09773  Catalpol;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09773  Catalpol",NA,NA
361.1293085,C19H22O7,cpd:C09138,Nagilactone C,C19H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09138  Nagilactone C,NA,NA
361.1293085,C19H22O7,cpd:C09583,Vernolide,C19H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09583  Vernolide,NA,NA
361.1293085,C19H22O7,cpd:C11870,Gibberellin A8-catabolite,C19H22O7,Diterpenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11870  Gibberellin A8-catabolite;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11870  Gibberellin A8-catabolite,1.14.11.13,R06345
361.1656501,C20H26O6,cpd:C02034,Gibberellin A19;Gibberellin 19,C20H26O6,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C02034  Gibberellin A19;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C02034  Gibberellin A19,1.14.11.12,R03806 R03807 R06331 R07184
361.1656501,C20H26O6,cpd:C09090,Enmein,C20H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09090  Enmein,NA,NA
361.1656501,C20H26O6,cpd:C09184,Shikodonin,C20H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Kaurenes;    C09184  Shikodonin,NA,NA
361.1656501,C20H26O6,cpd:C09395,Deacetyleupaserrin,C20H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09395  Deacetyleupaserrin,NA,NA
361.1656501,C20H26O6,cpd:C09442,Eupatoriopicrin,C20H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09442  Eupatoriopicrin,NA,NA
361.1656501,C20H26O6,cpd:C09451,Fastigilin B,C20H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09451  Fastigilin B,NA,NA
361.1656501,C20H26O6,cpd:C09474,Heliangin,C20H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09474  Heliangin,NA,NA
361.1656501,C20H26O6,cpd:C11862,Gibberellin A36,C20H26O6,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A1 biosynthesis, GGPP => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11862  Gibberellin A36;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11862  Gibberellin A36,NA,R06325 R06327 R06335
361.1656501,C20H26O6,cpd:C18167,Secoisolariciresinol;(-)-Secoisolariciresinol,C20H26O6,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,"Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin",Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C18167  (-)-Secoisolariciresinol,1.1.1.331;1.23.1.2,R10129 R10226
361.1656501,C20H26O6,cpd:C19145,"Propyl isome;1,2,3,4-Tetrahydro-3-methyl-6,7-methylenebisoxynaphthalene-1,2-dicarboxylic acid dipropyl",C20H26O6,NA,NA,Pesticides [BR:br08007]; Obsolete pesticides;  Others;   Synergists;    C19145  Propyl isome,NA,NA
361.1656501,C20H26O6,cpd:C20456,(+)-Secoisolariciresinol,C20H26O6,Biosynthesis of various secondary metabolites - part 2;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C20456  (+)-Secoisolariciresinol,1.23.1.4,R10228
363.1449181,C19H24O7,cpd:C03579,Gibberellin A8;2beta-Hydroxygibberellin 1,C19H24O7,Diterpenoid biosynthesis,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C03579  Gibberellin A8;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C03579  Gibberellin A8,1.14.11.13,R03008 R06345
363.1449181,C19H24O7,cpd:C09585,Vernomygdin,C19H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09585  Vernomygdin,NA,NA
363.1449181,C19H24O7,cpd:C09607,Zexbrevin B,C19H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09607  Zexbrevin B,NA,NA
363.1813143,C20H28O6,cpd:C06095,Gibberellin A44 diacid;Gibberellin A44 open lactone,C20H28O6,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A4/A1 biosynthesis, GA12 => GA4 / GA53 => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C06095  Gibberellin A44 diacid;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C06095  Gibberellin A44 diacid,1.14.11.12,R03806 R05097 R06330
363.1813143,C20H28O6,cpd:C09155,Phorbol,C20H28O6,Inflammatory mediator regulation of TRP channels,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010433 Tigliane and ingenane diterpenoids;     C09155  Phorbol;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Tiglianes;    C09155  Phorbol;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Diterpenoids;    C09155  Phorbol,NA,NA
363.1813143,C20H28O6,cpd:C09178,Resiniferonol,C20H28O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Tiglianes;    C09178  Resiniferonol,NA,NA
363.1813143,C20H28O6,cpd:C09414,Eriolangin,C20H28O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Eudesmanes;    C09414  Eriolangin,NA,NA
363.1813143,C20H28O6,cpd:C09535,Pycnolide,C20H28O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09535  Pycnolide,NA,NA
363.1813143,C20H28O6,cpd:C11859,Gibberellin A37 open lactone,C20H28O6,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Gibberellin A1 biosynthesis, GGPP => GA1",Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010417 Gibberellins;     C11859  Gibberellin A37 open lactone;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Gibberellins;    C11859  Gibberellin A37 open lactone,NA,R06324 R06325 R06334
363.1813143,C20H28O6,cpd:C17642,Cinncassiol C2,C20H28O6,NA,NA,NA,NA,NA
363.1813143,C20H28O6,cpd:C21093,Terpentecin,C20H28O6,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Terpentecin biosynthesis, GGAP => terpentecin",NA,NA,R11069
365.1605852,C19H26O7,cpd:C09521,Orizabin,C19H26O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09521  Orizabin,NA,NA
365.1605852,C19H26O7,cpd:C09662,Diacetoxyscirpenol,C19H26O7,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Trichothecenes;    C09662  Diacetoxyscirpenol,NA,NA
365.1969543,C20H30O6,cpd:C05950,"20-COOH-Leukotriene B4;20-COOH-LTB4;20-Carboxy-leukotriene B4;5,12-Dihydroxy-Delta5,8,11,14-eicosapolyendioic acid",C20H30O6,Arachidonic acid metabolism,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0302 Leukotrienes;    C05950  20-Carboxy-leukotriene B4,NA,R04616
365.1969543,C20H30O6,cpd:C08758,Chaparrolide,C20H30O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08758  Chaparrolide,NA,NA
365.1969543,C20H30O6,cpd:C15438,Bis(2-butoxyethyl)phthalate;beta-Butoxyethyl phthalate,C20H30O6,NA,NA,NA,NA,NA
365.2333096,C21H34O5,cpd:C05472,"Urocortisol;Tetrahydrocortisol;5beta-Pregnane-3alpha,11beta,17alpha,21-tetrol-20-one",C21H34O5,Steroid hormone biosynthesis,NA,"Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;    C05472  Urocortisol",1.1.1.50;1.1.1.53,R04832 R04833 R04834
365.2333096,C21H34O5,cpd:C05481,Cortolone,C21H34O5,Steroid hormone biosynthesis,NA,NA,1.1.1.53,R04831
367.10344,C17H20O9,cpd:C02572,5-O-Feruloylquinic acid;O-Feruloylquinate;3-O-Feruloylquinic acid,C17H20O9,NA,NA,NA,2.3.1.99,R02195
367.2126189,C20H32O6,cpd:C05956,Prostaglandin G2;PGG2,C20H32O6,Arachidonic acid metabolism;Metabolic pathways;Platelet activation;Serotonergic synapse;Eicosanoids,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Prostaglandins;    C05956  Prostaglandin G2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05956  Prostaglandin G2,1.14.99.1,R00073 R01590
367.2126189,C20H32O6,cpd:C05962,6-Keto-prostaglandin E1;6-Keto-PGE1,C20H32O6,Arachidonic acid metabolism;Metabolic pathways,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05962  6-Keto-prostaglandin E1,NA,R05059
367.2126189,C20H32O6,cpd:C05964,11-Dehydro-thromboxane B2,C20H32O6,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Thromboxanes;    C05964  11-Dehydro-thromboxane B2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0303 Thromboxanes;    C05964  11-Dehydro-thromboxane B2,NA,R05060
367.2126189,C20H32O6,cpd:C12202,Platenolide A;Platenolide I,C20H32O6,NA,NA,NA,NA,NA
367.2126189,C20H32O6,cpd:C17653,Cinncassiol D2,C20H32O6,NA,NA,NA,NA,NA
367.2126189,C20H32O6,cpd:C17655,Cinncassiol D3,C20H32O6,NA,NA,NA,NA,NA
367.249036,C21H36O5,cpd:C05482,Cortol,C21H36O5,Steroid hormone biosynthesis,NA,NA,1.1.1.53,R04834
367.249036,C21H36O5,cpd:C06872,Carboprost,C21H36O5,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; G GENITO URINARY SYSTEM AND SEX HORMONES;  G02 OTHER GYNECOLOGICALS;   G02A UTEROTONICS;    G02AD Prostaglandins;     G02AD04 Carboprost;      D02343  Carboprost (USAN/INN);Target-based classification of drugs [BR:br08310]; G Protein-coupled receptors;  Rhodopsin family;   Prostaglandin;    PTGFR;     D02343  Carboprost (USAN/INN),NA,NA
369.067456,C12H18O13,cpd:C02273,Digalacturonate;Digalacturonic acid;alpha-D-Galacturonosyl-(1->4)-D-galacturonate,C12H18O13,Pentose and glucuronate interconversions;Metabolic pathways;ABC transporters,Pectin degradation,NA,3.2.1.15;3.2.1.67;3.2.1.82,R02360 R07413
369.067456,C12H18O13,cpd:C04354,"1,2-beta-D-Glucuronosyl-D-glucuronate;(1->2)-beta-D-Glucuronosyl-D-glucuronate",C12H18O13,NA,NA,NA,3.2.1.128,R03906
369.0827229,C16H18O10,cpd:C09266,Fraxin,C16H18O10,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09266  Fraxin;Glycosides [BR:br08021]; O-glycosides;  Coumarin glycosides;   C09266  Fraxin,NA,NA
369.0979868,C20H18O7,cpd:C10887,Styraxin,C20H18O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10887  Styraxin,NA,NA
369.0979868,C20H18O7,cpd:C20452,"Norsolorinic acid;Norsolorinate;2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinone",C20H18O7,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.349;1.13.12.20,R10224 R10309
369.2071487,C23H30O4,cpd:C18488,Spiromesifen,C23H30O4,NA,NA,Pesticides [BR:br08007]; Pesticides;  Insecticides;   Others;    C18488  Spiromesifen,NA,NA
369.2282681,C20H34O6,cpd:C05961,6-Keto-prostaglandin F1alpha;6-Keto-prostaglandin F1a;6-Keto-PGF1alpha;6-Keto-PGF1a,C20H34O6,Arachidonic acid metabolism;Metabolic pathways,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0301 Prostaglandins;    C05961  6-Keto-prostaglandin F1alpha,NA,R03521 R05059
369.2282681,C20H34O6,cpd:C05963,Thromboxane B2;TXB2,C20H34O6,Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse;Bile secretion,NA,Compounds with biological roles [BR:br08001]; Lipids;  Eicosanoids;   Thromboxanes;    C05963  Thromboxane B2;Lipids [BR:br08002]; FA  Fatty acyls;  FA03 Eicosanoids;   FA0303 Thromboxanes;    C05963  Thromboxane B2,NA,R03878 R05060
371.0408662,C18H12O9,cpd:C10334,Dothistromin,C18H12O9,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10334  Dothistromin,NA,NA
371.0619936,C15H16O11,cpd:C03062,2-O-Caffeoylglucarate,C15H16O11,NA,NA,NA,2.3.1.98,R02998
371.092491,C23H16O5,cpd:C09956,Ohioensin-A,C23H16O5,NA,NA,NA,NA,NA
371.113647,C20H20O7,cpd:C10186,"Sinensetin;5,6,7,3',4'-Pentamethoxyflavone",C20H20O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10186  Sinensetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10186  Sinensetin,NA,NA
371.113647,C20H20O7,cpd:C10190,"Tangeretin;5,6,7,8,4'-Pentamethoxyflavone",C20H20O7,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10190  Tangeretin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10190  Tangeretin,NA,NA
371.113647,C20H20O7,cpd:C10883,Sesamolinol,C20H20O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10883  Sesamolinol,NA,NA
371.113647,C20H20O7,cpd:C20499,"(1'S)-Averantin;1,3,6,8-Tetrahydroxy-[(1S)-2-hydroxyhexyl]-9,10-anthraquinone",C20H20O7,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.349;1.14.14.116,R10309 R10317 R10318
371.1347614,C17H24O9,cpd:C01533,Syringin;Eleutheroside B,C17H24O9,Phenylpropanoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C01533  Syringin,2.4.1.111;3.2.1.126,R03604 R03605
371.2439309,C20H36O6,cpd:C11989,"8,8a-Deoxyoleandolide",C20H36O6,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin","Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C11989  8,8a-Deoxyoleandolide",NA,R06453 R06454
373.0928851,C19H18O8,cpd:C10030,"Chrysosplenetin;Chrysosplenetin B;Quercetagetin 3,6,7,3'-tetramethyl ether",C19H18O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10030  Chrysosplenetin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10030  Chrysosplenetin,NA,NA
373.0928851,C19H18O8,cpd:C10183,Scullcapflavone II,C19H18O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10183  Scullcapflavone II,NA,NA
373.1140217,C16H22O10,cpd:C01957,Secologanate,C16H22O10,Monoterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Secoiridoids;    C01957  Secologanate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C01957  Secologanate,1.14.19.62;2.1.1.50,R05833 R05834
373.1140217,C16H22O10,cpd:C09800,Swertiamarin,C16H22O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Secoiridoids;    C09800  Swertiamarin,NA,NA
373.1140217,C16H22O10,cpd:C11673,Geniposidic acid,C16H22O10,Monoterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C11673  Geniposidic acid;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11673  Geniposidic acid,NA,R05899 R05900
373.1140217,C16H22O10,cpd:C16963,Gardoside,C16H22O10,NA,NA,NA,NA,NA
373.1292707,C20H22O7,cpd:C02549,Kievitone hydrate,C20H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C02549  Kievitone hydrate,4.2.1.95,R03622
373.1292707,C20H22O7,cpd:C09073,Chasmanthin,C20H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09073  Chasmanthin,NA,NA
373.1292707,C20H22O7,cpd:C09151,Palmarin,C20H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09151  Palmarin,NA,NA
373.1292707,C20H22O7,cpd:C09168,Plaunol D,C20H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09168  Plaunol D,NA,NA
373.1292707,C20H22O7,cpd:C09351,Budlein A,C20H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09351  Budlein A,NA,NA
373.1292707,C20H22O7,cpd:C09402,Elephantin,C20H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09402  Elephantin,NA,NA
373.1292707,C20H22O7,cpd:C10725,Nortrachelogenin,C20H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10725  Nortrachelogenin,NA,NA
373.1292707,C20H22O7,cpd:C22302,(+)-6-Hydroxypinoresinol,C20H22O7,NA,NA,NA,1.17.9.2,R12653
373.1503955,C17H26O9,cpd:C06071,Deoxyloganin;7-Deoxyloganin,C17H26O9,Monoterpenoid biosynthesis;Biosynthesis of terpenoids and steroids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C06071  Deoxyloganin;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C06071  Deoxyloganin",1.14.14.85;2.4.1.324,R03556 R10835
373.1503955,C17H26O9,cpd:C11648,8-Epideoxyloganin,C17H26O9,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11648  8-Epideoxyloganin;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11648  8-Epideoxyloganin",NA,NA
373.16557,C21H26O6,cpd:C09527,Phantomolin,C21H26O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09527  Phantomolin,NA,NA
373.16557,C21H26O6,cpd:C17826,Hexahydrocurcumin,C21H26O6,NA,NA,NA,NA,NA
373.16557,C21H26O6,cpd:C17848,Biondinin A,C21H26O6,NA,NA,NA,NA,NA
375.1296723,C16H24O10,cpd:C01512,Loganate;Loganic acid,C16H24O10,Monoterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C01512  Loganate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C01512  Loganate,1.14.14.85;1.14.19.62;2.1.1.50,R03554 R05832 R05833 R05898
375.1296723,C16H24O10,cpd:C11661,7-Epiloganic acid,C16H24O10,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11661  7-Epiloganic acid,NA,NA
375.1449294,C20H24O7,cpd:C08747,Ailanthone,C20H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08747  Ailanthone,NA,NA
375.1449294,C20H24O7,cpd:C09202,Tripdiolide;Triptodiolide,C20H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09202  Tripdiolide,NA,NA
375.1449294,C20H24O7,cpd:C09434,Euparotin,C20H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09434  Euparotin,NA,NA
375.1449294,C20H24O7,cpd:C09448,Eupatundin,C20H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09448  Eupatundin,NA,NA
375.1813231,C21H28O6,cpd:C09714,Rhipocephalin,C21H28O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09714  Rhipocephalin,NA,NA
375.1813231,C21H28O6,cpd:C17050,Picrasin B;Nigakilactone I,C21H28O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17050  Nigakilactone I,NA,NA
377.1241933,C19H22O8,cpd:C09477,Hydroxyvernolide,C19H22O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09477  Hydroxyvernolide,NA,NA
377.1241933,C19H22O8,cpd:C21786,Oleuropein aglycone,C19H22O8,NA,NA,NA,3.2.1.206,R11942
377.1605908,C20H26O7,cpd:C08757,Chaparrinone,C20H26O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08757  Chaparrinone,NA,NA
377.1605908,C20H26O7,cpd:C09362,Cnicin,C20H26O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09362  Cnicin,NA,NA
377.1605908,C20H26O7,cpd:C09433,Eupahyssopin,C20H26O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09433  Eupahyssopin,NA,NA
377.1605908,C20H26O7,cpd:C09517,Niveusin C,C20H26O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09517  Niveusin C,NA,NA
377.1969676,C21H30O6,cpd:C15291,"6alpha-Hydroxycortisol;6alpha,11beta,17,21-Tetrahydroxypregn-4-ene-3,20-dione",C21H30O6,NA,NA,NA,NA,NA
377.1969676,C21H30O6,cpd:C17012,Nigakilactone A;Quassin,C21H30O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17012  Nigakilactone A,NA,NA
379.1762504,C20H28O7,cpd:C08756,Chaparrin,C20H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08756  Chaparrin,NA,NA
379.1762504,C20H28O7,cpd:C17643,Cinncassiol C1,C20H28O7,NA,NA,NA,NA,NA
381.0616018,C20H14O8,cpd:C10306,Bikaverin,C20H14O8,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Naphthopyrones;    C10306  Bikaverin,NA,NA
381.0616018,C20H14O8,cpd:C12416,Nogalonate;Nogalonic acid,C20H14O8,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,1.13.12.22;2.1.1.-,R06675 R09327
381.1918914,C20H30O7,cpd:C17641,Cinncassiol C3,C20H30O7,NA,NA,NA,NA,NA
381.1918914,C20H30O7,cpd:C17645,Cinncassiol A,C20H30O7,NA,NA,NA,NA,NA
381.207169,C24H30O4,cpd:C09056,Ammoresinol,C24H30O4,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09056  Ammoresinol,NA,NA
381.2282653,C21H34O6,cpd:C17770,Sarcostin,C21H34O6,NA,NA,NA,NA,NA
383.0772066,C20H16O8,cpd:C12366,Tetracenomycin F2;Tcm F2,C20H16O8,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,2.3.1.235;4.2.1.154,R06699 R09355 R10960
383.0772066,C20H16O8,cpd:C18709,Decaketide tricyclic intermediate,C20H16O8,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide",NA,NA,R09350
383.0772066,C20H16O8,cpd:C20503,1'-Hydroxyversicolorone;Hydroxyversicolorone,C20H16O8,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.353,R09756 R10476 R10477
383.3530543,C24H48O3,cpd:C17873,2-Hydroxytetracosanoic acid,C24H48O3,NA,NA,NA,NA,NA
385.077651,C16H18O11,cpd:C03156,O-Feruloylgalactarate;O-Feruloylgalactaric acid;2'-(E)-O-Feruloylgalactaric acid,C16H18O11,NA,NA,NA,2.3.1.130,R03727
385.0929081,C20H18O8,cpd:C03503,Glucosyloxyanthraquinone,C20H18O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C03503  Glucosyloxyanthraquinone,2.4.1.181,R04108
385.0929081,C20H18O8,cpd:C09922,Cleomiscosin A,C20H18O8,NA,NA,NA,NA,NA
385.0929081,C20H18O8,cpd:C09924,Daphneticin,C20H18O8,NA,NA,NA,NA,NA
385.0929081,C20H18O8,cpd:C10446,Diferulic acid,C20H18O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Neolignans;    C10446  Diferulic acid,NA,NA
385.0929081,C20H18O8,cpd:C17958,Irisflorentin,C20H18O8,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C17958  Irisflorentin,NA,NA
385.0929081,C20H18O8,cpd:C20502,"5'-Oxoaverantin;1,3,6,8-Tetrahydroxy-2-[(1S)-1-hydroxy-5-oxohexyl]anthracene-9,10-dione",C20H18O8,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.352;4.2.1.142,R10310 R10311 R10475
385.0929081,C20H18O8,cpd:C20504,Versicolorone,C20H18O8,Aflatoxin biosynthesis;Biosynthesis of secondary metabolites,NA,NA,1.1.1.353,R09756 R10478
385.1140266,C17H22O10,cpd:C01175,1-O-Sinapoyl-beta-D-glucose;1-O-Sinapoyl beta-D-glucoside,C17H22O10,Phenylpropanoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Sinapate derivatives;    C01175  1-O-Sinapoyl-beta-D-glucose,2.3.1.91;2.3.1.92;2.3.1.103;2.4.1.120;2.4.1.126;2.4.1.299,R00063 R02380 R03075 R03323 R10261 R10298 R10299
385.1140266,C17H22O10,cpd:C02919,4-O-beta-D-Glucosyl-sinapate,C17H22O10,NA,NA,NA,2.4.1.126,R08533
385.1293335,C21H22O7,cpd:C09270,Isosamidin,C21H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09270  Isosamidin,NA,NA
385.1293335,C21H22O7,cpd:C09284,Peucenidin,C21H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09284  Peucenidin,NA,NA
385.1293335,C21H22O7,cpd:C09307,Pteryxin,C21H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09307  Pteryxin,NA,NA
385.1293335,C21H22O7,cpd:C09310,Samidin,C21H22O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09310  Samidin,NA,NA
385.1293335,C21H22O7,cpd:C14948,"2-(4-Ethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",C21H22O7,NA,NA,NA,NA,NA
385.1293335,C21H22O7,cpd:C21184,"(-)-5'-Demethylyatein;(3R,4R)-4-(2H-1,3-Benzodioxol-5-ylmethyl)-3-[(3-hydroxy-4,5-dimethoxyphenyl)methyl]oxolan-2-one",C21H22O7,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,"Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin",NA,1.14.14.131;2.1.1.330,R11211 R11545
385.2231905,C20H34O7,cpd:C11990,Oleandolide,C20H34O7,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin",Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C11990  Oleandolide,NA,R06454 R06455
385.2595606,C21H38O6,cpd:C03240,6-Deoxyerythronolide B,C21H38O6,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C03240  6-Deoxyerythronolide B,1.14.15.35;2.3.1.94,R00918 R05270
387.1085541,C20H20O8,cpd:C20500,"(1'S,5'S)-5'-Hydroxyaverantin;(1'S,5'S)-Hydroxyaverantin",C20H20O8,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.352;1.14.14.116,R10310 R10317
387.1085541,C20H20O8,cpd:C20501,"(1'S,5'R)-5'-Hydroxyaverantin;(1'S,5'R)-Hydroxyaverantin",C20H20O8,Aflatoxin biosynthesis;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.352;1.14.14.116,R10311 R10318
387.1296972,C17H24O10,cpd:C01852,Secologanin;(-)-Secologanin,C17H24O10,Indole alkaloid biosynthesis;Monoterpenoid biosynthesis;Isoquinoline alkaloid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of terpenoids and steroids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of alkaloids derived from terpenoid and polyketide;Metabolic pathways;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C01852  Secologanin;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Secoiridoids;    C01852  Secologanin;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C01852  Secologanin",1.14.19.62;2.1.1.50;4.3.3.2;4.3.3.3;4.3.3.4,R03555 R03738 R05749 R05750 R05834 R08500
387.1296972,C17H24O10,cpd:C09781,Geniposide,C17H24O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09781  Geniposide;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09781  Geniposide,NA,NA
387.1296972,C17H24O10,cpd:C09802,Verbenalin;Cornin (glycoside),C17H24O10,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09802  Verbenalin;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09802  Verbenalin;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09802  Verbenalin;   C09802  Verbenalin",NA,NA
387.1449489,C21H24O7,cpd:C09059,Alectrol;Orobanchyl acetate,C21H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09059  Alectrol,NA,NA
387.1449489,C21H24O7,cpd:C09260,Dihydrosamidin,C21H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09260  Dihydrosamidin,NA,NA
387.1449489,C21H24O7,cpd:C09316,Visnadin;Visnadine,C21H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09316  Visnadin;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C04 PERIPHERAL VASODILATORS;   C04A PERIPHERAL VASODILATORS;    C04AX Other peripheral vasodilators;     C04AX24 Visnadine;      D08735  Visnadine (INN),NA,NA
387.1449489,C21H24O7,cpd:C10891,Trachelogenin;(-)-Trachelogenin,C21H24O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10891  Trachelogenin,NA,NA
387.1660679,C18H28O9,cpd:C08558,Tuberonic acid glucoside,C18H28O9,NA,NA,Lipids [BR:br08002]; FA  Fatty acyls;  FA13 Fatty acyl glycosides;   FA1301 Fatty acyl glycosides of mono- and disaccharides;    C08558  Tuberonic acid glucoside,NA,NA
387.1812913,C22H28O6,cpd:C08778,Quassin;Nigakilactone D,C22H28O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0106 C30 isoprenoids (triterpenes);    PR010611 Nortriterpenoids;     C08778  Quassin;Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08778  Nigakilactone D,NA,NA
387.1812913,C22H28O6,cpd:C10888,Surinamensin,C22H28O6,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Neolignans;    C10888  Surinamensin,NA,NA
387.2024618,C19H32O8,cpd:C17452,Rehmaionoside C,C19H32O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17452  Rehmaionoside C,NA,NA
389.1089292,C16H22O11,cpd:C09788,Monotropein,C16H22O11,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09788  Monotropein;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09788  Monotropein;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09788  Monotropein",NA,NA
389.1241968,C20H22O8,cpd:C10275,"Piceid;Polydatin;3,4,5-Trihydroxystilbene-3-beta-monoglucoside",C20H22O8,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;    C10275  Piceid;Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Stilbenoids;   Stilbenes;    C10275  Piceid",NA,NA
389.1241968,C20H22O8,cpd:C10823,Populin,C20H22O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Phenolic glycosides;   C10823  Populin,NA,NA
389.1453421,C17H26O10,cpd:C01433,Loganin,C17H26O10,Monoterpenoid biosynthesis;Biosynthesis of terpenoids and steroids;Metabolic pathways;Biosynthesis of secondary metabolites,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C01433  Loganin;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C01433  Loganin;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C01433  Loganin",1.14.14.85;1.14.19.62;2.1.1.50,R03554 R03555 R03556
389.1606227,C21H26O7,cpd:C09412,Erioflorin acetate,C21H26O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09412  Erioflorin acetate,NA,NA
389.1969617,C22H30O6,cpd:C08771,Neoquassin,C22H30O6,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0106 C30 isoprenoids (triterpenes);    PR010611 Nortriterpenoids;     C08771  Neoquassin;Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08771  Neoquassin,NA,NA
389.1969617,C22H30O6,cpd:C09491,Laserolide,C22H30O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09491  Laserolide sesqui,NA,NA
389.1969617,C22H30O6,cpd:C10690,Megaphone,C22H30O6,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Neolignans;    C10690  Megaphone,NA,NA
389.1969617,C22H30O6,cpd:C17051,Picrasin D,C22H30O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17051  Picrasin D,NA,NA
389.1969617,C22H30O6,cpd:C20197,Prostratin,C22H30O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Tiglianes;    C20197  Prostratin,NA,NA
389.2181094,C19H34O8,cpd:C17450,Rehmaionoside A,C19H34O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17450  Rehmaionoside A,NA,NA
389.2181094,C19H34O8,cpd:C17451,Rehmaionoside B,C19H34O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17451  Rehmaionoside B,NA,NA
391.124604,C16H24O11,cpd:C17066,Shanzhiside,C16H24O11,NA,NA,NA,NA,NA
391.1398366,C20H24O8,cpd:C09443,Eupatoroxin,C20H24O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09443  Eupatoroxin,NA,NA
391.1398366,C20H24O8,cpd:C09447,10-epi-Eupatoroxin,C20H24O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09447  10-epi-Eupatoroxin,NA,NA
391.1398366,C20H24O8,cpd:C09577,Vernodalol,C20H24O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Others;    C09577  Vernodalol,NA,NA
391.1762077,C21H28O7,cpd:C09586,Viguiestenin,C21H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09586  Viguiestenin,NA,NA
391.1762077,C21H28O7,cpd:C17054,Picrasin G,C21H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17054  Picrasin G,NA,NA
391.212615,C22H32O6,cpd:C09115,Isodomedin,C22H32O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Kaurenes;    C09115  Isodomedin,NA,NA
391.212615,C22H32O6,cpd:C17013,Nigakilactone B;Simalikalactone A;Quassin,C22H32O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17013  Nigakilactone B,NA,NA
393.1191047,C19H22O9,cpd:C08994,Aloesin,C19H22O9,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C08994  Aloesin;Glycosides [BR:br08021]; C-glycosides;  C08994  Aloesin,NA,NA
393.1191047,C19H22O9,cpd:C09172,Podolactone B,C19H22O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09172  Podolactone B,NA,NA
393.1554815,C20H26O8,cpd:C08764,Glaucarubolone,C20H26O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08764  Glaucarubolone,NA,NA
393.1554815,C20H26O8,cpd:C09799,Specionin,C20H26O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09799  Specionin,NA,NA
393.1918562,C21H30O7,cpd:C17035,Nigakilactone M,C21H30O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17035  Nigakilactone M,NA,NA
393.1918562,C21H30O7,cpd:C17036,Nigakilactone N,C21H30O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17036  Nigakilactone N,NA,NA
397.0929474,C21H18O8,cpd:C12418,Dihydro-NAME;Dihydro-nogalonic acid methyl ester,C21H18O8,Biosynthesis of type II polyketide products,NA,NA,NA,R06678
397.0929474,C21H18O8,cpd:C12419,Auramycinone,C21H18O8,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,1.1.1.362,R06677
397.0929474,C21H18O8,cpd:C18631,Nogalavinone;Nogalamycinone,C21H18O8,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,1.1.1.-,R09329 R09330
397.186786,C20H30O8,cpd:C17659,Cinncassiol E,C20H30O8,NA,NA,NA,NA,NA
397.186786,C20H30O8,cpd:C19515,Ptaquiloside;Braxin C,C20H30O8,NA,NA,Phytochemical compounds [BR:br08003]; Others;  Others;   Others;    C19515  Braxin C;Natural toxins [BR:br08009]; Phytotoxins;  Others;   Others;    C19515  Ptaquiloside,NA,NA
399.0721576,C20H16O9,cpd:C12382,4-Demethylpremithramycinone,C20H16O9,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,2.1.1.-,R06715
399.0721576,C20H16O9,cpd:C20505,Versiconal hemiacetal acetate,C20H16O9,Aflatoxin biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1",NA,1.1.1.353;3.1.1.94,R10399 R10401 R10477
399.1085221,C21H20O8,cpd:C03502,Flavonol 3-O-D-galactoside,C21H20O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C03502  Flavonol 3-O-D-galactoside,NA,NA
399.1085221,C21H20O8,cpd:C03946,Flavonol 3-O-beta-D-glucoside;Flavonol 3-O-D-glucoside,C21H20O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C03946  Flavonol 3-O-beta-D-glucoside,2.3.1.116;2.4.1.91;2.4.1.159;2.4.1.239,R03267 R03880 R04356 R07339
399.1085221,C21H20O8,cpd:C04074,Isoflavone 7-O-beta-D-glucoside,C21H20O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C04074  Isoflavone 7-O-beta-D-glucoside,2.4.1.170,R07332
399.1085221,C21H20O8,cpd:C10553,4'-Demethylpodophyllotoxin,C21H20O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10553  4'-Demethylpodophyllotoxin,NA,NA
399.1085221,C21H20O8,cpd:C10729,alpha-Peltatin,C21H20O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10729  alpha-Peltatin,NA,NA
399.1085221,C21H20O8,cpd:C14963,"2-[4-(Acetyloxy)phenyl]-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",C21H20O8,NA,NA,NA,NA,NA
399.1085221,C21H20O8,cpd:C15555,Flavonol 3-O-D-glycoside;Flavonol 3-O-beta-D-glycoside,C21H20O8,NA,NA,NA,2.4.2.35,R03268
399.1085221,C21H20O8,cpd:C21185,"4'-Demethylepipodophyllotoxin;(-)-4'-Demethylepipodophyllotoxin;(5R,5aR,8aR,9S)-9-Hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one",C21H20O8,NA,NA,NA,1.14.14.132,R11212
399.1449347,C22H24O7,cpd:C10557,"Dihydroanhydropodorhizol;Yatein;(-)-Yatein;(3R,4R)-4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)dihydrofuran-2(3H)-one",C22H24O7,Biosynthesis of various secondary metabolites - part 2;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10557  Dihydroanhydropodorhizol,1.14.20.8;2.1.1.330,R11210 R11545
399.1449347,C22H24O7,cpd:C17845,(+)-Aschantin,C22H24O7,NA,NA,NA,NA,NA
399.2024618,C20H32O8,cpd:C17648,Cinncassiol B,C20H32O8,NA,NA,NA,NA,NA
399.2388377,C21H36O7,cpd:C17860,Atractyloside C,C21H36O7,NA,NA,NA,NA,NA
401.0877877,C20H18O9,cpd:C04719,"1-Hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone",C20H18O9,NA,NA,"Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C04719  1-Hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone",2.4.1.103,R03573
401.0877877,C20H18O9,cpd:C10349,Frangulin B,C20H18O9,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10349  Frangulin B;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10349  Frangulin B,NA,NA
401.0877877,C20H18O9,cpd:C20506,Versiconol acetate,C20H18O9,Aflatoxin biosynthesis;Biosynthesis of secondary metabolites,NA,NA,1.1.1.353;3.1.1.94,R10398 R10399 R10478
401.1241723,C21H22O8,cpd:C04007,Flavanone 7-O-beta-D-glucoside;Flavanone 7-O-glucoside,C21H22O8,NA,NA,NA,2.4.1.185;2.4.1.236,R07333 R07337
401.1241723,C21H22O8,cpd:C09262,"(3'R,4'R)-3'-Epoxyangeloyloxy-4'-acetoxy-3',4'-dihydroseselin",C21H22O8,NA,NA,"Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Coumarins;    C09262  (3'R,4'R)-3'-Epoxyangeloyloxy-4'-acetoxy-3',4'-dihydroseselin",NA,NA
401.1241723,C21H22O8,cpd:C10112,"Nobiletin;Hexamethoxyflavone;5,6,7,8,3',4'-Hexamethoxyflavone",C21H22O8,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10112  Nobiletin,NA,NA
401.1241723,C21H22O8,cpd:C14943,"2-(2,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",C21H22O8,NA,NA,NA,NA,NA
401.1241723,C21H22O8,cpd:C14944,"2-(3,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",C21H22O8,NA,NA,NA,NA,NA
401.1241723,C21H22O8,cpd:C22067,3'-(beta-D-Glucopyranosyl)-2'-hydroxy-beta-oxodihydrochalcone,C21H22O8,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Chalcone glycosides;   C22067  3'-(beta-D-Glucopyranosyl)-2'-hydroxy-beta-oxodihydrochalcone,2.4.1.360,R12290
401.2545028,C21H38O7,cpd:C06635,Erythronolide B,C21H38O7,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",NA,1.14.15.35;2.4.1.328,R05270 R05530
403.1245946,C17H24O11,cpd:C09779,Gardenoside,C17H24O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09779  Gardenoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09779  Gardenoside,NA,NA
403.1245946,C17H24O11,cpd:C09798,Scandoside methyl ester,C17H24O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09798  Scandoside methyl ester;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09798  Scandoside methyl ester,NA,NA
403.1398664,C21H24O8,cpd:C10708,Mallotophenone,C21H24O8,NA,NA,NA,NA,NA
403.176186,C22H28O7,cpd:C09117,Isodonal,C22H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09117  Isodonal,NA,NA
403.176186,C22H28O7,cpd:C09361,Chromolaenide,C22H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09361  Chromolaenide,NA,NA
403.176186,C22H28O7,cpd:C09427,Eupacunin,C22H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09427  Eupacunin,NA,NA
403.176186,C22H28O7,cpd:C09436,Eupaserrin,C22H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09436  Eupaserrin,NA,NA
403.176186,C22H28O7,cpd:C09437,Eupatocunin,C22H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09437  Eupatocunin,NA,NA
403.176186,C22H28O7,cpd:C09572,Ursiniolide A,C22H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09572  Ursiniolide A,NA,NA
403.176186,C22H28O7,cpd:C17849,Biondinin B,C22H28O7,NA,NA,NA,NA,NA
403.1948439,C23H32O4S,cpd:C14922,"15beta-Hydroxy-7alpha-mercapto-pregn-4-ene-3,20-dione 7-acetate",C23H32O4S,NA,NA,NA,NA,NA
405.0827298,C19H18O10,cpd:C10075,"Lancerin;4-C-Glucosyl-1,3,7-trihydroxyxanthone",C19H18O10,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10075  Lancerin;Glycosides [BR:br08021]; C-glycosides;  C10075  Lancerin,NA,NA
405.1190979,C20H22O9,cpd:C10245,Astringin,C20H22O9,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;    C10245  Astringin;Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Stilbenoids;   Stilbenes;    C10245  Astringin",NA,NA
405.1190979,C20H22O9,cpd:C10835,Trichocarpin,C20H22O9,NA,NA,NA,NA,NA
405.1402251,C17H26O11,cpd:C09784,Ipolamiide,C17H26O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09784  Ipolamiide;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09784  Ipolamiide,NA,NA
405.1402251,C17H26O11,cpd:C11659,10-Hydroxyloganin,C17H26O11,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11659  10-Hydroxyloganin;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11659  10-Hydroxyloganin",NA,NA
405.1402251,C17H26O11,cpd:C17000,Morroniside,C17H26O11,NA,NA,NA,NA,NA
405.1919212,C22H30O7,cpd:C09486,Isomontanolide,C22H30O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09486  Isomontanolide,NA,NA
405.1919212,C22H30O7,cpd:C17033,Nigakilactone K,C22H30O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17033  Nigakilactone K,NA,NA
405.1919212,C22H30O7,cpd:C17034,Nigakilactone L,C22H30O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17034  Nigakilactone L,NA,NA
405.1919212,C22H30O7,cpd:C17052,Picrasin E,C22H30O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17052  Picrasin E,NA,NA
407.0983574,C19H20O10,cpd:C09011,Khellol glucoside;Khelloside,C19H20O10,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Chromones;    C09011  Khellol glucoside,NA,NA
407.1347555,C20H24O9,cpd:C07601,Ginkgolide A,C20H24O9,Biosynthesis of terpenoids and steroids;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010454 Ginkgolides and Bilobalides;     C07601  Ginkgolide A;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Ginkgolides;    C07601  Ginkgolide A,NA,R08402
407.1347555,C20H24O9,cpd:C09279,Nodakenin,C20H24O9,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09279  Nodakenin,NA,NA
407.1711515,C21H28O8,cpd:C09579,Vernoflexuoside,C21H28O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09579  Vernoflexuoside,NA,NA
407.2075262,C22H32O7,cpd:C09071,Cascarillin,C22H32O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09071  Cascarillin,NA,NA
407.2075262,C22H32O7,cpd:C17031,Nigakilactone F,C22H32O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17031  Nigakilactone F,NA,NA
407.243956,C23H36O6,cpd:C09063,Asebotoxin II,C23H36O6,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Grayanoids;    C09063  Asebotoxin II;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Diterpenoids;    C09063  Asebotoxin II,NA,NA
409.0201303,C20H10O10,cpd:C18013,"3,3'-Biflaviolin;3,3',6,6',8,8'-Hexahydroxy-2,2'-binaphthalene-1,1',4,4'-tetraone",C20H10O10,NA,NA,NA,1.14.19.69,R08912
409.0201303,C20H10O10,cpd:C18014,"3,8'-Biflaviolin;2,3',4,6',7,8'-Hexahydroxy-1,2'-binaphthalene-1',4',5,8-tetraone",C20H10O10,NA,NA,NA,1.14.19.69,R08913
409.1504331,C20H26O9,cpd:C08752,Bruceine D,C20H26O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08752  Bruceine D,NA,NA
409.2231766,C22H34O7,cpd:C08772,Nigakihemiacetal A,C22H34O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08772  Nigakihemiacetal A,NA,NA
409.2231766,C22H34O7,cpd:C09076,Coleonol;Colforsin;Forskolin,C22H34O7,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010403 Labdane and halimane diterpenoids;     C09076  Coleonol;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09076  Coleonol;Target-based classification of compounds [BR:br08010]; Enzymes;  Lyases;   adenylate cyclase;    C09076  Coleonol;Target-based classification of drugs [BR:br08310]; Enzymes;  Lyases (EC4);   Phosphorus-oxygen lyases;    ADCY;     D03584  Colforsin (USAN/INN),NA,NA
409.25958,C23H38O6,cpd:C03641,Sterol 3-beta-D-glucoside,C23H38O6,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Saponins;   Steroid;    C03641  Sterol 3-beta-D-glucoside,2.4.1.173,R02113
409.3112134,C28H42O2,cpd:C14154,beta-Tocotrienol,C28H42O2,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Tocopherol/tocotorienol biosynthesis, homogentisate + phytyl/geranylgeranyl-PP => tocopherol/tocotorienol",Lipids [BR:br08002]; PR  Prenol lipids;  PR02 Quinones and hydroquinones;   PR0202 Vitamin E;    C14154  beta-Tocotrienol,2.1.1.95,R10492
409.3112134,C28H42O2,cpd:C14155,gamma-Tocotrienol,C28H42O2,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Tocopherol/tocotorienol biosynthesis, homogentisate + phytyl/geranylgeranyl-PP => tocopherol/tocotorienol",Lipids [BR:br08002]; PR  Prenol lipids;  PR02 Quinones and hydroquinones;   PR0202 Vitamin E;    C14155  gamma-Tocotrienol,2.1.1.95;5.5.1.24,R10491 R10624
409.3112134,C28H42O2,cpd:C20738,"6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol",C28H42O2,Ubiquinone and other terpenoid-quinone biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,"Tocopherol/tocotorienol biosynthesis, homogentisate + phytyl/geranylgeranyl-PP => tocopherol/tocotorienol",NA,2.1.1.295;5.5.1.24,R10624 R10710
411.108594,C22H20O8,cpd:C10875,Podophyllotoxone,C22H20O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10875  Podophyllotoxone,NA,NA
411.108594,C22H20O8,cpd:C12424,Aklavinone,C22H20O8,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,1.1.1.362;1.14.13.180;2.4.1.326,R06682 R06683 R09331
411.108594,C22H20O8,cpd:C20046,Mollicellin C,C22H20O8,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C20046  Mollicellin C,NA,NA
411.2388314,C22H36O7,cpd:C09103,Grayanotoxin I;Rhodotoxine,C22H36O7,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010418 Leucothol and grayanotoxane diterpenoids;     C09103  Grayanotoxin I;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Grayanoids;    C09103  Grayanotoxin I;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Diterpenoids;    C09103  Grayanotoxin I;Target-based classification of compounds [BR:br08010]; Ion channels;  Voltage-gated cation channels;   Na+ channel, SCN alpha, NaV1.x;    voltage-gated sodium channel;     C09103  Grayanotoxin I",NA,NA
411.3268417,C28H44O2,cpd:C08211,Doxercalciferol;1alpha-Hydroxyergocalciferol,C28H44O2,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;  H05 CALCIUM HOMEOSTASIS;   H05B ANTI-PARATHYROID AGENTS;    H05BX Other anti-parathyroid agents;     H05BX03 Doxercalciferol;      D01009  Doxercalciferol (USAN/INN) &lt;US&gt;;USP drug classification [BR:br08302]; Metabolic Bone Disease Agents;  Vitamin D-related Agents;   Doxercalciferol;    D01009  Doxercalciferol (USAN/INN);Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Thyroid hormone like receptors;   Vitamin D3 like receptor;    NR1I1 (VDR);     D01009  Doxercalciferol (USAN/INN) &lt;US&gt;;New drug approvals in the USA [br08319.html]; New molecular entities and new therapeutic biological products;  D01009;New drug approvals in the USA, Europe and Japan [br08328.html]; Approval dates by FDA, EMA and PMDA;  D01009",NA,NA
411.3268417,C28H44O2,cpd:C21958,"(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoic acid;10Z,13Z,16Z,19Z,22Z,25Z-Octacosahexaenoic acid;(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosa-10,13,16,19,22,25-hexaenoic acid",C28H44O2,NA,NA,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0103 Unsaturated fatty acids;    Polyunsaturated fatty acids;     C21958  (10Z,13Z,16Z,19Z,22Z,25Z)-Octacosa-10,13,16,19,22,25-hexaenoic acid",NA,NA
413.0878233,C21H18O9,cpd:C12383,Premithramycinone,C21H18O9,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,2.1.1.-;2.4.1.-,R06715 R06716
413.0878233,C21H18O9,cpd:C18632,1-OH-Nogalamycinone,C21H18O9,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,NA,R09330
413.1089318,C18H22O11,cpd:C09769,Asperuloside,C18H22O11,Monoterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09769  Asperuloside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09769  Asperuloside,NA,R05900
413.1089318,C18H22O11,cpd:C09795,Paederoside,C18H22O11S,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09795  Paederoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09795  Paederoside,NA,NA
413.1242192,C22H22O8,cpd:C10871,Picropodophyllin,C22H22O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10871  Picropodophyllin,NA,NA
413.1242192,C22H22O8,cpd:C10874,Podophyllotoxin,C22H22O8,Biosynthesis of various secondary metabolites - part 2;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,"Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin","Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10874  Podophyllotoxin;Natural toxins [BR:br08009]; Phytotoxins;  Others;   Others;    C10874  Podophyllotoxin;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; D DERMATOLOGICALS;  D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;   D06B CHEMOTHERAPEUTICS FOR TOPICAL USE;    D06BB Antivirals;     D06BB04 Podophyllotoxin;      D05529  Podofilox (USAN) &lt;US&gt;;USP drug classification [BR:br08302]; Dermatological Agents;  Dermatological Agents, Other;   Warts and Actinic Keratosis Agents;    Podofilox;     D05529  Podofilox (USAN);Antimicrobials [BR:br08307]; Antivirals;  Others;   Natural product;    D05529  Podofilox (USAN) &lt;US&gt;;Antimicrobials abbreviations [BR:br08327]; Antivirals;  Others;   Natural product;    D05529  Podofilox (USAN)",NA,R12127
413.160657,C23H26O7,cpd:C10707,Neoisostegane,C23H26O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10707  Neoisostegane,NA,NA
415.1034575,C21H20O9,cpd:C10216,Daidzin;Daidzein 7-O-glucoside,C21H20O9,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10216  Daidzin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10216  Daidzin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C10216  Daidzin,2.3.1.115;2.4.1.170,R07720 R07721
415.1034575,C21H20O9,cpd:C10316,Chrysophanol 8-O-beta-D-glucoside;Chrysophanol 8-glucoside,C21H20O9,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1304 Anthracenes and phenanthrenes;    C10316  Chrysophanol 8-O-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10316  Chrysophanol 8-O-beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10316  Chrysophanol 8-O-beta-D-glucoside,NA,NA
415.1034575,C21H20O9,cpd:C10346,Frangulin A,C21H20O9,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10346  Frangulin A;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10346  Frangulin A,NA,NA
415.1034575,C21H20O9,cpd:C10524,Puerarin,C21H20O9,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10524  Puerarin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10524  Puerarin;Glycosides [BR:br08021]; C-glycosides;  C10524  Puerarin,NA,NA
415.1034575,C21H20O9,cpd:C15580,Flavonol 7-O-beta-D-glucoside,C21H20O9,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C15580  Flavonol 7-O-beta-D-glucoside,2.4.1.237,R07338
415.1398262,C22H24O8,cpd:C10544,1-Acetoxypinoresinol,C22H24O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10544  1-Acetoxypinoresinol,NA,NA
415.1398262,C22H24O8,cpd:C13680,Lophotoxin,C22H24O8,NA,NA,NA,NA,NA
415.1762394,C23H28O7,cpd:C09413,Erioflorin methacrylate,C23H28O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09413  Erioflorin methacrylate,NA,NA
415.1948575,C24H32O4S,cpd:C07310,Spironolactone,C24H32O4S,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C03 DIURETICS;   C03D POTASSIUM-SPARING AGENTS;    C03DA Aldosterone antagonists;     C03DA01 Spironolactone;      D00443  Spironolactone (JP18/USP/INN) &lt;JP/US&gt;;USP drug classification [BR:br08302]; Cardiovascular Agents;  Diuretics, Potassium-sparing;   Spironolactone;    D00443  Spironolactone (JP18/USP/INN);Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  21  Cardiovascular agents;   213  Diuretics;    2133  Antialdosterones;     D00443  Spironolactone (JP18/USP/INN);Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Estrogen like receptors;   3-Ketosteroid receptor;    NR3C2 (MR);     D00443  Spironolactone (JP18/USP/INN) &lt;JP/US&gt;;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00443  Spironolactone;  D00443  Spironolactone tablets",NA,NA
415.2337175,C21H36O8,cpd:C17864,Atractyloside G,C21H36O8,NA,NA,NA,NA,NA
417.0827027,C20H18O10,cpd:C20727,Kaempferol 3-O-beta-D-xyloside,C20H18O10,NA,NA,NA,2.4.2.56,R10609
417.1191098,C21H22O9,cpd:C10305,Barbaloin;Aloin;Aloin A,C21H22O9,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthrone type;    C10305  Barbaloin;Glycosides [BR:br08021]; C-glycosides;  C10305  Barbaloin;Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Aloin;    C10305  Barbaloin,NA,NA
417.1191098,C21H22O9,cpd:C16978,Isoliquiritin,C21H22O9,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C16978  Isoliquiritin;Glycosides [BR:br08021]; O-glycosides;  Chalcone glycosides;   C16978  Isoliquiritin,NA,NA
417.1191098,C21H22O9,cpd:C16989,Liquiritin;Liquiritigenin-4'-beta-glucoside,C21H22O9,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C16989  Liquiritin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C16989  Liquiritin,NA,NA
417.1191098,C21H22O9,cpd:C17778,Isobarbaloin;Aloin B,C21H22O9,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthrone type;    C17778  Isobarbaloin;Glycosides [BR:br08021]; C-glycosides;  C17778  Isobarbaloin,NA,NA
417.1191098,C21H22O9,cpd:C17809,Polygonimitin B,C21H22O9,NA,NA,NA,NA,NA
417.155492,C22H26O8,cpd:C09435,Euparotin acetate,C22H26O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09435  Euparotin acetate,NA,NA
417.155492,C22H26O8,cpd:C09493,Liatrin,C22H26O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09493  Liatrin sesqui,NA,NA
417.155492,C22H26O8,cpd:C10889,(+)-Syringaresinol,C22H26O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10889  (+)-Syringaresinol,NA,NA
417.1918656,C23H30O7,cpd:C17820,Gomisin H,C23H30O7,NA,NA,NA,NA,NA
417.1918656,C23H30O7,cpd:C17852,Biondinin E,C23H30O7,NA,NA,NA,NA,NA
417.2104841,C24H34O4S,cpd:C15180,17beta-Hydroxy-4-mercaptoandrost-4-en-3-one 4-acetate 17-propionate,C24H34O4S,NA,NA,NA,NA,NA
419.1195241,C17H24O12,cpd:C11674,Secogalioside,C17H24O12,NA,NA,NA,NA,NA
419.1347727,C21H24O9,cpd:C09500,Melampodin A,C21H24O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09500  Melampodin A sesqui,NA,NA
419.1347727,C21H24O9,cpd:C09754,Glycyphyllin;Phloretin 2'-O-rhamnoside,C21H24O9,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C09754  Glycyphyllin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihydrochalcones;    C09754  Glycyphyllin,NA,NA
419.1347727,C21H24O9,cpd:C10266,Isorhapontin,C21H24O9,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;    C10266  Isorhapontin;Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Stilbenoids;   Stilbenes;    C10266  Isorhapontin",NA,NA
419.1347727,C21H24O9,cpd:C10288,Rhaponticin;Rhapontin,C21H24O9,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;    C10288  Rhaponticin;Phytochemical compounds [BR:br08003]; Shikimate / acetate-malonate pathway derived compounds;  Stilbenoids;   Stilbenes;    C10288  Rhaponticin",NA,NA
419.1559148,C18H28O11,cpd:C11645,Lamioside,C18H28O11,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11645  Lamioside;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C11645  Lamioside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11645  Lamioside",NA,NA
419.1711784,C22H28O8,cpd:C09428,Eupacunolin,C22H28O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09428  Eupacunolin,NA,NA
419.1711784,C22H28O8,cpd:C09429,Eupacunoxin,C22H28O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09429  Eupacunoxin,NA,NA
419.1711784,C22H28O8,cpd:C09432,Eupaformosanin,C22H28O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09432  Eupaformosanin,NA,NA
419.1711784,C22H28O8,cpd:C09439,Eupatocunoxin,C22H28O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09439  Eupatocunoxin,NA,NA
419.1711784,C22H28O8,cpd:C09475,Hiyodorilactone A,C22H28O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09475  Hiyodorilactone A,NA,NA
421.0776589,C19H18O11,cpd:C10077,Mangiferin;Chinomin,C19H18O11,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10077  Mangiferin;Glycosides [BR:br08021]; C-glycosides;  C10077  Mangiferin,NA,NA
421.0776589,C19H18O11,cpd:C10089,Norswertianolin,C19H18O11,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10089  Norswertianolin,NA,NA
421.0776589,C19H18O11,cpd:C10095,Tripteroside;Norathyriol-6-O-beta-D-glucoside,C19H18O11,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10095  Tripteroside,NA,NA
421.0776589,C19H18O11,cpd:C16979,Isomangiferin,C19H18O11,NA,NA,Glycosides [BR:br08021]; C-glycosides;  C16979  Isomangiferin,NA,NA
421.1140204,C20H22O10,cpd:C09617,Catechin 7-O-beta-D-xyloside,C20H22O10,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09617  Catechin 7-O-beta-D-xyloside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C09617  Catechin 7-O-beta-D-xyloside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavans;    C09617  Catechin 7-O-beta-D-xyloside",NA,NA
421.1140204,C20H22O10,cpd:C10873,Plicatic acid,C20H22O10,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10873  Plicatic acid,NA,NA
421.1350735,C17H26O12,cpd:C11644,Lamiide,C17H26O12,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11644  Lamiide,NA,NA
421.1350735,C17H26O12,cpd:C11660,10-Hydroxymorroniside,C17H26O12,NA,NA,NA,NA,NA
421.1868013,C22H30O8,cpd:C09801,Valtratum;Valtrate,C22H30O8,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09801  Valtratum;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09801  Valtratum",NA,NA
421.1868013,C22H30O8,cpd:C16809,Isovaltrate,C22H30O8,NA,NA,NA,NA,NA
421.1868013,C22H30O8,cpd:C17053,Picrasin F,C22H30O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17053  Picrasin F,NA,NA
421.2078767,C19H34O10,cpd:C17614,1-Octen-3-ol-3-o-beta-D-xylopyranosyl(1->6)-beta-D-glucopyranoside,C19H34O10,NA,NA,NA,NA,NA
421.2232078,C23H34O7,cpd:C08776,Picrasin C;Nigakilactone J;Quassin,C23H34O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08776  Nigakilactone J,NA,NA
421.2265399,C20H38O7S,cpd:C07874,"1,4-Bis(2-ethylhexyl) sulfosuccinate;Docusate hydrogen",C20H38O7S,NA,NA,NA,NA,NA
423.1296936,C20H24O10,cpd:C07602,Ginkgolide B,C20H24O10,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010454 Ginkgolides and Bilobalides;     C07602  Ginkgolide B;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Ginkgolides;    C07602  Ginkgolide B,NA,NA
423.1296936,C20H24O10,cpd:C07604,Ginkgolide J;BN 52024,C20H24O10,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010454 Ginkgolides and Bilobalides;     C07604  Ginkgolide J;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Ginkgolides;    C07604  Ginkgolide J,NA,NA
423.1296936,C20H24O10,cpd:C09309,Rutarin,C20H24O10,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09309  Rutarin;Glycosides [BR:br08021]; O-glycosides;  Coumarin glycosides;   C09309  Rutarin,NA,NA
423.1296936,C20H24O10,cpd:C16816,Ginkgolide M,C20H24O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Ginkgolides;    C16816  Ginkgolide M,NA,NA
423.1660657,C21H28O9,cpd:C10463,Grandidentatin,C21H28O9,NA,NA,NA,NA,NA
423.2024953,C22H32O8,cpd:C09776,Didrovaltratum;Didrovaltrate,C22H32O8,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09776  Didrovaltratum;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09776  Didrovaltratum",NA,NA
423.2024953,C22H32O8,cpd:C17032,Nigakilactone H,C22H32O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17032  Nigakilactone H,NA,NA
423.2024953,C22H32O8,cpd:C19952,HT-2 Toxin,C22H32O8,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Trichothecenes;    C19952  HT-2 Toxin,NA,NA
423.2388789,C23H36O7,cpd:C01844,Pravastatin,C23H36O7,Bile secretion,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C10 LIPID MODIFYING AGENTS;   C10A LIPID MODIFYING AGENTS, PLAIN;    C10AA HMG CoA reductase inhibitors;     C10AA03 Pravastatin;      D08410  Pravastatin (INN);Target-based classification of drugs [BR:br08310]; Enzymes;  Oxidoreductases (EC1);   Dehydrogenases;    HMGCR;     D08410  Pravastatin (INN);Drug metabolizing enzymes and transporters [br08309.html]; Drug transporters;  D08410",NA,NA
425.1817801,C21H30O9,cpd:C15970,Abscisic acid glucose ester;Abscisic acid-beta-D-glucopyranosyl ester;beta-D-Glucopyranosyl abscisate,C21H30O9,Carotenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,NA,2.4.1.263;3.2.1.175,R07575 R09723
427.103449,C22H20O9,cpd:C12425,epsilon-Rhodomycinone;Rhodomycinone,C22H20O9,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,1.14.13.180;2.4.1.-,R06683 R06684 R09336
427.1398377,C23H24O8,cpd:C10730,beta-Peltatin A methyl ether,C23H24O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10730  beta-Peltatin A methyl ether,NA,NA
427.1398377,C23H24O8,cpd:C15181,Wortmannin,C23H24O8,NA,NA,NA,NA,NA
427.1610128,C20H28O10,cpd:C10458,Furcatin,C20H28O10,NA,NA,NA,NA,NA
429.1191119,C22H22O9,cpd:C10509,Ononin;Formononetin 7-O-glucoside,C22H22O9,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10509  Ononin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10509  Ononin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C10509  Ononin,2.3.1.115;2.4.1.170,R07729 R07731 R07732 R07733
429.1249273,C15H26O14,cpd:C21968,2-O-[alpha-D-Glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate,C15H26O14,NA,NA,NA,2.3.1.273,R12159
429.1555244,C23H26O8,cpd:C10884,Sesartemin,C23H26O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10884  Sesartemin,NA,NA
429.1919394,C24H30O7,cpd:C09123,Athamantin,C24H30O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09123  Athamantin,NA,NA
431.0983982,C21H20O10,cpd:C01460,Vitexin;Apigenin 8-C-glucoside,C21H20O10,Flavonoid biosynthesis;Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C01460  Vitexin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C01460  Vitexin;Glycosides [BR:br08021]; C-glycosides;  C01460  Vitexin,2.4.1.105,R03565 R06822 R06823 R08130
431.0983982,C21H20O10,cpd:C01714,Isovitexin;Saponaretin;Apigenin-6-C-glucoside;6-C-Glucosylapigenin;Apigenin 6-C-glucoside,C21H20O10,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C01714  Apigenin-6-C-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C01714  Isovitexin;Glycosides [BR:br08021]; C-glycosides;  C01714  Isovitexin,2.4.1.106,R03686 R06825 R08126
431.0983982,C21H20O10,cpd:C04608,"Apigenin 7-O-beta-D-glucoside;7-O-beta-D-Glucosyl-5,7,4'-trihydroxyflavone;Apigenin 7-O-glucoside;Apigetrin;7-(beta-D-Glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;Cosmetin;Cosmosiin",C21H20O10,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C04608  Apigenin 7-O-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C04608  Apigenin 7-O-beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C04608  Apigenin 7-O-beta-D-glucoside,2.3.1.115;2.4.1.81;2.4.1.236;2.4.2.25,R03574 R04526 R06821 R06826
431.0983982,C21H20O10,cpd:C09126,Genistein 7-O-beta-D-glucoside;Genistein,C21H20O10,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C09126  Genistein 7-O-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C09126  Genistein 7-O-beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C09126  Genistein 7-O-beta-D-glucoside,2.3.1.115;2.4.1.170,R02932 R07757
431.0983982,C21H20O10,cpd:C10345,"Emodin 8-glucoside;1-beta-D-Glucopyranosyloxy-3-methyl-6-hydroxy-8-hydroxy-9,10-anthraquinone",C21H20O10,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1304 Anthracenes and phenanthrenes;    C10345  Emodin 8-glucoside;Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10345  Emodin 8-glucoside;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10345  Emodin 8-glucoside,NA,NA
431.0983982,C21H20O10,cpd:C10420,Genistein 8-C-glucoside,C21H20O10,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10420  Genistein 8-C-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10420  Genistein 8-C-glucoside;Glycosides [BR:br08021]; C-glycosides;  C10420  Genistein 8-C-glucoside,NA,NA
431.0983982,C21H20O10,cpd:C16911,Afzelin;Kaempferin;Kaempferol 3-O-alpha-L-rhamnoside,C21H20O10,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C16911  Afzelin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C16911  Afzelin,2.4.1.-,R09802 R12047
431.1347773,C22H24O9,cpd:C14942,"2-(2,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",C22H24O9,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C14942  2-(2,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",NA,NA
431.1347773,C22H24O9,cpd:C14953,"2-(3,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",C22H24O9,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C14953  2-(3,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",NA,NA
431.1347773,C22H24O9,cpd:C16223,(-)-Medicocarpin;Medicarpin 3-O-glucoside,C22H24O9,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C16223  (-)-Medicocarpin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C16223  (-)-Medicocarpin,2.3.1.115;2.4.1.170,R07740 R07741 R07742 R07743
431.1558967,C19H28O11,cpd:C17564,Zizybeoside I,C19H28O11,NA,NA,NA,NA,NA
431.1711685,C23H28O8,cpd:C20196,Salvinorin A,C23H28O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C20196  Salvinorin A;Target-based classification of compounds [BR:br08010]; G Protein-coupled receptors;  Rhodopsin family: peptide receptors;   Opioid;    kappa-opioid receptor;     C20196  Salvinorin A,NA,NA
431.2074756,C24H32O7,cpd:C09111,"Inflexin;3beta,11beta-Diacetoxy-1alpha-hydroxykaura-16-ene-6,15-dione",C24H32O7,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Kaurenes;    C09111  Inflexin,NA,NA
431.2074756,C24H32O7,cpd:C10622,Grandisin,C24H32O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10622  Grandisin,NA,NA
431.2074756,C24H32O7,cpd:C10657,Magnosalicin,C24H32O7,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10657  Magnosalicin,NA,NA
431.2074756,C24H32O7,cpd:C17064,Schizandrin,C24H32O7,NA,NA,NA,NA,NA
433.1140264,C21H22O10,cpd:C09099,Naringenin 7-O-beta-D-glucoside;Prunin,C21H22O10,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09099  Naringenin 7-O-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09099  Naringenin 7-O-beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09099  Naringenin 7-O-beta-D-glucoside,2.4.1.185;2.4.1.236,R02897 R06820
433.1140264,C21H22O10,cpd:C16406,Phlorizin chalcone;Chalcone 2'-O-glucoside,C21H22O10,Flavonoid biosynthesis,NA,Glycosides [BR:br08021]; O-glycosides;  Chalcone glycosides;   C16406  Phlorizin chalcone,2.4.1.-,R08013
433.1140264,C21H22O10,cpd:C16407,"2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside;THC 4'-glucoside;Chalconaringenin 4'-glucoside;2',4,4',6'-Tetrahydroxychalcone 4'-O-beta-D-glucoside",C21H22O10,Flavonoid biosynthesis,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C16407  2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside;Glycosides [BR:br08021]; O-glycosides;  Chalcone glycosides;   C16407  2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside",1.21.3.6;2.4.1.286,R08006 R08008
433.1140264,C21H22O10,cpd:C16492,8-C-Glucosylnaringenin,C21H22O10,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C16492  8-C-Glucosylnaringenin;Glycosides [BR:br08021]; C-glycosides;  C16492  8-C-Glucosylnaringenin,NA,R08129 R08130
433.1504339,C22H26O9,cpd:C09401,Eleganin,C22H26O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09401  Eleganin,NA,NA
433.1504339,C22H26O9,cpd:C09469,Graminiliatrin,C22H26O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09469  Graminiliatrin,NA,NA
435.0933157,C20H20O11,cpd:C10067,Irisxanthone,C20H20O11,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10067  Irisxanthone;Glycosides [BR:br08021]; C-glycosides;  C10067  Irisxanthone,NA,NA
435.0933157,C20H20O11,cpd:C10093,Swertianolin;Bellidifolin-8-O-glucoside,C20H20O11,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Pyrones;   Xanthenes;    C10093  Swertianolin,NA,NA
435.1296878,C21H24O10,cpd:C01604,Phlorizin;Phlorhizin;Phloridzin,C21H24O10,Flavonoid biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C01604  Phlorizin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihydrochalcones;    C01604  Phlorizin;Glycosides [BR:br08021]; O-glycosides;  Phenolic glycosides;   C01604  Phlorizin;Target-based classification of compounds [BR:br08010]; Transporters;  Solute carrier family;   SLC5;    SLC5A1 (SGLT1);     C01604  Phlorizin;    SLC5A2 (SGLT2);     C01604  Phlorizin,2.4.1.357,R12088
435.2025167,C23H32O8,cpd:C09532,Polhovolide,C23H32O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09532  Polhovolide,NA,NA
437.1453389,C21H26O10,cpd:C09465,Glaucolide B,C21H26O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09465  Glaucolide B,NA,NA
437.1453389,C21H26O10,cpd:C17484,sec-o-Glucosylhamaudol,C21H26O10,NA,NA,NA,NA,NA
439.1246152,C20H24O11,cpd:C07603,Ginkgolide C;BN 52022,C20H24O11,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010454 Ginkgolides and Bilobalides;     C07603  Ginkgolide C;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Ginkgolides;    C07603  Ginkgolide C,NA,NA
439.1973658,C22H32O9,cpd:C11899,10-Deacetyl-2-debenzoylbaccatin III,C22H32O9,Diterpenoid biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,NA,2.3.1.166,R06310 R06318 R06319
439.3217991,C29H44O3,cpd:C08965,Pfaffic acid,C29H44O3,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Others;    C08965  Pfaffic acid,NA,NA
441.1553878,C24H26O8,cpd:C09013,Mallotochromene,C24H26O8,NA,NA,NA,NA,NA
441.1766192,C21H30O10,cpd:C10474,Lusitanicoside,C21H30O10,NA,NA,NA,NA,NA
441.2857686,C24H42O7,cpd:C20340,"L-Ascorbic acid, 6-octadecanoate;L-Ascorbic acid monostearate",C24H42O7,NA,NA,NA,NA,NA
443.0984059,C22H20O10,cpd:C06799,Granaticin,C22H20O10,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,NA,NA
445.0776409,C21H18O11,cpd:C10025,Baicalin;Baicalein 7-O-glucuronide,C21H18O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10025  Baicalin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10025  Baicalin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10025  Baicalin,2.4.1.253;3.2.1.167,R09529 R09533
445.0810247,C18H22O11S,cpd:C09795,Paederoside,C18H22O11S,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09795  Paederoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09795  Paederoside,NA,NA
445.1140579,C22H22O10,cpd:C05376,Biochanin A-beta-D-glucoside;Biochanin A 7-O-beta-D-glucoside;Sissotrin,C22H22O10,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C05376  Biochanin A-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C05376  Biochanin A-beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C05376  Biochanin A-beta-D-glucoside,2.3.1.115;2.4.1.170,R06795 R06796
445.1140579,C22H22O10,cpd:C10381,Obtusifolin 2-glucoside,C22H22O10,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10381  Obtusifolin 2-glucoside;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10381  Obtusifolin 2-glucoside,NA,NA
445.1140579,C22H22O10,cpd:C10384,Physcion 8-glucoside;Physcion 8-O-beta-D-monoglucoside,C22H22O10,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1304 Anthracenes and phenanthrenes;    C10384  Physcion 8-glucoside;Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10384  Physcion 8-glucoside;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10384  Physcion 8-glucoside,NA,NA
445.1140579,C22H22O10,cpd:C10538,Trifolirhizin;(-)-Maackiain 3-O-glucoside,C22H22O10,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C10538  Trifolirhizin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C10538  Trifolirhizin,2.3.1.115;2.4.1.170,R07753 R07754 R07755 R07756
445.1140579,C22H22O10,cpd:C16195,Glycitin;Glycitein 7-O-glucoside,C22H22O10,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C16195  Glycitin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C16195  Glycitin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C16195  Glycitin,2.3.1.115;2.4.1.170,R07718 R07719
445.1140579,C22H22O10,cpd:C17835,Swertisin,C22H22O10,NA,NA,Glycosides [BR:br08021]; C-glycosides;  C17835  Swertisin,NA,NA
445.1140579,C22H22O10,cpd:C18359,Dihydrogranaticin,C22H22O10,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,NA,NA
445.1867776,C24H30O8,cpd:C10894,Yangambin;Lirioresinol-B dimethyl ether,C24H30O8,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10894  Yangambin,NA,NA
445.1867776,C24H30O8,cpd:C11133,Estrone glucuronide;Estrone 3-glucuronide;Estrone beta-D-glucuronide,C24H30O8,Steroid hormone biosynthesis,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C11133  Estrone 3-glucuronide;  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11133  Estrone 3-glucuronide,2.4.1.17,R02358
447.0933037,C21H20O11,cpd:C01750,Quercitrin;Quercetin 3-L-rhamnoside;Quercetin 3-O-alpha-L-rhamnopyranoside,C21H20O11,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C01750  Quercitrin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C01750  Quercitrin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C01750  Quercitrin,2.4.1.-;3.2.1.66,R02436 R09803 R09804
447.0933037,C21H20O11,cpd:C01821,Isoorientin;Homoorientin,C21H20O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C01821  Isoorientin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C01821  Isoorientin;Glycosides [BR:br08021]; C-glycosides;  C01821  Isoorientin,2.1.1.78,R03731
447.0933037,C21H20O11,cpd:C03951,"Luteolin 7-O-beta-D-glucoside;Luteolin 7-O-glucoside;7-O-beta-D-Glucosyl-5,7,3',4'-tetrahydroxyflavone",C21H20O11,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C03951  Luteolin 7-O-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C03951  Luteolin 7-O-beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C03951  Luteolin 7-O-beta-D-glucoside,2.4.1.81;2.4.1.236,R03588 R06829
447.0933037,C21H20O11,cpd:C08598,Carthamone,C21H20O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C08598  Carthamone;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C08598  Carthamone,NA,NA
447.0933037,C21H20O11,cpd:C10042,Fisetin 8-C-glucoside,C21H20O11,NA,NA,Glycosides [BR:br08021]; C-glycosides;  C10042  Fisetin 8-C-glucoside,NA,NA
447.0933037,C21H20O11,cpd:C10114,Orientin;Luteolin 8-C-glucoside,C21H20O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10114  Orientin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10114  Orientin;Glycosides [BR:br08021]; C-glycosides;  C10114  Orientin,NA,NA
447.0933037,C21H20O11,cpd:C12249,Kaempferol 3-O-glucoside;Kaempferol 3-O-beta-D-glucoside;Astragalin,C21H20O11,Flavone and flavonol biosynthesis;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12249  Astragalin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C12249  Kaempferol 3-O-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12249  Kaempferol 3-O-glucoside,2.4.1.91;2.4.1.159;2.4.1.239,R06611 R06804 R12046
447.0933037,C21H20O11,cpd:C12626,Kaempferol-3-O-galactoside;Kaempferol 3-O-beta-D-galactoside;Trifolin,C21H20O11,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12626  Kaempferol 3-O-beta-D-galactoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C12626  Kaempferol-3-O-galactoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12626  Kaempferol-3-O-galactoside,2.4.1.234;2.4.1.-,R06808 R08128
447.0933037,C21H20O11,cpd:C16409,Aureusidin 6-O-glucoside;Aureusidin 6-O-beta-D-glucoside,C21H20O11,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Aurones;    C16409  Aureusidin 6-O-glucoside,1.21.3.6,R08008 R08010
447.0933037,C21H20O11,cpd:C17056,Plantaginin;Scutellarein 7beta-D-glucopyranoside,C21H20O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C17056  Plantaginin,NA,NA
447.1296722,C22H24O10,cpd:C17391,Sakuranin;NSC 407308,C22H24O10,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C17391  Sakuranin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C17391  Sakuranin,NA,NA
447.2025051,C24H32O8,cpd:C04300,Estradiol-17alpha 3-D-glucuronoside,C24H32O8,NA,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C04300  Estradiol-17alpha 3-D-glucuronoside;  ST05 Steroid conjugates;   ST0501 Glucuronides;    C04300  Estradiol-17alpha 3-D-glucuronoside,2.4.1.39,R04451
447.2025051,C24H32O8,cpd:C05503,Estradiol-17beta 3-glucuronide;17beta-Estradiol 3-(beta-D-glucuronide),C24H32O8,Steroid hormone biosynthesis;Bile secretion,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C05503  17beta-Estradiol 3-(beta-D-glucuronide);  ST05 Steroid conjugates;   ST0501 Glucuronides;    C05503  17beta-Estradiol 3-(beta-D-glucuronide),2.4.1.17,R03091
447.2025051,C24H32O8,cpd:C09121,Jodrellin A,C24H32O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09121  Jodrellin A,NA,NA
447.2025051,C24H32O8,cpd:C11237,17beta-Estradiol 17-(beta-D-glucuronide);Estradiol-17beta-glucuronide;Glucuronosylestradiol,C24H32O8,NA,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C11237  17beta-Estradiol 17-(beta-D-glucuronide);  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11237  17beta-Estradiol 17-(beta-D-glucuronide),NA,NA
447.2235982,C21H36O10,cpd:C17858,Atractyloside A,C21H36O10,NA,NA,NA,NA,NA
449.1089589,C21H22O11,cpd:C09803,"Neoastilbin;(2S,3S)-Taxifolin 3-rhamnoside",C21H22O11,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C09803  Neoastilbin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09803  Neoastilbin,NA,NA
449.1089589,C21H22O11,cpd:C16408,"2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside;PHC 4'-O-glucoside;2',3,4,4',6'-Pentahydroxychalcone 4'-O-beta-D-glucoside",C21H22O11,Flavonoid biosynthesis,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C16408  2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside;Glycosides [BR:br08021]; O-glycosides;  Chalcone glycosides;   C16408  2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside",1.21.3.6;2.4.1.286,R08007 R08009 R08010
449.1089589,C21H22O11,cpd:C17449,Astilbin,C21H22O11,NA,NA,NA,NA,NA
449.1089589,C21H22O11,cpd:C17675,Neocarthamin,C21H22O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C17675  Neocarthamin,NA,NA
449.1453714,C22H26O10,cpd:C09478,"Auriculoside;7,3',5'-Trihydroxy-4'-methoxyflavan 3'-glucoside",C22H26O10,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09478  Auriculoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavans;    C09478  Auriculoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavans;    C09478  Auriculoside",NA,NA
449.21811,C24H34O8,cpd:C17030,Nigakilactone E,C24H34O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17030  Nigakilactone E,NA,NA
451.103573,C24H20O9,cpd:C10217,Cinchonain 1a,C24H20O9,NA,NA,NA,NA,NA
451.2337914,C24H36O8,cpd:C19992,"Rhodojaponin I;Grayanotoxane-5,6,10,14,16-pentol, 2,3-epoxy-, 6,14-diacetate, (2beta,3beta,6beta,14R)-",C24H36O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Grayanoids;    C19992  Rhodojaponin I;Natural toxins [BR:br08009]; Phytotoxins;  Terpenoids;   Diterpenoids;    C19992  Rhodojaponin I,NA,NA
453.2494062,C24H38O8,cpd:C09180,Rhodojaponin IV,C24H38O8,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010418 Leucothol and grayanotoxane diterpenoids;     C09180  Rhodojaponin IV;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Grayanoids;    C09180  Rhodojaponin IV,NA,NA
455.1346619,C24H24O9,cpd:C10886,Steganacin;(-)-Steganacin,C24H24O9,Biosynthesis of phenylpropanoids;Biosynthesis of secondary metabolites,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10886  Steganacin;Target-based classification of compounds [BR:br08010]; Others;  Cytoskeleton proteins;   beta-tubulin;    C10886  Steganacin,NA,NA
457.0776158,C22H18O11,cpd:C09731,Epigallocatechin 3-gallate,C22H18O11,AMPK signaling pathway,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1203 Proanthocyanidins;    C09731  Epigallocatechin 3-gallate;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavan 3-ols;    C09731  Epigallocatechin 3-gallate,NA,NA
457.0776158,C22H18O11,cpd:C12379,8-Demethyltetracenomycin C,C22H18O11,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C;Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,1.14.13.200;2.4.1.331,R10954 R10955
457.2231104,C26H34O7,cpd:C08867,Hellebrigenin 3-acetate,C26H34O7,NA,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST01 Sterols;   ST0113 Bufanolides and derivatives;    C08867  Hellebrigenin 3-acetate;Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Bufanolide;    C08867  Hellebrigenin 3-acetate,NA,NA
457.2231104,C26H34O7,cpd:C09668,Fumagillin,C26H34O7,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0103 C15 isoprenoids (sesquiterpenes);    PR010306 Bisabolane sesquiterpenoids;     C09668  Fumagillin;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;  P01 ANTIPROTOZOALS;   P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;    P01AX Other agents against amoebiasis and other protozoal diseases;     P01AX10 Fumagillin;      C09668  Fumagillin",NA,NA
457.2231104,C26H34O7,cpd:C16932,Cinobufotalin,C26H34O7,NA,NA,Compounds with biological roles [BR:br08001]; Steroids;  24-Carbon atoms;   Bufanolide derivatives;    C16932  Cinobufotalin;Natural toxins [BR:br08009]; Venoms;  Frog venoms;   Bufotoxins;    C16932  Cinobufotalin,NA,NA
459.1507756,C20H28O12,cpd:C10715,Paeonolide,C20H28O12,NA,NA,NA,NA,NA
459.166049,C24H28O9,cpd:C09055,6-Acetylpicropolin,C24H28O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09055  6-Acetylpicropolin,NA,NA
459.20246,C25H32O8,cpd:C10672,Aspidin,C25H32O8,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Others;   Phloroglucinols;    C10672  Aspidin,NA,NA
459.20246,C25H32O8,cpd:C10704,alpha-Kosin,C25H32O8,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Others;   Phloroglucinols;    C10704  alpha-Kosin,NA,NA
459.20246,C25H32O8,cpd:C15429,"17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-(hydrogensuccinate);21-(3-Carboxy-1-oxopropoxy)-17-hydroxypregn-4-ene-3,11,20-trione;Cortisone 21-succinate",C25H32O8,NA,NA,NA,NA,NA
459.20246,C25H32O8,cpd:C20206,Albaspidin BB,C25H32O8,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Others;   Phloroglucinols;    C20206  Albaspidin BB,NA,NA
461.0725928,C21H18O12,cpd:C03515,Luteolin 7-O-glucuronide;Luteolin 7-O-beta-D-glucuronide,C21H18O12,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C03515  Luteolin 7-O-glucuronide;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C03515  Luteolin 7-O-glucuronide;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C03515  Luteolin 7-O-glucuronide,2.4.1.189;2.4.1.190,R03589 R06827
461.108947,C22H22O11,cpd:C05990,Isoscoparine;Isoscoparin;C-Glucosyl-6 chrysoeriol;Chrysoeriol 6-C-glucoside,C22H22O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C05990  Isoscoparine;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C05990  Isoscoparine;Glycosides [BR:br08021]; C-glycosides;  C05990  Isoscoparine,2.1.1.78,R03731
461.108947,C22H22O11,cpd:C10104,6-Methoxyluteolin 7-rhamnoside,C22H22O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10104  6-Methoxyluteolin 7-rhamnoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10104  6-Methoxyluteolin 7-rhamnoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10104  6-Methoxyluteolin 7-rhamnoside,NA,NA
461.108947,C22H22O11,cpd:C10187,Swertiajaponin,C22H22O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10187  Swertiajaponin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10187  Swertiajaponin;Glycosides [BR:br08021]; C-glycosides;  C10187  Swertiajaponin,NA,NA
461.108947,C22H22O11,cpd:C10533,Tectoridin;Shekanin,C22H22O11,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10533  Tectoridin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10533  Tectoridin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C10533  Tectoridin,NA,NA
461.108947,C22H22O11,cpd:C17762,Homoplantaginin;Hispidulin 7-O-glucoside;Hispiduloside,C22H22O11,NA,NA,NA,NA,NA
461.2028582,C21H34O11,cpd:C11640,Patrinoside,C21H34O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11640  Patrinoside,NA,NA
461.2028582,C21H34O11,cpd:C17068,Valerosidatum;Valerosidate,C21H34O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17068  Valerosidatum,NA,NA
461.2181555,C25H34O8,cpd:C12888,"Hydrocortisone succinate;11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 21-(hydrogensuccinate);Cortisol succinate",C25H34O8,NA,NA,"Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;    C12888  Hydrocortisone succinate;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A01 STOMATOLOGICAL PREPARATIONS;   A01A STOMATOLOGICAL PREPARATIONS;    A01AC Corticosteroids for local oral treatment;     A01AC03 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18);  A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;   A07E INTESTINAL ANTIINFLAMMATORY AGENTS;    A07EA Corticosteroids acting locally;     A07EA02 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18); C CARDIOVASCULAR SYSTEM;  C05 VASOPROTECTIVES;   C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;    C05AA Corticosteroids;     C05AA01 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18); D DERMATOLOGICALS;  D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS;   D07A CORTICOSTEROIDS, PLAIN;    D07AA Corticosteroids, weak (group I);     D07AA02 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18);   D07X CORTICOSTEROIDS, OTHER COMBINATIONS;    D07XA Corticosteroids, weak, other combinations;     D07XA01 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18); H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;  H02 CORTICOSTEROIDS FOR SYSTEMIC USE;   H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;    H02AB Glucocorticoids;     H02AB09 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18); S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01B ANTIINFLAMMATORY AGENTS;    S01BA Corticosteroids, plain;     S01BA02 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18);   S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;    S01CB Corticosteroids/antiinfectives/mydriatics in combination;     S01CB03 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18);  S02 OTOLOGICALS;   S02B CORTICOSTEROIDS;    S02BA Corticosteroids;     S02BA01 Hydrocortisone;      D01442  Hydrocortisone succinate (JP18);Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Estrogen like receptors;   3-Ketosteroid receptor;    NR3C1 (GR);     D01442  Hydrocortisone succinate (JP18);Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D01442  Hydrocortisone succinate;Drug metabolizing enzymes and transporters [br08309.html]; Drug metabolizing enzymes;  D01442",NA,NA
463.0882336,C21H20O12,cpd:C05623,"Quercetin 3-O-glucoside;Isoquercitrin;2-(3,4-Dihidroxyphenyl)-3-(beta-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;Isotrifoliin",C21H20O12,Flavone and flavonol biosynthesis;Metabolic pathways;Biosynthesis of secondary metabolites,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C05623  Quercetin 3-O-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C05623  Quercetin 3-O-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C05623  Quercetin 3-O-glucoside,2.3.1.116;2.4.1.91;2.4.1.159;2.4.1.239;2.4.2.35,R02158 R04900 R06797 R06812 R06814
463.0882336,C21H20O12,cpd:C10050,Gossypetin 8-rhamnoside,C21H20O12,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10050  Gossypetin 8-rhamnoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10050  Gossypetin 8-rhamnoside,NA,NA
463.0882336,C21H20O12,cpd:C10073,Hyperin;Quercetin 3-galactoside,C21H20O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10073  Hyperin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10073  Hyperin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10073  Hyperin,NA,NA
463.0882336,C21H20O12,cpd:C10108,Myricitrin;Myricetin 3-O-rhamnoside,C21H20O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10108  Myricitrin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C10108  Myricitrin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10108  Myricitrin,NA,NA
463.0882336,C21H20O12,cpd:C12639,Quercimeritrin;Quercetin 7-O-beta-D-glucoside,C21H20O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12639  Quercetin 7-O-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C12639  Quercimeritrin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12639  Quercimeritrin,2.4.1.237,R06810
463.0882336,C21H20O12,cpd:C16410,Bracteatin 6-O-glucoside;Bracteatin 6-O-beta-D-glucoside,C21H20O12,Flavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Aurones;    C16410  Bracteatin 6-O-glucoside,1.21.3.6,R08009
463.0882336,C21H20O12,cpd:C17763,6-Hydroxyluteolin 7-glucoside,C21H20O12,NA,NA,NA,NA,NA
463.1246213,C22H24O11,cpd:C16422,Hesperetin 7-O-glucoside,C22H24O11,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C16422  Hesperetin 7-O-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C16422  Hesperetin 7-O-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C16422  Hesperetin 7-O-glucoside,2.4.1.185;2.4.1.236,R08021 R08022
463.1609821,C23H28O10,cpd:C09405,Enhydrin,C23H28O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09405  Enhydrin,NA,NA
463.1609821,C23H28O10,cpd:C09463,Glaucolide A,C23H28O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09463  Glaucolide A,NA,NA
463.1609821,C23H28O10,cpd:C09636,Diffutin,C23H28O10,NA,NA,"Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1202 Flavans, Flavanols and Leucoanthocyanidins;    C09636  Diffutin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavans;    C09636  Diffutin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavans;    C09636  Diffutin",NA,NA
463.1609821,C23H28O10,cpd:C14895,"1-(2-Hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(2,3,4,6-tetramethoxyphenyl)-2-propen-1-one",C23H28O10,NA,NA,NA,NA,NA
463.1973849,C24H32O9,cpd:C05504,"16-Glucuronide-estriol;16alpha,17beta-Estriol 16-(beta-D-glucuronide)",C24H32O9,Steroid hormone biosynthesis,NA,"Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide);  ST05 Steroid conjugates;   ST0501 Glucuronides;    C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide)",2.4.1.17,R04683
463.1973849,C24H32O9,cpd:C11288,"16alpha,17beta-Estriol 3-(beta-D-glucuronide)",C24H32O9,NA,NA,"Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C11288  16alpha,17beta-Estriol 3-(beta-D-glucuronide);  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11288  16alpha,17beta-Estriol 3-(beta-D-glucuronide)",NA,NA
463.1973849,C24H32O9,cpd:C11346,"16alpha,17beta-Estriol 17-(beta-D-glucuronide)",C24H32O9,NA,NA,"Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C11346  16alpha,17beta-Estriol 17-(beta-D-glucuronide);  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11346  16alpha,17beta-Estriol 17-(beta-D-glucuronide);Glycosides [BR:br08021]; O-glycosides;  Saponins;   Steroid;    C11346  16alpha,17beta-Estriol 17-(beta-D-glucuronide)",NA,NA
463.1973849,C24H32O9,cpd:C16859,Renillafoulin A,C24H32O9,NA,NA,NA,NA,NA
463.2338498,C25H36O8,cpd:C11134,Testosterone glucuronide;Testosterone 17beta-(beta-D-glucuronide),C25H36O8,Steroid hormone biosynthesis,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0202 C19 steroids (androgens) and derivatives;    C11134  Testosterone 17beta-(beta-D-glucuronide);  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11134  Testosterone glucuronide,2.4.1.17,R02502
465.103814,C21H22O12,cpd:C17531,Plantagoside,C21H22O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C17531  Plantagoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C17531  Plantagoside,NA,NA
465.1402449,C22H26O11,cpd:C09765,Agnuside,C22H26O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09765  Agnuside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09765  Agnuside,NA,NA
465.2130582,C24H34O9,cpd:C09738,T-2 Toxin,C24H34O9,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Trichothecenes;    C09738  T-2 Toxin,NA,NA
465.2494001,C25H38O8,cpd:C11135,Androsterone glucuronide;Androsterone 3-glucuronide,C25H38O8,Steroid hormone biosynthesis,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0202 C19 steroids (androgens) and derivatives;    C11135  Androsterone 3-glucuronide;  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11135  Androsterone 3-glucuronide,2.4.1.17,R02478
465.2494001,C25H38O8,cpd:C11136,Etiocholan-3alpha-ol-17-one 3-glucuronide,C25H38O8,Steroid hormone biosynthesis,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11136  Etiocholan-3alpha-ol-17-one 3-glucuronide,2.4.1.17,R04352
465.3044369,C27H46O4S,cpd:C18043,Cholesterol sulfate;Cholest-5-en-3beta-ol sulfate,C27H46O4S,Steroid hormone biosynthesis,NA,NA,2.8.2.2;2.8.2.14;3.1.6.2,R08941 R08977
467.0620052,C23H16O11,cpd:C06928,Cromolyn;Cromoglicic acid,C23H16O11,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;   A07E INTESTINAL ANTIINFLAMMATORY AGENTS;    A07EB Antiallergic agents, excl. corticosteroids;     A07EB01 Cromoglicic acid;      D07753  Cromoglicic acid (INN); D DERMATOLOGICALS;  D11 OTHER DERMATOLOGICAL PREPARATIONS;   D11A OTHER DERMATOLOGICAL PREPARATIONS;    D11AH Agents for dermatitis, excluding corticosteroids;     D11AH03 Cromoglicic acid;      D07753  Cromoglicic acid (INN); R RESPIRATORY SYSTEM;  R01 NASAL PREPARATIONS;   R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;    R01AC Antiallergic agents, excl. corticosteroids;     R01AC01 Cromoglicic acid;      D07753  Cromoglicic acid (INN);  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;   R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS;    R03BC Antiallergic agents, excl. corticosteroids;     R03BC01 Cromoglicic acid;      D07753  Cromoglicic acid (INN); S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01G DECONGESTANTS AND ANTIALLERGICS;    S01GX Other antiallergics;     S01GX01 Cromoglicic acid;      D07753  Cromoglicic acid (INN);Risk category of Japanese OTC drugs [BR:br08312]; Second-class OTC drugs;  Inorganic and organic chemicals;   Cromoglicic acid;    D07753  Cromoglicic acid (INN)",NA,NA
467.1923112,C23H32O10,cpd:C09525,Paucin,C23H32O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Pseudoguaianolide;    C09525  Paucin,NA,NA
467.196858,C20H38O8P2,cpd:C20270,Copal-8-ol diphosphate;(13E)-8alpha-Hydroxylabd-13-en-15-yl diphosphate,C20H38O8P2,Diterpenoid biosynthesis;Biosynthesis of secondary metabolites,NA,NA,4.2.1.133;4.2.3.140;4.2.3.141;4.2.3.190,R09967 R10241 R10276 R11857
467.196858,C20H38O8P2,cpd:C21656,ent-8alpha-Hydroxylabd-13-en-15-yl diphosphate,C20H38O8P2,Diterpenoid biosynthesis,NA,NA,4.2.1.173;4.2.3.186,R11820 R11851
467.196858,C20H38O8P2,cpd:C21658,Peregrinol diphosphate;(13E)-9-Hydroxy-8alpha-labda-13-en-15-yl diphosphate,C20H38O8P2,NA,NA,NA,4.2.1.174;4.2.3.189,R11821 R11856
469.1351558,C21H26O12,cpd:C09797,Plumieride,C21H26O12,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09797  Plumieride;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09797  Plumieride,NA,NA
471.0932476,C23H20O11,cpd:C06801,Tetracenomycin C,C23H20O11,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,1.14.13.200,R06704
471.1660762,C25H28O9,cpd:C18681,C1'-C9-Glycosylated UWM6,C25H28O9,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,2.4.1.-,R09345
473.0725436,C22H18O12,cpd:C10437,Chicoric acid,C22H18O12,NA,NA,NA,NA,NA
473.1817456,C25H30O9,cpd:C09968,Robustaol A,C25H30O9,NA,NA,NA,NA,NA
473.2181075,C26H34O8,cpd:C10671,Agrimophol,C26H34O8,NA,NA,NA,NA,NA
473.2181075,C26H34O8,cpd:C17049,Picrasin A;Nigakilactone G,C26H34O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C17049  Nigakilactone G,NA,NA
475.1821175,C21H32O12,cpd:C17428,Kanokoside A,C21H32O12,NA,NA,NA,NA,NA
475.1973861,C25H32O9,cpd:C11132,2-Methoxyestrone 3-glucuronide,C25H32O9,Steroid hormone biosynthesis,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C11132  2-Methoxyestrone 3-glucuronide;  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11132  2-Methoxyestrone 3-glucuronide,2.4.1.17,R04353
475.233843,C26H36O8,cpd:C11061,all-trans-Retinoyl-beta-glucuronide;Retinoyl glucuronide,C26H36O8,Retinol metabolism,NA,NA,2.4.1.17,R02902
477.197712,C21H34O12,cpd:C17429,Kanokoside B;Suspensolide F,C21H34O12,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17429  Kanokoside B,NA,NA
477.2129885,C25H34O9,cpd:C08746,Ailanthinone,C25H34O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08746  Ailanthinone,NA,NA
477.2129885,C25H34O9,cpd:C08755,Castelanone,C25H34O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08755  Castelanone,NA,NA
477.2129885,C25H34O9,cpd:C08783,Simalikilactone D,C25H34O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08783  Simalikilactone D,NA,NA
477.2129885,C25H34O9,cpd:C11131,2-Methoxy-estradiol-17beta 3-glucuronide,C25H34O9,Steroid hormone biosynthesis,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST02 Steroids;   ST0201 C18 steroids (estrogens) and derivatives;    C11131  2-Methoxy-estradiol-17beta 3-glucuronide;  ST05 Steroid conjugates;   ST0501 Glucuronides;    C11131  2-Methoxy-estradiol-17beta 3-glucuronide,2.4.1.17,R04354
477.2492952,C26H38O8,cpd:C21847,4'-O-Demethylsordarin,C26H38O8,NA,NA,NA,2.4.1.353,R12012
479.0831653,C21H20O13,cpd:C10051,Gossypin;Gossypetin 8-O-glucoside,C21H20O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10051  Gossypin,NA,NA
479.0831653,C21H20O13,cpd:C17514,4-o-Galloylbergenin,C21H20O13,NA,NA,NA,NA,NA
479.0831653,C21H20O13,cpd:C17520,11-o-Galloylbergenin,C21H20O13,NA,NA,NA,NA,NA
479.1558827,C23H28O11,cpd:C08751,Bruceine B,C23H28O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08751  Bruceine B,NA,NA
479.1558827,C23H28O11,cpd:C08770,Isobrucein B,C23H28O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08770  Isobrucein B,NA,NA
479.1558827,C23H28O11,cpd:C09959,Paeoniflorin,C23H28O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09959  Paeoniflorin,NA,NA
479.1558827,C23H28O11,cpd:C17457,Albiflorin,C23H28O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C17457  Albiflorin,NA,NA
479.192306,C24H32O10,cpd:C16752,Acevaltrate,C24H32O10,NA,NA,NA,NA,NA
479.337828,C28H48O6,cpd:C08814,Brassinolide,C28H48O6,Brassinosteroid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of terpenoids and steroids;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Plant hormone signal transduction,NA,Compounds with biological roles [BR:br08001]; Steroids;  28-Carbon atoms;   Campestane derivatives;    C08814  Brassinolide;Lipids [BR:br08002]; ST  Sterol lipids;  ST01 Sterols;   ST0114 Brassinolides and derivatives;    C08814  Brassinolide;Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Ergostane;    C08814  Brassinolide,1.14.-.-,R07471 R09762 R10682
479.337828,C28H48O6,cpd:C11049,24-epi-Brassinolide,C28H48O6,NA,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST01 Sterols;   ST0114 Brassinolides and derivatives;    C11049  24-epi-Brassinolide;Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Ergostane;    C11049  24-epi-Brassinolide,NA,NA
479.337828,C28H48O6,cpd:C19873,26-Hydroxycastasterone,C28H48O6,Brassinosteroid biosynthesis,NA,NA,1.14.-.-,R09761
481.113921,C25H22O10,cpd:C07610,Silymarin;Silibinin;Silybin,C25H22O10,NA,NA,"Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C07610  Silymarin;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A05 BILE AND LIVER THERAPY;   A05B LIVER THERAPY, LIPOTROPICS;    A05BA Liver therapy;     A05BA03 Silymarin;      D08515  Silibinin (INN)",NA,NA
481.113921,C25H22O10,cpd:C08717,Silychristin,C25H22O10,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C08717  Silychristin,NA,NA
481.113921,C25H22O10,cpd:C16808,Isosilybin,C25H22O10,NA,NA,NA,NA,NA
481.1351518,C22H26O12,cpd:C09775,Catalposide,C22H26O12,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09775  Catalposide;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09775  Catalposide,NA,NA
481.2806793,C26H42O8,cpd:C09093,Fusicoccin H,C26H42O8,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010435 Fusicoccane diterpenoids;     C09093  Fusicoccin H;Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09093  Fusicoccin H,NA,NA
481.4262065,C30H58O4,cpd:C22026,(R)-3-(Tetradecanoyloxy)hexadecanoic acid,C30H58O4,NA,NA,NA,3.1.1.-,R12204
483.0780345,C20H20O14,cpd:C04101,"1-O,6-O-Digalloyl-beta-D-glucose",C20H20O14,NA,NA,NA,2.3.1.90,R00049
485.1089298,C24H22O11,cpd:C04385,Flavonol 3-O-(6-O-malonyl-beta-D-glucoside),C24H22O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C04385  Flavonol 3-O-(6-O-malonyl-beta-D-glucoside),2.3.1.116,R04356
485.1089298,C24H22O11,cpd:C12380,Tetracenomycin X,C24H22O11,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,NA,R06714
485.1453268,C25H26O10,cpd:C12412,Aquayamycin,C25H26O10,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,NA,R06665 R06666
485.1816943,C26H30O9,cpd:C08779,Rutaevin,C26H30O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Others;    C08779  Rutaevin,NA,NA
485.1816943,C26H30O9,cpd:C11608,Nafenopin glucuronide,C26H30O9,NA,NA,NA,NA,NA
487.1245959,C24H24O11,cpd:C10737,Phrymarolin I,C24H24O11,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignans;    C10737  Phrymarolin I;Natural toxins [BR:br08009]; Phytotoxins;  Others;   Others;    C10737  Phrymarolin I,NA,NA
487.197362,C26H32O9,cpd:C08768,Ichangin,C26H32O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Others;    C08768  Ichangin,NA,NA
487.197362,C26H32O9,cpd:C16717,Limonoate D-ring-lactone,C26H32O9,NA,NA,NA,3.1.1.36,R03624
487.197362,C26H32O9,cpd:C16718,Limonoate A-ring-lactone,C26H32O9,NA,NA,NA,2.4.1.210;3.1.1.36,R08462 R08859
489.2130764,C26H34O9,cpd:C04251,Deoxylimononic acid D-ring-lactone,C26H34O9,NA,NA,NA,3.1.1.46,R03803
489.2130764,C26H34O9,cpd:C19867,beta-D-Glucosyl crocetin,C26H34O9,Biosynthesis of various secondary metabolites - part 1;Metabolic pathways;Biosynthesis of secondary metabolites,"Crocin biosynthesis, crocetin => crocin",Phytochemical compounds [BR:br08003]; Terpenoids;  Carotenoids and apocarotenoids;   Apocarotenoids;    C19867  beta-D-Glucosyl crocetin,2.4.1.271;2.4.1.330,R09757 R09758 R10988
491.0831732,C22H20O13,cpd:C11254,Carmine;Carminic acid,C22H20O13,NA,NA,Glycosides [BR:br08021]; C-glycosides;  C11254  Carmine,NA,NA
491.1195566,C23H24O12,cpd:C10303,Aurantio-obtusin beta-D-glucoside,C23H24O12,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10303  Aurantio-obtusin beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10303  Aurantio-obtusin beta-D-glucoside,NA,NA
491.1922638,C25H32O10,cpd:C17507,Palmatoside G,C25H32O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C17507  Palmatoside G,NA,NA
491.2287031,C26H36O9,cpd:C09070,Caryoptin,C26H36O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09070  Caryoptin,NA,NA
493.1715423,C24H30O11,cpd:C09783,Harpagoside,C24H30O11,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C09783  Harpagoside;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Iridoids;    C09783  Harpagoside;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09783   Harpagoside",NA,NA
493.2079838,C25H34O10,cpd:C08763,Glaucarubinone,C25H34O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08763  Glaucarubinone,NA,NA
493.2079838,C25H34O10,cpd:C08784,Soularubinone,C25H34O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08784  Soularubinone,NA,NA
495.150838,C23H28O12,cpd:C20383,Mycophenolic acid O-acyl-glucuronide,C23H28O12,NA,NA,NA,3.1.1.93,R10134
495.2236785,C25H36O10,cpd:C08760,Glaucarubin,C25H36O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08760  Glaucarubin,NA,NA
495.2962588,C27H44O8,cpd:C08834,Polypodine B,C27H44O8,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cholestane;    C08834  Polypodine B,NA,NA
495.2962588,C27H44O8,cpd:C16500,"20,26-Dihydroxyecdysone",C27H44O8,Insect hormone biosynthesis,NA,NA,1.14.-.-,R08143
497.2028946,C24H34O11,cpd:C11657,Iridodial glucoside tetraacetate,C24H34O11,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11657  Iridodial glucoside tetraacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11657  Iridodial glucoside tetraacetate",NA,NA
497.2028946,C24H34O11,cpd:C11658,8-Epiiridodial glucoside tetraacetate,C24H34O11,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11658  8-Epiiridodial glucoside tetraacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11658  8-Epiiridodial glucoside tetraacetate",NA,NA
499.2913019,C26H44O9,cpd:C11758,Mupirocin;Pseudomonic acid A,C26H44O9,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; D DERMATOLOGICALS;  D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;   D06A ANTIBIOTICS FOR TOPICAL USE;    D06AX Other antibiotics for topical use;     D06AX09 Mupirocin;      D01076  Mupirocin (USP/INN) &lt;US&gt;; R RESPIRATORY SYSTEM;  R01 NASAL PREPARATIONS;   R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;    R01AX Other nasal preparations;     R01AX06 Mupirocin;      D01076  Mupirocin (USP/INN) &lt;US&gt;;USP drug classification [BR:br08302]; Dermatological Agents;  Topical Anti-infectives;   Antibacterials, dermatological;    Mupirocin;     D01076  Mupirocin (USP/INN);Antimicrobials [BR:br08307]; Antibacterials;  Protein biosynthesis inhibitor;   Other protein biosynthesis inhibitor;    D01076  Mupirocin (USP/INN) &lt;US&gt;",NA,NA
501.1039108,C24H22O12,cpd:C16191,Malonyldaidzin,C24H22O12,Isoflavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C16191  Malonyldaidzin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C16191  Malonyldaidzin,2.3.1.115,R07721
501.2129723,C27H34O9,cpd:C09746,Verrucarin A;Muconomycin A,C27H34O9,NA,NA,NA,NA,NA
501.2341154,C24H38O11,cpd:C17888,Eriojaposide A,C24H38O11,NA,NA,NA,NA,NA
503.1559284,C25H28O11,cpd:C08782,Sergeolide,C25H28O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08782  Sergeolide,NA,NA
503.1559284,C25H28O11,cpd:C12410,Urdamycinone F,C25H28O11,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,NA,NA,R06664 R06665
503.264963,C28H40O8,cpd:C03634,"Phorbol 12,13-dibutanoate;Phorbol-12,13-dibutyrate",C28H40O8,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0104 C20 isoprenoids (diterpenes);    PR010433 Tigliane and ingenane diterpenoids;     C03634  Phorbol 12,13-dibutanoate",3.1.1.51,R04119
503.264963,C28H40O8,cpd:C15537,Taxuyunnanin C,C28H40O8,NA,NA,NA,2.3.1.163,R07252
503.264963,C28H40O8,cpd:C20152,"Taxusin;Taxa-4(20),11-diene-5alpha,9alpha,10beta,13alpha-tetrayl tetraacetate",C28H40O8,NA,NA,NA,1.14.13.147,R09868
505.0928835,C30H18O8,cpd:C10308,Cassiamin C,C30H18O8,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10308  Cassiamin C,NA,NA
505.207913,C26H34O10,cpd:C01593,Limonoate,C26H34O10,NA,NA,NA,3.1.1.36,R03624
507.056942,C25H16O12,cpd:C12048,Griseorhodin A,C25H16O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1302 Naphthalenes and naphthoquinones;    C12048  Griseorhodin A,NA,NA
507.1871927,C25H32O11,cpd:C04070,Gibberellin 2-O-beta-D-glucoside,C25H32O11,NA,NA,NA,2.4.1.176,R03680
515.1195191,C25H24O12,cpd:C10445,"1,3-Dicaffeoylquinic acid;Cynarin",C25H24O12,NA,NA,NA,NA,NA
515.1195191,C25H24O12,cpd:C10468,Isochlorogenic acid b,C25H24O12,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Caffeate derivatives;    C10468  Isochlorogenic acid b,NA,NA
515.1195191,C25H24O12,cpd:C16222,Formononetin 7-O-glucoside-6''-O-malonate,C25H24O12,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C16222  Formononetin 7-O-glucoside-6''-O-malonate;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C16222  Formononetin 7-O-glucoside-6''-O-malonate;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C16222  Formononetin 7-O-glucoside-6''-O-malonate,2.3.1.115,R07731 R07732
515.1921868,C27H32O10,cpd:C08766,Harrisonin,C27H32O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Others;    C08766  Harrisonin,NA,NA
515.1921868,C27H32O10,cpd:C09551,Spicatin,C27H32O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09551  Spicatin,NA,NA
515.2497939,C25H40O11,cpd:C17889,Eriojaposide B,C25H40O11,NA,NA,NA,NA,NA
515.2862125,C26H44O10,cpd:C11991,L-Olivosyl-oleandolide,C26H44O10,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin",Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C11991  L-Olivosyl-oleandolide,2.1.1.239,R06455 R06456
517.09878,C24H22O13,cpd:C10020,Apigenin 7-(6''-malonylglucoside);Apigenin 7-O-(6-malonyl-beta-D-glucoside),C24H22O13,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10020  Apigenin 7-(6''-malonylglucoside);Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10020  Apigenin 7-(6''-malonylglucoside);Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10020  Apigenin 7-(6''-malonylglucoside),2.3.1.115,R06821
517.09878,C24H22O13,cpd:C16192,Malonylgenistin,C24H22O13,Isoflavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C16192  Malonylgenistin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C16192  Malonylgenistin,2.3.1.115,R07757
517.1351664,C25H26O12,cpd:C16224,Medicarpin 3-O-glucoside-6'-malonate,C25H26O12,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1207 Pterocarpans;    C16224  Medicarpin 3-O-glucoside-6'-malonate;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C16224  Medicarpin 3-O-glucoside-6'-malonate,2.3.1.115,R07741 R07742
517.1715533,C26H30O11,cpd:C09808,Phellamurin;8-Prenyldihydrokaempferol 7-glucoside,C26H30O11,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Dihyroflavonols;    C09808  Phellamurin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09808  Phellamurin,NA,NA
517.1715533,C26H30O11,cpd:C10885,Simplexoside,C26H30O11,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C10885  Simplexoside,NA,NA
517.1715533,C26H30O11,cpd:C16767,Rubratoxin B,C26H30O11,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C16767  Rubratoxin B,NA,NA
517.207885,C27H34O10,cpd:C09533,Provincialin,C27H34O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09533  Provincialin,NA,NA
519.1507914,C25H28O12,cpd:C10313,Chryso-obtusin glucoside,C25H28O12,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10313  Chryso-obtusin glucoside;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10313  Chryso-obtusin glucoside,NA,NA
519.1871759,C26H32O11,cpd:C08754,Brusatol,C26H32O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08754  Brusatol,NA,NA
519.1871759,C26H32O11,cpd:C17529,(-)-Pinoresinol glucoside,C26H32O11,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C17529  (-)-Pinoresinol glucoside,NA,NA
519.2599017,C28H40O9,cpd:C20153,7beta-Hydroxytaxusin,C28H40O9,NA,NA,NA,1.14.13.147,R09868
521.1300911,C24H26O13,cpd:C10465,Iridin,C24H26O13,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10465  Iridin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C10465  Iridin,NA,NA
521.1664866,C25H30O12,cpd:C09501,Melampodinin,C25H30O12,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Germacrenes;    C09501  Melampodinin sesqui,NA,NA
521.202863,C26H34O11,cpd:C08769,Isobrucein A,C26H34O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08769  Isobrucein A,NA,NA
521.2392165,C27H38O10,cpd:C09563,Trilobolide,C27H38O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09563  Trilobolide,NA,NA
523.2185164,C26H36O11,cpd:C09132,Mascaroside,C26H36O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09132  Mascaroside,NA,NA
525.1613497,C24H30O13,cpd:C09114,Inumakilactone A glycoside,C24H30O13,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Others;    C09114  Inumakilactone A glycoside,NA,NA
527.134743,C30H24O9,cpd:C10234,"Mahuannin D;ent-Apigeniflavan-(2alpha->7,4alpha->8)-epiafzelechin",C30H24O9,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1203 Proanthocyanidins;    C10234  Mahuannin D;Phytochemical compounds [BR:br08003]; Flavonoids;  Complex flavonoids;   Proanthocyanidins;    C10234  Mahuannin D,NA,NA
527.1558122,C27H28O11,cpd:C09973,Tremulacin,C27H28O11,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Phenolic glycosides;   C09973  Tremulacin,NA,NA
527.1770056,C24H32O13,cpd:C11647,Deoxyloganic acid tetraacetate,C24H32O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11647  Deoxyloganic acid tetraacetate,NA,NA
529.1714506,C27H30O11,cpd:C17749,Curcumin monoglucoside,C27H30O11,"Stilbenoid, diarylheptanoid and gingerol biosynthesis",NA,NA,2.4.1.-,R08813 R08814
529.2079037,C28H34O10,cpd:C17816,Gomisin D,C28H34O10,NA,NA,NA,NA,NA
529.301848,C27H46O10,cpd:C11992,L-Oleandrosyl-oleandolide,C27H46O10,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin",Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C11992  L-Oleandrosyl-oleandolide,2.1.1.239,R06456 R06457
529.462707,C35H62O3,cpd:C08484,Epoxymurin-A,C35H62O3,NA,NA,NA,NA,NA
531.1144172,C25H24O13,cpd:C12625,Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside);Biochanin A 7-O-beta-D-glucoside 6''-O-malonate,C25H24O13,Isoflavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside);Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside);Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside),2.3.1.115,R06796
531.1144172,C25H24O13,cpd:C16197,Malonylglycitin,C25H24O13,Isoflavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C16197  Malonylglycitin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Isoflavones;    C16197  Malonylglycitin,2.3.1.115,R07719
531.1144172,C25H24O13,cpd:C16231,(-)-Maackiain-3-O-glucosyl-6''-O-malonate,C25H24O13,Isoflavonoid biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Pterocarpans;    C16231  (-)-Maackiain-3-O-glucosyl-6''-O-malonate,2.3.1.115,R07754 R07755
531.15075,C26H28O12,cpd:C04068,Flavonol 3-O-D-xylosylglucoside,C26H28O12,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C04068  Flavonol 3-O-D-xylosylglucoside,NA,NA
531.15075,C26H28O12,cpd:C04069,Flavonol 3-O-D-xylosylglycoside;Flavonol 3-O-[D-xylosyl-(1->2)-beta-D-glycoside];Flavonol 3-[beta-D-xylosyl-(1->2)-beta-D-glycoside],C26H28O12,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C04069  Flavonol 3-O-D-xylosylglycoside,2.4.2.35,R03268
531.15075,C26H28O12,cpd:C04193,Flavonol 3-O-D-xylosylgalactoside,C26H28O12,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C04193  Flavonol 3-O-D-xylosylgalactoside,NA,NA
531.2235297,C28H36O10,cpd:C08767,12alpha-Hydroxyamoorstatin,C28H36O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Others;    C08767  12alpha-Hydroxyamoorstatin,NA,NA
531.25991,C29H40O9,cpd:C08854,Calactin,C29H40O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08854  Calactin;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08854  Calactin,NA,NA
531.25991,C29H40O9,cpd:C08855,Calotropin,C29H40O9,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08855  Calotropin;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08855  Calotropin,NA,NA
531.25991,C29H40O9,cpd:C09716,Roridin A,C29H40O9,NA,NA,NA,NA,NA
533.0937102,C24H22O14,cpd:C10103,Luteolin 7-O-(6''-malonylglucoside),C24H22O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10103  Luteolin 7-O-(6''-malonylglucoside);Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10103  Luteolin 7-O-(6''-malonylglucoside);Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10103  Luteolin 7-O-(6''-malonylglucoside),NA,NA
533.1664362,C26H30O12,cpd:C10416,Dalpanin,C26H30O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10416  Dalpanin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavanones;    C10416  Dalpanin,NA,NA
533.2027701,C27H34O11,cpd:C08787,Undulatone,C27H34O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08787  Undulatone,NA,NA
533.2027701,C27H34O11,cpd:C16915,Arctiin,C27H34O11,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C16915  Arctiin,NA,NA
533.2027701,C27H34O11,cpd:C17048,Forsythin;Phillyrin,C27H34O11,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C17048  Forsythin,NA,NA
535.2184989,C27H36O11,cpd:C08777,Quassimarin,C27H36O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08777  Quassimarin,NA,NA
535.291298,C29H44O9,cpd:C08877,Rhodexin A;Sarmentogenin 3-O-alpha-L-rhamnoside,C29H44O9,NA,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST01 Sterols;   ST0112 Cardanolides and derivatives;    C08877  Rhodexin A;Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08877  Rhodexin A;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08877  Rhodexin A;Natural toxins [BR:br08009]; Phytotoxins;  Glycosides;   Cardiac glycosides;    C08877  Rhodexin A,NA,NA
535.291298,C29H44O9,cpd:C17522,Mallogenin-3-o-alpha-L-rhamnopyranoside;Malloside,C29H44O9,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C17522  Mallogenin-3-o-alpha-L-rhamnopyranoside,NA,NA
535.291298,C29H44O9,cpd:C17524,Coroglaucigenin-3-o-alpha-L-rhamnopyranoside,C29H44O9,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C17524  Coroglaucigenin-3-o-alpha-L-rhamnopyranoside,NA,NA
537.103836,C27H22O12,cpd:C08745,Lithospermic acid,C27H22O12,NA,NA,NA,NA,NA
539.1770423,C25H32O13,cpd:C09794,Oleuropein,C25H32O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09794  Oleuropein,3.2.1.206,R11942
539.1770423,C25H32O13,cpd:C11664,10-Deoxygeniposide tetraacetate,C25H32O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11664  10-Deoxygeniposide tetraacetate,NA,NA
539.1770423,C25H32O13,cpd:C11665,7-Deoxygardoside metyl ester tetraacetate,C25H32O13,NA,NA,NA,NA,NA
541.1926467,C25H34O13,cpd:C11646,Deoxyloganin tetraacetate,C25H34O13,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11646  Deoxyloganin tetraacetate",NA,NA
541.1926467,C25H34O13,cpd:C11650,8-Epideoxyloganin tetraacetate,C25H34O13,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11650  8-Epideoxyloganin tetraacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11650  8-Epideoxyloganin tetraacetate",NA,NA
543.1507546,C27H28O12,cpd:C12384,Premithramycin A1,C27H28O12,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,2.4.1.-,R06716 R06717
545.1664116,C27H30O12,cpd:C04194,Flavonol 3-O-[alpha-L-rhamnosyl-(1->6)-beta-D-glucoside];Flavonol 3-O-rutinoside,C27H30O12,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C04194  Flavonol 3-O-[alpha-L-rhamnosyl-(1->6)-beta-D-glucoside],2.4.1.159,R03880
545.3331752,C28H50O10,cpd:C06630,"3-O-alpha-Mycarosylerythronolide B;3-alpha-L-Mycarosylerythronolide B;4-(4,5-Dihydroxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy)-14-ethyl-6,7,12-trihydroxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",C28H50O10,"Biosynthesis of 12-, 14- and 16-membered macrolides;Metabolic pathways;Biosynthesis of secondary metabolites","Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",NA,2.4.1.278;2.4.1.328,R05530 R05531
547.1456964,C26H28O13,cpd:C17057,Puerarin xyloside,C26H28O13,NA,NA,Glycosides [BR:br08021]; C-glycosides;  C17057  Puerarin xyloside,NA,NA
547.1821029,C27H32O12,cpd:C15579,Flavanone 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside],C27H32O12,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C15579  Flavanone 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside],2.4.1.236,R07337
547.2184467,C28H36O11,cpd:C08749,Bruceantin,C28H36O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08749  Bruceantin,NA,NA
547.2548441,C29H40O10,cpd:C09296,Archangelolide,C29H40O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Sesquiterpenoids (C15);   Guaianolide;    C09296  Archangelolide,NA,NA
549.0885718,C24H22O15,cpd:C12638,Quercetin 3-O-(6-O-malonyl-beta-D-glucoside);Quercetin 3-O-malonylglucoside;Quercetin-3-O-(6''-malonylglucoside),C24H22O15,Flavone and flavonol biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C12638  Quercetin 3-O-(6-O-malonyl-beta-D-glucoside);Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12638  Quercetin 3-O-(6-O-malonyl-beta-D-glucoside),2.3.1.116,R06797
549.1977741,C27H34O12,cpd:C10560,Eucommin A;Medioresinol 4'-O-beta-D-glucopyranoside,C27H34O12,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C10560  Eucommin A,NA,NA
551.286244,C29H44O10,cpd:C08848,Antioside;Antiogenin 3-O-alpha-L-rhamnoside,C29H44O10,NA,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST01 Sterols;   ST0112 Cardanolides and derivatives;    C08848  Antioside;Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08848  Antioside;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08848  Antioside,NA,NA
551.286244,C29H44O10,cpd:C08851,Bipindoside,C29H44O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08851  Bipindoside;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08851  Bipindoside,NA,NA
551.286244,C29H44O10,cpd:C08874,Lokundjoside;Cuspidoside;Bipindogenin 3-O-alpha-L-rhamnoside,C29H44O10,NA,NA,Lipids [BR:br08002]; ST  Sterol lipids;  ST01 Sterols;   ST0112 Cardanolides and derivatives;    C08874  Lokundjoside;Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08874  Lokundjoside;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08874  Lokundjoside,NA,NA
551.286244,C29H44O10,cpd:C17523,Panogenin-3-o-alpha-L-rhamnopyranoside;Panoside,C29H44O10,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C17523  Panogenin-3-o-alpha-L-rhamnopyranoside,NA,NA
553.1926583,C26H34O13,cpd:C17476,Osthenol-7-O-beta-D-gentiobioside,C26H34O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Coumarin glycosides;   C17476  Osthenol-7-O-beta-D-gentiobioside,NA,NA
555.171927,C25H32O14,cpd:C11668,7-Dehydrologanin tetraacetate,C25H32O14,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11668  7-Dehydrologanin tetraacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11668  7-Dehydrologanin tetraacetate",NA,NA
555.171927,C25H32O14,cpd:C11669,Deutzioside pentaacetate,C25H32O14,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11669  Deutzioside pentaacetate",NA,NA
555.2082869,C26H36O13,cpd:C11666,11-Hydroxyiridodial glucoside pentaacetate,C26H36O13,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11666  11-Hydroxyiridodial glucoside pentaacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11666  11-Hydroxyiridodial glucoside pentaacetate",NA,NA
555.2082869,C26H36O13,cpd:C11667,8-epi-11-Hydroxyiridodial glucoside pentaacetate,C26H36O13,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11667  8-epi-11-Hydroxyiridodial glucoside pentaacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11667  8-epi-11-Hydroxyiridodial glucoside pentaacetate",NA,NA
557.1875431,C25H34O14,cpd:C11662,7-Epiloganin tetraacetate,C25H34O14,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11662  7-Epiloganin tetraacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11662  7-Epiloganin tetraacetate",NA,NA
559.2184141,C29H36O11,cpd:C08870,Labriformidin,C29H36O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08870  Labriformidin;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08870  Labriformidin,NA,NA
561.1613364,C27H30O13,cpd:C15581,Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside,C27H30O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C15581  Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside,2.4.1.239;2.4.1.240,R07339 R07340
561.2342575,C29H38O11,cpd:C08865,Eriocarpin,C29H38O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08865  Eriocarpin;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08865  Eriocarpin,NA,NA
561.2917037,C27H46O12,cpd:C17861,Atractyloside D,C27H46O12,NA,NA,NA,NA,NA
563.1406842,C26H28O14,cpd:C04858,"Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside];7-O-(beta-D-Apiofuranosyl-1,2-beta-D-glucosyl)-5,7,4'-trihydroxyflavone;Apiin;7-[(2-O-D-Apio-beta-D-furanosyl-beta-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxy-phenyl)-4H-1-benzopyran-4-one;Apioside",C26H28O14,Flavone and flavonol biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C04858  Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside];Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C04858  Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside],2.3.1.115;2.4.2.25,R04526 R04618
563.1406842,C26H28O14,cpd:C10110,Neoschaftoside,C26H28O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10110  Neoschaftoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10110  Neoschaftoside;Glycosides [BR:br08021]; C-glycosides;  C10110  Neoschaftoside,NA,NA
563.1406842,C26H28O14,cpd:C10181,Schaftoside,C26H28O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10181  Schaftoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10181  Schaftoside;Glycosides [BR:br08021]; C-glycosides;  C10181  Schaftoside,NA,NA
563.1406842,C26H28O14,cpd:C16491,Isovitexin 2''-O-arabinoside,C26H28O14,NA,NA,Glycosides [BR:br08021]; C-glycosides;  C16491  Isovitexin 2''-O-arabinoside,NA,R08126
563.1406842,C26H28O14,cpd:C16803,Glucofrangulin B,C26H28O14,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C16803  Glucofrangulin B;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C16803  Glucofrangulin B,NA,NA
563.1770231,C27H32O13,cpd:C09828,Pinocembrin 7-rhamnosylglucoside,C27H32O13,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09828  Pinocembrin 7-rhamnosylglucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09828  Pinocembrin 7-rhamnosylglucoside,NA,NA
563.1770231,C27H32O13,cpd:C16800,Cascaroside D,C27H32O13,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthrone type;    C16800  Cascaroside D,NA,NA
563.1770231,C27H32O13,cpd:C16801,Cascaroside C,C27H32O13,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthrone type;    C16801  Cascaroside C,NA,NA
563.1770231,C27H32O13,cpd:C17779,Aloinoside A,C27H32O13,NA,NA,NA,NA,NA
563.1770231,C27H32O13,cpd:C17780,Aloinoside B,C27H32O13,NA,NA,NA,NA,NA
563.2861416,C30H44O10,cpd:C08875,Musaroside;Sarmutogenin 3-O-beta-D-digitaloside,C30H44O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08875  Musaroside;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08875  Musaroside,NA,NA
563.2861416,C30H44O10,cpd:C08884,Vernadigin;Strophadogenin 3-O-beta-D-diginoside,C30H44O10,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08884  Vernadigin;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08884  Vernadigin,NA,NA
565.2653728,C29H42O11,cpd:C08847,alpha-Antiarin;Antiarigenin 3-O-beta-D-antiaroside,C29H42O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08847  alpha-Antiarin;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08847  alpha-Antiarin;Natural toxins [BR:br08009]; Phytotoxins;  Glycosides;   Cardiac glycosides;    C08847  alpha-Antiarin,NA,NA
567.2235125,C31H36O10,cpd:C17812,Lappaol D,C31H36O10,NA,NA,NA,NA,NA
567.2810542,C29H44O11,cpd:C08878,Sarmentoloside;Sarmentologenin 3-O-(6-deoxy-alpha-L-taloside),C29H44O11,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C08878  Sarmentoloside;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C08878   Sarmentoloside,NA,NA
569.1875422,C26H34O14,cpd:C09257,Decuroside III,C26H34O14,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Coumarins;   Furanocoumarins;    C09257  Decuroside III,NA,NA
573.104002,C30H22O12,cpd:C16763,Luteoskyrin,C30H22O12,NA,NA,Natural toxins [BR:br08009]; Fungal toxins;  Mycotoxins;   Others;    C16763  Luteoskyrin,NA,NA
575.2709343,C27H44O13,cpd:C17866,Atractyloside I,C27H44O13,NA,NA,NA,NA,NA
577.1350965,C30H26O12,cpd:C10221,Epicatechin-(4beta->8)-ent-epicatechin,C30H26O12,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Complex flavonoids;   Proanthocyanidins;    C10221  Epicatechin-(4beta->8)-ent-epicatechin,NA,NA
577.1350965,C30H26O12,cpd:C10238,Procyanidin B4;Catechin-(4alpha->8)-epicatechin,C30H26O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1203 Proanthocyanidins;    C10238  Procyanidin B4;Phytochemical compounds [BR:br08003]; Flavonoids;  Complex flavonoids;   Proanthocyanidins;    C10238  Procyanidin B4,NA,NA
577.1350965,C30H26O12,cpd:C17639,Procyanidin B2;Procyanidol B2,C30H26O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1203 Proanthocyanidins;    C17639  Procyanidin B2,NA,NA
577.1350965,C30H26O12,cpd:C17640,Procyanidin B5;Procyanidol B5,C30H26O12,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1203 Proanthocyanidins;    C17640  Procyanidin B5,NA,NA
577.1562081,C27H30O14,cpd:C10196,Violanthin,C27H30O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10196  Violanthin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10196  Violanthin;Glycosides [BR:br08021]; C-glycosides;  C10196  Violanthin,NA,NA
577.1562081,C27H30O14,cpd:C12627,Apigenin 7-O-neohesperidoside;Rhoifolin;Rhoifoloside,C27H30O14,Flavone and flavonol biosynthesis,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C12627  Apigenin 7-O-neohesperidoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12627  Apigenin 7-O-neohesperidoside,2.4.1.236,R06826
577.1562081,C27H30O14,cpd:C12628,Vitexin 2''-O-beta-L-rhamnoside;2''-O-Rhamnosylvitexin;Vitexin 2''-rhamnoside,C27H30O14,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12628  Vitexin 2''-O-beta-L-rhamnoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C12628  Vitexin 2''-O-beta-L-rhamnoside;Glycosides [BR:br08021]; C-glycosides;  C12628  Vitexin 2''-O-beta-L-rhamnoside,2.1.1.153,R06823 R06824
577.1562081,C27H30O14,cpd:C16802,Glucofrangulin A,C27H30O14,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C16802  Glucofrangulin A;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C16802  Glucofrangulin A,NA,NA
577.1562081,C27H30O14,cpd:C16981,Kaempferitrin;Kaempferol-dirhamnoside;Lespenefril,C27H30O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C16981  Kaempferitrin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C16981  Kaempferitrin,NA,NA
577.1925965,C28H34O13,cpd:C10876,Podorhizol beta-D-glucoside,C28H34O13,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C10876  Podorhizol beta-D-glucoside,NA,NA
579.1355577,C26H28O15,cpd:C10026,Carlinoside,C26H28O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10026  Carlinoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10026  Carlinoside;Glycosides [BR:br08021]; C-glycosides;  C10026  Carlinoside,NA,NA
579.1355577,C26H28O15,cpd:C10109,Neocarlinoside,C26H28O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10109  Neocarlinoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10109  Neocarlinoside;Glycosides [BR:br08021]; C-glycosides;  C10109  Neocarlinoside,NA,NA
579.1719067,C27H32O14,cpd:C09789,Naringin;Naringenin 7-O-neohesperidoside;Naringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside],C27H32O14,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09789  Naringin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09789  Naringin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09789  Naringin,2.4.1.236,R06820 R08024
579.1719067,C27H32O14,cpd:C09793,Narirutin;Naringenin 7-O-rutinoside,C27H32O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09793  Narirutin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09793  Narirutin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09793  Narirutin,NA,NA
579.1719067,C27H32O14,cpd:C10307,Cascaroside A,C27H32O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1304 Anthracenes and phenanthrenes;    C10307  Cascaroside A;Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthrone type;    C10307  Cascaroside A,NA,NA
579.1719067,C27H32O14,cpd:C16423,Naringin chalcone,C27H32O14,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Chalcone glycosides;   C16423  Naringin chalcone,NA,R08023 R08024
579.1719067,C27H32O14,cpd:C16799,Cascaroside B,C27H32O14,NA,NA,Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthrone type;    C16799  Cascaroside B,NA,NA
579.2082503,C28H36O13,cpd:C10890,(+)-Syringaresinol O-beta-D-glucoside;Acanthoside B,C28H36O13,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C10890  (+)-Syringaresinol O-beta-D-glucoside,NA,NA
581.1511943,C26H30O15,cpd:C11655,Asperuloside tetraacetate,C26H30O15,NA,NA,NA,NA,NA
583.2759985,C29H44O12,cpd:C01443,Ouabain;G-Strophanthin,C29H44O12,Bile secretion,NA,Compounds with biological roles [BR:br08001]; Steroids;  23-Carbon atoms;   Cardanolide derivatives;    C01443  Ouabain;Lipids [BR:br08002]; ST  Sterol lipids;  ST01 Sterols;   ST0112 Cardanolides and derivatives;    C01443  Ouabain;Phytochemical compounds [BR:br08003]; Terpenoids;  Steroids;   Cardanolide;    C01443  Ouabain;Glycosides [BR:br08021]; O-glycosides;  Cardiac glycosides;   C01443  Ouabain;Natural toxins [BR:br08009]; Phytotoxins;  Glycosides;   Cardiac glycosides;    C01443  Ouabain;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C01 CARDIAC THERAPY;   C01A CARDIAC GLYCOSIDES;    C01AC Strophantus glycosides;     C01AC01 G-strophanthin;      D00112  G-Strophanthin (JAN);Target-based classification of drugs [BR:br08310]; Enzymes;  Hydrolases (EC3);   ATPase;    ATP1A;     D00112  G-Strophanthin (JAN),NA,NA
585.1614609,C29H30O13,cpd:C09767,Amarogentin,C29H30O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C09767  Amarogentin,NA,NA
585.1614609,C29H30O13,cpd:C10870,Phyllanthostatin A,C29H30O13,NA,NA,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Lignans;   Lignan glycosides;    C10870  Phyllanthostatin A,NA,NA
587.1769384,C29H32O13,cpd:C01576,Etoposide;VP-16,C29H32O13,Bile secretion,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;  L01 ANTINEOPLASTIC AGENTS;   L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;    L01CB Podophyllotoxin derivatives;     L01CB01 Etoposide;      D00125  Etoposide (JP18/USP/INN) &lt;JP/US&gt;;USP drug classification [BR:br08302]; Antineoplastics;  Enzyme Inhibitors;   Etoposide;    D00125  Etoposide (JP18/USP/INN);Therapeutic category of drugs in Japan [BR:br08301]; 4  Agents affecting cellular function;  42  Antineoplastics;   424  Plant extract preparations;    4240  Plant extract preparations;     D00125  Etoposide (JP18/USP/INN);Target-based classification of drugs [BR:br08310]; Enzymes;  Isomerases (EC5);   DNA topoisomerase;    TOP2;     D00125  Etoposide (JP18/USP/INN) &lt;JP/US&gt;;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00125  Etoposide,NA,NA
589.098707,C30H22O13,cpd:C09763,Manniflavanone,C30H22O13,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1204 Biflavonoids and polyflavonoids;    C09763  Manniflavanone;Phytochemical compounds [BR:br08003]; Flavonoids;  Complex flavonoids;   Biflavonoids and polyflavonoids;    C09763  Manniflavanone,NA,NA
591.1718883,C28H32O14,cpd:C04275,"1,2-Bis-O-sinapoyl-beta-D-glucose;1,2-Bis-O-sinapoyl-beta-D-glucoside",C28H32O14,NA,NA,NA,2.3.1.103,R00063
591.1718883,C28H32O14,cpd:C12629,Isoswertisin 2''-rhamnoside;7-O-Methylvitexin 2''-O-beta-L-rhamnoside;2''-O-Rhamnosylisoswertisin,C28H32O14,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12629  7-O-Methylvitexin 2''-O-beta-L-rhamnoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C12629  Isoswertisin 2''-rhamnoside;Glycosides [BR:br08021]; C-glycosides;  C12629  Isoswertisin 2''-rhamnoside,2.1.1.153,R06824
593.130117,C30H26O13,cpd:C17140,Tribuloside,C30H26O13,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C17140  Tribuloside,NA,NA
593.1511192,C27H30O15,cpd:C03870,Isoorientin 2''-O-rhamnoside,C27H30O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C03870  Isoorientin 2''-O-rhamnoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C03870  Isoorientin 2''-O-rhamnoside;Glycosides [BR:br08021]; C-glycosides;  C03870  Isoorientin 2''-O-rhamnoside,NA,NA
593.1511192,C27H30O15,cpd:C04024,Vitexin 2''-O-beta-D-glucoside;Flavosativaside;2''-O-Glucosylvitexin,C27H30O15,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C04024  Vitexin 2''-O-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C04024  Vitexin 2''-O-beta-D-glucoside;Glycosides [BR:br08021]; C-glycosides;  C04024  Vitexin 2''-O-beta-D-glucoside,2.4.1.105,R03565
593.1511192,C27H30O15,cpd:C04199,Isovitexin 2''-O-beta-D-glucoside,C27H30O15,Flavone and flavonol biosynthesis,NA,Glycosides [BR:br08021]; C-glycosides;  C04199  Isovitexin 2''-O-beta-D-glucoside,2.4.1.106,R03686
593.1511192,C27H30O15,cpd:C08064,Saponarin;Isovitexin-7-O-beta-D-glucopyranoside,C27H30O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C08064  Saponarin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C08064  Saponarin;Glycosides [BR:br08021]; C-glycosides;  C08064  Saponarin,NA,NA
593.1511192,C27H30O15,cpd:C10195,"Vicenin-2;Apigenin-6,8-di-C-glycoside;5,7,4'-Trihydroxyflavone-6,8-di-C-glucoside",C27H30O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C10195  Vicenin-2;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10195  Vicenin-2;Glycosides [BR:br08021]; C-glycosides;  C10195  Vicenin-2,NA,NA
593.1511192,C27H30O15,cpd:C10513,Paniculatin,C27H30O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1205 Isoflavonoids;    C10513  Paniculatin;Phytochemical compounds [BR:br08003]; Flavonoids;  Isoflavonoids;   Isoflavones;    C10513  Paniculatin;Glycosides [BR:br08021]; C-glycosides;  C10513  Paniculatin,NA,NA
593.1511192,C27H30O15,cpd:C12630,Scolymoside;Luteolin 7-O-neohesperidoside;Veronicastroside,C27H30O15,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12630  Luteolin 7-O-neohesperidoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C12630  Scolymoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12630  Scolymoside,2.4.1.236,R06829
593.1511192,C27H30O15,cpd:C17600,Multiflorin B,C27H30O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C17600  Multiflorin B;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C17600  Multiflorin B,NA,NA
593.1511192,C27H30O15,cpd:C21833,Kaempferol-3-O-rutinoside;Nictoflorin,C27H30O15,Flavone and flavonol biosynthesis;Biosynthesis of secondary metabolites,NA,NA,2.4.1.159,R12046
593.1511192,C27H30O15,cpd:C21854,Kaempferol 3-O-rhamnoside-7-O-glucoside,C27H30O15,Flavone and flavonol biosynthesis,NA,NA,2.4.1.-,R12047
593.1875085,C28H34O14,cpd:C09830,Poncirin;Isosakuranetin 7-O-neohesperidoside,C28H34O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09830  Poncirin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09830  Poncirin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09830  Poncirin,NA,NA
595.1304006,C26H28O16,cpd:C12637,Quercetin 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside],C26H28O16,Flavone and flavonol biosynthesis,NA,NA,2.4.2.35,R06814
595.1668209,C27H32O15,cpd:C08649,Isobutrin,C27H32O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1212 Chalcones and dihydrochalcones;    C08649  Isobutrin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Chalcones;    C08649  Isobutrin;Glycosides [BR:br08021]; O-glycosides;  Chalcone glycosides;   C08649  Isobutrin,NA,NA
595.1668209,C27H32O15,cpd:C09616,"Butrin;Butin 7,3'-di-O-glucoside",C27H32O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09616  Butrin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09616  Butrin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09616  Butrin,NA,NA
595.1668209,C27H32O15,cpd:C09732,Eriocitrin;Eriodictyol 7-O-rutinoside,C27H32O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09732  Eriocitrin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09732  Eriocitrin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09732  Eriocitrin,NA,NA
595.1668209,C27H32O15,cpd:C09805,Neoeriocitrin;Eriodictyol 7-O-neohesperidoside,C27H32O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09805  Neoeriocitrin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09805  Neoeriocitrin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09805  Neoeriocitrin,NA,NA
597.1825106,C27H34O15,cpd:C11639,Geniposide pentaacetate;Pentaacetyl geniposide,C27H34O15,NA,NA,NA,NA,NA
597.1977125,C31H34O12,cpd:C18684,Landomycin D,C31H34O12,Biosynthesis of type II polyketide products;Biosynthesis of secondary metabolites,NA,Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C18684  Landomycin D,NA,R09348 R09349
599.198169,C27H36O15,cpd:C11663,Loganin pentaacetate,C27H36O15,NA,NA,"Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;     C11663  Loganin pentaacetate;Glycosides [BR:br08021]; O-glycosides;  Iridoid glycosides;   C11663  Loganin pentaacetate",NA,NA
601.1563307,C29H30O14,cpd:C17519,Amaroswerin,C29H30O14,NA,NA,NA,NA,NA
603.1355204,C28H28O15,cpd:C20974,8-Demethyl-8-alpha-L-rhamnosyltetracenomycin C,C28H28O15,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,2.1.1.305;2.4.1.331,R10955 R10956
603.17776,C22H36O19,cpd:C20573,Aldotetraouronic acid,C22H36O19,ABC transporters,NA,NA,NA,NA
605.2239496,C30H38O13,cpd:C08750,Bruceantinol,C30H38O13,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Dammarenes;    C08750  Bruceantinol,NA,NA
605.260201,C31H42O12,cpd:C09074,Clerodendrin A,C31H42O12,NA,NA,Phytochemical compounds [BR:br08003]; Terpenoids;  Diterpenoids (C20);   Clerodanes;    C09074  Clerodendrin A,NA,NA
607.1668119,C28H32O15,cpd:C10039,Diosmin;Diosmetin 7-O-rutinoside,C28H32O15,NA,NA,Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C10039  Diosmin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C10039  Diosmin;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C05 VASOPROTECTIVES;   C05C CAPILLARY STABILIZING AGENTS;    C05CA Bioflavonoids;     C05CA03 Diosmin;      D07858  Diosmin (INN),NA,NA
607.1668119,C28H32O15,cpd:C10382,Physcion 8-gentiobioside;Physcion diglucoside;Physcion 8-O-beta-D-gentiobioside,C28H32O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK13 Aromatic polyketides;   PK1304 Anthracenes and phenanthrenes;    C10382  Physcion 8-gentiobioside;Phytochemical compounds [BR:br08003]; Polyketides;  Anthraquinones;   Anthraquinone type;    C10382  Physcion 8-gentiobioside;Glycosides [BR:br08021]; O-glycosides;  Anthraquinone glycosides;   C10382  Physcion 8-gentiobioside,NA,NA
607.1668119,C28H32O15,cpd:C17834,Spinosin,C28H32O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C17834  Spinosin;Glycosides [BR:br08021]; C-glycosides;  C17834  Spinosin,NA,NA
607.1668119,C28H32O15,cpd:C17837,Isospinosin,C28H32O15,NA,NA,NA,NA,NA
609.124807,C30H26O14,cpd:C10227,Gallocatechin-(4alpha->8)-epigallocatechin,C30H26O14,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1203 Proanthocyanidins;    C10227  Gallocatechin-(4alpha->8)-epigallocatechin;Phytochemical compounds [BR:br08003]; Flavonoids;  Complex flavonoids;   Proanthocyanidins;    C10227  Gallocatechin-(4alpha->8)-epigallocatechin,NA,NA
609.1823423,C28H34O15,cpd:C09755,Hesperidin;Hesperetin 7-O-rutinoside;Ciratin,C28H34O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09755  Hesperidin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09755  Hesperidin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09755  Hesperidin;Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Hesperidin;    D01038  Hesperidin (JAN),3.2.1.168,R09534
609.1823423,C28H34O15,cpd:C09806,Neohesperidin;Hesperetin 7-O-neohesperidoside,C28H34O15,Flavonoid biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1214 Flavanones;    C09806  Neohesperidin;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavanones;    C09806  Neohesperidin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C09806  Neohesperidin,2.4.1.236,R08022
617.1511742,C29H30O15,cpd:C20975,8-Demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C,C29H30O15,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,2.1.1.305;2.1.1.306,R10956 R10957
621.1824522,C29H34O15,cpd:C10481,Orobanchoside;Crenatoside,C29H34O15,NA,NA,NA,NA,NA
623.1983063,C29H36O15,cpd:C10456,Forsythiaside,C29H36O15,NA,NA,NA,NA,NA
623.1983063,C29H36O15,cpd:C10501,Verbascoside;Acteoside,C29H36O15,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Phenolic glycosides;   C10501  Verbascoside,NA,NA
623.1983063,C29H36O15,cpd:C17393,Methyl hesperidin,C29H36O15,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavanones;    C17393  Methyl hesperidin;Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Methyl hesperidin;    C17393  Methyl hesperidin,NA,NA
623.1983063,C29H36O15,cpd:C17678,Magnoloside A,C29H36O15,NA,NA,NA,NA,NA
623.3438103,C33H52O11,cpd:C20007,Caribenolide I,C33H52O11,NA,NA,Natural toxins [BR:br08009]; Marine biotoxins;  Diarrhetic shellfish poisoning; DSP;   Macrolides;    C20007  Caribenolide I,NA,NA
625.1409803,C27H30O17,cpd:C12667,Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside;Baimaside;Quercetin 3-beta-D-sophoroside;Quercetin 3-O-sophoroside;QUOSP,C27H30O17,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside;Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavonols;    C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside,2.4.1.239;2.4.1.240,R06812 R06813
631.1667924,C30H32O15,cpd:C20976,"8-Demethyl-8-(2,3-di-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",C30H32O15,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,2.1.1.306;2.1.1.307,R10957 R10958
633.0733037,C27H22O18,cpd:C10219,Corilagin,C27H22O18,NA,NA,Phytochemical compounds [BR:br08003]; Others;  Tannins and galloyl derivatives;   Ellagitannins;    C10219  Corilagin,NA,NA
635.0890635,C27H24O18,cpd:C04360,"1-O,2-O,6-O-Trigalloyl-beta-D-glucose;1,2,6-Trigalloylglucose",C27H24O18,NA,NA,NA,NA,NA
635.0890635,C27H24O18,cpd:C17458,"Gallotannin;1,3,6-Tri-o-galloyl-beta-D-glucose",C27H24O18,NA,NA,NA,NA,NA
637.1046065,C27H26O18,cpd:C12632,Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide];Luteolin 7-O-beta-D-diglucuronide,C27H26O18,Flavone and flavonol biosynthesis,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide];Phytochemical compounds [BR:br08003]; Flavonoids;  Flavonoids;   Flavones;    C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide];Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide],2.4.1.190;2.4.1.191;3.2.1.31,R06827 R06828 R08127
639.1929801,C29H36O16,cpd:C10485,Plantamajoside,C29H36O16,NA,NA,NA,NA,NA
639.1929801,C29H36O16,cpd:C10499,Suspensaside,C29H36O16,NA,NA,NA,NA,NA
639.1929801,C29H36O16,cpd:C17528,beta-Hydroxyacteoside,C29H36O16,NA,NA,NA,NA,NA
645.1824481,C31H34O15,cpd:C20977,"8-Demethyl-8-(2,3,4-tri-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",C31H34O15,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,2.1.1.307;2.1.1.-,R10958 R10959
655.1878729,C29H36O17,cpd:C10466,Hellicoside,C29H36O17,NA,NA,NA,NA,NA
659.197956,C32H36O15,cpd:C12381,Elloramycin A,C32H36O15,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,2.1.1.-,R10959
669.3854455,C35H58O12,cpd:C13299,Fungichromin;Pentamycin,C35H58O12,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; G GENITO URINARY SYSTEM AND SEX HORMONES;  G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;   G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;    G01AA Antibiotics;     G01AA11 Pentamycin;      D01829  Pentamycin (JAN);Antimicrobials [BR:br08307]; Antifungals;  Cell membrane function inhibitor;   Polyene macrolide;    D01829  Pentamycin (JAN);Antimicrobials abbreviations [BR:br08327]; Antifungals;  Cell membrane function inhibitor;   Polyene macrolide;    D01829  Pentamycin (JAN)",NA,NA
673.2137429,C33H38O15,cpd:C12385,Premithramycin A2',C33H38O15,Biosynthesis of type II polyketide products;Metabolic pathways;Biosynthesis of secondary metabolites,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,2.4.1.-,R06717 R06718
675.2296085,C33H40O15,cpd:C17555,Icariin,C33H40O15,NA,NA,Lipids [BR:br08002]; PK  Polyketides;  PK12 Flavonoids;   PK1211 Flavones and Flavonols;    C17555  Icariin;Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C17555  Icariin,NA,NA
719.2557225,C35H44O16,cpd:C08748,Azadirachtin A;Azadirachtin,C35H44O16,Biosynthesis of terpenoids and steroids,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0106 C30 isoprenoids (triterpenes);    PR010610 Apotirucallane triterpenoids;     C08748  Azadirachtin A,NA,R08377
719.2557225,C35H44O16,cpd:C11047,Azadirachtinin;3-Acetyl-1-tigloylazadirachtinin,C35H44O16,NA,NA,Lipids [BR:br08002]; PR  Prenol lipids;  PR01 Isoprenoids;   PR0106 C30 isoprenoids (triterpenes);    PR010610 Apotirucallane triterpenoids;     C11047  3-Acetyl-1-tigloylazadirachtinin;Phytochemical compounds [BR:br08003]; Terpenoids;  Triterpenoids (C30);   Limonoids;    C11047  Azadirachtinin,NA,NA
723.214363,C33H40O18,cpd:C15582,Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,C33H40O18,NA,NA,Glycosides [BR:br08021]; O-glycosides;  Flavonoid glycosides;   Flavones and flavonols;    C15582  Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,2.4.1.240,R07340
875.48006,C47H72O15,cpd:C11959,Avermectin B2b,C47H72O15,"Biosynthesis of 12-, 14- and 16-membered macrolides",NA,Lipids [BR:br08002]; PK  Polyketides;  PK04 Macrolides and lactone polyketides;   C11959  Avermectin B2b,2.4.1.-,R06493
